# Bisson_2013_Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults.

Cochrane
Library

Cochrane Database of Systematic Reviews

Psychological therapies for chronic post-traumatic stress disorder
(PTSD) in adults (Review)

Bisson JI, Roberts NP, Andrew M, Cooper R, Lewis C

Bisson JI, Roberts NP, Andrew M, Cooper R, Lewis C. 
Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults. 
Cochrane Database of Systematic Reviews 2013, Issue 12. Art. No.: CD003388. 
DOI: 10.1002/14651858.CD003388.pub4.

www.cochranelibrary.com

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

T A B L E   O F   C O N T E N T S

ABSTRACT.....................................................................................................................................................................................................
PLAIN LANGUAGE SUMMARY.......................................................................................................................................................................
SUMMARY OF FINDINGS..............................................................................................................................................................................
BACKGROUND..............................................................................................................................................................................................
OBJECTIVES..................................................................................................................................................................................................
METHODS.....................................................................................................................................................................................................
RESULTS........................................................................................................................................................................................................
Figure 1..................................................................................................................................................................................................
Figure 2..................................................................................................................................................................................................
Figure 3..................................................................................................................................................................................................
Figure 4..................................................................................................................................................................................................
Figure 5..................................................................................................................................................................................................
Figure 6..................................................................................................................................................................................................
DISCUSSION..................................................................................................................................................................................................
AUTHORS' CONCLUSIONS...........................................................................................................................................................................
ACKNOWLEDGEMENTS................................................................................................................................................................................
REFERENCES................................................................................................................................................................................................
CHARACTERISTICS OF STUDIES..................................................................................................................................................................
DATA AND ANALYSES....................................................................................................................................................................................
Analysis  1.1.  Comparison  1  Trauma-focused  CBT/Exposure  therapy  vs  waitlist/usual  care,  Outcome  1  Severity  of  PTSD
symptoms - clinician.............................................................................................................................................................................
Analysis  1.2.  Comparison  1  Trauma-focused  CBT/Exposure  therapy  vs  waitlist/usual  care,  Outcome  2  Severity  of  PTSD
symptoms at 1 - 4 month follow-up....................................................................................................................................................
Analysis  1.3.  Comparison  1  Trauma-focused  CBT/Exposure  therapy  vs  waitlist/usual  care,  Outcome  3  Severity  of  PTSD
symptoms at 5 - 8 month follow-up....................................................................................................................................................
Analysis  1.4.  Comparison  1  Trauma-focused  CBT/Exposure  therapy  vs  waitlist/usual  care,  Outcome  4  Severity  of  PTSD
symptoms 9 - 12 month follow-up......................................................................................................................................................
Analysis 1.5. Comparison 1 Trauma-focused CBT/Exposure therapy vs waitlist/usual care, Outcome 5 Leaving the study early
for any reason.......................................................................................................................................................................................
Analysis  1.6.  Comparison  1  Trauma-focused  CBT/Exposure  therapy  vs  waitlist/usual  care,  Outcome  6  Severity  of  PTSD
symptoms - self report: 1 - 4 month follow-up...................................................................................................................................
Analysis  1.7.  Comparison  1  Trauma-focused  CBT/Exposure  therapy  vs  waitlist/usual  care,  Outcome  7  Severity  of  PTSD
symptoms - self report: 5 - 8 months).................................................................................................................................................
Analysis  1.8.  Comparison  1  Trauma-focused  CBT/Exposure  therapy  vs  waitlist/usual  care,  Outcome  8  Severity  of  PTSD
symptoms - self report: 9 - 12 month follow up.................................................................................................................................
Analysis 1.9. Comparison 1 Trauma-focused CBT/Exposure therapy vs waitlist/usual care, Outcome 9 Depression......................
Analysis 1.10. Comparison 1 Trauma-focused CBT/Exposure therapy vs waitlist/usual care, Outcome 10 Depression 1 - 4 month
follow-up................................................................................................................................................................................................
Analysis 1.11. Comparison 1 Trauma-focused CBT/Exposure therapy vs waitlist/usual care, Outcome 11 Depression 5 - 8 month
follow-up................................................................................................................................................................................................
Analysis 1.12. Comparison 1 Trauma-focused CBT/Exposure therapy vs waitlist/usual care, Outcome 12 Depression 9 - 12 month
follow-up................................................................................................................................................................................................
Analysis 1.13. Comparison 1 Trauma-focused CBT/Exposure therapy vs waitlist/usual care, Outcome 13 Anxiety........................
Analysis 1.14. Comparison 1 Trauma-focused CBT/Exposure therapy vs waitlist/usual care, Outcome 14 Anxiety 1 - 4 month
follow-up................................................................................................................................................................................................
Analysis 1.15. Comparison 1 Trauma-focused CBT/Exposure therapy vs waitlist/usual care, Outcome 15 Anxiety 9 - 12 month
follow-up................................................................................................................................................................................................
Analysis  1.16.  Comparison  1  Trauma-focused  CBT/Exposure  therapy  vs  waitlist/usual  care,  Outcome  16  Exploration  of
publication bias.....................................................................................................................................................................................
Analysis 1.17. Comparison 1 Trauma-focused CBT/Exposure therapy vs waitlist/usual care, Outcome 17 Sensitivity analysis -
clinician-rated PTSD symptoms - studies at low risk of bias only.....................................................................................................
Analysis 1.18. Comparison 1 Trauma-focused CBT/Exposure therapy vs waitlist/usual care, Outcome 18 PTSD diagnosis after
treatment...............................................................................................................................................................................................

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

1
2
3
16
17
17
20
20
22
23
36
37
38
38
40
41
42
50
111
113

115

115

116

116

117

117

118

118
119

119

119

119
120

120

121

121

122

i

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 2.1. Comparison 2 Trauma-focused CBT/Exposure therapy vs non-TFCBT, Outcome 1 Severity of PTSD Symptoms -
clinician..................................................................................................................................................................................................
Analysis  2.2.  Comparison  2  Trauma-focused  CBT/Exposure  therapy  vs  non-TFCBT,  Outcome  2  Severity  of  PTSD  symptoms  -
clinician - follow-up (1 - 4 months).....................................................................................................................................................
Analysis  2.3.  Comparison  2  Trauma-focused  CBT/Exposure  therapy  vs  non-TFCBT,  Outcome  3  Severity  of  PTSD  symptoms  -
clinician - follow-up (5 - 8 months).....................................................................................................................................................
Analysis  2.4.  Comparison  2  Trauma-focused  CBT/Exposure  therapy  vs  non-TFCBT,  Outcome  4  Severity  of  PTSD  symptoms  -
clinician - follow-up (9 - 12 months)...................................................................................................................................................
Analysis 2.5. Comparison 2 Trauma-focused CBT/Exposure therapy vs non-TFCBT, Outcome 5 Leaving the study early for any
reason....................................................................................................................................................................................................
Analysis 2.6. Comparison 2 Trauma-focused CBT/Exposure therapy vs non-TFCBT, Outcome 6 Severity of PTSD symptoms - self
report.....................................................................................................................................................................................................
Analysis 2.7. Comparison 2 Trauma-focused CBT/Exposure therapy vs non-TFCBT, Outcome 7 Severity of PTSD symptoms - self
report - follow-up (1-4 months)...........................................................................................................................................................
Analysis 2.8. Comparison 2 Trauma-focused CBT/Exposure therapy vs non-TFCBT, Outcome 8 Depression..................................
Analysis  2.9.  Comparison  2  Trauma-focused  CBT/Exposure  therapy  vs  non-TFCBT,  Outcome  9  Depression  -  follow-up  (1  -  4
months)..................................................................................................................................................................................................
Analysis 2.10. Comparison 2 Trauma-focused CBT/Exposure therapy vs non-TFCBT, Outcome 10 Depression - follow-up (5 - 8
months)..................................................................................................................................................................................................
Analysis 2.11. Comparison 2 Trauma-focused CBT/Exposure therapy vs non-TFCBT, Outcome 11 Depression - follow-up (9 - 12
months)..................................................................................................................................................................................................
Analysis 2.12. Comparison 2 Trauma-focused CBT/Exposure therapy vs non-TFCBT, Outcome 12 Anxiety.....................................
Analysis  2.13.  Comparison  2  Trauma-focused  CBT/Exposure  therapy  vs  non-TFCBT,  Outcome  13  Anxiety  -  follow-up  (1  -  4
months)..................................................................................................................................................................................................
Analysis  2.14.  Comparison  2  Trauma-focused  CBT/Exposure  therapy  vs  non-TFCBT,  Outcome  14  Anxiety  -  follow-up  (5  -  8
months)..................................................................................................................................................................................................
Analysis  2.15.  Comparison  2  Trauma-focused  CBT/Exposure  therapy  vs  non-TFCBT,  Outcome  15  Anxiety  -  follow-up  (9  -  12
months)..................................................................................................................................................................................................
Analysis  2.16.  Comparison  2  Trauma-focused  CBT/Exposure  therapy  vs  non-TFCBT,  Outcome  16  PTSD  diagnosis  after
treatment...............................................................................................................................................................................................
Analysis 3.1. Comparison 3 Trauma-focused CBT/Exposure Therapy vs other therapies, Outcome 1 Severity of PTSD symptoms
- clinician...............................................................................................................................................................................................
Analysis 3.2. Comparison 3 Trauma-focused CBT/Exposure Therapy vs other therapies, Outcome 2 Severity of PTSD symptoms
- clinician - 1 - 4 month follow-up.......................................................................................................................................................
Analysis 3.3. Comparison 3 Trauma-focused CBT/Exposure Therapy vs other therapies, Outcome 3 Severity of PTSD symptoms
- clinician - 5 - 8 month follow-up.......................................................................................................................................................
Analysis 3.4. Comparison 3 Trauma-focused CBT/Exposure Therapy vs other therapies, Outcome 4 Severity of PTSD symptoms
- clinician - 9 - 12 month follow-up.....................................................................................................................................................
Analysis 3.5. Comparison 3 Trauma-focused CBT/Exposure Therapy vs other therapies, Outcome 5 Leaving the study early for
any reason.............................................................................................................................................................................................
Analysis 3.6. Comparison 3 Trauma-focused CBT/Exposure Therapy vs other therapies, Outcome 6 Severity of PTSD symptoms
- self report............................................................................................................................................................................................
Analysis 3.7. Comparison 3 Trauma-focused CBT/Exposure Therapy vs other therapies, Outcome 7 Severity of PTSD symptoms
- self report - follow-up (1 - 4 months)................................................................................................................................................
Analysis 3.8. Comparison 3 Trauma-focused CBT/Exposure Therapy vs other therapies, Outcome 8 Severity of PTSD symptoms
- self-report - follow-up (5 - 8 months)................................................................................................................................................
Analysis 3.9. Comparison 3 Trauma-focused CBT/Exposure Therapy vs other therapies, Outcome 9 Severity of PTSD symptoms
- self-report - follow-up (9 - 12 months)..............................................................................................................................................
Analysis 3.10. Comparison 3 Trauma-focused CBT/Exposure Therapy vs other therapies, Outcome 10 Depression - self report.....
Analysis 3.11. Comparison 3 Trauma-focused CBT/Exposure Therapy vs other therapies, Outcome 11 Depression - self-report
- follow-up (1-4 months).......................................................................................................................................................................
Analysis 3.12. Comparison 3 Trauma-focused CBT/Exposure Therapy vs other therapies, Outcome 12 Depression - follow-up
(5-8 months)..........................................................................................................................................................................................
Analysis 3.13. Comparison 3 Trauma-focused CBT/Exposure Therapy vs other therapies, Outcome 13 Depression 9-12 month
follow up................................................................................................................................................................................................
Analysis 3.14. Comparison 3 Trauma-focused CBT/Exposure Therapy vs other therapies, Outcome 14 Anxiety - self report.........

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

123

124

124

124

125

125

125

126
126

126

127

127
127

127

128

128

130

130

130

131

131

132

132

132

133

133
133

134

134

134

ii

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis  3.15.  Comparison  3  Trauma-focused  CBT/Exposure  Therapy  vs  other  therapies,  Outcome  15  Anxiety  -  self-report  -
follow-up (1 - 4 months).......................................................................................................................................................................
Analysis 3.16. Comparison 3 Trauma-focused CBT/Exposure Therapy vs other therapies, Outcome 16 Anxiety - follow-up (5 - 8
months)..................................................................................................................................................................................................
Analysis  3.17.  Comparison  3  Trauma-focused  CBT/Exposure  Therapy  vs  other  therapies,  Outcome  17  PTSD  diagnosis  after
treatment...............................................................................................................................................................................................
Analysis  3.18.  Comparison  3  Trauma-focused  CBT/Exposure  Therapy  vs  other  therapies,  Outcome  18  Severity  of  PTSD
symptoms - clinician - 13-24 month follow-up...................................................................................................................................
Analysis 3.19. Comparison 3 Trauma-focused CBT/Exposure Therapy vs other therapies, Outcome 19 Sensitivity analysis - PTSD
symptoms - studies at low risk of bias only........................................................................................................................................
Analysis 3.20. Comparison 3 Trauma-focused CBT/Exposure Therapy vs other therapies, Outcome 20 Sensitivity analysis - drop-
out - studies at low risk of bias only...................................................................................................................................................
Analysis  3.21.  Comparison  3  Trauma-focused  CBT/Exposure  Therapy  vs  other  therapies,  Outcome  21  Subgroup  analysis:
severity of PTSD symptoms - women-only studies............................................................................................................................
Analysis  3.22.  Comparison  3  Trauma-focused  CBT/Exposure  Therapy  vs  other  therapies,  Outcome  22  Subgroup  analysis:
severity of PTSD symptoms - clinician - excluding Vietnam veterans...............................................................................................
Analysis 4.1. Comparison 4 EMDR vs waitlist/usual care, Outcome 1 Severity of PTSD symptoms - Clinician................................
Analysis 4.2. Comparison 4 EMDR vs waitlist/usual care, Outcome 2 Leaving study early due to any reason.................................
Analysis 4.3. Comparison 4 EMDR vs waitlist/usual care, Outcome 3 Severity of PTSD symptoms - self report..............................
Analysis 4.4. Comparison 4 EMDR vs waitlist/usual care, Outcome 4 Depression............................................................................
Analysis 4.5. Comparison 4 EMDR vs waitlist/usual care, Outcome 5 Anxiety..................................................................................
Analysis 4.6. Comparison 4 EMDR vs waitlist/usual care, Outcome 6 PTSD diagnosis after treatment...........................................
Analysis 5.1. Comparison 5 EMDR vs Trauma-focused CBT, Outcome 1 Severity of PTSD symptoms - clinician.............................
Analysis 5.2. Comparison 5 EMDR vs Trauma-focused CBT, Outcome 2 Severity of PTSD symptoms - clinician - follow-up (1 - 4
months)..................................................................................................................................................................................................
Analysis 5.3. Comparison 5 EMDR vs Trauma-focused CBT, Outcome 3 Leaving study early for any reason...................................
Analysis 5.4. Comparison 5 EMDR vs Trauma-focused CBT, Outcome 4 Severity of PTSD symptoms - self report..........................
Analysis 5.5. Comparison 5 EMDR vs Trauma-focused CBT, Outcome 5 Severity of PTSD symptoms - self-report - follow-up (1
- 4 months)............................................................................................................................................................................................
Analysis 5.6. Comparison 5 EMDR vs Trauma-focused CBT, Outcome 6 Depression........................................................................
Analysis 5.7. Comparison 5 EMDR vs Trauma-focused CBT, Outcome 7 Depression - follow-up (1 - 4 months)..............................
Analysis 5.8. Comparison 5 EMDR vs Trauma-focused CBT, Outcome 8 Anxiety...............................................................................
Analysis 5.9. Comparison 5 EMDR vs Trauma-focused CBT, Outcome 9 Anxiety - follow-up (1 - 4 months)....................................
Analysis 5.10. Comparison 5 EMDR vs Trauma-focused CBT, Outcome 10 PTSD diagnosis after treatment....................................
Analysis 6.1. Comparison 6 EMDR vs non-TFCBT, Outcome 1 Severity of PTSD symptoms - clinician.............................................
Analysis 6.2. Comparison 6 EMDR vs non-TFCBT, Outcome 2 Severity of PTSD symptoms - clinician - follow-up (1-4 months).......
Analysis 6.3. Comparison 6 EMDR vs non-TFCBT, Outcome 3 Leaving the study early for any reason.............................................
Analysis 6.4. Comparison 6 EMDR vs non-TFCBT, Outcome 4 Severity of PTSD symptoms - self report..........................................
Analysis 6.5. Comparison 6 EMDR vs non-TFCBT, Outcome 5 Severity of PTSD symptoms - self-report - follow-up (1 - 4 months)....
Analysis 6.6. Comparison 6 EMDR vs non-TFCBT, Outcome 6 Depression........................................................................................
Analysis 6.7. Comparison 6 EMDR vs non-TFCBT, Outcome 7 Depression - follow-up (1 - 4 months)..............................................
Analysis 6.8. Comparison 6 EMDR vs non-TFCBT, Outcome 8 Anxiety...............................................................................................
Analysis 6.9. Comparison 6 EMDR vs non-TFCBT, Outcome 9 Anxiety - follow-up (1 - 4 months)....................................................
Analysis 6.10. Comparison 6 EMDR vs non-TFCBT, Outcome 10 PTSD diagnosis after treatment....................................................
Analysis 7.1. Comparison 7 EMDR vs other therapies, Outcome 1 Leaving study early for any reason............................................
Analysis 7.2. Comparison 7 EMDR vs other therapies, Outcome 2 Severity of PTSD symptoms - self report...................................
Analysis 7.3. Comparison 7 EMDR vs other therapies, Outcome 3 Depression.................................................................................
Analysis 7.4. Comparison 7 EMDR vs other therapies, Outcome 4 Anxiety.......................................................................................
Analysis 7.5. Comparison 7 EMDR vs other therapies, Outcome 5 PTSD diagnosis after treatment................................................
Analysis 8.1. Comparison 8 Non-TFCBT vs waitlist/usual care, Outcome 1 Severity of PTSD symptoms - Clinician.......................
Analysis 8.2. Comparison 8 Non-TFCBT vs waitlist/usual care, Outcome 2 Leaving the study early for any reason.......................
Analysis 8.3. Comparison 8 Non-TFCBT vs waitlist/usual care, Outcome 3 Severity of PTSD symptoms - Self-report....................
Analysis 8.4. Comparison 8 Non-TFCBT vs waitlist/usual care, Outcome 4 Depression...................................................................
Analysis 8.5. Comparison 8 Non-TFCBT vs waitlist/usual care, Outcome 5 Anxiety.........................................................................

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

135

135

135

136

136

136

136

137

137
138
138
139
139
139
140
141

141
141
142

142
142
143
143
143
145
145
145
145
146
146
146
147
147
147
148
148
148
149
149
150
150
150
151
151

iii

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 8.6. Comparison 8 Non-TFCBT vs waitlist/usual care, Outcome 6 PTSD diagnosis after treatment..................................
Analysis 9.1. Comparison 9 Non-TFCBT vs other therapies, Outcome 1 Severity of PTSD symptoms - Clincian.............................
Analysis 9.2. Comparison 9 Non-TFCBT vs other therapies, Outcome 2 Severity of PTSD symptoms - clinician - follow-up (3
months)..................................................................................................................................................................................................
Analysis 9.3. Comparison 9 Non-TFCBT vs other therapies, Outcome 3 Leaving the study early for any reason............................
Analysis 9.4. Comparison 9 Non-TFCBT vs other therapies, Outcome 4 Depression - self report....................................................
Analysis 9.5. Comparison 9 Non-TFCBT vs other therapies, Outcome 5 Depression - self report - follow-up (3 months)...............
Analysis 9.6. Comparison 9 Non-TFCBT vs other therapies, Outcome 6 Anxiety - self report..........................................................
Analysis 9.7. Comparison 9 Non-TFCBT vs other therapies, Outcome 7 Anxiety - self report - follow-up (3 months).....................
Analysis 9.8. Comparison 9 Non-TFCBT vs other therapies, Outcome 8 PTSD diagnosis after treatment.......................................
Analysis 10.1. Comparison 10 Group TFCBT vs waitlist/usual care/minimal contact, Outcome 1 Clinician-rated..........................
Analysis 10.2. Comparison 10 Group TFCBT vs waitlist/usual care/minimal contact, Outcome 2 Severity of PTSD 5 - 8 month
follow-up................................................................................................................................................................................................
Analysis 10.3. Comparison 10 Group TFCBT vs waitlist/usual care/minimal contact, Outcome 3 Leaving the study early for any
reason....................................................................................................................................................................................................
Analysis 10.4. Comparison 10 Group TFCBT vs waitlist/usual care/minimal contact, Outcome 4 Severity of PTSD symptoms -
self report..............................................................................................................................................................................................
Analysis 10.5. Comparison 10 Group TFCBT vs waitlist/usual care/minimal contact, Outcome 5 Severity of PTSD - self report -
1 - 4 months..........................................................................................................................................................................................
Analysis 10.6. Comparison 10 Group TFCBT vs waitlist/usual care/minimal contact, Outcome 6 Depression................................
Analysis 10.7. Comparison 10 Group TFCBT vs waitlist/usual care/minimal contact, Outcome 7 Depression 1 - 4 month follow-
up...........................................................................................................................................................................................................
Analysis 10.8. Comparison 10 Group TFCBT vs waitlist/usual care/minimal contact, Outcome 8 Anxiety......................................
Analysis 10.9. Comparison 10 Group TFCBT vs waitlist/usual care/minimal contact, Outcome 9 Anxiety 1 - 4 month follow-up.....
Analysis  10.10.  Comparison  10  Group  TFCBT  vs  waitlist/usual  care/minimal  contact,  Outcome  10  PTSD  diagnosis  after
treatment...............................................................................................................................................................................................
Analysis 11.1. Comparison 11 Group CBT (trauma-focused) vs Group CBT (non-trauma-focused), Outcome 1 Severity of PTSD
symptoms..............................................................................................................................................................................................
Analysis 11.2. Comparison 11 Group CBT (trauma-focused) vs Group CBT (non-trauma-focused), Outcome 2 Leaving the study
early for any reason..............................................................................................................................................................................
Analysis 11.3. Comparison 11 Group CBT (trauma-focused) vs Group CBT (non-trauma-focused), Outcome 3 PTSD diagnosis
after treatment......................................................................................................................................................................................
Analysis 12.1. Comparison 12 Other therapies vs waitlist/usual care, Outcome 1 Severity of PTSD symptoms - clinician.............
Analysis 12.2. Comparison 12 Other therapies vs waitlist/usual care, Outcome 2 Leaving the study early due to any reason........
Analysis 12.3. Comparison 12 Other therapies vs waitlist/usual care, Outcome 3 Severity of PTSD symptoms - self report..........
Analysis 12.4. Comparison 12 Other therapies vs waitlist/usual care, Outcome 4 Depression........................................................
Analysis 12.5. Comparison 12 Other therapies vs waitlist/usual care, Outcome 5 Anxiety - Self report..........................................
Analysis 12.6. Comparison 12 Other therapies vs waitlist/usual care, Outcome 6 PTSD diagnosis after treatment.......................
Analysis 13.1. Comparison 13 Group non-TFCBT vs waitlist/usual care, Outcome 1 Leaving the study early for any reason.........
Analysis 13.2. Comparison 13 Group non-TFCBT vs waitlist/usual care, Outcome 2 Severity of PTSD symptoms - self report.......
Analysis 13.3. Comparison 13 Group non-TFCBT vs waitlist/usual care, Outcome 3 Severity of PTSD symptoms - self report 1
- 4 months.............................................................................................................................................................................................
Analysis 13.4. Comparison 13 Group non-TFCBT vs waitlist/usual care, Outcome 4 Depression....................................................
Analysis 13.5. Comparison 13 Group non-TFCBT vs waitlist/usual care, Outcome 5 Depression - 1 - 4 months.............................
WHAT'S NEW.................................................................................................................................................................................................
HISTORY........................................................................................................................................................................................................
CONTRIBUTIONS OF AUTHORS...................................................................................................................................................................
DECLARATIONS OF INTEREST.....................................................................................................................................................................
INDEX TERMS...............................................................................................................................................................................................

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

151
152
152

152
153
153
153
153
153
154
155

155

155

156

156
156

156
157
157

157

158

158

158
159
159
159
160
160
161
161
161

161
162
162
162
162
162
162

iv

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

[Intervention Review]

Cochrane Database of Systematic Reviews

Psychological therapies for chronic post-traumatic stress disorder
(PTSD) in adults

Jonathan I Bisson1, Neil P Roberts1,2, Martin Andrew1, Rosalind Cooper2, Catrin Lewis1

1Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Cardiff, UK. 2Psychology and
Counselling Direcorate, Cardiff and Vale University Health Board, Cardiff, UK

Contact: Jonathan I Bisson, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Hadyn
Ellis Building, Maindy Road, Cardiff, CF24 4HQ, UK. bissonji@cardiff.ac.uk, jon.bisson@btinternet.com.

Editorial group: Cochrane Common Mental Disorders Group.
Publication status and date: Edited (no change to conclusions), published in Issue 8, 2015.

Citation:  Bisson JI, Roberts NP, Andrew M, Cooper R, Lewis C. Psychological therapies for chronic post-traumatic stress disorder (PTSD)
in adults. Cochrane Database of Systematic Reviews 2013, Issue 12. Art. No.: CD003388. DOI: 10.1002/14651858.CD003388.pub4.

Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Background

A B S T R A C T

Post-traumatic stress disorder (PTSD) is a distressing condition, which is often treated with psychological therapies. Earlier versions of this
review, and other meta-analyses, have found these to be effective, with trauma-focused treatments being more effective than non-trauma-
focused treatments. This is an update of a Cochrane review first published in 2005 and updated in 2007.

Objectives

To assess the effects of psychological therapies for the treatment of adults with chronic post-traumatic stress disorder (PTSD).

Search methods

For  this  update,  we  searched  the  Cochrane  Depression,  Anxiety  and  Neurosis  Group's  Specialised  Register  (CCDANCTR-Studies  and
CCDANCTR-References) all years to 12th April 2013. This register contains relevant randomised controlled trials from: The Cochrane Library
(all years), MEDLINE (1950 to date), EMBASE (1974 to date), and PsycINFO (1967 to date). In addition, we handsearched the Journal of
Traumatic Stress, contacted experts in the field, searched bibliographies of included studies, and performed citation searches of identified
articles.

Selection criteria

Randomised  controlled  trials  of  individual  trauma-focused  cognitive  behavioural  therapy  (TFCBT),  eye  movement  desensitisation
and  reprocessing  (EMDR),  non-trauma-focused  CBT  (non-TFCBT),  other  therapies  (supportive  therapy,  non-directive  counselling,
psychodynamic therapy and present-centred therapy), group TFCBT, or group non-TFCBT, compared to one another or to a waitlist or usual
care group for the treatment of chronic PTSD. The primary outcome measure was the severity of clinician-rated traumatic-stress symptoms.

Data collection and analysis

We extracted data and entered them into Review Manager 5 software. We contacted authors to obtain missing data. Two review authors
independently performed 'Risk of bias' assessments. We pooled the data where appropriate, and analysed for summary effects.

Main results

We include 70 studies involving a total of 4761 participants in the review. The first primary outcome for this review was reduction in the
severity of PTSD symptoms, using a standardised measure rated by a clinician. For this outcome, individual TFCBT and EMDR were more
effective than waitlist/usual care (standardised mean difference (SMD) -1.62; 95% CI -2.03 to -1.21; 28 studies; n = 1256 and SMD -1.17;
95% CI -2.04 to -0.30; 6 studies; n = 183 respectively). There was no statistically significant difference between individual TFCBT, EMDR and

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

1

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Stress Management (SM) immediately post-treatment although there was some evidence that individual TFCBT and EMDR were superior
to non-TFCBT at follow-up, and that individual TFCBT, EMDR and non-TFCBT were more effective than other therapies. Non-TFCBT was
more effective than waitlist/usual care and other therapies. Other therapies were superior to waitlist/usual care control as was group
TFCBT. There was some evidence of greater drop-out (the second primary outcome for this review) in active treatment groups. Many of the
studies were rated as being at 'high' or 'unclear' risk of bias in multiple domains, and there was considerable unexplained heterogeneity; in
addition, we assessed the quality of the evidence for each comparison as very low. As such, the findings of this review should be interpreted
with caution.

Authors' conclusions

The evidence for each of the comparisons made in this review was assessed as very low quality. This evidence showed that individual TFCBT
and EMDR did better than waitlist/usual care in reducing clinician-assessed PTSD symptoms. There was evidence that individual TFCBT,
EMDR and non-TFCBT are equally effective immediately post-treatment in the treatment of PTSD. There was some evidence that TFCBT and
EMDR are superior to non-TFCBT between one to four months following treatment, and also that individual TFCBT, EMDR and non-TFCBT
are more effective than other therapies. There was evidence of greater drop-out in active treatment groups. Although a substantial number
of studies were included in the review, the conclusions are compromised by methodological issues evident in some. Sample sizes were
small, and it is apparent that many of the studies were underpowered. There were limited follow-up data, which compromises conclusions
regarding the long-term effects of psychological treatment.

P L A I N   L A N G U A G E   S U M M A R Y

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults

Background:  Post-traumatic  stress  disorder  (PTSD)  can  occur  following  a  traumatic  event.  It  is  characterised  by  symptoms  of  re-
experiencing the trauma (in the form of nightmares, flashbacks and distressing thoughts), avoiding reminders of the traumatic event,
negative alterations in thoughts and mood, and symptoms of hyper-arousal (feeling on edge, being easily startled, feeling angry, having
difficulties sleeping, and problems concentrating).

Previous  reviews  have  supported  the  use  of  individual  trauma-focused  cognitive  behavioural  therapy  (TFCBT)  and  eye  movement
desensitisation  and  reprocessing  (EMDR)  in  the  treatment  of  PTSD.  TFCBT  is  a  variant  of  cognitive  behavioural  therapy  (CBT),  which
includes a number of techniques to help a person overcome a traumatic event. It is a combination of cognitive therapy aimed at changing
the way a person thinks, and behavioural therapy, which aims to change the way a person acts. TFCBT helps an individual come to terms
with a trauma through exposure to memories of the event. EMDR is a psychological therapy, which aims to help a person reprocess their
memories of a traumatic event. The therapy involves bringing distressing trauma-related images, beliefs, and bodily sensations to mind,
whilst the therapist guides eye movements from side to side. More positive views of the trauma memories are identified, with the aim of
replacing the ones that are causing problems.

TFCBT and EMDR are currently recommended as the treatments of choice by guidelines such as those published by the United Kingdom's
National Institute of Health and Clinical Excellence (NICE).

Study characteristics: This review draws together up-to-date evidence from 70 studies including a total of 4761 people.

Key findings: There is continued support for the efficacy of individual TFCBT, EMDR, non-TFCBT and group TFCBT in the treatment of
chronic PTSD in adults. Other non-trauma-focused psychological therapies did not reduce PTSD symptoms as significantly. There was
evidence that individual TFCBT, EMDR and non-TFCBT are equally effective immediately post-treatment in the treatment of PTSD. There
was some evidence that TFCBT and EMDR are superior to non-TFCBT between one to four months following treatment, and also that
individual TFCBT, EMDR and non-TFCBT are more effective than other therapies. No specific conflicts of interest were identified.

Quality of the evidence: Although we included a substantial number of studies in this review, each only included small numbers of people
and some were poorly designed. We assessed the overall quality of the studies as very low and so the findings of this review should be
interpreted with caution. There is insufficient evidence to show whether or not psychological therapy is harmful.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

2

 
 
C
o
p
y
r
i
g
h
t

©
2
0
1
5
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

P
s
y
c
h
o
l
o
g
i
c
a
l

t
h
e
r
a
p
i
e
s
f
o
r
c
h
r
o
n
i
c
p
o
s
t
-
t
r
a
u
m
a
t
i
c
s
t
r
e
s
s
d
i
s
o
r
d
e
r

(
P
T
S
D
)

i

n
a
d
u
l
t
s
(
R
e
v
i
e
w

)

S U M M A R Y   O F   F I N D I N G S

Summary of findings for the main comparison.   Trauma-focused CBT/Exposure therapy compared with Waitlist/Usual Care for chronic post-traumatic
stress disorder (PTSD) in adults

Trauma-focused CBT/Exposure therapy versus Waitlist/Usual Care

Patient or population: Adults with PTSD for at least 3 months
Settings: Primary care, community, outpatient
Intervention: Trauma-focused CBT/Exposure Therapy

Outcomes

Illustrative comparative risks* (95% CI)

Assumed risk

Corresponding risk

Control

Trauma Focused CBT/ Exposure Therapy

Relative effect
(95% CI)

No of Partici-
pants
(studies)

Quality of the
evidence
(GRADE)

Comments

Severity of PTSD
symptoms - Clini-
cian-rated

Leaving the study
early for any rea-
son

The mean severity of PTSD symptoms - clini-
cian-rated in the intervention groups was

1.62 standard devi-
ations lower 
(2.03 to 1.21 lower)

1256
(28 studies)

⊕⊝⊝⊝
very low 1,2,3

Study population

130 per 1000

189 per 1000 
(150 to 240)

Moderate

85 per 1000

124 per 1000 
(99 to 157)

RR 1.64 
(1.30 to 2.06)

1756
(33 studies)

⊕⊝⊝⊝
very low 1,2,3

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio;

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1Some studies were judged to pose a high risk of bias
2Unexplained heterogeneity

3

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
C
o
p
y
r
i
g
h
t

©
2
0
1
5
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

P
s
y
c
h
o
l
o
g
i
c
a
l

t
h
e
r
a
p
i
e
s
f
o
r
c
h
r
o
n
i
c
p
o
s
t
-
t
r
a
u
m
a
t
i
c
s
t
r
e
s
s
d
i
s
o
r
d
e
r

(
P
T
S
D
)

i

n
a
d
u
l
t
s
(
R
e
v
i
e
w

)

3Small sample sizes

Summary of findings 2.   Trauma-focused CBT/Exposure therapy compared with non-TFCBT for chronic post-traumatic stress disorder (PTSD) in adults

Trauma-focused CBT/Exposure therapy compared with non-TFCBT for chronic post-traumatic stress disorder (PTSD) in adults

Patient or population: Adults with PTSD for at least 3 months
Settings: Primary care, community, outpatient
Intervention: Trauma-focused CBT/Exposure therapy
Comparison: non-Trauma-focused CBT

Outcomes

Illustrative comparative risks* (95% CI)

Assumed risk

Corresponding risk

Non-TFCBT

Trauma Focused CBT/ Exposure Therapy

Relative effect
(95% CI)

No of Partici-
pants
(studies)

Quality of the
evidence
(GRADE)

Comments

Severity of PTSD
Symptoms -
Clinician-rated

Leaving the
study early for
any reason

The mean severity of PTSD symptoms - clinician-rated
in the intervention groups was
0.27 standard deviations lower 
(0.63 lower to 0.10 higher)

267
(7 studies)

⊕⊝⊝⊝
very low 1,2

Study population

154 per 1000

183 per 1000 
(109 to 308)

Moderate

154 per 1000

183 per 1000 
(109 to 308)

RR 1.19 
(0.71 to 2.00)

312
(7 studies)

⊕⊝⊝⊝
very low 1,2,3

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio;

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1Some studies were judged to pose a high risk of bias

4

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
2Unexplained heterogeneity
3Small sample sizes

Summary of findings 3.   Trauma-focused CBT/Exposure therapy compared with other therapies for chronic post-traumatic stress disorder (PTSD) in
adults

Trauma-focused CBT/Exposure therapy compared with other therapies for chronic post-traumatic stress disorder (PTSD) in adults

Patient or population: Adults with PTSD for at least 3 months
Settings: Primary care, community, outpatient
Intervention: Trauma-focused CBT/Exposure therapy
Comparison: other therapies

Outcomes

Illustrative comparative risks* (95% CI)

Assumed risk

Corresponding risk

Other Therapies

Trauma Focused CBT/Exposure Therapy

Relative effect
(95% CI)

No of Partici-
pants
(studies)

Quality of the
evidence
(GRADE)

Comments

Severity of PTSD
symptoms - Clini-
cian-rated

Leaving the study
early for any rea-
son

The mean severity of PTSD symptoms - clin-
ician in the intervention groups was

-0.48 standard devia-
tions lower 
(-0.83 to -0.43 lower)

612
(10 studies)

⊕⊝⊝⊝
very low 1,2,3

Study population

142 per 1000

198 per 1000 
(144 to 274)

Moderate

138 per 1000

192 per 1000 
(139 to 265)

RR 1.39 
(1.01 to 1.92)

762
(11 studies)

⊕⊝⊝⊝
very low 1,2,3

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio;

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

C
o
p
y
r
i
g
h
t

©
2
0
1
5
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

P
s
y
c
h
o
l
o
g
i
c
a
l

t
h
e
r
a
p
i
e
s
f
o
r
c
h
r
o
n
i
c
p
o
s
t
-
t
r
a
u
m
a
t
i
c
s
t
r
e
s
s
d
i
s
o
r
d
e
r

(
P
T
S
D
)

i

n
a
d
u
l
t
s
(
R
e
v
i
e
w

)

5

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
1Some studies were judged to pose a high risk of bias
2Unexplained heterogeneity
3Small sample sizes

Summary of findings 4.   EMDR compared with Waitlist/Usual Care for chronic post-traumatic stress disorder (PTSD) in adults

EMDR compared with Waitlist/Usual Care for chronic post-traumatic stress disorder (PTSD) in adults

Patient or population: Adults with PTSD for at least 3 months
Settings: Primary care, community, outpatient
Intervention: Eye movement desensitization and reprocessing (EMDR)
Comparison: Waitlist/Usual Care

Outcomes

Illustrative comparative risks* (95% CI)

Assumed risk

Corresponding risk

Waitlist/Usual
Care

EMDR

Relative effect
(95% CI)

No of Partici-
pants
(studies)

Quality of the
evidence
(GRADE)

Comments

Severity of PTSD
symptoms - Clini-
cian-rated

The mean severity of PTSD symptoms -
clinician in the intervention groups was

1.17 standard devia-
tions lower 
(2.04 to 0.30 lower)

183
(6 studies)

⊕⊝⊝⊝
very low 1,2,3

Leaving study ear-
ly for any reason

Study population

RR 1.05 
(0.62 to 1.79)

227
(7 studies)

⊕⊝⊝⊝
very low 1,3

178 per 1000

188 per 1000 
(104 to 313)

Moderate

172 per 1000

182 per 1000 
(101 to 305)

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: risk ratio;

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

C
o
p
y
r
i
g
h
t

©
2
0
1
5
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

P
s
y
c
h
o
l
o
g
i
c
a
l

t
h
e
r
a
p
i
e
s
f
o
r
c
h
r
o
n
i
c
p
o
s
t
-
t
r
a
u
m
a
t
i
c
s
t
r
e
s
s
d
i
s
o
r
d
e
r

(
P
T
S
D
)

i

n
a
d
u
l
t
s
(
R
e
v
i
e
w

)

6

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
1Some studies were judged to pose a high risk of bias
2Unexplained heterogeneity
3Small sample sizes

Summary of findings 5.   EMDR compared with Trauma-focused CBT for chronic post-traumatic stress disorder (PTSD) in adults

EMDR compared with Trauma-focused CBT for chronic post-traumatic stress disorder (PTSD) in adults

Patient or population: Adults with PTSD for at least 3 months
Settings: Primary care, community, outpatient
Intervention: Eye movement desensitization and reprocessing (EMDR)
Comparison: Trauma-focused CBT

Outcomes

Illustrative comparative risks* (95% CI)

Assumed risk

Corresponding risk

Trauma Focused
CBT

EMDR

Severity of PTSD
symptoms - Clini-
cian-rated

The mean severity of PTSD symptoms -
clinician in the intervention groups was

Leaving study ear-
ly for any reason

Study population

279 per 1000

268 per 1000 
(191 to 367)

Moderate

257 per 1000

247 per 1000 
(174 to 342)

Relative effect
(95% CI)

No of Partici-
pants
(studies)

Quality of the
evidence
(GRADE)

Comments

0.03 standard devia-
tions lower 
(0.43 lower to 0.38
higher)

327
(7 studies)

⊕⊝⊝⊝
very low 1,2,3

RR 1.00 
(0.74 to 1.35)

400
(8 studies)

⊕⊝⊝⊝
very low 1,2,3

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: risk ratio;

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.

C
o
p
y
r
i
g
h
t

©
2
0
1
5
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

P
s
y
c
h
o
l
o
g
i
c
a
l

t
h
e
r
a
p
i
e
s
f
o
r
c
h
r
o
n
i
c
p
o
s
t
-
t
r
a
u
m
a
t
i
c
s
t
r
e
s
s
d
i
s
o
r
d
e
r

(
P
T
S
D
)

i

n
a
d
u
l
t
s
(
R
e
v
i
e
w

)

7

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
C
o
p
y
r
i
g
h
t

©
2
0
1
5
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

P
s
y
c
h
o
l
o
g
i
c
a
l

t
h
e
r
a
p
i
e
s
f
o
r
c
h
r
o
n
i
c
p
o
s
t
-
t
r
a
u
m
a
t
i
c
s
t
r
e
s
s
d
i
s
o
r
d
e
r

(
P
T
S
D
)

i

n
a
d
u
l
t
s
(
R
e
v
i
e
w

)

8

Very low quality: We are very uncertain about the estimate.

1Some studies were judged as posing a high risk of bias
2Unexplained heterogeneity
3Small sample sizes

Summary of findings 6.   EMDR compared with non-TFCBT for chronic post-traumatic stress disorder (PTSD) in adults

EMDR compared with non-TFCBT for chronic post-traumatic stress disorder (PTSD) in adults

Patient or population: Adults with PTSD for at least 3 months
Settings: Primary care, community, outpatient
Intervention: Eye movement desensitization and reprocessing (EMDR)
Comparison: non-trauma-focused CBT

Outcomes

Illustrative comparative risks* (95% CI)

Assumed risk

Corresponding risk

Non-TFCBT

EMDR

Severity of PTSD
symptoms - Clini-
cian-rated

Leaving the study
early for any rea-
son

The mean severity of PTSD symptoms - clin-
ician in the intervention groups was

Study population

140 per 1000

144 per 1000 
(46 to 367)

Moderate

91 per 1000

94 per 1000 
(29 to 264)

Relative effect
(95% CI)

No of Partici-
pants
(studies)

Quality of the
evidence
(GRADE)

Comments

0.35 standard devia-
tions lower 
(0.90 lower to 0.19
higher)

53
(2 studies)

⊕⊝⊝⊝
very low 1,2

RR 1.03 
(0.37 to 2.88)

84
(3 studies)

⊕⊝⊝⊝
very low 1,2

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: risk ratio;

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
C
o
p
y
r
i
g
h
t

©
2
0
1
5
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

P
s
y
c
h
o
l
o
g
i
c
a
l

t
h
e
r
a
p
i
e
s
f
o
r
c
h
r
o
n
i
c
p
o
s
t
-
t
r
a
u
m
a
t
i
c
s
t
r
e
s
s
d
i
s
o
r
d
e
r

(
P
T
S
D
)

i

n
a
d
u
l
t
s
(
R
e
v
i
e
w

)

9

Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1Studies reported insufficient information to judge risk of bias
2Small sample sizes. Only two studies.

Summary of findings 7.   EMDR compared with other therapies for chronic post-traumatic stress disorder (PTSD) in adults

EMDR compared with other therapies for chronic post-traumatic stress disorder (PTSD) in adults

Patient or population: Adults with PTSD for at least 3 months
Settings: Primary care, community, outpatient
Intervention: Eye movement desensitization and reprocessing (EMDR)
Comparison: other therapies

Outcomes

Illustrative comparative risks* (95% CI)

Assumed risk

Corresponding risk

Other Therapies

EMDR

Leaving study
early for any
reason

Study population

32 per 1000

Moderate

32 per 1000

47 per 1000 
(8 to 234)

48 per 1000 
(8 to 236)

Relative effect
(95% CI)

No of Partici-
pants
(studies)

Quality of the
evidence
(GRADE)

Comments

RR 1.48 
(0.26 to 8.54)

127
(2 studies)

⊕⊝⊝⊝
very low 1,2

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: risk ratio;

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1One study was judged to pose a high risk of bias. The other study reported insufficient information for a judgement to be made

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
2Only two studies. Small sample sizes

Summary of findings 8.   Non-TFCBT compared with Waitlist/Usual Care for chronic post-traumatic stress disorder (PTSD) in adults

Non-TFCBT compared with Waitlist/Usual Care for chronic post-traumatic stress disorder (PTSD) in adults

Patient or population: Adults with PTSD for at least 3 months
Settings: Primary care, community, outpatient
Intervention: non-trauma-focused CBT
Comparison: Waitlist/Usual Care

Outcomes

Illustrative comparative risks* (95% CI)

Assumed risk

Corresponding risk

Waitlist/Usual
Care

Non-TFCBT Therapy

Relative effect
(95% CI)

No of Partici-
pants
(studies)

Quality of the
evidence
(GRADE)

Comments

Severity of PTSD
symptoms - Clini-
cian-rated

Leaving the study
early due to any
reason

The mean severity of PTSD symptoms - clinician in
the intervention groups was
1.22 standard deviations lower 
(1.76 to 0.69 lower)

106
(4 studies)

⊕⊝⊝⊝
very low 1,2,3

Study population

78 per 1000

Moderate

83 per 1000

153 per 1000 
(55 to 428)

163 per 1000 
(58 to 455)

RR 1.96 
(0.70 to 5.48)

141
(5 studies)

⊕⊝⊝⊝
very low 1,2,3

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio;

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

C
o
p
y
r
i
g
h
t

©
2
0
1
5
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

P
s
y
c
h
o
l
o
g
i
c
a
l

t
h
e
r
a
p
i
e
s
f
o
r
c
h
r
o
n
i
c
p
o
s
t
-
t
r
a
u
m
a
t
i
c
s
t
r
e
s
s
d
i
s
o
r
d
e
r

(
P
T
S
D
)

i

n
a
d
u
l
t
s
(
R
e
v
i
e
w

)

1
0

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
1Insufficient data to judge risk of bias
2Unexplained heterogeneity
3Small sample sizes

Summary of findings 9.   Non-TFCBT compared with other therapies for chronic post-traumatic stress disorder (PTSD) in adults

Non-TFCBT compared with other therapies for chronic post-traumatic stress disorder (PTSD)

Patient or population: Adults with PTSD for at least 3 months
Settings: Primary care, community, outpatient
Intervention: non-trauma-focused CBT
Comparison: other therapies

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of Participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Non-TFCBT

See comment

See comment

Not estimable

See comment

See comment

Not estimable

Severity of PTSD symptoms -
Clincian-rated

Leaving the study early for
any reason

25
(1 study)

31
(1 study)

⊕⊝⊝⊝
very low 1,2,3

⊕⊝⊝⊝
very low 1,2,3

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1Some studies were judged to pose a high risk of bias
2Unexplained heterogeneity
3Small sample sizes

C
o
p
y
r
i
g
h
t

©
2
0
1
5
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

P
s
y
c
h
o
l
o
g
i
c
a
l

t
h
e
r
a
p
i
e
s
f
o
r
c
h
r
o
n
i
c
p
o
s
t
-
t
r
a
u
m
a
t
i
c
s
t
r
e
s
s
d
i
s
o
r
d
e
r

(
P
T
S
D
)

i

n
a
d
u
l
t
s
(
R
e
v
i
e
w

)

1
1

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Summary of findings 10.   Group TFCBT compared with Waitlist/Usual Care for chronic post-traumatic stress disorder (PTSD) in adults

Group TFCBT compared with Waitlist/Usual Care for chronic post-traumatic stress disorder (PTSD)

Patient or population: Adults with PTSD for at least 3 months
Settings: Primary care, community, outpatient
Intervention: Group TFCBT
Comparison: Waitlist/Usual Care/Minimal Contact

Outcomes

Illustrative comparative risks* (95% CI)

Assumed risk

Corresponding risk

Group TFCBT

Relative effect
(95% CI)

No of Partici-
pants
(studies)

Quality of the
evidence
(GRADE)

Comments

Severity of PTSD
symptoms - Clini-
cian-rated

Leaving the study
early for any rea-
son

The mean severity of PTSD symptoms - clinician in
the intervention groups was
1.28 standard deviations lower 
(2.25 to 0.31 lower)

185
(3 studies)

⊕⊝⊝⊝
very low 1,2,3

Study population

262 per 1000

317 per 1000 
(246 to 406)

Moderate

200 per 1000

242 per 1000 
(188 to 310)

RR 1.21 
(0.94 to 1.55)

573
(7 studies)

⊕⊝⊝⊝
very low 1,2,3

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio;

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1Insufficient information to judge risk of bias
2Unexplained heterogeneity
3Small sample sizes

C
o
p
y
r
i
g
h
t

©
2
0
1
5
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

P
s
y
c
h
o
l
o
g
i
c
a
l

t
h
e
r
a
p
i
e
s
f
o
r
c
h
r
o
n
i
c
p
o
s
t
-
t
r
a
u
m
a
t
i
c
s
t
r
e
s
s
d
i
s
o
r
d
e
r

(
P
T
S
D
)

i

n
a
d
u
l
t
s
(
R
e
v
i
e
w

)

1
2

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
C
o
p
y
r
i
g
h
t

©
2
0
1
5
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

P
s
y
c
h
o
l
o
g
i
c
a
l

t
h
e
r
a
p
i
e
s
f
o
r
c
h
r
o
n
i
c
p
o
s
t
-
t
r
a
u
m
a
t
i
c
s
t
r
e
s
s
d
i
s
o
r
d
e
r

(
P
T
S
D
)

i

n
a
d
u
l
t
s
(
R
e
v
i
e
w

)

Summary of findings 11.   Group TFCBT compared with Group non-TFCBT for chronic post-traumatic stress disorder (PTSD) in adults

Group CBT (trauma focused) compared with Group CBT (non-trauma focused) for chronic post-traumatic stress disorder (PTSD) in adults

Patient or population: Adults with PTSD for at least 3 months
Settings: Primary care, community, outpatient
Intervention: Group TFCBT
Comparison: Group non-TFCBT

Outcomes

Illustrative comparative risks* (95% CI)

Assumed risk

Corresponding risk

Group CBT (non-trau-
ma focused)

Group CBT (trauma fo-
cused)

Relative effect
(95% CI)

No of Partici-
pants
(studies)

Quality of the evi-
dence
(GRADE)

Comments

Severity of PTSD symptoms -
Clinician-rated

Leaving the study early for any
reason

See comment

See comment

Not estimable

See comment

See comment

Not estimable

325
(1 study)

360
(1 study)

⊕⊝⊝⊝
very low 1,2

⊕⊝⊝⊝
very low 1,2

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval;

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1Insufficient information to judge risk of bias
2One study with a small sample size

Summary of findings 12.   Other therapies compared with Waitlist/Usual Care for chronic post-traumatic stress disorder (PTSD) in adults

Other therapies compared with Waitlist/Usual Care for chronic post-traumatic stress disorder (PTSD) in adults

Patient or population: Adults with PTSD for at least 3 months
Settings: Primary care, community, outpatient
Intervention: Other therapies

1
3

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
C
o
p
y
r
i
g
h
t

©
2
0
1
5
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

P
s
y
c
h
o
l
o
g
i
c
a
l

t
h
e
r
a
p
i
e
s
f
o
r
c
h
r
o
n
i
c
p
o
s
t
-
t
r
a
u
m
a
t
i
c
s
t
r
e
s
s
d
i
s
o
r
d
e
r

(
P
T
S
D
)

i

n
a
d
u
l
t
s
(
R
e
v
i
e
w

)

Comparison: Waitlist/Usual Care

Outcomes

Illustrative comparative risks* (95% CI)

Assumed risk

Corresponding risk

Waitlist/Usual
Care

Other therapies

Relative effect
(95% CI)

No of Partici-
pants
(studies)

Quality of the
evidence
(GRADE)

Comments

Severity of PTSD
symptoms - Clin-
ician

Leaving the
study early due
to any reason

The mean severity of PTSD symptoms - clinician in
the intervention groups was
0.58 standard deviations lower 
(0.96 to 0.20 lower)

112
(3 studies)

⊕⊝⊝⊝
very low 1

Study population

74 per 1000

Moderate

72 per 1000

181 per 1000 
(73 to 452)

176 per 1000 
(71 to 439)

RR 2.45 
(0.99 to 6.10)

211
(4 studies)

⊕⊝⊝⊝
very low 1,2

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio;

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1Small sample sizes
2Studies were judged to pose a low/unclear risk of bias

Summary of findings 13.   Group non-TFCBT compared with Waitlist/Usual Care for chronic post-traumatic stress disorder (PTSD) in adults

Group non-TFCBT compared to Waitlist/Usual Care for chronic post-traumatic stress disorder (PTSD) in adults

Patient or population: Adults with PTSD for at least 3 months
Settings: Primary care, community, outpatient

1
4

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Intervention: Group non-TFCBT
Comparison: Waitlist/Usual Care

Outcomes

Illustrative comparative risks* (95% CI)

Assumed risk

Corresponding risk

Waitlist/Usual Care

Group nonTFCBT

Relative effect
(95% CI)

No of Participants
(studies)

Quality of the evi-
dence
(GRADE)

Comments

Leaving the study
early for any rea-
son

See comment

See comment

Not estimable

47
(1 study)

⊕⊝⊝⊝
very low 1,2

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval;

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1Only one study. Risk of bias high/unclear in several domains.
2Only one study

C
o
p
y
r
i
g
h
t

©
2
0
1
5
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

P
s
y
c
h
o
l
o
g
i
c
a
l

t
h
e
r
a
p
i
e
s
f
o
r
c
h
r
o
n
i
c
p
o
s
t
-
t
r
a
u
m
a
t
i
c
s
t
r
e
s
s
d
i
s
o
r
d
e
r

(
P
T
S
D
)

i

n
a
d
u
l
t
s
(
R
e
v
i
e
w

)

1
5

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

B A C K G R O U N D

Description of the condition

Post-traumatic  stress  disorder  (PTSD) 
is  a  well  recognised
psychiatric disorder that occurs following a major traumatic event.
Characteristic symptoms include re-experiencing phenomena such
as  nightmares  and  recurrent  distressing  thoughts  of  the  event,
avoidance  of  talking  or  being  reminded  of  the  traumatic  event,
negative  alterations  in  thoughts  and  mood,  and  hyperarousal
symptoms  including  sleep  disturbance,  increased  irritability  and
hypervigilance. PTSD can be diagnosed after a one-month duration
of symptoms. The condition is considered chronic once symptoms
have been present for three months. PTSD is a relatively common
condition. The National Co-morbidity Survey (Kessler 1995) found
that 7.8% of 5877 American adults had suffered from PTSD at some
time  in  their  lives.  When  data  were  examined  from  individuals
who had been exposed to a traumatic event, rates of PTSD varied
according  to  the  type  of  stressor.  For  example,  physical  assaults
amongst women led to a lifetime prevalence of 29% and combat
experience amongst men to a lifetime prevalence of 39%.

Description of the intervention

Psychological  therapies  have  been  advocated  as  being  effective
in  the  treatment  of  PTSD  since  its  conception.  Various  forms
of  psychological  therapy  have  been  used  including  exposure
therapy  (Creamer  2004),  cognitive  therapy  (Ehlers  2005;  Resick
1992),  psychodynamic  psychotherapy  (Brom  1989)  and  eye
movement  desensitisation  and  reprocessing  (EMDR)  (Shapiro
1989b).  Exposure  therapy  usually  involves  asking  the  participant
to  relive  the  trauma  imaginally.  This  is  often  done  by  creating  a
detailed present tense account of exactly what happened, making
an audio tape recording or transcript of it and asking the individual
to listen to/read this over and over again. Another form of exposure
therapy  involves  exposing  participants  to  cues  associated  with
the  traumatic  event  (for  example,  graded  re-exposure  to  car
travel following a road traffic accident). Trauma-focused cognitive
therapy  involves  helping  the  individual  to  identify  distorted
thinking  patterns  regarding  themselves,  the  traumatic  incident
and  the  world.  Individuals  are  encouraged  to  challenge  their
thoughts  by  weighing  up  available  evidence  and  through  the
utilisation of various techniques by the therapist, including specific
questioning that leads the individual to challenge distorted views.
EMDR  involves  the  PTSD  sufferer  focusing  on  a  traumatic  image,
thought, emotion and a bodily sensation whilst receiving bilateral
stimulation, most commonly in the form of eye movements. Non-
TFCBT usually focuses on techniques for the reduction of anxiety.
The  most  widely  used  protocol  for  anxiety  reduction  in  PTSD  is
stress inoculation training (SIT), which teaches skills for managing
stress, such as relaxation, thought stopping and guided dialogue.
It  provides  the  opportunity  to  practise  acquired  skills  gradually,
across a variety of settings. Psychodynamic psychotherapy focuses
on  integrating  the  traumatic  experience  into  the  life  experience
of the individual as a whole; childhood issues are often felt to be
important.

How the intervention might work

The psychological therapies considered by this review stem from
various  theoretical  perspectives.  Individual  protocols  describe
how  therapies  might  work  in  detail.  TFCBT  protocols  draw  on
four core components emphasised in varying degrees: 1) psycho-

Cochrane Database of Systematic Reviews

education; 2) anxiety management; 3) exposure; and 4) cognitive
restructuring.  Earlier  therapies  tended  to  be  more  behaviourally
based, focusing heavily on exposure work. Cognitive components
have become more prominent over time, in line with the popularity
of  information  processing  accounts  of  the  disorder.  Exposure
plays  an  important  role  in  many  TFCBT  protocols.    It  may  be
carried out in vivo (real life), or imaginally. It is common for both
to  be  used  in  the  treatment  of  PTSD,  to  target  internally  and
externally feared stimuli. The rationale behind the use of imaginal
exposure varies according to the specific TFCBT protocol. Imaginal
exposure  is  based  on  principles  of  habituation  (the  reduction
of  anxiety  after  prolonged  exposure)  or  information  processing
(allowing  re-evaluation  of  old  information  and  incorporation  of
new  information  into  the  trauma  memory),  or  a  combination  of
both.  In  addition,  cognitive  restructuring  has  an  important  role,
seeking  to  identify  and  modify  dysfunctional  thoughts  by  testing
and  challenging  self-held  beliefs,  based  on  the  assumption  that
these  usually  unquestioned  thoughts  are  distorted  or  unhelpful.
EMDR  is  an  integrative  trauma-focused  therapy  encompassing
elements  from  various  effective  psychotherapies  in  a  structured
protocol  drawn  from  an  information  processing  model  of  PTSD.
There  is  no  agreed  mechanism  by  which  EMDR  is  thought  to
operate. Shapiro 1989b discovered EMDR accidentally. Her account
implicates  personal  experience  of  rapid  eye  movements  easing
distress. On the basis of this experience, Shapiro elaborated EMDR
for  the  treatment  of  Vietnam  war  veterans  and  abuse  sufferers.
It  is  suggested  that  bilateral  stimulation  aids  the  processing  of
traumatic memories. Non-TFCBT interventions such as SIT operate
by  teaching  the  individuals  techniques  to  minimise  and  control
their anxiety. In terms of other psychological therapies considered
by  this  review,  psychodynamic  psychotherapy  places  emphasis
on the unconscious mind, aiming to resolve inner conflict arising
from  the  traumatic  event.  Person-centred  therapy/supportive
counselling  allows  the  individual  to  talk  through  problems  and
resolve  difficulties  with  minimal  guidance  and  direction  from
the  therapist.  The  therapist  is  accepting  and  non-judgemental.
This  style  encourages  the  individual  to  feel  comfortable  in  the
expression of feelings, facilitating positive change. Unlike trauma-
focused  therapies,  person-centred/supportive  counselling  does
not encourage exploration of the trauma memory.

For  a  summary  of  psychological  models  of  PTSD  providing  the
rationale for many of the treatment approaches considered here,
see Brewin 2003.

Why it is important to do this review

It  is  apparent  that  PTSD  causes  clinically  significant  suffering
and  that  developing  effective  interventions  is  important.  Earlier
versions  of  this  review  and  other  meta-analyses  have  found
psychological  therapies  to  be  effective  (e.g.  Bradley  2005),  with
trauma-focused treatments being more effective than non-trauma-
focused  treatments  (Bisson  2007a).  This  is  an  update  of  a
Cochrane  review  first  published  in  2005  and  updated  in  2007,
bringing  together  current  evidence  concerning  the  psychological
treatment of chronic PTSD in adults. Other Cochrane Collaboration
reviews have considered single-session psychological 'debriefing'
to prevent PTSD (Rose 2002), multiple-session early psychological
interventions 
(Roberts  2009),
early  psychological  therapies  to  treat  acute  traumatic  stress
symptoms  (Roberts  2010),  pharmacological  treatments  (Stein
2006), combined pharmacotherapy and psychological therapies for

for  the  prevention  of  PTSD 

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

16

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

PTSD (Hetrick 2010), and psychological therapies for the treatment
of PTSD in children and adolescents (Gillies 2012).

O B J E C T I V E S

To assess the effects of psychological therapies for the treatment of
adults with chronic post-traumatic stress disorder (PTSD).

M E T H O D S

Criteria for considering studies for this review

Types of studies

We  include  randomised  controlled  trials  (RCTs)  of  psychological
therapies for chronic PTSD in adults. Cluster-RCTs and cross-over
trials were considered eligible for inclusion. We did not use sample
size, language or publication status to determine whether or not a
study was included.

Types of participants

Age

This review considered studies of adults only (aged 18 or over).

Diagnosis

Any individual suffering from chronic traumatic stress symptoms,
i.e.  with  a  duration  of  three  months  or  more.  At  least  70%  of
participants were required to be diagnosed as suffering from PTSD
according to DSM-III (APA 1980), DSM-IIIR (APA 1987), DSM-IV (APA
2000),ICD-9  (WHO  1979)  or  ICD-10  (WHO  1992)  criteria,  by  means
of a structured interview or diagnosis by a clinician. There was no
restriction on the basis of severity of PTSD symptoms or the type of
traumatic event.

Co-morbidities

There was no restriction on the basis of comorbidity, although we
required that PTSD be the primary diagnosis.

Setting

There was no restriction on the basis of study setting.

Types of interventions

This  review  considered  any  psychological  therapy  designed  to
reduce  symptoms  of  chronic  PTSD.  Group  interventions  were
considered separately from those delivered on an individual basis.
Psychological  therapy  provided  in  a  group  format  is  clinically
distinct from its individually-delivered counterparts, not least due
to the reduced therapist 'dose' associated with group therapy.

3. Non-trauma-focused  CBT: 

therapy
that  predominantly  used  non-trauma-focused  cognitive,
behavioural  or  cognitive-behavioural  techniques,  for  example
stress inoculation training (SIT) (Meichenbaum 1988).

any  psychological 

4. Group  TFCBT:  any  approach  delivered  in  a  group  setting  that
predominantly used trauma-focused cognitive, behavioural or
cognitive-behavioural techniques.

5. Group  non-TFCBT:  any  approach  delivered 

in  a  group
that  predominantly  used  non-trauma-focused  cognitive,
behavioural or cognitive-behavioural techniques.

6. Other  psychological  therapy:  any  psychological  therapy
that  predominantly  used  non-trauma-focused  techniques
that  would  not  be  considered  cognitive,  behavioural  or
cognitive-behavioural  techniques.  This  category  comprised
non-directive/supportive/person-centred  counselling  (Rogers
1961), hypnotherapy, psychodynamic therapy (Brom 1989) and
present-centred treatment.

Comparator interventions

1. Waitlist,  treatment  as  usual,  symptom  monitoring,  repeated

assessment or other minimal attention control group;

2. An alternative psychological treatment.

Types of outcome measures

Primary outcomes

1. Reduction 

in  the  severity  of  PTSD  symptoms  using  a
standardised measure (i.e. a test that is administered and scored
in  a  consistent  way)  rated  by  a  clinician  (e.g.  the  Clinician
Administered PTSD Symptom Scale (Blake 1995)).

2. Drop-out rates.

Secondary outcomes

1. Severity  of  self-reported  traumatic  stress  symptoms  using  a
standardised measure (e.g. the Impact of Event Scale (Horowitz
1979)).

2. Severity  of  depressive  symptoms  (e.g.  the  Beck  Depression

Inventory (Beck 1961)).

3. Severity of anxiety symptoms using scales (e.g. the Spielberger

State Trait Anxiety Inventory (Spielberger 1973)).

4. PTSD diagnosis after treatment.
5. Any adverse effects, e.g. increased PTSD symptoms.

We produced hierarchies of the standardised measures, based on
their  frequency  of  use  within  the  included  studies.  Where  a  trial
reported data from two or more measures of the same outcome, we
used only data from the measure ranked highest.

Experimental interventions

Timing of outcome assessment

1. Individual  trauma-focused  cognitive  behavioural  therapy
(TFCBT):  any  psychological  therapy  that  predominantly  used
trauma-focused cognitive, behavioural or cognitive-behavioural
techniques. This category included exposure therapy. Examples
of  therapies  within  this  category  are  cognitive  therapy  (Ehlers
2005), cognitive processing therapy (Resick 1992) and prolonged
exposure (Foa 2000).

2. Eye  movement  desensitisation  and  reprocessing  (Shapiro

1989b).

We conducted separate pair-wise meta-analyses of follow-up data
at  one  to  four  months,  five  to  eight  months,  nine  months  to  one
year, and over one year.

Search methods for identification of studies

Electronic searches

The  Cochrane,  Depression,  Anxiety  and  Neurosis  Group's
Specialised Register (CCDANCTR)
The  Cochrane  Depression,  Anxiety  and  Neurosis  Group  (CCDAN)
maintain  two  clinical  trials  registers  at  their  editorial  base  in

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

17

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Bristol, UK: a references register and a studies-based register. The
CCDANCTR-References  Register  contains  over  33,000  reports  of
randomised controlled trials in depression, anxiety and neurosis.
Approximately  65%  of  these  references  have  been  tagged  to
individual, coded trials. The coded trials are held in the CCDANCTR-
Studies Register and records are linked between the two registers
through the use of unique Study ID tags. Coding of trials is based on
the EU-Psi coding manual. Please contact the CCDAN Trials Search
Co-ordinator  for  further  details.  Reports  of  trials  for  inclusion  in
the  Group's  registers  are  collated  from  routine  (weekly),  generic
searches of OVID MEDLINE (1950-), EMBASE (1974-) and PsycINFO
(1967-);  quarterly  searches  of  the  Cochrane  Central  Register
of  Controlled  Trials  (CENTRAL)  and  review-specific  searches  of
additional  databases.  Reports  of  trials  are  also  sourced  from
international  trials  registers  c/o  the  World  Health  Organization’s
trials  portal  (ICTRP),  ClinicalTrials.gov,  drug  companies,  the
handsearching of key journals, conference proceedings and other
(non-Cochrane) systematic reviews and meta-analyses. Details of
CCDAN's  generic  search  strategies  can  be  found  on  the  Group's
website.

We searched the CCDANCTR (Studies and References Registers, all
years  to  12th  April  2013)  on  condition  alone,  using  the  following
terms:
(PTSD  or  posttrauma*  or  post-trauma*  or  “post  trauma*”  or
(combat and disorder*))

Searching other resources

Grey literature
We  searched  abstracts  from  meetings  of  the  European  and
International  Societies  of  Traumatic  Stress  Studies.  We  also
searched websites and discussion fora related to PTSD.

Handsearching
We handsearched the Journal of Traumatic Stress and the ISTSS
Treatment Guidelines (Foa 2000; Foa 2009) for relevant articles.

Reference lists
We scrutinised the reference lists of included studies for additional
studies meeting the inclusion criteria.

Correspondence
The  main  correspondence  was  with  the  UK  NICE  guidelines
development group who kindly shared the results of their searches
and communications (see Acknowledgements).

Data collection and analysis

Selection of studies

Two review authors independently read abstracts of all potential
trials identified through the search strategy. If we felt an abstract
represented a possible RCT, each review author independently read
the full report to determine if the trial met the inclusion criteria. Any
differences prompted re-evaluation of the study, and we discussed
disagreements with a third review author to reach a consensus.

Data extraction and management

We  extracted  data  from  published  reports  and  entered  them
into  Review  Manager  5  Software  (RevMan  5).  We  contacted
authors  to  obtain  missing  information.  Extracted  data  included
demographic details of participants, details of the traumatic event,
the randomisation process, the therapy used, and outcome data.

Main comparisons

1. Individual TFCBT versus waitlist/usual care
2. Individual TFCBT versus non-TFCBT
3. Individual TFCBT versus other therapies
4. EMDR versus waitlist/usual care
5. EMDR versus individual TFCBT
6. EMDR versus non-TFCBT
7. EMDR versus other therapies
8. Non-TFCBT versus waitlist/usual care
9. Non-TFCBT versus other therapy
10.Group TFCBT versus waitlist/usual care
11.Group TFCBT versus group non-TFCBT
12.Other therapies versus waitlist/usual care
13.Group non-TFCBT versus waitlist/usual care
14.Individual TFCBT versus group TFCBT
15.Individual TFCBT versus group non-TFCBT
16.EMDR versus group TFCBT
17.EMDR versus group non-TFCBT
18.Individual non-TFCBT versus group TFCBT
19.Individual non-TFCBT versus group non-TFCBT

Assessment of risk of bias in included studies

We assessed all included studies for risk of bias, using the standard
approach  described  in  the  Cochrane  Handbook  for  Systematic
Review of Interventions (Higgins 2011). This considered (1) sequence
allocation  for  randomisation;  (2)  allocation  concealment;  (3)
blinding of personnel and assessors; (4) incomplete outcome data;
(5) selective reporting; and (6) any other notable risks of bias. Each
was judged to pose a 'high', 'low' or 'unclear' risk of bias. Two review
authors conducted the assessments, discussing any disagreements
with a third review author to reach a consensus.

1. Sequence allocation randomisation

Randomisation  was  judged  as  posing  a  'low'  risk  of  bias  if  each
participant had an equal chance of being randomised to a group.
Low-risk  methods  included  referring  to  a  random  number  table,
use of a computerised random number generator, shuffling sealed
envelopes  or  throwing  a  dice.  Methods  judged  as  posing  a  'high'
risk of bias included use of a sequence generated by e.g. date of
birth, clinic number, date of admission to the study, or allocation
by  availability  of  the  intervention.  When  insufficient  information
was  given  to  permit  judgement  of  high  or  low  risk  of  bias,  we
describe the study as being at an 'unclear' risk of bias attributable
to sequence allocation.

2. Allocation concealment

Concealment  of  intervention  allocation  was  said  to  be  at  'low'
risk  when  there  was  no  chance  of  the  investigator  foreseeing  a
participant's assignment. Methods judged as posing a low risk of
bias included central allocation (e.g. by telephone or the internet)
or  sequentially  numbered  opaque  sealed  envelopes.  High-risk
methods included alternation or rotation of assignment or using an
open random allocation schedule (e.g. a list of random numbers).
When insufficient information was reported to permit judgement of
high or low risk, we describe the study as being at an 'unclear' risk
of bias attributable to allocation concealment.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

18

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

3. Blinding of personnel and assessors

Studies with multiple treatment groups

It  is  not  possible  to  blind  either  the  participants  or  those
administering  psychological  interventions.  However,  outcome
assessors can be blinded. Those studies which blinded assessors
were deemed to be at a low risk of bias, those which did not were
judged as being at a high risk of bias. When insufficient information
was reported to permit judgement of high or low risk, we describe
the  study  as  being  at  an  'unclear'  risk  of  bias  attributable  to
blinding.

4. Incomplete outcome data

We  judged  incomplete  data  to  have  been  handled  appropriately
when reported completely, including attrition rates and exclusions,
with consideration of the issue in terms of analysing the data. Low
risk of bias was associated with no missing outcome data, or the
use of data imputed using appropriate methods. Methods judged
as  posing  a  high  risk  of  bias  included  analyses  that  considered
only the data of treatment-completers, or potentially inappropriate
application  of  simple  imputation.  When  insufficient  information
was reported to permit judgement of high or low risk, we describe
the  study  as  being  at  an  'unclear'  risk  of  bias  attributable  to
incomplete data.

5. Selective reporting

We  judged  a  study  to  be  at  a  low  risk  of  bias  if  a  protocol
was  available  and  all  prespecified  outcomes  were  reported.  If
there  was  no  available  protocol,  the  study  was  assigned  a  low
risk  in  this  domain  if  it  was  clear  that  the  published  reports
included  all  expected  outcomes,  including  those  prespecified.
When insufficient information was reported to permit judgement of
high or low risk, we describe the study as being at an 'unclear' risk
of bias attributable to selective reporting.

6. Other notable risks of bias

We noted any other potential threats to validity and judged them
to  be  at  a  high  or  low  risk  of  bias.  We  describe  them  as  being  at
'unclear'  risk  of  bias  when  there  was  insufficient  information  to
assess additional risk of bias.

Measures of treatment effect

Continuous data

We  analysed  continuous  outcomes  as  standardised  mean
differences (SMDs) to allow ease of comparison across studies. All
outcomes are presented using 95% confidence intervals (CIs).

Dichotomous data

We  analysed  categorical  outcomes  as  risk  ratios  (RRs),  these
being  more  widely  used  in  medical  practice  than  odds  ratios.  All
outcomes are presented using 95% confidence intervals.

Unit of analysis issues

Cross-over trials

We included only outcome data from the first randomisation period
when a study adopted a cross-over design.

If  the  trial  had  three  (or  more)  arms,  we  undertook  pair-wise
meta-analysis  with  each  arm,  depending  upon  the  nature  of  the
intervention in each arm and the relevance to the review objectives.
We avoided multiple comparisons as far as possible, to limit the risk
of false positive results. When a study had three or more arms that
were relevant to the review we considered the appropriateness of
combining data from two arms if therapies were sufficiently similar
or  of  using  data  from  the  arms  of  the  trial  which  fit  closest  to
the review objective. Decisions followed guidance provided by the
Cochrane Handbook (Higgins 2011).

Cluster-randomised trials

We  had  planned  to  include  cluster-RCTs,  although  none  was
identified by the searches to date. In future updates of the review,
the  methodology  for  dealing  with  these  types  of  studies  will
follow  that  outlined  by  the  Cochrane  Handbook  (Higgins  2011).
We  will  adjust  sample  sizes  using  an  estimate  of  the  intracluster
or  intraclass  correlation  coefficient  (ICC),  which  describes  the
'similarity' of individuals within the same cluster. We will derive this
from the trial if possible, or from another source, such as a similar
study, or from a resource providing examples of ICCs.

Dealing with missing data

We  contacted  authors  to  obtain  any  data  missing  from  the
published  report  of  included  studies.  We  used  intention-to-treat
(ITT) data where possible, but used data from completers analyses
when ITT data were not available.

Assessment of heterogeneity

We initially assessed studies included within each comparison for
clinical heterogeneity in terms of variability in the experimental and
control interventions, participants and settings, and outcomes. To
further assess heterogeneity, we used both the I2 statistic (Higgins
2003) and the Chi2 test of heterogeneity, as well as visual inspection
of the forest plots.

Assessment of reporting biases

When  sufficient  studies  were  available,  we  constructed  funnel
plots and scrutinised them for signs of asymmetry. Since reporting
bias is just one possible reason for observed asymmetry, we also
considered alternative explanations.

Data synthesis

We pooled data from more than one study using a fixed-effect meta-
analysis, except where heterogeneity was present, in which case we
used a random-effects model.

Subgroup analysis and investigation of heterogeneity

We  performed  clinical  heterogeneity  subgroup  analyses  (when
sufficient data were available) as follows:

1. Type  of  traumatic  event  (combat-related  trauma  versus  rape

and sexual assault versus other civilian trauma)

2. Participant characteristics (men only versus women only)

Sensitivity analysis

We  conducted  sensitivity  analyses  to  assess  the  effect  of  high  or
unclear risk of bias in any of the following domains:

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

19

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

1. Sequence generation
2. Allocation concealment
3. Blinding of outcome assessment

R E S U L T S

Description of studies

These  analyses  were  performed  for  comparisons  including  10  or
more studies.

See  Characteristics  of  included  studies  and  Characteristics  of
excluded studies.

Results of the search

The  search  yielded  1477  articles  for  consideration.  We  reviewed
abstracts and obtained full-text copies for 129 potentially relevant
studies. Seventy RCTs (79 comparisons) met the inclusion criteria
for the review. Figure 1 presents a flow diagram for study selection.

Figure 1.   Study flow diagram.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

20

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Included studies

Design

All included studies were RCTs.

Sample sizes

The number of participants randomised in the trials ranged from 9
(Ready 2010) to 360 (Schnurr 2003). Eleven studies included sample
sizes of over 100: Brom 1989 (n = 112); Cloitre 2010 (n = 104); Foa
2005 (n = 171); Krakow 2000 (n = 169); Krakow 2001 (n = 114); Mueser
2008 (n = 108); Nijdam 2012 (n = 140); Power 2002 (n = 105); Resick
2002 (n = 121); Schnurr 2003 (n = 360); Schnurr 2007 (n = 284).

Settings

USA (33 studies), UK (6 studies), Australia (7 studies), Netherlands (4
studies), Hawaii (3 studies), Germany (3 studies), Turkey (2 studies),
Sweden (2 studies), Uganda (2 studies), Japan (1 study), Romania
(1 study), Thailand (1 study), Canada (1 study), Portugal (1 study),
Cambodia (1 study), China (1 study), Spain (1 study).       

Participants

The  study  populations  were  varied  and  often  not  directly
comparable  (i.e.  there  was  significant  clinical  heterogeneity).
Studies included individuals traumatised by combat (13 studies),
sexual assault (13 studies), war/persecution (6 studies), road traffic
accidents  (4  studies),  earthquake  (3  studies),  childhood  sexual
abuse (3 studies), political detainment (1 study), terrorism (1 study),
sexual or physical assault (1 study) and serving in the police force.
The remainder of the studies included individuals traumatised by
various traumatic events (24 studies).

Cochrane Database of Systematic Reviews

2. Non-TFCBT: Eight studies considered non-TFCBT - Carlson 1998;
Echeburua  1997;  Foa  1991;  Foa  1999;  Kearney  2013;  Marks  1998;
Taylor 2003; Vaughan 1994.

3. Eye Movement Desensitisation and Reprocessing: Sixteen studies
considered  eye  movement  desensitisation  and  reprocessing  -
Carlson  1998;  Devilly  1998;  Devilly  1999;  Hogberg  2007;  Ironson
2002; Jensen 1994; Lee 2002; Marcus 1997; Power 2002; Rothbaum
1997;  Rothbaum  2005;  Scheck  1998;  Taylor  2003;  Vaughan  1994;
Nijdam 2012.

4. Group TFCBT: Ten studies considered group TFCBT - Beck 2009;
Chard  2005;  Classen  2001;  Hinton  2011;  Hollifield  2007;  Kearney
2013; Krakow 2000; Krakow 2001; Schnurr 2003; Zlotnick 1997.

5.  Group  non-TFCBT:  One  study  considered  group  non-TFCBT:
Schnurr 2003

6.  Other  therapies:  Nine  studies  considered  other  therapies
(supportive  counselling,  present-centred  therapy,  hypnotherapy
and psychodynamic therapy) - Blanchard 2003; Brom 1989; Bryant
2003;  Cloitre  2010;  Feske  2008;  Foa  1991;  McDonagh  2005;  Ready
2010; Schnurr 2007.

Comparisons

The included trials compared
(i) Psychological therapy versus waitlist or usual care control (some
studies  allowed  the  control  group  to  receive  pharmacological
treatments  and/or  psychological  therapies  that  were  not  being
considered specifically);
(ii) Psychological therapy versus other psychological therapy.

Time post-trauma

We made the following specific comparisons:

All  studies  included  individuals  at  least  three  months  after  the
trauma. The range was large, from three months to over 40 years
(Bichescu 2007). There was often a wide range of times since trauma
included in individual studies.

Interventions

In  order  to  present  the  results  in  a  meaningful  way,  we  decided
to  pool  data  that  used  a  similar  theoretical  methodology.
This  was  conducted  a  priori,  resulting  in  the  establishment
of  six  groups: 
individual  TFCBT,  non-TFCBT,  EMDR,  group
TFCBT,  group  non-TFCBT  and  other  therapies  (psychodynamic
therapy,  hypnotherapy,  supportive  counselling  and  present-
centred counselling).

1. Trauma-focused cognitive behavioural therapy: Forty-nine studies
considered individual TFCBT - Adenauer 2011; Asukai 2010; Basoglu
2005;  Basoglu  2007;  Bichescu  2007;  Blanchard  2003;  Brom  1989;
Bryant 2003; Bryant 2011; Cloitre 2002; Cloitre 2010; Cooper 1989;
Devilly 1999; Duffy 2007; Dunne 2012; Echeburua 1997; Ehlers 2005;
Fecteau  1999;  Feske  2008;  Foa  1991;  Foa  1999;  Foa  2005;  Forbes
2012; Galovski 2012; Gamito 2010; Gersons 2000; Hensel-Dittmann
2011; Hinton 2005; Ironson 2002; Keane 1989; Kubany 2003; Kubany
2004; Lindauer 2005; McDonagh 2005; Marks 1998; Monson 2006;
Mueser  2008;  Neuner  2004;  Neuner  2008;  Neuner  2010;  Paunovic
2011; Peniston 1991; Power 2002; Ready 2010; Resick 2002; Schnurr
2007; Taylor 2003; Vaughan 1994; Nijdam 2012; Zang 2013.

1.  Individual  TFCBT  versus  waitlist/usual  care:  Adenauer  2011;
Asukai 2010; Basoglu 2005; Basoglu 2007; Bichescu 2007; Blanchard
2003;  Brom  1989;  Cloitre  2002;  Cooper  1989;  Duffy  2007;  Dunne
2012; Ehlers 2003; Ehlers 2005; Fecteau 1999; Foa 1991; Foa 1999;
Foa 2005; Forbes 2012; Galovski 2012; Gamito 2010; Gersons 2000;
Hinton  2005;  Keane  1989;  Kubany  2003;  Kubany  2004;  Lindauer
2005;  McDonagh  2005;  Monson  2006;  Mueser  2008;  Neuner  2010;
Paunovic 2011; Peniston 1991; Power 2002; Resick 2002; Vaughan
1994; Wells 2012; Zang 2013.

2.  Individual  TFCBT  versus  non-TFCBT:  Echeburua  1997;  Foa  1991;
Foa 1999; Hensel-Dittmann 2011; Marks 1998; Taylor 2003; Vaughan
1994.

3.Individual  TFCBT  versus  other  therapies:  Blanchard  2003;  Brom
1989; Bryant 2003; Bryant 2011; Cloitre 2010; Feske 2008; Foa 1991;
McDonagh 2005; Neuner 2004; Ready 2010; Schnurr 2007.

4.  EMDR  versus  waitlist/usual  care:  Carlson  1998;  Devilly  1998;
Hogberg  2007;  Jensen  1994;  Power  2002;  Rothbaum  1997;
Rothbaum 2005; Vaughan 1994.

5.  EMDR  versus  individual  TFCBT:  Devilly  1999:  Ironson  2002:  Lee
2002:  Nijdam  2012;  Power  2002:  Rothbaum  2005;  Taylor  2003;
Vaughan 1994.

6. EMDR versus non-TFCBT: Carlson 1998; Taylor 2003; Vaughan 1994.

7. EMDR versus other therapy: Marcus 1997; Scheck 1998.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

21

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

8. Individual non-TFCBT versus waitlist/usual care: Carlson 1998; Foa
1991; Foa 1999; Vaughan 1994; Wells 2012.

9. Non-TFCBT versus other therapy: Foa 1991.

10. Group TFCBT versus waitlist/usual care: Beck 2009; Chard 2005;
Hinton 2011; Hollifield 2007; Krakow 2001, Krakow 2000, Zlotnick
1997.

11. Group TFCBT versus group non-TFCBT: Schnurr 2003.

12.Other therapies versus waitlist/usual care: Blanchard 2003; Brom
1989; Foa 1991; McDonagh 2005.

13. Group non-TFCBT versus waitlist/usual care: no studies

14. Individual TFCBT versus group TFCBT: no studies

15. Individual TFCBT versus group non-TFCBT: no studies

16. EMDR versus group TFCBT: no studies

17. EMDR versus group non-TFCBT: no studies

18. Individual non-TFCBT versus group TFCBT: no studies

19. Individual non-TFCBT versus group non-TFCBT: no studies

Outcomes

Primary  outcomes  were  reduction 
in  severity  of  clinician-
rated  PTSD  symptoms  and  drop-out  rate.  Secondary  outcome
measures  were  severity  of  self-reported  PTSD  symptom,  severity
of  depressive  symptoms,  severity  of  anxiety  symptoms,  PTSD
diagnosis  after  treatment  and  adverse  side  effects  (such  as
increased PTSD symptoms).

Cochrane Database of Systematic Reviews

Excluded studies

We  excluded  studies  if  they  did  not  satisfy  the  inclusion  criteria.
Some studies made no formal diagnosis of PTSD (Abbasnejad 2007;
Classen  2001;  Classen  2010;  Cole  2007;  Edmond  1999;  Edmond
2004; Falsetti 2001; Ginzberg 2009; Hiari 2005;, Knaevelsrud 2007;
Lange 2001; Lange 2003; Litz 2007; Price 2007; Ryan 2005; Shapiro
1989a;  Sloan  2004;  Sloan  2005),  and  in  other  studies  fewer  than
70%  of  participants  met  full  diagnostic  criteria  for  the  disorder
(Davis  2007;  Difede  2007a;  DuHamel  2010;  Maercker  2006;  Rabe
2008; Van Emmerik 2008; Wilson 1995). Other reasons for excluding
specific studies were a duration of less than three months following
trauma  (Echeburua  1996;  some  participants  within,  Foa  2006;
Spence 2011), treatment did not target traumatic stress symptoms
(Dunn  2007;  Chemtob  1997),  comparison  of  two  psychological
therapies  in  the  same  category  (Arntz  2007;  Mithoefer  2011;
Paunovic  2001;  Tarrier  1999;  Watson  1997),  the  intervention  was
not  a  psychological  therapy  (Gidron  1996),  including  individuals
under  18  years  of  age  (Jaberghaderi  2004;  Najavits  2006;  Schaal
2009),  comparison  of  two  non-TFCBT  therapies,  and  comparison
with pharmacotherapy (Frommberger 2004; Rothbaum 2006).

See Characteristics of excluded studies table for further details.

Studies awaiting classification

Krupnick 2008 is awaiting classification as we need to obtain further
information.

Risk of bias in included studies

A graphical representation of the overall risk of bias for each domain
and each study is available in Figure 2 and Figure 3 respectively.

Figure 2.   Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages
across all included studies.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

22

 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Figure 3.   Risk of bias summary: review authors' judgements about each risk of bias item for each included study.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

23

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Figure 3.   (Continued)

Cochrane Database of Systematic Reviews

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

24

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Figure 3.   (Continued)

Cochrane Database of Systematic Reviews

Allocation

Sequence allocation randomisation

Fifteen  studies  reported  a  method  of  allocation  that  we  felt  to
be  appropriate,  and  which  we  judged  to  be  at  low  risk  of  bias
(Adenauer 2011; Asukai 2010; Basoglu 2005; Basoglu 2007; Bryant
2003; Bryant 2011; Fecteau 1999; Hensel-Dittmann 2011; Hogberg
2007;  Hollifield  2007;  Lindauer  2005;  Neuner  2004;  Power  2002;
Scheck 1998; Wells 2012). We judged the method of allocation to
be  at  high  risk  of  bias  in  six  studies  (Bichescu  2007;  Blanchard
2003;  Cooper  1989;  Devilly  1999;  Ehlers  2003;  Schnurr  2003).  The
remainder of the studies reported insufficient information for us to
make a judgement.

Allocation concealment

Many  studies  did  not  provide  full  details  of  the  method  of
randomisation  and  we  therefore  judged  concealment  to  be  at
unclear  risk  of  bias  in  the  majority.  Fifteen  studies  reported
adequate allocation concealment, representing a low risk of bias

(Basoglu 2005; Basoglu 2007; Bryant 2011; Cloitre 2010; Duffy 2007;
Ehlers 2003; Foa 2005; Forbes 2012; Krakow 2001; Lindauer 2005;
Monson  2006;  Mueser  2008;  Nijdam  2012;  Power  2002;  Scheck
1998).  We  judged  one  study  to  be  at  high  risk  in  terms  of  failure
to  conceal  allocation  (Cooper  1989).  None  of  the  other  studies
reported any methods of concealing allocation and we judged them
to be at unclear risk of bias in this domain.

Blinding

In  common  with  all  studies  of  psychological  therapies  a  double-
blind  methodology  is  virtually  impossible,  as  it  is  clear  to  the
participant  what  treatment  they  are  receiving.  However,  a  well-
designed study should ensure blinding of the assessor of outcome
measures.  In  six  of  the  included  studies,  the  assessor  was  aware
of the participant's allocation (Basoglu 2005; Carlson 1998; Ironson
2002;  Keane  1989;  Marcus  1997;  Paunovic  2011).  It  was  unclear
whether  or  not  the  assessor  was  blind  in  14  studies  (Brom  1989;
Cooper  1989;  Duffy  2007;  Dunne  2012;  Echeburua  1997;  Fecteau

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

25

 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

1999; Feske 2008; Forbes 2012; Gamito 2010; Hinton 2011; Jensen
1994; Kearney 2013; Krakow 2000; Scheck 1998).

Incomplete outcome data

Loss to follow-up

Drop-out  rates  were  high  in  many  of  the  studies  and  reasons  for
attrition were generally poorly reported. We judged 21 studies to
be  at  high  risk  of  bias  for  incomplete  outcome  data  (Adenauer
2011; Basoglu 2005; Basoglu 2007; Beck 2009; Brom 1989; Carlson
1998; Cooper 1989; Devilly 1998; Devilly 1999; Ehlers 2003; Fecteau
1999;  Feske  2008;  Foa  1991;  Hogberg  2007;  Jensen  1994;  Krakow
2000; Paunovic 2011; Power 2002; Rothbaum 1997; Rothbaum 2005;
Scheck 1998; Zlotnick 1997). It was unclear how missing data were
handled  in  six  studies  (Gamito  2010;  Keane  1989;  Marcus  1997;
Peniston 1991; Ready 2010). We judged the remainder to have dealt
with drop-outs appropriately, i.e. at low risk of bias.

Selective reporting

It was difficult to draw any meaningful conclusions with regards to
the  issue  of  selective  reporting.  Very  few  of  the  included  studies
had published protocols available. It was therefore impossible to
know  whether  prespecified  outcome  measures  were  adequately
reported. The majority of studies adequately reported all outcomes
outlined within the Methods section of the trial report.

Other potential sources of bias

A strength of the majority of the studies was having clear objectives,
but  sample  sizes  were  often  small  and  the  follow-up  period  was
limited. The treatments delivered were reasonably well-described
and  the  majority  of  studies  reported  on  the  credentials  and
experience of therapists. A high proportion of the included studies
made some assessment of treatment adherence. Most studies used
well-validated outcome measures although there was considerable
variation  in  the  actual  measures  used.  For  practical  and  ethical
reasons  there  were  rarely  follow-up  data  available  from  waitlist
groups.  We  could  not  rule  out  potential  researcher  allegiance  in
many  of  the  studies.  A  number  of  the  included  trials  were  of
interventions that were evaluated by their originators.

Effects of interventions

See:  Summary  of  findings  for  the  main  comparison  Trauma-
focused CBT/Exposure therapy compared with Waitlist/Usual Care
for  chronic  post-traumatic  stress  disorder  (PTSD)  in  adults;
Summary  of  findings  2  Trauma-focused  CBT/Exposure  therapy
compared  with  non-TFCBT  for  chronic  post-traumatic  stress
disorder (PTSD) in adults; Summary of findings 3 Trauma-focused
CBT/Exposure therapy compared with other therapies for chronic
post-traumatic  stress  disorder  (PTSD)  in  adults;  Summary  of
findings  4  EMDR  compared  with  Waitlist/Usual  Care  for  chronic
post-traumatic  stress  disorder  (PTSD)  in  adults;  Summary  of
findings 5 EMDR compared with Trauma-focused CBT for chronic
post-traumatic  stress  disorder  (PTSD)  in  adults;  Summary  of
findings  6  EMDR  compared  with  non-TFCBT  for  chronic  post-
traumatic stress disorder (PTSD) in adults; Summary of findings
7 EMDR compared with other therapies for chronic post-traumatic
stress  disorder  (PTSD)  in  adults;  Summary  of  findings  8  Non-
TFCBT  compared  with  Waitlist/Usual  Care  for  chronic  post-
traumatic stress disorder (PTSD) in adults; Summary of findings
9  Non-TFCBT  compared  with  other  therapies  for  chronic  post-
traumatic stress disorder (PTSD) in adults; Summary of findings 10

Cochrane Database of Systematic Reviews

Group TFCBT compared with Waitlist/Usual Care for chronic post-
traumatic stress disorder (PTSD) in adults; Summary of findings
11 Group TFCBT compared with Group non-TFCBT for chronic post-
traumatic stress disorder (PTSD) in adults; Summary of findings
12 Other therapies compared with Waitlist/Usual Care for chronic
post-traumatic  stress  disorder  (PTSD)  in  adults;  Summary  of
findings 13 Group non-TFCBT compared with Waitlist/Usual Care
for chronic post-traumatic stress disorder (PTSD) in adults

The  full  results  are  contained  in  the  Tables  and  are  summarised
below.

Comparison 1. Individual TFCBT/Exposure therapy versus
waitlist/usual care

37  studies 
comparison.

including  1830  participants  contributed  to  this

Primary outcomes

1.1. Clinician-rated PTSD symptoms

Twenty-eight  studies  considered  this  outcome  with  a  total  of
1256 individuals (Analysis 1.1). There was heterogeneity between
these  trials  (Chi2  =  237.95,  P  =  0.00001;  I2  =  89%)  and  we  used
a  random-effects  model  to  pool  the  data.  The  individual  TFCBT
group  did  better  than  the  waitlist/usual  care  group  immediately
after  treatment  (standardised  mean  difference  (SMD)  -1.62;  95%
confidence interval (CI) -2.03 to -1.21).

At 1- to 4-month follow-up four studies compared this outcome with
336  individuals  (Analysis  1.2).  There  was  heterogeneity  between
these  trials  (Chi2  =  52.30;  P  <  0.00001;  I2  =  94%).  The  individual
TFCBT  group  did  significantly  better  than  the  waitlist/usual  care
group (SMD -1.18; 95% CI -2.20 to -0.17).

At 5- to 8-month follow-up three  studies compared this outcome
with 192  individuals (Analysis 1.3). There was little heterogeneity
between these trials (Chi2 = 0.68; P = 0.71; I2 = 0%). The individual
TFCBT  group  did  better  than  the  waitlist/usual  care  group  (SMD
-0.47; 95% CI -0.77 to -0.18).

At  9-  to  12-month  follow-up  one  study  reported  this  outcome
with 109 individuals (Analysis 1.4). The individual TFCBT group did
significantly better than the waitlist/usual care group (SMD -0.78;
95% CI -1.18 to -0.39).

1.2. Drop-outs

Thirty-four    studies  with  a  total  of  1776    individuals  recorded
whether  individuals  left  the  study  early  for  any  reason  by  group
(Analysis  1.5).  There  was  considerable  clinical  heterogeneity
between these trials. The individual TFCBT group did significantly
worse than the waitlist/usual care group (RR 1.64; 95% CI 1.30 to
2.06).

Secondary outcomes

1.3 Self-reported PTSD symptoms

Seventeen  studies  considered  this  outcome  with  a  total  of  686
  individuals  (Analysis  1.1.4).  There  was  heterogeneity  between
these  trials  (Chi2  =  82.15;  P  <  0.00001;  I2  =  81%)  and  we  used  a
random-effects model to pool the data. The individual TFCBT group

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

26

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

did  better  than  the  waitlist/usual  care  group  immediately  after
treatment (SMD -1.60; 95% CI -2.02 to -1.18).

At  1-  to  4-month  follow-up  two  studies  compared  this  outcome
with 181 individuals (Analysis 1.6). There was marked heterogeneity
between these trials (Chi2 = 40.04; P = 0.00001; I2 = 98%). There were
no significant differences between groups (SMD -3.03; 95% CI -6.51
to 0.45).

At  5-  to  8-month  follow-up  two  studies    compared  this  outcome
with 208  individuals (Analysis 1.7). The individual TFCBT group did
better than the waitlist/usual care group (SMD -0.61; 95% CI -0.90
 to -0.32).

At  9-  to  12-month  follow-up  one  study  compared  this  outcome
with 121 individuals (Analysis 1.8). The individual TFCBT group did
better than the waitlist/usual care group (SMD -1.22; 95% CI -1.61
to -0.83).

1.4 Depression

Twenty-nine    studies  considered  this  outcome  with  a  total  of
1233  individuals (Analysis 1.9). There was heterogeneity between
these  trials  (Chi2  =  174.84,  P  <  0.00001;  I2  =  84%)  and  we  used
a  random-effects  model  to  pool  the  data.  The  individual  TFCBT
group  did  better  than  the  waitlist/usual  care  group  immediately
after treatment (SMD -1.31; 95% CI -1.65 to -0.98).

At 1- to 4-month follow-up seven studies compared this outcome
with  413  individuals  (Analysis  1.10).  There  was  heterogeneity
between  these  trials  (Chi2  =  41.24;  P  <  0.00001;  I2  =  85%).  The
individual  TFCBT  group  did  better  than  the  waitlist/usual  care
group (SMD -0.75; 95% CI -1.33 to -0.18).

At 5- to 8-month follow-up two studies compared this outcome with
150    individuals  (Analysis  1.11).  The  individual  TFCBT  group  did
better than the waitlist/usual care group (SMD -0.50; 95% CI -0.82
to -0.17).

At  9-  to  12-month  follow-up  one  study  compared  this  outcome
with 108 individuals (Analysis 1.12). The individual TFCBT group did
better than the waitlist/usual care group (SMD -0.60; 95% CI -0.99
to -0.21).

1.5 Anxiety

Eighteen    studies  considered  this  outcome  with  a  total  of  664
 individuals (Analysis 1.13). There was heterogeneity between these
trials (Chi2 = 27.43; P = 0.04; I2 = 38%) and we used a random-effects
model to pool the data. The individual TFCBT group did better than
the  waitlist/usual  care  group  immediately  after  treatment  (SMD
-0.82; 95% CI -1.03 to -0.61).

At  1-to  4-month  follow-up  three  studies  compared  this  outcome
with 189 individuals (Analysis 1.14). There was little heterogeneity
between trials (Chi2 = 2.16; P = 0.34; I2 = 7%). The TFCBT group did
better than the waitlist/usual care group (SMD -0.32; 95% CI -0.60
to -0.03).

At 9- to 12-month follow-up one study compared this outcome with
108  individuals  (Analysis  1.15).  There  was  no  difference  between
the two groups (SMD -0.33; 95% CI -0.71 to 0.05).

1.6 PTSD diagnosis after treatment

Cochrane Database of Systematic Reviews

Nineteen  studies  with  a  total  of  910  individuals  reported  this
outcome  (Analysis  1.18).  There  was  significant  heterogeneity
between  these  trials  (Chi2  =  101.56;  P  <  0.00001;  I2  =  82%)  and
we used a random-effects model to pool the data. The individual
TFCBT group did better than the waitlist/usual care group (RR 0.51;
95% CI 0.41 to 0.64).

1.7 Adverse effects

No studies formally considered adverse effects.

Comparison 2. TFCBT versus non-TFCBT

Seven  studies  including  267  participants  contributed  to  this
comparison.

Primary outcomes

2.1 Clinician-rated PTSD symptoms

Seven  studies  considered  this  outcome  with  a  total  of  267
individuals  (Analysis  2.1).  There  was  evidence  of  heterogeneity
between these trials (Chi2 = 11.25; P = 0.08; I2 = 47%), and we used
a random-effects model to pool the data. There was no difference
between  TFCBT  and  non-TFCBT  in  terms  of  clinician-rated  PTSD
symptoms immediately after treatment (SMD -0.27; 95% CI -0.63 to
0.10).

At  1-  to  4-month  follow-up  five  studies  considered  this  outcome
with  a  total  of  127  individuals  (Analysis  2.2).  There  was  evidence
of  heterogeneity  between  these  trials  (Chi2  =  7.30;  P  =  0.12;  I2  =
45%), and we used a random-effects model to pool the data. The
individual TFCBT group did better than the non-TFCBT group (SMD
-0.51; 95% CI -1.00 to -0.01).

At 5- to 8-month follow-up two studies compared this outcome with
48 individuals (Analysis 2.3). There was evidence of heterogeneity
between these trials (Chi2 = 3.32; P = 0.07; I2 = 70%) and we used a
random-effects model to pool the data. Based on these two trials,
there was no difference between TFCBT and non-TFCBT in terms of
clinician-rated PTSD symptoms at five to eight months (SMD -1.00;
95% CI -2.17 to 0.17).

At  9-  to  12-month  follow-up  two  studies  compared  this  outcome
with  48  individuals  (Analysis  2.4).  There  was  no  evidence  of
heterogeneity between these trials (Chi2 = 0.08; P = 0.78; I2 = 0%) and
we used a random-effects model to pool the data. Based on these
two trials, there was no difference between TFCBT and non-TFCBT
in terms of clinician-rated PTSD symptoms at 9 to 12 months (SMD
-12.93; 95% CI -18.72 to -7.14).

2.2 Drop-outs

Seven  studies  with  a  total  of  312  individuals  recorded  whether
individuals  left  the  study  early  for  any  reason  by  group  (Analysis
2.5).  There  was  no  difference  between  the  TFCBT  group  and  the
non-TFCBT on this measure (RR 1.19; 95% CI 0.71 to 2.0).

Secondary outcomes

2.3 Self-reported PTSD symptoms

Three  studies  considered  this  outcome  with  a  total  of  127
individuals  (Analysis  2.6).  There  was  no  evidence  of  significant
heterogeneity between these trials. The individual TFCBT group did
better than the non-TFCBT group (SMD -0.37; 95% CI -0.74 to 0.01).

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

27

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

At  1-  to  4-month  follow-up  two  studies  considered  this  outcome
with a total of 54 individuals (Analysis 2.7). There was no significant
heterogeneity between these trials (Chi2 = 0.78; P = 0.38; I2 = 0%).
There  was  no  difference  between  the  TFCBT  group  and  the  non-
TFCBT on this measure (SMD -0.44; 95% CI -0.99 to 0.10).

No studies formally considered adverse effects.

Comparison 3. TFCBT versus other therapies

Eleven  studies  including  762  participants  contributed  to  this
comparison.

2.4 Depression

Six studies considered this outcome with a total of 189 individuals
(Analysis  2.8).  There  was  no  evidence  of  heterogeneity  between
these trials (Chi2 = 4.23; P = 0.52; I2 = 0%). There was no difference
between  the  individual  TFCBT  group  and  the  non-TFCBT  group
immediately after treatment (SMD -0.27; 95% CI -0.56 to 0.03).

At  1-  to  4-month  follow-up  five  studies  considered  this  outcome
with a total of 147 individuals (Analysis 2.9). There was no evidence
of significant heterogeneity between these trials (Chi2 = 4.47; P =
0.35;  I2  =  11%).  There  was  no  difference  between  the  individual
TFCBT group and the non-TFCBT group (SMD -0.28; 95% CI -0.62 to
0.06).

At 5- to 8-month follow-up two studies compared this outcome with
48 individuals (Analysis 2.10). There was no evidence of significant
heterogeneity between these trials (Chi2 = 0.26; P = 0.61; I2 = 0%).
The individual TFCBT group did better than the non-TFCBT group
(SMD -0.71; 95% CI -1.30 to -0.12).

At  9-  to  12-month  follow-up  one  study  compared  this  outcome
with  20  individuals  (Analysis  2.11).  The  individual  TFCBT  group
did better than the non-TFCBT group (SMD -8.00; 95% CI -14.44 to
-1.86).

2.5 Anxiety

Four studies considered this outcome with a total of 127 individuals
(Analysis 2.12). There was no evidence of significant heterogeneity
between these trials (Chi2 = 3.12; P = 0.37; I2 = 4%). There was no
difference between the individual TFCBT group and the non-TFCBT
group (SMD -0.12; 95% CI -0.49 to 0.26).

At  1-  to  4-month  follow-up  four  studies  considered  this  outcome
with a total of 117 individuals (Analysis 2.13). There was evidence of
heterogeneity between these trials (Chi2 = 5.56; P = 0.13; I2 = 46%).
There was no difference between the individual TFCBT group and
the non-TFCBT group (SMD -0.24; 95% CI -0.79 to 0.30).

At 5- to 8-month follow-up one study compared this outcome with
20 individuals (Analysis 2.14). There was no difference between the
individual TFCBT group and the non-TFCBT group (SMD -0.62; 95%
CI -1.52 to 0.28).

At 9- to 12-month follow-up one study compared this outcome with
20 individuals (Analysis 2.15). There were no significant differences
between groups (SMD -0.88; 95% CI -1.81 to 0.04).

2.6 PTSD diagnosis after treatment

Six  studies  with  a  total  of  284  individuals  reported  this  outcome
(Analysis  2.16).  There  was  no  difference  between  the  individual
TFCBT  group  and  the  stress  non-TFCBT  group  (RR  0.83;  95%  CI
0.60  to  1.17),  using  a  random-effects  model  due  to  moderate
heterogeneity (Chi2 = 8.59; P = 0.13; I2 = 42%).

2.7 Adverse effects

Primary outcomes

3.1 Clinician rated PTSD symptoms

Ten studies considered this outcome with a total of 625 individuals
(Analysis 3.1). There was evidence of heterogeneity between these
trials (Chi2 = 29.33; P = 0.0006; I2 = 69%) and we used a random-
effects  model  to  pool  the  data  The  individual  TFCBT  group  did
better than the 'other therapies' group immediately after treatment
(SMD -0.48; 95% CI -0.83 to -0.14).

At 1- to 4-month follow-up eight studies considered this outcome
with  a  total  of  548  individuals  (Analysis  3.2).  There  was  evidence
of  significant  heterogeneity  between  these  trials  (Chi2  =  15.13;  P
= 0.03; I2 = 54%). The individual TFCBT group did better than the
'other therapies' group (SMD -0.34; 95% CI -0.64 to -0.04).

At 5- to 8-month follow-up four studies compared this outcome with
434  individuals  (Analysis  3.3).  There  was  evidence  of  significant
heterogeneity  between  these  trials  (Chi2  =  19.43;  P  =  0.0002;  I2  =
85%), and we used a random-effects model to pool the data. There
were  no  differences  between  groups  (SMD  -0.58;  95%  CI  -1.20  to
0.04).

At  9-  to  12-month 
follow-up  two  studies  compared  this
outcome  with  90  individuals  (Analysis  3.4).  There  was  significant
heterogeneity  between  these  trials  (Chi2  =  1.75;  P  =  0.19;  I2  =
43%), and we used a random-effects model to pool the data. The
individual TFCBT group did better than the 'other therapies' group
(SMD -0.76; 95% CI -1.35 to -0.17).

3.2 Drop-outs

Eleven studies with a total of 762 individuals reported this outcome
(Analysis 3.5). There was little heterogeneity between these trials.
'Other  therapies'  did  better  than  TFCBT  (RR  1.39;  95%  CI  1.01  to
1.92).

Secondary outcomes

3.3 Self-reported PTSD symptoms

Six studies considered this outcome with a total of 574 individuals
(Analysis 3.6). There was evidence of heterogeneity between these
trials (Chi2 = 39.39; P < 0.00001; I2 = 87%) and we used a random-
effects  model  to  pool  the  data.  The  individual  TFCBT  group  did
better than the 'other therapies' group immediately after treatment
(SMD -0.60; 95% CI -1.15 to -0.06).

At  1-  to  4-month  follow-up  five  studies  considered  this  outcome
with a total of 526 individuals (Analysis 3.7). There was no evidence
of heterogeneity between these trials. The individual TFCBT group
did better than the 'other therapies' group (SMD -0.29; 95% CI -0.47
to -0.12).

At  5-  to  8-month 
follow-up  three  studies  compared  this
outcome with 338 individuals (Analysis 3.8). There was significant
heterogeneity  between  these  trials  (Chi2  =  16.14;  P  =  0.0003;  I2  =
88%) and we used a random-effects model to pool the data. There

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

28

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

were  no  differences  between  groups  (SMD  -0.90;  95%  CI  -2.05  to
0.25).

At  9-  to  12-month  follow-up  two  studies  compared  this  outcome
with  90  individuals  (Analysis  3.9).  There  was  no  evidence  of
heterogeneity between these trials (Chi2 = 0.26; P = 0.61; I2 = 0%).
Based on these two trials, there was no difference between TFCBT
and  'other  therapies'  in  terms  of  clinician-rated  PTSD  symptoms
(SMD -2.66; 95% CI -5.71 to 0.38).

3.4 Depression

Nine studies considered this outcome with a total of 570 individuals
(Analysis 3.10). There was evidence of heterogeneity between these
trials (Chi2 = 13.34; P = 0.10; I2 = 40%), and we used a random-effects
model to pool the data. The individual TFCBT group did better than
the 'other therapies' group (SMD -0.37; 95% CI -0.63 to -0.11).

At 1- to 4-month follow-up seven studies considered this outcome
individuals  (Analysis  3.11).  There  was
with  a  total  of  510 
heterogeneity between these trials (Chi2 = 13.28; P = 0.04; I2 = 55%).
There  was  no  difference  between  the  groups  (SMD  -0.29;  95%  CI
-0.62 to 0.03).

At  5-  to  8-month  follow-up  five  studies  considered  this  outcome
with  a  total  of  443 
individuals  (Analysis  3.12).  There  was
heterogeneity between these trials (Chi2 = 12.31; P = 0.02; I2 = 68%),
and we used a random-effects model to pool the data. There were
no differences between groups (SMD -0.43; 95% CI -0.87 to 0.01).

At 9- to 12-month follow-up

3.5 Anxiety

Seven  studies  considered  this  outcome  with  a  total  of  539
individuals (Analysis 3.14). There was heterogeneity between these
trials (Chi2 = 14.75; P = 0.02; I2 = 59%), and we used a random-effects
model to pool the data. The individual TFCBT group did better than
the 'other therapies' group (SMD -0.45; 95% CI -0.77 to -0.12).

At  1-  to  4-month  follow-up  five  studies  considered  this  outcome
with  a  total  of  454 
individuals  (Analysis  3.15).  There  was
heterogeneity between these trials (Chi2 = 8.54; P = 0.07; I2 = 53%),
and we used a random-effects model to pool the data. There was no
difference between the individual TFCBT and the 'other therapies'
groups (SMD -0.33; 95% CI -0.68 to 0.02).

Two trials reported this outcome at 5- to 8-month follow-up with
a total of 329 individuals (Analysis 3.16). There was heterogeneity
between these trials (Chi2 = 10.28; P = 0.001; I2 = 90%), and we used
a random-effects model to pool the data. There was no difference
between groups (SMD -0.56; 95% CI -1.69 to 0.58).

3.6 PTSD diagnosis after treatment

Seven studies with a total of 358 individuals reported this outcome
(Analysis  3.17).  There  was  evidence  of  significant  heterogeneity
between these trials (Chi2 = 9.54; P = 0.15; I2 = 37%), and we used a
random-effects model to pool the data. The individual TFCBT group
did better than the 'other therapies' group (RR 0.75; 95% CI 0.59 to
0.96).

3.7 Adverse effects

No studies formally considered adverse effects.

Cochrane Database of Systematic Reviews

Comparison 4. EMDR versus waitlist/usual care

Eight  studies  including  301  participants  contributed  to  this
comparison.

Primary outcomes

4.1 Clinician-rated PTSD symptoms

Six studies considered this outcome with a total of 183 individuals
(Analysis 4.1). There was evidence of heterogeneity between these
trials (Chi2 = 31.52; P = 0.00001; I2 = 84%) and we used a random-
effects model to pool the data. The EMDR group did better than the
waitlist/usual care group immediately after treatment (SMD -1.17;
95% CI -2.04 to -0.30).

4.2 Drop-outs

Seven  studies  with  a  total  of  227  individuals  recorded  whether
individuals  left  the  study  early  for  any  reason  by  group  (Analysis
4.2). There was no evidence of heterogeneity between these trials.
There was no difference between the EMDR and waitlist/usual care
groups (RR 1.05; 95% CI 0.62 to 1.79).

Secondary outcomes

4.3 Self-reported PTSD symptoms

Six studies considered this outcome with a total of 159 individuals
(Analysis 4.3). There was heterogeneity between these trials (Chi2 =
30.66; P < 0.00001; I2 = 84%) and we used a random-effects model to
pool the data. There was no difference between studies (SMD -0.80;
95% CI -1.68 to 0.07).

4.4 Depression

Seven  studies  considered  this  outcome  with  a  total  of  226
individuals (Analysis 4.4). There was heterogeneity between these
trials (Chi2 = 9.61; P = 0.14; I2 = 38%), and we used a random-effects
model to pool the data. The EMDR group did better than the control
group (SMD -1.15; 95% CI -1.52 to -0.78).

4.5 Anxiety

Six studies considered this outcome with a total of 160 individuals
(Analysis 4.5). There was no evidence of significant heterogeneity
between these trials (Chi2 = 3.20; P = 0.67; I2 = 0%). The EMDR group
did better than the control group (SMD -1.02; 95% CI -1.36 to -0.69).

4.7 PTSD diagnosis after treatment

Six  studies  with  a  total  of  209  individuals  reported  this  outcome
(Analysis  4.6).  There  was  no  significant  heterogeneity  between
these trials. The EMDR group did better than the controls (RR 0.51;
95% CI 0.42 to 0.62).

4.6 Adverse effects

No studies formally considered adverse effects.

Comparison 5. EMDR versus individual TFCBT/Exposure
therapy

Eight  studies  including  400  participants  contributed  to  this
comparison.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

29

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Primary outcomes

5.1 Clinician-rated PTSD symptoms

Seven  studies  considered  this  outcome  with  a  total  of  327
individuals  (Analysis  5.1).  There  was  evidence  of  heterogeneity
between these trials (Chi2 = 16.49; P = 0.01; I2 = 64%), and we used
a random-effects model to pool the data. There was no difference
between groups (SMD -0.03; 95% CI -0.43 to 0.38).

At 1- to 4-month follow-up three studies considered this outcome
with a total of 76 individuals (Analysis 5.2). There was significant
heterogeneity between these trials (Chi2 = 5.56; P = 0.06; I2 = 64%),
and we used a random-effects model to pool the data. There was
no difference between groups (SMD -0.19; 95% CI -0.97 to 0.58).

5.2 Drop-outs

Eight  studies  with  a  total  of  400  individuals  recorded  whether
individuals  left  the  study  early  for  any  reason  by  group  (Analysis
5.3). There was little heterogeneity (I2 = 3%) between these trials.
There was no difference between groups (RR 1.00; 95% CI 0.74 to
1.35).

Secondary outcomes

5.3 Self-reported PTSD symptoms

Seven  studies  considered  this  outcome  with  a  total  of  306
individuals (Analysis 5.4). There was heterogeneity between these
trials  (Chi2  =  8.82;  P  =  0.18;  I2  =  32%).  There  was  no  significant
difference  between  the  EMDR  group  and  the  individual  TFCBT
group immediately after treatment (SMD -0.30; 95% CI -0.60 to 0.01).

At  1-  to  4-month  follow-up  five  studies  considered  this  outcome
with  a  total  of  111  individuals  (Analysis  5.5).  There  was  evidence
of  heterogeneity  (Chi2  =  8.46;  P  =  0.08;  I2  =  53%),  and  we  used  a
random-effects  model  to  pool  the  data.  There  was  no  difference
between groups (SMD -0.04; 95% CI -0.61 to 0.52).

At 9- to 12-mont follow-up

5.4 Depression

Eight  studies  considered  this  outcome  with  a  total  of  346
individuals (Analysis 5.6. There was heterogeneity between these
trials  (Chi2  =  24.04;  P  =  0.001;  I2  =  71%),  and  we  used  a  random-
effects model to pool the data. There was no difference between
groups (SMD -0.31; 95% CI -0.75 to 0.13).

Cochrane Database of Systematic Reviews

There was no difference between groups (SMD 0.24; 95% CI -0.33 to
0.81).

5.6 PTSD diagnosis after treatment

Eight studies with a total of 400 individuals reported this outcome
(Analysis 5.10). There was heterogeneity between these trials (Chi2
= 15.56; P = 0.03; I2 = 55%), and we used a random-effects model
to pool the data. There was no difference between the groups (RR
0.95; 95% CI 0.74 to 1.22).

5.7 Adverse effects

No studies formally considered adverse effects.

Comparison 6. EMDR versus non-TFCBT

Three  studies 
comparison.

including  84  participants  contributed  to  this

Primary outcomes

6.1 Clinician-rated PTSD symptoms

Two studies considered this outcome with a total of 53 individuals
(Analysis 6.1). There was little heterogeneity between these trials
(Chi2  =  0.69;  P  =  0.41;  I2  =  0%).  There  was  no  difference  between
groups (SMD -0.35; 95% CI -0.90 to 0.19).

At 1- to 4-month follow-up three studies considered this outcome
with a total of 71 individuals (Analysis 6.2). There was heterogeneity
between these trials (Chi2 = 6.16; P = 0.05; I2 = 68%), and we used
a random-effects model to pool the data. There was no difference
between groups (SMD -0.74; 95% CI -1.64 to 0.15).

6.2 Drop-outs

Three  studies  with  a  total  of  84  individuals  recorded  whether
individuals  left  the  study  early  for  any  reason  by  group  (Analysis
6.3). There was little heterogeneity between these trials. There was
no difference between groups (RR 1.03; 95% CI 0.37 to 2.88).

Secondary outcomes

6.3 Self-reported PTSD symptoms

Three studies considered this outcome with a total of 75 individuals
(Analysis 6.4). There was little heterogeneity between these trials
(Chi2  =  0.64;  P  =  0.73;  I2  =  0%).  There  was  no  difference  between
groups (SMD -0.40; 95% CI -0.86 to 0.06).

At  1-  to  4-month  follow-up  five  studies  considered  this  outcome
with  a  total  of  111 
individuals  (Analysis  5.7).  There  was
heterogeneity between these trials (Chi2 = 6.93; P = 0.14; I2 = 42%).
There was no difference between groups (SMD -0.13; 95% CI -0.64
to 0.38).

At 1- to 4-month follow-up three studies considered this outcome
with  a  total  of  75  individuals  (Analysis  6.5).  There  was  little
heterogeneity between these trials (Chi2 = 0.89; P = 0.64; I2 = 0%).The
EMDR  group  did  significantly  better  than  the  non-TFCBT  group
immediately after treatment (SMD -0.52; 95% CI -0.98 to -0.05).

5.5 Anxiety

6.4 Depression

Four studies considered this outcome with a total of 236 individuals
(Analysis 5.8). There was little heterogeneity between these trials
(Chi2 = 1.94; P = 0.58; I2 = 0%). The EMDR group did better than the
TFCBT group (SMD -0.28; 95% CI -0.53 to -0.02).

Three studies considered this outcome with a total of 75 individuals
(Analysis 6.6). There was little heterogeneity between these trials.
(Chi2 = 1.02; P = 0.60; I2 = 0%). The EMDR group did better than the
non-TFCBT group (SMD -0.67; 95% CI -1.14 to -0.20).

At  1-  to  4-month  follow-up  two  studies  considered  this  outcome
with  a  total  of  48  individuals  (Analysis  5.9).  There  was  little
heterogeneity between these trials (Chi2 = 0.70; P = 0.40; I2 = 0%).

At 1- to 4-month follow-up three studies considered this outcome
with a total of 75 individuals (Analysis 6.7). There was heterogeneity
between these trials. (Chi2 = 3.45; P = 0.18; I2 = 42%), and we used

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

30

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

a random-effects model to pool the data. There was no difference
between groups (SMD -0.25; 95% CI -0.86 to 0.36).

(Chi2 = 0.10; P = 0.75; I2 = 0%). The EMDR group did better than the
'other therapies' group (SMD -0.72; 95% CI -1.08 to -0.36).

6.5 Anxiety

7.6 PTSD diagnosis after treatment (Analysis 7.5)

Two studies considered this outcome with a total of 45 individuals
(Analysis 6.8). There was little heterogeneity between these trials
(Chi2 = 0.37; P = 0.54; I2 = 0%). The EMDR group did better than the
non-TFCBT group (SMD -0.75; 95% CI -1.36 to -0.13).

At  1-  to  4-month  follow-up  two  studies  considered  this  outcome
with a total of 45 individuals (Analysis 6.9). There was heterogeneity
between these trials (Chi2 = 8.09; P = 0.004; I2 = 88%), and we used
a random-effects model to pool the data. There was no difference
between groups (SMD -0.42; 95% CI -2.21 to 1.37).

6.6 PTSD diagnosis after treatment

Three studies with a total of 84 individuals reported this outcome
(Analysis 6.10). There was significant heterogeneity between these
trials. There was no difference between groups ((RR 0.71; 95% CI
0.41 to 1.22).

7.7 Adverse effects

No studies formally considered adverse effects.

Comparison 8. Non-TFCBT versus waitlist/usual care

Five  studies 
comparison.

including  141  participants  contributed  to  this

Primary outcomes

8.1 Clinician-rated PTSD symptoms

Four studies considered this outcome with a total of 106 individuals
(Analysis 8.1). There was heterogeneity between these trials (Chi2 =
4.62; P = 0.2; I2 = 35%), and we used a random-effects model to pool
the data. The non-TFCBT group did better than the controls (SMD
-1.22; 95% CI -1.76 to -0.69).

6.7 Adverse effects

8.2 Drop-outs

No studies formally considered adverse effects.

Comparison 7. EMDR versus 'other therapies'

Two  studies 
comparison.

including  127  participants  contributed  to  this

Four  studies  with  a  total  of  121  individuals  recorded  whether
individuals  left  the  study  early  for  any  reason  by  group  (Analysis
8.2).  There  was  no  significant  heterogeneity  between  these  trials
(Chi2 = 1.10; P = 0.89; I2 = 0%). There was no difference between the
groups (RR 1.96; 95% CI 0.70 to 5.48).

Primary outcomes

7.1 Clinician rated PTSD symptoms

No studies formally considered this outcome.

7.2 Drop-outs

Two  studies  with  a  total  of  127  individuals  recorded  whether
individuals  left  the  study  early  for  any  reason  by  group  (Analysis
7.1). There was little heterogeneity between these trials. There was
no difference between groups (RR 1.48; 95% CI 0.26 to 8.54).

Secondary outcomes

7.3 Self-reported PTSD symptoms

Two studies considered this outcome with a total of 124 individuals
(Analysis 7.2). There was little heterogeneity between these trials
(Chi2  =  0.19;  P  =  0.66;  I2  =  0%).  The  EMDR  group  did  better  than
the 'other therapies' group immediately after treatment (SMD -0.84;
95% CI -1.21 to -0.47).

7.4 Depression

Two studies considered this outcome with a total of 127 individuals
(Analysis 7.3). There was little heterogeneity between these trials
(Chi2 = 0.05; P = 0.82; I2 = 0%). The EMDR group did better than the
'other therapies' group (SMD -0.67; 95% CI -1.03 to -0.32).

7.5 Anxiety

Two studies considered this outcome with a total of 126 individuals
(Analysis 7.4). There was little heterogeneity between these trials

Secondary outcomes

8.3 Self-reported PTSD symptoms

Two studies considered this outcome with a total of 44 individuals
(Analysis 8.3). There was considerable heterogeneity between the
groups (Chi2 = 11.83; P = 0.0006; I2 = 92%), and we used a random-
effects model to pool the data. There was no difference between the
non-TFCBT  group  and  the  waitlist/usual  care  group  immediately
after treatment (SMD -0.86; 95% CI -3.27 to 1.55).

8.4 Depression

Five studies considered this outcome with a total of 129 individuals
(Analysis 8.4). There was heterogeneity between these trials (Chi2
= 7.04; P = 0.13; I2 = 43%), and we used a random-effects model to
pool the data. The non-TFCBT group did better than the waitlist/
usual care group immediately after treatment (SMD -0.93; 95% CI
-1.43 to -0.42).

8.5 Anxiety

Four studies considered this outcome with a total of 102 individuals
(Analysis  8.5).  There  was  no  heterogeneity  between  these  trials
(Chi2  =  2.38;  P  =  0.50;  I2  =  0%).  Non-TFCBT  did  better  than  the
waitlist/usual care group immediately after treatment (SMD -0.83;
95% CI -1.24 to -0.42).

8.6 PTSD diagnosis after treatment

Four studies with a total of 121 individuals reported this outcome
(Analysis 8.6). There was heterogeneity between these trials (Chi2
= 6.15; P = 0.10; I2 = 51%), and we used a random-effects model to
pool the data. The non-TFCBT group did better than the waitlist/
usual care group (RR 0.65; 95% CI 0.50 to 0.86).

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

31

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

8.7 Adverse effects

Comparison 10. Group TFCBT versus waitlist/usual care

No studies formally considered adverse effects.

Comparison 9. Non-TFCBT versus other therapies

One study including 31 participants contributed to this comparison.

Primary outcomes

9.1 Clinician-rated PTSD symptoms

One study considered this outcome with a total of 25 individuals
(Analysis 9.1). The stress non-TFCBT group did better than the other
therapies  group  immediately  after  treatment  (SMD  -1.22;  95%  CI
-2.09 to -0.35).

At 1- to 4-month follow-up one study considered this outcome with
a total of 18 individuals (Analysis 9.2). The stress non-TFCBT group
did no better than the 'other therapies' group (SMD -0.38; 95% CI
-1.31 to 0.55).

9.2 Drop-outs

One  study  with  a  total  of  31  individuals  recorded  whether
individuals  left  the  study  early  for  any  reason  by  group  (Analysis
9.3). There was no difference between groups (RR 0.82; 95% CI 0.20
to 3.46).

Secondary outcomes

9.3 Self-reported PTSD symptoms

No studies considered this outcome.

9.4 Depression

One study considered this outcome with a total of 25 individuals
(Analysis 9.4). There was no difference between groups (SMD -0.51;
95% CI -1.31 to 0.30).

At 1- to 4-month follow-up one study considered this outcome with
a  total  of  18  individuals  (Analysis  9.5).  There  was  no  difference
between groups (SMD -0.48; 95% CI -1.42 to 0.46).

9.5 Anxiety

One study considered this outcome with a total of 25 individuals
(Analysis 9.6). There was no difference between groups (SMD -0.51;
95% CI -1.32 to 0.29).

At 1- to 4-month follow-up one study considered this outcome with
a  total  of  18  individuals  (Analysis  9.7).  There  was  no  difference
between groups (SMD -0.68; 95% CI -1.64 to 0.28).

9.6 PTSD diagnosis after treatment

One  study  with  a  total  of  31  individuals  reported  this  outcome
(Analysis  9.8).  There  was  no  difference  between  groups  (RR  0.58;
95% CI 0.30 to 1.11).

9.7 Adverse effects

No studies formally considered adverse effects.

Seven  studies  including  573  participants  contributed  to  this
comparison.

Primary outcomes

10.1 Clinician-rated PTSD symptoms

Three  studies  considered  this  outcome  with  a  total  of  185
individuals (Analysis 10.1). There was heterogeneity between these
trials (Chi2 = 15.60; P = 0.0004; I2 = 87%), and we used a random-
effects model to pool the data. The Group TFCBT group did better
than  the  waitlist/usual  care  group  immediately  after  treatment
(SMD -1.28; 95% CI -2.25 to -0.31).

At 5- to 8-month follow-up one study compared this outcome with
97  individuals  (Analysis  10.2).  The  Group  TFCBT  group  did  better
than the waitlist/usual care group (SMD -0.72; 95% CI -1.14 to -0.31).

10.2 Drop-outs

Seven  studies  with  a  total  of  573  individuals  recorded  whether
individuals  left  the  study  early  for  any  reason  by  group  (Analysis
10.3). There was no significant heterogeneity between these trials
(Chi2 = 2.28; P = 0.81; I2 = 0%). There was no difference between the
Group TFCBT group and the waitlist/usual care group (RR 1.21; 95%
CI 0.94 to 1.55).

Secondary outcomes

10.3 Self-reported PTSD symptoms

Six studies considered this outcome with a total of 274 individuals
(Analysis 10.4). There was heterogeneity between these trials (Chi2
= 17.53; P = 0.004; I2 = 71%), and we used a random-effects model to
pool the data. The Group TFCBT group did better than the waitlist/
usual care group immediately after treatment (SMD -1.20; 95% CI
-1.70 to -0.69).

At  1-  to  4-month  follow-up  two  studies  compared  this  outcome
with 73 individuals (Analysis 10.5). There was some heterogeneity
between  these  trials  (Chi2  =  1.45;  P  =  0.23;  I2  =  31%).  The
Group TFCBT group did better than the waitlist/usual care group
immediately after treatment (SMD -1.14; 95% CI -1.78 to - 0.50).

10.4 Depression

Three studies with a total of 137 individuals reported this outcome
(Analysis 10.6). There was heterogeneity between these trials (Chi2
= 9.91; P = 0.007; I2 = 80%), and we used a random-effects model to
pool the data. The Group TFCBT group did significantly better than
the waitlist/usual care group (SMD -1.15; 95% CI -1.98 to -0.32).

At 1- to 4-month follow-up one study compared this outcome with
49  individuals  (Analysis  10.7).  The  Group  TFCBT  group  did  better
than the waitlist/usual care group (SMD -0.62; 95% CI -1.00 to -0.24).

10.5 Anxiety

Three studies with a total of 106 individuals reported this outcome
(Analysis 10.8). There was little heterogeneity between these trials.
The Group TFCBT group did significantly better than the waitlist/
usual care group immediately after treatment (SMD -0.66; 95% CI
-1.06 to -0.27).

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

32

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

At  1-  to  4-month  follow-up  two  studies  compared  this  outcome
with 61 individuals (Analysis 10.9). There was little heterogeneity
between  these  trials  (Chi2  =  1.20;  P  =  0.27;  I2  =  17%).  The  Group
TFCBT  group  did  significantly  better  than  the  waitlist/usual  care
group (SMD -0.43; 95% CI -0.72 to -0.14).

10.6 PTSD diagnosis after treatment

One  study  with  a  total  of  48  individuals  reported  this  outcome
(Analysis  10.10).There  was  no  significant  difference  between  the
Group TFCBT group and the waitlist/usual care group (RR 0.56; 95%
CI 0.31 to 1.01).

10.7 Adverse effects

No studies formally considered adverse effects.

Primary outcomes

12.1 Clinician-rated PTSD symptoms

Three  studies  considered  this  outcome  with  a  total  of  112
individuals  (Analysis  12.1).  There  was  no  heterogeneity  between
these  trials  (Chi2  =  1.61;  P  =  0.45;  I2  =  0%).  The  'other  therapies'
group  did  better  than  the  waitlist/usual  care  group  immediately
after treatment (SMD -0.58; 95% CI -0.96 to -0.20).

12.2 Drop-outs

Four  studies  with  a  total  of  211  individuals  recorded  whether
individuals  left  the  study  early  for  any  reason  by  group  (Analysis
12.2). There was no heterogeneity between these trials. The waitlist
group did better than the 'other therapies' group (RR 2.45; 95% CI
0.99 to 6.10).

Comparison 11. Group TFCBT versus group non-TF CBT

One  study 
comparison.

including  360  participants  contributed  to  this

Secondary outcomes

12.3 Self-reported PTSD symptoms

Primary outcomes

11.1 Clinician-rated PTSD symptoms

One study considered this outcome with a total of 325 individuals
(Analysis 11.1). There was no difference between the Group trauma-
focused CBT and Group non-trauma-focused CBT (SMD -0.12; 95%
CI -0.34 to 0.10).

11.2 Drop-outs

One  study  with  a  total  of  360  individuals  recorded  whether
individuals  left  the  study  early  for  any  reason  by  group  (Analysis
11.2).  There  was  no  significant  difference  between  the  Group
trauma-focused  CBT  and  Group  non-trauma-focused  CBT  groups
(RR 1.38; 95% CI 1.00 to 1.90).

Secondary outcomes

11.3 Self-reported PTSD symptoms

No studies considered this outcome.

11.4 Depression

No studies considered this outcome.

11.5 Anxiety

No studies considered this outcome.

11.6 PTSD diagnosis after treatment

One  study  with  a  total  of  360  individuals  reported  this  outcome
(Analysis 11.3). There was no difference between the Group trauma-
focused CBT and Group non-trauma-focused CBT groups (RR 0.98;
95% CI 0.83 to 1.16).

11.7 Adverse effects

Two studies considered this outcome with a total of 132 individuals
(Analysis  12.3).  There  was  no  heterogeneity  between  these  trials
(Chi2 = 0.29; P = 0.59; I2 = 0%). The 'other therapies' group did better
than  the  waitlist/usual  care  group  immediately  after  treatment
(SMD -0.61; 95% CI -0.98 to -0.24).

12.4 Depression

Three  studies  considered  this  outcome  with  a  total  of  112
individuals (Analysis 12.4). There was little heterogeneity between
these trials (Chi2 = 2.62; P = 0.27; I2 = 24%). The 'other therapies'
group  did  better  than  the  waitlist/usual  care  group  immediately
after treatment (SMD -0.45; 95% CI -0.83 to -0.07).

12.5 Anxiety

Four studies considered this outcome with a total of 193 individuals
(Analysis  12.5).  There  was  no  heterogeneity  between  these  trials
(Chi2  =  0.70;  P  =  0.87;  I2  =  0%).  The  'other  therapies'  group  did
significantly better than the waitlist/usual care group immediately
after treatment (SMD -0.52; 95% CI -0.82 to -0.22).

12.6 PTSD diagnosis after treatment

Four studies with a total of 210 individuals reported this outcome
(Analysis 12.6). There was heterogeneity between these trials (Chi2
=  8.34;  P  =  0.04;  I2  =  64%),  and  we  used  a  random-effects  model
to  pool  the  data.  There  was  no  difference  between  the  'other
therapies' and the waitlist/usual care group (RR 0.80; 95% CI 0.61
to 1.05).

12.7 Adverse effects

No studies formally considered adverse effects.

Comparison 13. Group non-TFCBT versus waitlist/usual care

One study including 47 participants contributed to this comparison.

No studies formally considered adverse effects.

Primary outcomes

Comparison 12. Other therapies versus waitlist/usual care

13.1 Clinician-rated PTSD symptoms

Four  studies 
comparison.

including  211  participants  contributed  to  this

No studies considered this outcome.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

33

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

13.2 Drop-outs

19. Risk of bias sensitivity analysis

One  study  with  a  total  of  47  individuals  recorded  whether
individuals  left  the  study  early  for  any  reason  by  group  (Analysis
13.1). There was no difference between groups (RR 1.76; 95% CI 0.17
to 18.11).

Secondary outcomes

13.3 Self-reported PTSD symptoms

One study considered this outcome with a total of 47 individuals
(Analysis 13.2). There was no difference between groups (SMD -0.49;
95% CI -1.07 to 0.09).

At 1- to 4-month follow-up one study considered this outcome with
a  total  of  47  individuals  (Analysis  13.3).  There  was  no  difference
between groups (SMD -0.40; 95% CI -0.98 to 0.18).

13.4 Depression

19.1 Comparison 1. Individual TFCBT/Exposure therapy versus
waitlist/usual care

Clinician-rated PTSD symptoms

Only  one  trial  (  Basoglu  2005)  including  59  participants  had  a
low  risk  of  bias  for  sequence  generation,  allocation  concealment
and  blinding  of  the  outcome  assessor.  Analysis  restricted  only
to  this  trial  (Analysis  1.17)  showed  no  difference  between  TFCBT
and  waitlist/usual  care  (SMD  -0.44;  95%  CI  -0.95  to  0.08),  which
differs from the overall meta-analysis, which showed a statistically
significant difference in favour of TFCBT (SMD -1.62; 95% CI -2.03 to
-1.21). However, the intervention was a single session of TFCBT.

Drop-outs

The intervention was a single session of TFCBT. On this basis, drop-
out was not a relevant comparison.

One study considered this outcome with a total of 47 individuals
(Analysis 13.4). There was no difference between groups (SMD -0.06;
95% CI -0.64 to 0.51).

19.2 Comparison 2. TFCBT versus non-TFCBT

Fewer than 10 studies made this comparison.

At 1- to 4-month follow-up one study considered this outcome with
a  total  of  47  individuals  (Analysis  13.5).  There  was  no  difference
between groups (SMD -0.03; 95% CI -0.60 to 0.54).

13.5 Anxiety

No studies considered this outcome.

13.6 PTSD diagnosis after treatment

No studies considered this outcome.

13.7 Adverse effects

No studies formally considered adverse effects.

Comparison 14. Individual TFCBT versus group TFCBT

19.3 Comparison 3. TFCBT versus other therapies

Clinician-rated PTSD symptoms

Only one trial (Bryant 2003) including 58 participants had a low risk
of  bias  in  terms  of  sequence  generation,  allocation  concealment
and  blinding  of  the  outcome  assessor.  Analysis  restricted  only  to
this trial (Analysis 3.19) favoured TFCBT (SMD -1.52; 95% CI -2.14 to
-0.89).

Drop-outs

One  study  with  a  total  of  58  participants  had  a  low  risk  of  bias
in  terms  of  sequence  generation,  allocation  concealment  and
blinding of the outcome assessor. There was no difference between
TFCBT and other therapy when the analysis was restricted to this
study (Analysis 3.20) (RR 1.50; 95% CI 0.47 to 4.8).

No studies made this comparison.

19.4 Comparison 4. EMDR versus waitlist/usual care

Comparison 15. Individual TFCBT versus group non-TFCBT

Fewer than 10 studies made this comparison.

No studies made this comparison.

Comparison 16. EMDR versus group TFCBT

No studies made this comparison.

Comparison 17. EMDR versus group non-TFCBT

No studies made this comparison.

Comparison 18. Individual non-TFCBT versus group TFCBT

No studies made this comparison.

Comparison 19. Individual non-TFCBT versus group non-TFCBT

No studies made this comparison.

19.5 Comparison 5. EMDR versus individual TFCBT/Exposure
therapy

Fewer than 10 studies made this comparison.

19.6 Comparison 6. EMDR versus non-TFCBT

Fewer than 10 studies made this comparison.

19.7 Comparison 7. EMDR versus other therapies

Fewer than 10 studies made this comparison.

19.8 Comparison 8. Non-TFCBT versus waitlist/usual care

Fewer than 10 studies made this comparison.

19.9 Comparison 9. Non-TFCBT versus other therapies

Fewer than 10 studies made this comparison.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

34

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

19.10 Comparison 10. Group TFCBT versus waitlist/usual care

Fewer than 10 studies made this comparison.

19.11 Comparison 11. Group TFCBT versus group non-TFCBT

after treatment (SMD -1.67; 95% CI -2.09 to -1.25), demonstrating
little  difference  from  the  overall  analyses.  Excluding  these  two
trials made little difference to the observed statistically significant
heterogeneity or to the effect estimate.

Fewer than 10 studies made this comparison.

20.2 Comparison 3. TFCBT versus other therapies

19.12 Comparison 12. Other therapies versus waitlist/usual care

Fewer than 10 studies made this comparison.

19.13 Comparison 13. Group non-TFCBT versus waitlist/usual
care

Fewer than 10 studies made this comparison.

20. Clinical heterogeneity sensitivity analyses

In  order  to  explore  clinical  heterogeneity,  we  conducted  two
subgroup analyses for the two comparisons including more than 10
studies.

20.1 Comparison 1. Individual TFCBT/Exposure therapy versus
waitlist/usual care

Twenty-eight studies considered this outcome with a total of 1256
individuals (Analysis 1.1.1). There was heterogeneity between these
trials  (Chi2  =  237.95;  P  =  0.00001;  I2  =  89%),  and  we  used  a
random-effects model to pool the data. The individual TFCBT group
did  better  than  the  waitlist/usual  care  group  immediately  after
treatment (SMD -1.62; 95% CI -2.03 to -1.21).

Women-only studies
Nine studies met this criterion, with a total of 562 women (Analysis
1.1.2). There was heterogeneity between these trials (Chi2 = 37.39;
P = 0.00001; I2 = 79%), and we used a random-effects model to pool
the data.The individual TFCBT group did better than the waitlist/
usual  care  group  immediately  after  treatment  (SMD  -1.83;  95%
CI  -2.31  to  -1.36),  demonstrating  a  larger  difference  in  favour  of
individual TFCBT than in the overall analyses.

Studies excluding Vietnam war veterans
Twenty-seven  studies  met  this  criterion,  with  a  total  of  1232
individuals (Analysis 1.1.3). There was heterogeneity between these
trials (Chi2 = 230.39; P = 0.00001; I2 = 89%), and we used a random-
effects  model  to  pool  the  data.The  individual  TFCBT  group  did
significantly better than the waitlist/usual care group immediately

Ten studies considered this outcome with a total of 608 individuals
(Analysis 3.1). There was evidence of heterogeneity between these
trials  (Chi2  =  25.08;  P  =  0.003;  I2  =  64%),  and  we  used  a  random-
effects  model  to  pool  the  data  The  individual  TFCBT  group  did
better than the 'other therapies' group immediately after treatment
(SMD -0.46; 95% CI -0.79 to -0.13).

Women-only studies (sexual assault/abuse)
Three studies met this criterion, with a total of 129 women (Analysis
3.21). There was no difference between groups (SMD 0.03; 95% CI
-0.42 to 0.47).

Studies excluding Vietnam war veterans
Nine  studies  met  this  criterion,  with  a  total  of  599  individuals
(Analysis  3.22).The  individual  TFCBT  group  did  better  than  the
'other  therapies'  group  (SMD  -0.46;  95%  CI  -0.80  to  -0.11),
demonstrating  minimal  difference  from  the  overall  analyses.
Excluding  this  one  trial  made  little  difference  to  the  observed
statistically significant heterogeneity or to the effect estimate.

20.3 Publication bias

All the studies identified for this review were published, and many
of  the  trials  were  undertaken  relatively  recently.  We  explored
the  potential  effects  of  publication  bias  using  funnel  plots.  We
constructed  two  funnel  plots  using  data  from  the  individual
TFCBT versus waitlist/usual care comparison (comparison 1), one
involving continuous data in the primary outcome, and the second
involving  dichotomous  data  in  a  secondary  outcome.  We  also
looked at the TFCBT versus 'other therapies' comparison (3.1).

The  first  funnel  plot  examined  the  measure  of  clinician-rated
PTSD symptoms (see Figure 4) and was roughly symmetrical with
the  exception  of  one  outlier  and  an  absence  of  smaller  studies
demonstrating  no  difference  or  a  difference  in  favour  of  waitlist/
usual care. This suggests the possibility of publication bias. As the
studies  become  less  precise  the  results  of  the  studies  tended  be
more variable and scattered to either side of the more precise larger
studies.  The  same  was  found  for  the  comparison  of  TFCBT  with
other therapies (see Figure 5).

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

35

 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Figure 4.   Funnel plot of comparison: 1 Individual trauma-focused CBT/Exposure therapy vs waitlist/usual care,
outcome: 3.1 Severity of PTSD symptoms - clinician-rated.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

36

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Figure 5.   Funnel plot of comparison: 3 Trauma-focused CBT/Exposure Therapy vs other therapies, outcome: 3.1
Severity of PTSD symptoms - clinician-rated.

The  second  funnel  plot  using  data  from  the  individual  TFCBT
versus waitlist/usual care comparison examined the dichotomous
measure  of  PTSD  diagnosis  after  treatment  (see  Figure  6).  This
funnel  plot  shows  that  larger  studies  demonstrated  smaller
differences between individual TFCBT and waitlist/usual care, and
also  suggests  an  absence  of  smaller  studies  demonstrating  no

difference  or  a  difference  in  favour  of  waitlist/usual  care.  This
funnel  plot  therefore  shows  some  evidence  of  publication  bias.
It  is  possible  that,  due  to  the  greater  likelihood  of  publication  of
positive studies, the true difference between groups is smaller than
is suggested by this review.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

37

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Figure 6.   Funnel plot of comparison: 1 Individual trauma-focused CBT/Exposure therapy vs waitlist/usual care,
outcome: 1.7 PTSD diagnosis after treatment.

D I S C U S S I O N

Summary of main results

We  include  70  studies  of  4761  participants  in  this  review.  We
have  created  a  'Summary  of  findings'  table  for  each  of  the  13
comparisons  we  were  able  to  conduct.  We  assessed  the  quality
of  the  evidence  for  each  comparison  as  very  low.  Statistically,
individual trauma-focused cognitive behavioural therapy (TFCBT)
and  eye  movement  desensitisation  and  reprocessing  (EMDR)
did  better  than  waitlist/usual  care  in  reducing  clinician-assessed
post-traumatic  stress  disorder  (PTSD)  symptoms.  Non-TFCBT  did
significantly  better  than  waitlist/usual  care  and  other  therapies.
Other  therapies  did  significantly  better  than  waitlist/usual  care
control,  as  did  group-TFCBT.  There  was  no  difference  between
group non-TFCBT and waitlist/usual care. There was no statistically
significant  difference  between  individual  TFCBT,  EMDR  and  non-
TFCBT  immediately  post-treatment  although  there  was  some
evidence  that  individual  TFCBT  and  EMDR  are  superior  to  non-
TFCBT at between one and four months following treatment, and
that individual TFCBT, EMDR and non-TFCBT were more effective
than  other  therapies.  There  was  some  evidence  of  greater  drop-
out  in  active  treatment  groups.  The  considerable  unexplained
heterogeneity  observed  in  these  comparisons,  and  the  potential
impact  of  publication  bias  on  these  data,  suggest  the  need  for
caution in interpreting the results of this review.

Trauma-focused cognitive behavioural therapy

There  was  very  low  quality  evidence  that  individual  TFCBT
was  better  than  waitlist/usual  care  in  reducing  traumatic  stress
symptoms  and  associated  symptoms  of  depression  and  anxiety.
The  overall  standardised  mean  difference  for  traumatic  stress
symptoms  post-treatment  represents  an  effect  size  generally
accepted  as  indicating  a  strong  positive  effect.  After  exploration
of  heterogeneity  this  finding  remains  robust  although  there  is
statistically significant heterogeneity present in all analyses. There
is  not  enough  evidence  to  confirm  whether  this  advantage  is
maintained  over  time.  There  is  evidence  that  individual  TFCBT
is a more effective treatment than non-trauma-focused therapies
classed as 'other therapies'. There is also evidence that individual
TFCBT  is  superior  to  non-TFCBT,  although  this  is  not  apparent
immediately after treatment.

Eye movement desensitisation and reprocessing

There  was  very  low  quality  evidence  that  EMDR  was  better  than
waitlist/usual  care  in  reducing  traumatic  stress  symptoms  and
additionally  associated  symptoms  of  depression  and  anxiety.
The overall standardised mean differences for clinician-rated and
self-rated  traumatic  stress  symptoms  post-treatment  represents
a  strong  positive  effect  size.  There  is  not  enough  evidence  to
determine  whether  these  improvements  are  maintained  in  the
long-term  as  there  were  no  follow-up  comparisons  of  EMDR  and
waitlist  groups.  There  were  limited  data  to  suggest  a  better
outcome than non-TFCBT at between one- and four-month follow-

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

38

 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

up.  EMDR  appeared  to  have  similar  effectiveness  to  individual
TFCBT in the studies that compared them directly. There was some
evidence  that  EMDR  was  a  more  effective  treatment  than  other
therapies.

Non-trauma-focused cognitive behavioural therapy

There  was  very  low  quality  evidence  that  non-TFCBT  was  better
than  waitlist/usual  care  in  reducing  traumatic  stress  symptoms
and additionally associated symptoms of depression and anxiety.
It  is  worth  noting  that  the  meta-analyses  of  non-TFCBT  included
fewer participants than TFCBT and EMDR, and demonstrated high
heterogeneity, indicating that these results should be interpreted
with caution. There was some evidence that non-TFCBT is a more
effective treatment than other non-trauma-focused therapies, but
this  was  from  the  results  of  one  study  only.  Non-TFCBT  was
less  effective  than  TFCBT  at  follow-up.  Whilst  this  might  indicate
insufficient statistical power, it may also indicate that non-TFCBT
provides only temporary relief of symptoms, or that TFCBT provides
a basis for continued improvement.

Other therapies

There  was  very  low  quality  evidence  that  other  therapies  were
better  than  waitlist/usual  care  in  reducing  traumatic  stress
symptoms and associated symptoms of depression and anxiety. As
stated above, other therapies were statistically significantly worse
in  terms  of  the  primary  outcome  measure  of  reducing  traumatic
stress  symptoms  when  directly  compared  with  individual  TFCBT
and  non-TFCBT.  There  was  a  statistically  significant  difference  in
favour of other therapies in comparison with individual TFCBT in
terms  of  drop-out.  This  finding  suggests  the  possibility  of  non-
trauma-focused therapies being easier to tolerate than individual
TFCBT, although this finding is based on studies of variable quality.

Group TFCBT

There was very low quality evidence that group TFCBT was better
than  waitlist/usual  care  in  reducing  traumatic  stress  symptoms.
There  was  no  difference  between  group  TFCBT  and  non-trauma-
focused group CBT.

Group non-TFCBT

There  was  no  evidence  that  group  non-TFCBT  was  any  better
than waitlist/usual care in reducing traumatic stress symptoms or
depression immediately after treatment or at four-month follow-up
in the one study making this comparison.

Drop-outs

Individual TFCBT and other therapies both did worse than waitlist/
usual care on this outcome measure. There was also some evidence
that individual TFCBT incurred a greater drop-out rate than other
therapies.

Adverse effects

Unfortunately  no  studies  reported  adverse  effects.  It  is  well
recognised that these may occur, such as increased re-experiencing
following exposure treatment (e.g. Pitman 1991), and the absence
of any reporting of them is of major concern.

Cochrane Database of Systematic Reviews

Anxiety and depression

Symptoms  of  anxiety  and  depression  generally  improved  in  line
with  improvements  in  traumatic  stress  symptoms.  This  is  no
surprise for treatments such as cognitive restructuring where many
of the approaches used for PTSD would also be used for anxiety and
depression.  However  other  treatments  such  as  exposure  therapy
do not address depressive symptoms per se yet still appeared to
reduce  depressive  and  anxiety  symptoms.  This  suggests  that  the
anxiety  and  depressive  symptoms  found  in  many  PTSD  sufferers
in  these  studies  were  secondary  to  the  PTSD  rather  than  being
discrete conditions requiring specific treatment.

Heterogeneity

The  forest  plots  of  the  pooled  results  demonstrated  statistically
significant  heterogeneity  between  the  studies.  For  example,
heterogeneity  levels  of  P  <  0.00001  were  observed  in  several
analyses of the primary outcome measure. There are likely to be
several factors that contribute to this heterogeneity. There is clearly
considerable  clinical  diversity  within  the  studies  considered.  We
attempted  to  explore  this  by  performing  subgroup  analyses  on
the primary outcome measure of individual TFCBT versus waitlist/
usual care. Those studies including only women, all of whom had
been sexually or non-sexually assaulted, produced more positive
results than the overall results. Possible explanations include the
treatments having been superior, women being more responsive to
individual TFCBT than men, traumatisation by assault being more
responsive  to  individual  TFCBT,  a  combination  of  these  and/or
other factors. Those studies that did not include only Vietnam war
veterans produced a slightly more positive result than all studies.
However  there  was  only  one  study  excluded  from  this  subgroup
analysis, which may therefore lack power to show a real difference;
great caution must be exercised in interpreting this finding.

Overall completeness and applicability of evidence

This  review  considers  randomised  controlled  trials  (RCTs)  of
a  wide  range  of  psychological  therapies  for  chronic  PTSD,
including  individual  TFCBT,  EMDR,  non-TFCBT,  group  TFCBT,
group  non-TFCBT,  and  other  psychological  therapies  (see  Types
of  interventions).  Studies  included  participants  from  different
countries  and  backgrounds,  who  had  been  exposed  to  a  variety
of  different  traumatic  events  (see  Types  of  participants).  The
majority  of  studies  reported  on  the  use  of  qualified  and
experienced therapists, and a high proportion included assessment
of  adherence  to  a  treatment  protocol  (see  Characteristics  of
included studies). Many factors, however, limit the generalisability
of  conclusions  reached  by  this  review.  Most  studies  to  date  have
been conducted in the USA, Canada, Australia and Europe, limiting
generalisability  of  results  to  the  rest  of  the  world.  Although  we
have  included  the  full  range  of  psychological  therapies  for  PTSD
considered  by  RCTs  to  date,  insufficient  data  preclude  meta-
analysis  of  a  number  of  outcomes  in  some  treatment  groups.
There  are  many  more  studies  of  individual  TFCBT  than  other
therapies,  for  example,  those  taking  a  person-centred  only  or
psychodynamic approach, which were considered within a single
category.  The  majority  of  studies  did  not  include  participants
with comorbid psychiatric diagnoses and substance dependence,
excluding  individuals  who  are  arguably  more  difficult  to  treat.
This  may  have  resulted  in  the  exclusion  of  individuals  with
complicated  histories  and  the  experience  of  multiple  traumatic
events. Generalising the results to more complex presentations of

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

39

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

the disorder is therefore problematic. There were very limited long-
term  follow-up  data,  especially  for  waitlist  groups.  This  prevents
determination  of  the  long-term  efficacy  of  therapies,  but  the
incremental  improvement  of  the  active  treatment  groups  in  the
trials with longer follow-ups suggests that benefits are maintained.
Comparison  on  the  basis  of  trauma  type,  study  setting  and
participant  variables  would  be  an  interesting  addition  to  future
versions of this review.

Most  studies  reported  on  drop-outs  by  group;  drop-out  rates
are  likely  to  be  influenced  by  adverse  effects  along  with  other
factors. The major distinction between the treatments classed as
TFCBT and those classed as 'other therapies' was the inclusion of
exposure-based components. Since the treatments that included
exposure  had  a  significantly  greater  drop-out  rate,  this  raises
questions surrounding the tolerability of exposure work. Although
it is well documented that exposure-based treatments can cause
short-term exacerbation of symptoms (e.g. Tarrier 1999), we have
little understanding of how this impacts on drop-out rates. Given
that the included studies provide little disclosure of adverse events
and few explanations for drop-outs, it is difficult to ascertain why
participants were less able to tolerate exposure-based treatments.
This  is  an  important  finding  and  one  that  should  stimulate  the
development  of  interventions  that  are  more  acceptable  to  those
who receive them.

Quality of the evidence

Methodological quality varied considerably (see Characteristics of
included  studies).  Risk  of  bias  was  high  or  unclear  for  multiple
domains  in  a  large  proportion  of  older  studies,  especially  those
published before 2000. Most studies rated as having a low risk of
bias  were  of  individual  TFCBT.  In  a  large  proportion  of  studies,
the information provided by the published report was insufficient
to determine the risk of bias associated with key methodological
indicators.  There  was  considerable  unexplained  heterogeneity
for  some  analyses  and  the  quality  of  evidence  for  each  of  the
comparisons was rated as very low.

As  with  all  psychological  therapy  trials,  there  are  issues  with
the control groups. The development of a 'psychological therapy
placebo'  is  very  difficult,  if  not  impossible,  as  is  blinding  of
participants  and  therapists.  It  is  possible  that  the  efficacy  of
psychological therapies is stronger than suggested by the data, as in
several studies the waitlist/usual care group received some contact
and the expectation that they would be treated, which may have
been therapeutic. It is, however, also possible that waitlist groups
do  worse  than  usual  care  groups  because  they  do  not  expect  to
improve until they receive the active therapy.

Potential biases in the review process

The  review  followed  guidelines  set  out  by  The  Cochrane
Collaboration (Higgins 2011). Two authors independently read all
the candidate studies, assessed them for inclusion, and rated them
for  risk  of  bias.  We  discussed  any  disagreements  with  a  third
review author with the aim of reaching a consensus. This will have
minimised potential bias, but several unavoidable issues remain.
For  example,  all  studies  included  in  the  review  were  published,
resulting  in  the  possibility  of  publication  bias.  We  explored  and
confirmed  this  using  funnel  plots  (Figures  4,  5  and  6).  Several
studies reported incomplete data, although we contacted authors
to  obtain  missing  results  where  possible.  Although  we  searched

Cochrane Database of Systematic Reviews

numerous  online  databases  systematically,  scrutinised  reference
lists,  contacted  experts  in  the  field,  and  handsearched  relevant
additional  sources,  we  cannot  rule  out  the  possibility  of  missed
RCTs. There was a great deal of heterogeneity between trials of the
psychological  therapies  included  within  specific  categories.  This
was especially notable within the 'other therapies' group. Although
all were examples of non-trauma-focused psychological therapies
that were not based on the principles of CBT, interventions included
psychodynamic  therapy,  hypnotherapy,  supportive  counselling
and present-centred counselling, which differ in terms of proposed
active ingredients and the way in which they are delivered. There
was  also  considerable  statistical  heterogeneity  evident  in  many
of  the  comparisons.  In  circumstances  where  heterogeneity  was
thought  to  be  an  issue,  we  used  a  random-effects  model,  and
reported  this.  In  addition,  therapies  within  the  'other  therapies'
category  were  not  always  delivered  with  the  intention  of  being
as  effective  as  the  other  treatment  under  study,  but  to  act  as  a
control (e.g.Bryant 2003; Bryant 2011; Feske 2008). It is clear that
TFCBT performed very well versus waitlist/usual care comparison,
but it must also be considered that this comparison included by far
the  most  studies.  It  is  fair  to  say  that  other  categories  (e.g.  other
therapies) may have performed better had they been represented
by a larger number of studies. Finally, it is worth noting that there
were differences in terms of acceptance into treatment protocols
(for  example,  the  requirement  of  diagnosis  through  structured
interview  versus  self-reported  measures),  which  is  likely  to  have
resulted in some studies that were overly inclusive and others that
exercised more conservative guidelines.

Agreements and disagreements with other studies or
reviews

This  review  supports  the  efficacy  of  psychological  therapy  for
chronic  PTSD,  which  is  consistent  with  the  results  of  many  other
reviews  (e.g.  Bisson  2007b;  Bradley  2005;  Van  Etten  1988).  It  is
also consistent with current practice guidelines which recommend
individual TFCBT and EMDR as frontline treatments for the disorder
(ACPMH 2007; NICE 2005).

A U T H O R S '   C O N C L U S I O N S

Implications for practice

1. Psychological therapies are more effective than waitlist or usual

care in treating adults with chronic PTSD.
2. Trauma-focused  cognitive  behavioural 

therapy  and  eye
movement  desensitisation  and  reprocessing  have  the  best
evidence for efficacy at present.

3. There is evidence that non-TFCBT is effective in the short term.
4. There  is  more  limited  evidence  that  some  other  non-trauma-

focused psychological therapies may be effective.

5. Drop-out  from  treatment  is  an  issue  with  currently  available
psychological therapies. Issues of engagement are an important
consideration.

Although  a  substantial  number  of  studies  were  included  in  the
review, the conclusions are compromised by methodological issues
evident in some. Sample sizes were small, and it is apparent that
many of the studies were underpowered. There were limited follow-
up  data,  which  compromise  conclusions  regarding  the  long-term
effects  of  psychological  treatment.  We  assessed  the  evidence  for
each of the comparisons made in this review as of very low quality.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

40

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Implications for research

1. Further  well-designed  trials  of  psychological  therapies  are
required, incorporating appropriate methods of randomisation,
blinding  of  assessors,  long-term  follow  up  and  appropriate
training of therapists and monitoring of treatment adherence.
2. There  is  a  requirement  for  further  comparison  studies  of  one

type of psychological therapy against another.

3. Future trials should consider adverse events and tolerability of

treatment in more detail.

4. The  role  of  psychological  therapy  in  combination  and  as  an
alternative to medication is unclear. Further research in this area
would be useful.

A C K N O W L E D G E M E N T S

We  should  like  to  thank  the  Cochrane  Depression,  Anxiety  and
Neurosis Group (CCDAN) editorial base for their help with searches,
helpful  comments  on  the  protocol  and  assistance  with  the
methodology. We should also like to thank the NICE PTSD guideline
development group for allowing us access to their data sets. We also
thank the following:

Arnoud  Arntz  (Scientific  Director  of  the  Research  Institute  of
Experimental Psychopathology, Maastricht University)
Merel Kindt (Head of the Department of Clinical Psychology at the
University of Amsterdam)
Richard Bryant (Professor at the University of New South Wales)
Willi Butollo (Professor at Ludwig-Maximilian University of Munich)
Claude  Chemtob  (Research  Professor  in  the  Departments  of
Psychiatry and Child and Adolescent Psychiatry at the NYU School
of Medicine)
Judith Cohen (Medical Director of the Center for Traumatic Stress in
Children & Adolescents at Allegheny General Hospital in Pittsburgh)
Mark Creamer (Director of the Australian Centre for Posttraumatic
Mental Health (ACPMH))
Jonathan Davidson (Director of the Anxiety and Traumatic Stress
Program at Duke University Medical Centre, North Carolina)
Enrique  Echeburua  (Professor  of  Clinical  Psychology  at  the
University of the Basque Country (Spain))
Paul Emmelkamp (Academy Professor, Royal Academy of Arts and
Sciences (KNAW), University of Amsterdam)
Edna Foa (Director of the Centre for the Treatment and Study of
Anxiety)
Chris Freeman (Consultant Psychiatrist, Royal Edinburgh Hospital)
Matt Friedman (Executive Director of the National Centre for PTSD)
Berthold Gersons (Distinguished AMC-Professor and Professor of
Psychiatry  at  the  Academical  Medical  Center  of  the  University  of
Amsterdam)
Louise Humprheys
Terry  Keane  (Director  of  the  Behavioral  Science  Division  of  the
National Center for PTSD, USA)
Dean  Kilpatrick  (Professor  and  Director,  National  Crime  Victims
Center, Medical University of South Carolina)
Edward Kubany (University of Hawaii)

Cochrane Database of Systematic Reviews

Brett  Litz  (Professor  in  the  Departments  of  Psychiatry  and
Psychology at Boston University)
Andreas  Maercker  (Head  of  Division,  Department  of  Psychology
Psychopathology and Clinical Intervention, University of Zurich)
Charles Marmar (Chair of the Department of Psychiatry, New York
University Langone Medical Center)
Sandy  McFarlane  (Director  of  the  Centre  for  Traumatic  Stress
Studies, the University of Adelaide)
Thomas Mellman (Director, Clinical and Translational Research and
Stress and Sleep Studies Programs, Howard University College of
Medicine)
Lars-Goran  Öst  (Professor  of  Clinical  Psychology,  Department  of
Psychology, Stockholm University, Sweden)
Michael  Otto  (Director,  Translational  Research  Program  at  the
Center for Anxiety and Related Disorders, Boston University)
Roger Pitman (Professor of Psychiatry at Harvard Medical School)
Mark  Pollack  (Director  of  the  Center  for  Anxiety  and  Traumatic
Stress Disorders, Massachusetts General Hospital)
Patti Resick (Director of the Women’s Health Sciences Division of
the  National  Center  for  PTSD  at  the  Veterans  Affairs  (VA)  Boston
Healthcare System)
David  Riggs  (Executive  Director  of  the  Center  for  Deployment
Psychology (CDP))
Sue Rose
Barbara  Rothbaum  (Associate  Vice  Chair  of  Clinical  Research
Department of Psychiatry, Emory School of Medicine)
Joe Ruzek (Director of the Dissemination and Training Division of
the National Center for Post-Traumatic Stress Disorder)
Paula Schnurr (Deputy Executive Director of the VA National Center
for PTSD)
Arieh  Shalev  (Professor  of  Psychiatry  in  the  Department  of
Psychiatry at Hadassah University Hospital in Jerusalem)
Dan Stein (Chair of the Department of Psychiatry and Mental Health
at the University of Cape Town)
Nick  Tarrier  (Professor  of  Clinical  Psychology  in  the  Faculty  of
Medical and Human Sciences at the University of Manchester)
Agnes  van  Minnen  (Professor  at  Behavioural  Science  Institute,
Radboud University Nijmegen)
Simon Wessely (Chair and Head of the Department of Psychological
Medicine at the Institute of Psychiatry, King's College London)
Patricia White
Rachel Yehuda (Director of the Traumatic Stress Studies Division
at  Icahn  School  of  Medicine,  and  the  Mental  Health  Patient  Care
Center  Director  at  the  James  J.  Peters  Veterans  Affairs  Medical
Center)

CRG Funding Acknowledgement:
The  National  Institute  for  Health  Research  (NIHR)  is  the  largest
single  funder  of  the  Cochrane  Depression,  Anxiety  and  Neurosis
Group.

Disclaimer:
The views and opinions expressed therein are those of the authors
and  do  not  necessarily  reflect  those  of  the  NIHR,  NHS  or  the
Department of Health.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

41

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

R E F E R E N C E S

References to studies included in this review

Adenauer 2011 {published data only}

Adenauer H, Catani C, Gola H, Keil J, Ruf M, Schauer M, et
al. Narrative exposure therapy for PTSD increases top-down
processing of aversive stimuli -evidence from a randomized
controlled treatment trial. BMC Neuroscience 2011;12:127. [DOI:
10.1186/1471-2202-12-127]

Asukai 2010 {published data only}

Asukai N, Saito A, Tsuruta N, Kishimoto J, Nishikawa, T. Efficacy
of exposure therapy for Japanese patients with posttraumatic
stress disorder due to mixed traumatic events: A randomized
controlled study. Journal of Traumatic Stress 2010;23(6):744-50.

Basoglu 2005 {published data only}

*  Basoglu H, Saleioglu E, Livanou M, Kalender D, Acar G.
Single-session behavioral treatment of earthquake-related
posttraumatic stress disorder: A randomised waiting list
controlled trial. Journal of Traumatic Stress 2005;18(1):1-11.

Salcioglu E, Basoglu M, Livanou M. Effects of live exposure on
symptoms of posttraumatic stress disorder: The role of reduced
behavioral avoidance in improvement. Behaviour Research and
Therapy 2007;45(10):2268-79.

Basoglu 2007 {published data only}

Basoglu M, Salcioglu E, Livanou M. A randomized controlled
study of single-session behavioural treatment of earthquake-
related post-traumatic stress disorder using an earthquake
simulator. Psychological Medicine 2007;37(2):203-13.

Beck 2009 {published data only}

Beck JG, Coffey SF, Foy DW, Keane TM, Blanchard EB. Group
cognitive behavior therapy for chronic posttraumatic stress
disorder: an initial randomized pilot study. Behavior Therapy
2009;40(1):82-92.

Bichescu 2007 {published data only}

Bichescu D, Neuner F, Schauer M, Elbert T. Narrative
exposure therapy for political imprisonment-related chronic
posttraumatic stress disorder and depression. Behaviour
Research and Therapy 2007;45(9):2212-20.

Blanchard 2003 {published data only}

Blanchard EB, Hickling EJ. The Albany treatment study: A
randomized, controlled comparison of cognitive-behavioral
therapy and support in the treatment of chronic PTSD
secondary to MVAs. After the crash: Psychological assessment
and treatment of survivors of motor vehicle accidents. 2nd
Edition. Washington, DC: American Psychological Association,
2004:315-47.

*  Blanchard EB, Hickling EJ, Devineni T, Veazey CH, Galovski TE,
Mundy E, et al. A controlled evaluation of cognitive behavioural
therapy for posttraumatic stress in motor vehicle accident
survivors. Behaviour Research & Therapy 2003;41(1):79-96.

Blanchard EB, Hickling EJ, Malta LS, Freidenberg BM, Canna MA,
Kuhn E, et al. One- and two-year prospective follow-up of

cognitive behavior therapy or supportive psychotherapy.
Behaviour Research and Therapy 2004;42(7):745-59.

Blanchard EB, Hickling EJ, Malta LS, Jaccard J, Devineni T,
Veazey CH, et al. Prediction of response to psychological
treatment among motor vehicle accident survivors with PTSD.
Behavior Therapy 2003;34(3):351-63.

Blanchard EB, Hickling EJ, Veazey CH, Buckley TC,
Freidenberg BM, Walsh JD, et al. Treatment-related changes
in cardiovascular reactivity to trauma cues in motor vehicle
accident-related PTSD. Behavior Therapy 2002;33(3):417-26.

Brom 1989 {published data only}

Brom D, Kleber RJ, Defares PB. Brief psychotherapy for
posttraumatic stress disorders. Journal of Consulting and
Clinical Psychology 1989;57(5):607-12.

Bryant 2003 {published data only}

Bryant RA, Moulds ML, Guthrie RM, Dang ST, Nixon RD.
Imaginal exposure alone and imaginal exposure with cognitive
restructuring in treatment of posttraumatic stress disorder.
Journal of Consulting and Clinical Psychology 2003;71(4):706-12.

Bryant 2011 {published data only}

Bryant RA, Ekasawin S, Chakrabhand S, Suwanmitri S,
Duangchun O, Chantaluckwong T. A randomised controlled
effectiveness trial of cognitive behaviour therapy for post-
traumatic stress disorder in terrorist-affected people in
Thailand. World Psychiatry 2011;10(3):205-9.

Carlson 1998 {published data only}

Carlson JG, Chemtob CM, Rusnak K, Hedlund NL, Muraoka MY.
Eye movement desensitization and reprocessing (EDMR)
treatment for combat-related posttraumatic stress disorder.
Journal of Traumatic Stress 1998;11(1):3-24.

Chard 2005 {published data only}

Chard KM. An evaluation of cognitive processing therapy for the
treatment of posttraumatic stress disorder related to childhood
sexual abuse. Journal of Consulting and Clinical Psychology
2005;73(5):965-71.

Cloitre 2002 {published data only}

Cloitre M. Emotion regulation and interpersonal skills training
for chronic PTSD related to childhood abuse and multiple
traumatization. Proceedings of the 157th Annual Meeting of the
American Psychiatric Association; 2004 May 1 - 6; New York, NY.
2004:26c.

Cloitre M. Emotional regulation and interpersonal skill as a
prerequisite to emotional processing of traumatic memories.
Proccedings of the 156th Annual Meeting of the American
Psychiatric Association; 2003 May 17 - 22; San Francisco, CA.
2003:96b.

Cloitre M. Skills training and exposure: Are both better than
one?. Proccedings of the 18th Annual Meeting, International
Society for Traumatic Stress Studies; 2002 Nov 7 - 10; Baltimore,
MD. 2002.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

42

 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

*  Cloitre M, Koenen KC, Cohen LR, Han H. Skills training
in affective and interpersonal regulation followed by
exposure: a phase-based treatment for PTSD related to
childhood abuse. Journal of Consulting and Clinical Psychology
2002;70(5):1067-74.

Ehlers 2005 {published data only}

Ehlers A, Clark DM, Hackmann A, McManus F, Fennell M.
Cognitive therapy for post-traumatic stress disorder:
development and evaluation. Behaviour Research and Therapy
2005;43(4):413-31.

Cloitre 2010 {published data only}

Cloitre M, Stovall-McClough KC, Nooner K, Zorbas P, Cherry S,
Jackson CL, et al. Treatment for PTSD related to childhood
abuse: a randomised controlled trial. American Journal of
Psychiatry 2010;167(8):915-24.

Cooper 1989 {published data only}

Cooper NA, Clum GA. Imaginal flooding as a supplementary
treatment for PTSD in combat veterans: a controlled study.
Behavior Therapy 1989;20(3):381-91.

Devilly 1998 {published data only}

Devilly GJ, Spence SH, Rapee RM. Statistical and reliable
change with eye movement desensitization and reprocessing:
treating trauma within a veteran population. Behavior Therapy
1998;29(3):435-55.

Devilly 1999 {published data only}

Devilly GJ. The successful treatment of PTSD through overt
cognitive behavioral therapy in non-responders to EMDR.
Behavioural and Cognitive Psychotherapy 2001;29(1):57-70.

*  Devilly GJ, Spence SH. The relative efficacy and treatment
distress of EMDR and a cognitive-behavior trauma treatment
protocol in the amelioration of posttraumatic stress disorder.
Journal of Anxiety Disorders 1999;13(1-2):131-57.

Duffy 2007 {published data only}

Duffy M, Gillespie K, Clark DM. Cognitive therapy for post-
traumatic stress disorder in the context of terrorism and other
civil conflict in Northern Ireland. Proceedings of the 34th Annual
Conference of the British Association for Behavioural and
Cognitive Psychotherapies; 2006 Jul 19 - 21, Warwick. 2006:44.

*  Duffy M, Gillespie K, Clark DM. Post-traumatic stress
disorder in the context of terrorism and other civil conflict
in Northern Ireland: Randomised Controlled Trial. BMJ
2007;334(7604):1147-50.

Dunne 2012 {published data only}

Dunne RL, Kenardy J, Sterling M. A randomized controlled trial
of cognitive behavioural therapy for the treatment of PTSD
in the context of chronic whiplash. Clinical Journal of Pain
2012;28(9):755-65.

Echeburua 1997 {published data only}

Echeburua E, De Corral P, Zubizarreta I, Sarasua B. Psychological
treatment of chronic posttraumatic stress disorder in victims of
sexual aggression. Behavior Modification 1997;21(4):433-56.

Ehlers 2003 {published data only}

Ehlers A, Clark DM, Hackmann A, McManus F, Fennell M,
Herbert C, et al. A randomised controlled trial of cognitive
therapy, a self help booklet, and repeated assessments as early
interventions for posttraumatic stress disorder. Archives of
General Psychiatry 2003;60(10):1024-32.

Fecteau 1999 {published data only}

*  Fecteau G, Nicki R. Cognitive behavioural treatment of
post traumatic stress disorder after motor vehicle accident.
Behavioural and Cognitive Psychotherapy 1999;27(3):201-14.

Fecteau GW. Treatment of posttraumatic stress reactions to
traffic accidents [thesis]. Dissertation Abstracts International
2000;61(1-B):527.

Feske 2008 {published data only}

Feske, U. Treating low income and minority women with post
traumatic stress disorder. Journal of Interpersonal Violence
2008;23(8):1027-40.

Foa 1991 {published data only}

Foa EB, Rothbaum BO, Riggs DS, Murdock TB. Treatment of
posttraumatic stress disorder in rape victims: a comparison
between cognitive-behavioral procedures and counselling.
Journal of Consulting and Clinical Psychology 1991;59(5):715-23.

Foa 1999 {published data only}

*  Foa EB, Dancu CV, Hembree EA, Jaycox LH, Meadows EA,
Street GP. A comparison of exposure therapy, stress inoculation
training, and their combination for reducing posttraumatic
stress disorder in female assault victims. Journal of Consulting
and Clinical Psychology 1999;67(2):194-200.

Zoellner LA, Feeny NC, Fitzgibbons LA, Foa EB. Response of
African American and caucasian women to cognitive behavioral
therapy for PTSD. Behavior Therapy 1999;30(4):581-95.

Foa 2005 {published data only}

Foa EB, Hembree EA, Cahill SP, Rauch SAM, Riggs DS.
Randomized trial of prolonged exposure for posttraumatic
stress disorder with and without cognitive restructuring:
Outcome at academic and community clinics. Journal of
Consulting and Clinical Psychology 2005;73(5):953-64.

Forbes 2012 {published data only}

Forbes D, Lloyd D, Nixon RD, Elliott P, Varker T, Perry D, et al. A
multisite randomized controlled effectiveness trail of cognitive
processing therapy for military-related post traumatic stress
disorder. Journal of Anxiety Disorders 2012;26(3):442-452.

Galovski 2012 {published data only}

Galovski T, Blain LM, Mott JM, Elwood L, Houle T. Manualized
therapy for PTSD: flexing the structure of cognitive processing
therapy. Journal of Consulting and Clinical Psychology
2012;80(6):968-81.

Gamito 2010 {published data only}

Gamito P, Oliveira J, Rosa P, Morais D, Duarte N, Oliveira S,
et al. PTSD elderly war veterans: a clinical controlled pilot
study. Cyberpsychology, Behavior and Social Networking
2010;13(1):43-8.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

43

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Gersons 2000 {published data only}

Kearney 2013 {published data only}

Gersons BP, Carlier IV, Lamberts RD, Van der Kolk BA.
Randomized clinical trial of brief eclectic psychotherapy for
police officers with posttraumatic stress disorder. Journal of
Traumatic Stress 2000;13(2):333-47.

Kearney DJ, McDermott K, Malte C, Martinez M, Simpson TL.
Effects of participation in a mindfulness program for veterans
with posttraumatic stress disorder: a randomised controlled
trial. Journal of Clinical Psychology 2013;69(1):14-27.

Hensel-Dittmann 2011 {published data only}

Krakow 2000 {published data only}

Hensel-Dittmann D, Schauer M, Ruf M, Catani C, Odenwald M,
Elbert T, et al. Treatment of traumatized victims of war
and torture: A randomized controlled comparison of
narrative exposure therapy and stress innoculation therapy.
Psychotherapy and Psychosomatics 2011;80(6):345-52.

Krakow B, Hollifield M, Schrader R, Koss M, Tandberg D,
Lauriello J, et al. A controlled study of imagery rehearsal
for chronic nightmares in sexual assault survivors with
PTSD: A preliminary report. Journal of Traumatic Stress
2000;13(4):589-609.

Hinton 2005 {published data only}

Krakow 2001 {published data only}

*  Hinton DE, Chhean D, Pich V, Safren SA, Hofmann SG,
Pollack MH. A randomised controlled trial of cognitive
behaviour therapy for Cambodian refugees with treatment
resistant PTSD and panic attacks: a cross over design. Journal of
Traumatic Stress 2005;18(6):617-29.

Krakow B, Hollifield M, Johnston L, Koss M, Schrader R,
Warner TD, et al. Imagery rehearsal therapy for chronic
nightmares in sexual assault survivors with posttraumatic
stress disorder. A randomized controlled trial. JAMA
2001;286(5):537-45.

Hinton DE, Hofmann SG, Pollack MH, Otto MW. Mechanisms
of efficacy of CBT for Cambodian refugees with PTSD:
improvement in emotion regulation and orthostatic blood
pressure response. CNS Neuroscience and Therapeutics
2009;15(3):255-63.

Hinton 2011 {published data only}

Hinton DE, Hofmann SG, Rivera E, Otto MW, Pollack MH.
Culturally adapted CBT (CA-CBT) for Latino women with
treatment-resistant PTSD: A pilot study comparing CA-CBT to
applied muscle relaxation. Behaviour Research and Therapy
2011;49(4):275-80.

Hogberg 2007 {published data only}

Hogberg G, Pagani M, Sundin O, Soares J, Aberg-Wistedt A,
Tarnell B, et al. On treatment with eye movement
desensitization and reprocessing of chronic post-traumatic
stress disorder in public transportation workers - a randomized
controlled trial. Nordic Journal of Psychiatry 2007;61(1):54-60.

Hollifield 2007 {published data only}

Hollifield M, Sinclair-Lian N, Warner TD, Hammerschlag R.
Acupuncture for posttraumatic stress disorder. Journal of
Nervous and Mental Disease 2010;195(6):504-13.

Ironson 2002 {published data only}

Ironson G, Freund B, Strauss JL, Williams J. Comparison of two
treatments for traumatic stress: a community based study of
EMDR and prolonged exposure. Journal of Clinical Psychology
2002;58(1):113-28.

Kubany 2003 {published data only}

Kubany ES, Hill EE, Owens JA. Cognitive trauma therapy for
battered women with PTSD: preliminary findings. Journal of
Traumatic Stress 2003;16(1):81-91.

Kubany 2004 {published data only}

Kubany ES, Hill EE, Owens JA. Cognitive trauma therapy for
battered women with PTSD (CTT-BW). Journal of Consulting and
Clinical Psychology 2004;72(1):3-18.

Lee 2002 {published data only}

Lee C, Gavriel H, Drummond P, Richards J, Greenwald R.
Treatment of PTSD: stress inoculation training with prolonged
exposure compared to EMDR. Journal of Clinical Psychology
2002;58(9):1071-89.

Lindauer 2005 {published data only}

Lindauer JL, Gersons BPR, Van Meijel EPM, Blom K, Carlier IVE,
Vrijlandt I, et al. Effects of brief eclectic psychotherapy in
patients with posttraumatic stress disorder: randomised clinical
trial. Journal of Traumatic Stress 2005;18(3):205-12.

Marcus 1997 {published data only}

Marcus S, Marquis P, Sakai C. Three and 6 month follow up
of EMDR treatment of PTSD in an HMO setting. International
Journal of Stress Management 2004;11(3):195-208.

*  Marcus SV, Marquis P, Sakai C. Controlled study of treatment
of PTSD using EMDR in an HMO setting. Psychotherapy
1997;34(3):307-15.

Jensen 1994 {published data only}

Marks 1998 {published data only}

Jensen JA. An investigation of eye movement desensitisation
and reprocessing as a treatment for posttraumatic stress
disorder symptoms of Vietnam combat veterans. Behavior
Therapy 1994;25(2):311-25.

*  Marks I, Lovell K, Noshirvani H, Livanou M, Thrasher S.
Treatment of posttraumatic stress disorder by exposure and/or
cognitive restructuring: a controlled study. Archives of General
Psychiatry 1998;55(4):317-25.

Keane 1989 {published data only}

Keane TM, Fairbank JA, Caddell JM, Zimering RT. Implosive
(flooding) therapy reduces symptoms of PTSD in Vietnam
combat veterans. Behavior Therapy 1989;20(2):245-60.

Thrasher S, Power M, Morant N, Marks I, Dalgleish T. Social
support moderates outcome in a randomized controlled trial
of exposure therapy and (or) cognitive restructuring for chronic

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

44

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

posttraumatic stress disorder. Canadian Journal of Psychiatry
2010;55(3):187-90.

McDonagh 2005 {published data only}

counselors in an African refugee settlement: A randomised
controlled trial. Journal of Consulting and Clinical Psychology
2008;76(4):686-94.

McDonagh A, Friedman M, McHugo G, Ford J, Sengupta A,
Mueser K, et al. Randomized controlled trial of cognitive-
behavioural therapy for chronic posttraumatic stress disorder
in adult female survivors of childhood sexual abuse. Journal of
Consulting and Clinical Psychology 2005;73(3):515-24.

Neuner 2010 {published data only}

Neuner F, Kurreck S, Ruf M, Odenwald M, Elbert T, Schauer M.
Can asylum seekers with posttraumatic stress disorder be
successfully treated? A randomized controlled pilot study.
Cognitive Behaviour Therapy 2010;39(2):81-91.

Monson 2006 {published data only}

Nijdam 2012 {published data only}

Monson CM, Gradus JL, Young-Xu Y, Schnurr P, Price JL,
Schumm JA. Change in posttraumatic stress disorder
symptoms: Do clinicians and patients agree?. Psychological
Assessment 2008;20(2):131-8.

Nijdam M, Gersons BPR, Reitsma JB, Olff M. Brief eclectic
psychotherapy v. eye movement desensitisation and
reprocessing for post traumatic stress disorder: randomised
controlled trial. British Journal of Psychiatry 2012;200(3):224-31.

*  Monson CM, Schnurr PP, Resick PA, Friedman MJ, Young-
Xu Y, Stevens SP. Cognitive processing therapy for veterans
with military related posttraumatic stress disorder. Journal of
Consulting and Clinical Psychology 2006;74(5):898-907.

Paunovic 2011 {published data only}

Paunovic N. Exposure Inhibition Therapy as a treatment for
chronic posttraumatic stress disorder: A controlled pilot study.
Psychology 2011;2(6):605-14.

Mueser 2008 {published data only}

Gottlieb JD, Mueser KT, Rosenberg SD, Xie H, Wolfe RS.
Psychotic depression, posttraumatic stress disorder, and
engagement in cognitive-behavioral therapy within an
outpatient sample of adults with serious mental illness.
Comprehensive Psychiatry 2011;52(1):41-9.

Mueser K. Cognitive-behavioural treatment of posttraumatic
stress disorder in people with severe mental illness.
Proceedings of the 30th Annual Conference of the British
Association for Behavioural and Cognitive Psychotherapies;
2002 July 17 - 20; Warwick. 2002.

Mueser KT, Rosenberg S, Jankowski K, Hamblen J, Carty P.
Cognitive-behavioral treatment of PTSD in clients with severe
mental illness. Proceedings of the 157th Annual Meeting of the
American Psychiatric Association; 2004 May 1 - 6; New York, NY.
2004:11d.

*  Mueser KT, Rosenburg SD, Xie H, Jankowski MK, Bolton EE,
Lu W, et al. A randomized controlled trial of cognitive-
behavioral treatment for posttraumatic stress disorder in severe
mental illness. Journal of Consulting and Clinical Psychology
2008;76(2):259-71.

Neuner 2004 {published data only}

*  Neuner F, Schauer M, Klaschik C, Karunakara U, Elbert T.
A comparison of narrative exposure therapy, supportive
counselling, and psychoeducation for treating posttraumatic
stress disorder in an African refugee settlement. Journal of
Consulting and Clinical Psychology 2004;72(4):579-87.

Schauer M, Neuner F, Rockstroh BS, Elber TR. Narrative
exposure treatment as intervention for survivors of organized
violence in refugee camps. Proceedings of the XII World
Congress of Psychiatry; 2002 Aug 24 - 29; Yokohama, Japan.
2002:FC-56-3.

Neuner 2008 {published data only}

Neuner F, Onyut PL, Ertl V, Odenwald M, Schauer E, Elbert T.
Treatment of posttraumatic stress disorder by trained lay

Peniston 1991 {published data only}

Peniston EG, Kulkosky PJ. Alpha-theta brainwave neuro-
feedback therapy for Vietnam veterans with combat-related
post-traumatic stress disorder. Medical Psychotherapy
1991;4:47-60.

Power 2002 {published data only}

Power K, McGoldrick T, Brown K, Buchanan R, Sharp D,
Swanson V, et al. A controlled comparison of eye movement
desensitisation and reprocessing versus exposure plus cognitive
restructuring versus waiting list in the treatment of post-
traumatic stress disorder. Clinical Psychology and Psychotherapy
2002;9(4):229-318.

Ready 2010 {published data only}

Ready DJ, Gerardi RJ, Backscheider AG, Mascaro N,
Rothbaum BO. Comparing virtual reality exposure therapy
to present centred therapy with 11 US Vietnam Veterans
with PTSD. Cyberpsychology, Behavior and Social Networking
2010;13(1):49-54.

Resick 2002 {published data only}

Nishith P, Nixon RDV, Resick PA. Resolution of trauma-related
guilt following treatment of PTSD in female rape victims: A
result of cognitive processing therapy targeting comorbid
depression?. Journal of Affective Disorders 2005;86(2-3):259-65.

Resick PA, Nishith P, Griffin MG. How well does cognitive-
behavioral therapy treat symptoms of complex PTSD? An
examination of child sexual abuse survivors within a clinical
trial. CNS Spectrums 2003;8(5):340-55.

*  Resick PA, Nishith P, Weaver TL, Astin MC, Feuer CA. A
comparison of cognitive-processing therapy with prolonged
exposure and a waiting condition for the treatment of chronic
posttraumatic stress disorder in female rape victims. Journal of
Consulting and Clinical Psychology 2002;70(4):867-79.

Rothbaum 1997 {published data only}

Rothbaum BO. A controlled study of eye movement
desensitization and reprocessing in the treatment of

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

45

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

posttraumatic stress disordered sexual assault victims. Bulletin
of the Menninger Clinic 1997;61(3):317-34.

post-traumatic stress disorder. Journal of Behavior Therapy and
Experimental Psychiatry 1994;25(4):283-91.

Rothbaum 2005 {published data only}

Wells 2012 {published data only}

Rothbaum BO, Astin MC, Marsteller F. Prolonged exposure
versus eye movement desensitisation and reprocessing
(EMDR) for PTSD rape victims. Journal of Traumatic Stress
2005;18:607-616.

Scheck 1998 {published data only}

Scheck MM, Schaeffer JA, Gillette C. Brief psychological
intervention with traumatized young women: the efficacy of
eye movement desensitisation and reprocessing. Journal of
Traumatic Stress 1998;11(1):25-44.

Schnurr 2003 {published data only}

Monson CM, Gradus JL, Young-Xu Y, Schnurr P, Price JL,
Schumm JA. Change in posttraumatic stress disorder
symptoms: Do clinicians and patients agree?. Psychological
Assessment 2008;20(2):131-8.

*  Schnurr PP, Friedman MJ, Foy DW, Shea MT, Hsieh FY,
Lavori PW, et al. Randomized trial of trauma-focused group
therapy for posttraumatic stress disorder. Archives of General
Psychiatry 2003;60(5):481-9.

Wells A, Colbear JS. Treating posttraumatic stress disorder with
metacognitive therapy: A preliminary controlled study. Journal
of Clinical Psychology 2012;68:373-81.

Zang 2013 {published data only}

Zang Y, Hunt N, Cox T. A randomised controlled pilot study: the
effectiveness of narrative exposure therapy with adult survivors
of the Sichuan earthquale. BMC Psychiatry 2013;13:41.

Zlotnick 1997 {published data only}

Zlotnick C, Shea MT, Pearlstein TB, Rosen KJ, Mulrenin K,
Simpson EB. Affect management group for survivors of sexual
abuse with PTSD. Proceedings of the 149th Annual Meeting of
the American Psychiatric Association; 1996 May 4 - 9; New York,
NY. 1996:0292.

*  Zlotnick C, Shea TM, Rosen K, Simpson E, Mulrenin K,
Begin A, et al. An affect-management group for women with
posttraumatic stress disorder and histories of childhood sexual
abuse. Journal of Traumatic Stress 1997;10(3):425-36.

Schnurr 2007 {published data only}

References to studies excluded from this review

Engel C, Friedman M, Foa E, Shea MT, Schnurr P, Resick P.
CSP #494: Primary Findings. Proceedings of the 22nd Annual
Meeting, International Society for Traumatic Stress Studies;
2006 November 4 - 7; Hollywood, CA. 2006:58.

Engel C, Friedman M, Foa E, Shea MT, Schnurr P, Resick P. Design
and Rationale for CSP #494. Proceedings of the 22nd Annual
Meeting, International Society for Traumatic Stress Studies;
2006 Nov 4 - 7; Hollywood, CA. 2006:58.

*  Schnurr PP, Friedman MJ, Engel CC, Foa EB, Shea MT,
Chow BK, et al. Cognitive behavioural therapy for posttraumatic
stress disorder in women. JAMA 2007;28(8):820-30.

Schnurr PP, Friedman MJ, Engel CC, Foa EB, Shea MT,
Resick PM, et al. Issues in the design of multisite clinical trials
of psychotherapy: VA Cooperative Study No. 494 as an example.
Contemporary Clinical Trials. 2005;26(6):626-36.

Taylor 2003 {published data only}

Taylor S. PTSD treatment outcome predictors: Exposure
therapy, EMDR and relaxation. Proceedings of the 19th Annual
Meeting, International Society for Traumatic Stress Studies;
2003 Oct 29 - Nov 1; Chicago, IL. 2003.

*  Taylor S, Thordarson DS, Maxfield L, Fedoroff IC, Lovell K,
Ogrodniczuk J. Comparative efficacy, speed, and adverse
effects of three PTSD treatments: exposure therapy, EMDR, and
relaxation training. Journal of Consulting and Clinical Psychology
2003;71(2):330-8.

Vaughan 1994 {published data only}

Vaughan K, Armstrong MS, Gold R, O'Connor N, Jenneke W,
Tarrier N. A trial of eye movement desensitization compared to
image habituation training and applied muscle relaxation in

Abbasnejad 2007 {published data only}

Abbasnejad M, Mahani KN, Zamyad A. Efficacy of "eye
movement desensitization and reprocessing" in reducing
anxiety and unpleasant feelings due to earthquake experience.
Psychological Research 2007;9(1):104-117.

Arntz 2007 {published data only}

Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison
of imaginal exposure with and without imagery rescripting.
Journal of Behavior Therapy and Experimental Psychiatry
2007;38(4):345-70.

Barabasz 2013 {published data only}

Barabasz A, Barabasz M, Christensen C, French B, Watkins JG.
Efficacy of single-session abreactive ego state therapy for
combat stress injury, PTSD, and ASD. International Journal of
Clinical and Experimental Hypnosis 2013;61(1):1-19.

Boudewyns 1990 {published data only}

Boudewyns PA, Hyer L. Physiological response to combat
memories and preliminary treatment outcome in Vietnam
veteran PTSD patients treated with direct therapeutic exposure.
Behavior Therapy 1990;21(1):63-87.

Chemtob 1997 {published data only}

Chemtob CM, Novaco RW, Hamada RS, Gross DM. Cognitive-
behavioral treatment for severe anger in posttraumatic
stress disorder. Journal of Consulting and Clinical Psychology
1997;65(1):184-9.

Classen 2001 {published data only}

Classen C, Butler LD, Koopman C, Miller E, DiMiceli S, Giese-
Davis J, et al. Supportive-expressive group therapy and distress
in patients with metastatic breast cancer: a randomized

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

46

 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

clinical intervention trial. Archives of General Psychiatry
2001;58(5):494-501.

treatment of posttraumatic stress disorder with panic attacks.
Behavior Modification 2005;29(1):70-94.

Classen 2010 {published data only}

Classen CC, Palesh OG, Cavanaugh CE, Koopman C, Kaupp JW,
Kraemer HC, et al. A comparison of trauma-focused and present
focused group therapy for survivors of childhood sexual abuse:
a randomised controlled trial. Psychological Trauma: Theory,
Research, Practice and Policy 2010;3(1):84-93.

Cole 2007 {published data only}

Cole KL, Sarlund-Heinrich P, Brown LS. Developing and
assessing effectiveness of a time limited therapy group for
incarcerated women survivors of childhood sexual abuse.
Journal of Trauma and Dissociation 2007;8(2):97-121.

Davis 2007 {published data only}

Davis JL, Wright DC. Randomized clinical trial for treatment
of chronic nightmares in trauma exposed adults. Journal of
Traumatic Stress 2007;20(2):123-33.

Difede 2007a {published data only}

Difede J, Malta LS, Best S, Hen-Haase C, Metzler T, Bryant R, et
al. A randomized controlled trial for world trade centre attack
related PTSD in disaster workers. Journal of Nervous and Mental
Disease 2007;195(10):861-5.

DuHamel 2010 {published data only}

DuHamel KN, Mosher CE, Winkel G, Labay LE, Rini C,
Meschian YM, et al. Randomized clinical trial of telephone
administered cognitive behavioural therapy to reduce post-
traumatic stress disorder and distress symptoms after
hematopoietic stem-cell transplantation. Journal of Clinical
Oncology 2010;28(23):3754-61.

*  Falsetti SA, Resnick HS, Davis J, Gallagher NG. Treatment of
posttraumatic stress disorder with comorbid panic attacks:
combining cognitive processing therapy with panic control
treatment techniques. Group Dynamics: Theory, Research and
Practice 2001;5(4):252-60.

Falsetti SA,  Erwin BA,  Resnick HS,  Davis J,  Combs-Lane AM.
Multiple channel exposure therapy of PTSD: Impact of
treatment on functioning and resources. Journal of Cognitive
Psychotherapy 2003;17(2):133-47.

Falsetti 2005 {published data only}

Falsetti S.A, Resnick H.S, Davis J. Multiple channel exposure
therapy. Behavior Modification 2005;29(1):70-94.

Foa 2006 {published data only}

Foa EB, Zoellner LA, Feeny NC. An evaluation of three brief
programmes for facilitating recovery after assault. Journal of
Traumatic Stress 2006;19(1):29-43.

Frommberger 2004 {published data only}

Frommberger U, Nyberg E, Richter H, Stieglitz R-D, Berger M.
Paroxetine vs. cognitive-behavioral therapy in the treatment of
depression in PTSD patients. Proceedings of the 21st Collegium
Internationale Neuro psychopharmacologicum; 1998 Jul 12 - 16;
Glasgow, Scotland. 1998:PM02013.

*  Frommberger U, Stieglitz R, Nyberg E, Richter H, Novelli-
Fischer U, Angenendt J, et al. Comparison between paroxetine
and behaviour therapy in patients with posttraumatic stress
disorder (PTSD): a pilot study. International Journal of Psychiatry
in Clinical Practice 2004;8(1):19-23.

Dunn 2007 {published data only}

Gidron 1996 {published data only}

Dunn NJ, Rehm LP, Schillaci J, Souchek J, Mehta P, Ashton CM,
et al. A randomized controlled trial of self-management and
psychoeducational group therapies for comorbid chronic
posttraumatic stress disorder and depressive disorder. Journal
of Traumatic Stress 2007;20(3):221-37.

Echeburua 1996 {published data only}

Echeburua E, De Corral P, Sarasua B, Zubizarreta I. Treatment
of acute posttraumatic stress disorder in rape victims:
an experimental study. Journal of Anxiety Disorders
1996;10(3):185-99.

Gidron Y, Peri T, Connolly JF, Shalev AY. Written disclosure in
posttraumatic stress disorder: is it beneficial for the patient?.
Journal of Nervous and Mental Disease 1996;184(8):505-7.

Ginzberg 2009 {published data only}

Ginzburg K, Butler LD, Giese-Davis J, Cavanaugh CE, Neri E,
Koopman C, et al. Shame, guilt, and posttraumatic stress
disorder in adult survivors of childhood sexual abuse at risk for
human immunodeficiency virus: outcomes of a randomized
clinical trial of group psychotherapy treatment. Journal od
Nervous and Mental Disorders 2009;197(7):536-42.

Edmond 1999 {published data only}

Glynn 1999 {published data only}

Edmond T, Rubin A. Assessing the long-term effects of EMDR:
Results from an 18 month follow-up study with adult female
survivors of CSA. Journal of Child Sexual Abuse 2004;13(1):69-86.

Edmond T, Rubin A, Wambach KG. The effectiveness of EMDR
with adult female survivors of childhood sexual abuse. Social
Work Research 1999;23:103-16.

Falsetti 2001 {published data only}

Falsetti SA, Resnick HS, Davis J. Multiple channel exposure
therapy - combining cognitive-behavioral therapies for the

Glynn SM, Eth S, Randolph ET, Foy DW, Urbaitis M, Boxer L, et
al. A test of behavioral family therapy to augment exposure
for combat-related posttraumatic stress disorder. Journal of
Consulting and Clinical Psychology 1999;67(2):243-51.

Hiari 2005 {published data only}

Hiari M, Clum GA. An internet based self-change programme for
traumatic event related fear, distress and maladaptive coping.
Journal of Traumatic Stress 2005;18(6):631-6.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

47

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Jaberghaderi 2004 {published data only}

Jaberghaderi N, Greenwald R, Rubin A, Dalatabadi S, Zand SO. A
comparison of CBT and EMDR for sexually-abused Iranian girls.
Proceedings of the 18th Annual Meeting, International Society
for Traumatic Stress Studies. Baltimore, MD, Nov 7 - 12, 2002.

*  Jaberghaderi N, Greenwald R, Rubin A, Zand SO, Dolatabadi S.
A comparison of CBT and EMDR for sexually-abused Iranian
girls. Clinical Psychology and Psychotherapy 2004;11(5):358-68.

stress disorder taking prescription analgesics for chronic pain: A
feasibility study. Alternative Therapies 2007;13(6):32-40.

Rabe 2008 {published data only}

Rabe S, Zoellner T, Beauducel A, Maercker A, Karl A. Changes
in brain electrical activity after cognitive behavioural therapy
for posttraumatic stress disorder in patients injured in motor
vehicle accidents. Psychosomatic Medicine 2008;70(1):13-9.

Rothbaum 2006 {published data only}

Knaevelsrud 2007 {published data only}

Knaevelsrud C, Maercker A. Internet-based treatment for PTSD
reduces distress and facilitates the development of a strong
therapeutic alliance. BMC Psychiatry 2007;7:142-147.

Rothbaum BO, Cahill SP, Foa EB, Davidson JR, Compton J,
Connor KM, et al. Augmentation of sertraline with prolonged
exposure in the treatment of posttraumatic stress disorder.
Journal of Traumatic Stress 2006;19(5):625-38.

Lange 2001 {published data only}

Ryan 2005 {published data only}

Lange A, Van de Ven JP, Schrieken B, Emmelkamp PMG.
Interapy: Treatment of posttraumatic stress through the
internet: A controlled trial. Journal of Behaviour Therapy and
Experimental Psychiatry 2001;55(6):603-11.

Ryan M, Nitsun M, Gilbert L, Mason H. A prospective study of the
effectiveness of group and individual psychotherapy for women
CSA survivors. Psychology and Psychotherapy: Theory, Research
and Practice 2005;78(Pt 4):465-79.

Lange 2003 {published data only}

Schaal 2009 {published data only}

Lange A, Rietdijk D, Hudcovicova M, Van de Ven JP, Schrieken B,
Emmelkamp PM. Interapy: a controlled randomised trial of
standardised treatment of post-traumatic stress through
the internet. Journal of Consulting and Clinical Psychology
2003;71(5):901-9.

Litz 2007 {published data only}

Litz BT, Engel CC, Bryant RA, Papa A. A randomized, controlled
proof-of-concept trial of an internet-based, therapist-assisted
self-management treatment for posttraumatic stress disorder.
American Journal of Psychiatry 2007;164(11):1676-83.

Maercker 2006 {published data only}

Maercker A, Zollner T, Menning H, Rabe S, Karl A. Dresden PTSD
treatment study: randomized controlled trial of motor vehicle
accident survivors. BMC Psychiatry 2006;29(6):1-8.

Mithoefer 2011 {published data only}

Mithoefer MC, Wagner MT, Mithoefer T, Jerome L,
Doblin R. The safety and efficacy of {+/-}3,4-
methylenedioxymethamphetamine- assisted psychotherapy in
subjects with chronic, treatment-resistant posttraumatic stress
disorder: the first randomized controlled pilot study. Journal of
Psychopharmacology 2011;25(4):439-52.

Najavits 2006 {published data only}

Najavits LM, Gallop RJ, Weiss RD. Seeking safety: Therapy
for adolescent girls with PTSD and substance use disorder:
A randomised controlled trial. Journal of Behavioural Health
Services and Research 2006;33(4):453-63.

Paunovic 2001 {published data only}

Paunovic N, Ost LG. Cognitive-behavior therapy versus exposure
therapy in the treatment of PTSD in refugees. Behaviour
Research and Therapy 2001;39(10):1183-97.

Price 2007 {published data only}

Price CJ, McBride B, Hyerle L, Kivlahan DR. Mindful awareness in
body-oriented therapy for female veterans with post-traumatic

Schaal S, Elbert T, Neuner F. Narrative exposure therapy versus
interpersonal psychotherapy. A pilot randomized controlled
trial with Rwandan genocide orphans. Psychotherapy and
Psychosomatics 2009;78(5):298-306.

Shapiro 1989a {published data only}

Shapiro F. Efficacy of eye movement desensitization procedure
in the treatment of traumatic memories. Journal of Traumatic
Stress 1989;2(2):199-223.

Sloan 2004 {published data only}

Sloan DM, Marx BP. A closer examination of the structured
written disclosure paradigm. Journal of Consulting and Clinical
Psychology 2004;72(2):165-75.

Sloan 2005 {published data only}

Sloan DM, Marx, BP, Epstein EM. Further examination of the
exposure model underlying the efficacy of written emotional
disclosure. Journal of Consulting and Clinical Psychology
2005;73(3):549-54.

Spence 2011 {published data only}

Spence J, Titov N, Dear BF, Johnston L, Solley K, Lorian C,
et al. Randomised controlled trial of internet delivered
cognitive behavioural therapy for posttraumatic stress disorder.
Depression and Anxiety 2011;28(7):541-50.

Tarrier 1999 {published data only}

Tarrier N, Pilgrim H, Sommerfield C. A randomised trial of
cognitive therapy and imaginal exposure in the treatment of
chronic posttraumatic stress disorder. Journal of Consulting and
Clinical Psychology 1999;67(1):13-8.

Tucker 2007 {published data only}

Tucker P, Trautman RP, Wyatt DB, Thompson J, Wu SC,
Capece JA, et al. Efficacy and safety of topiramate monotherapy
in civilian posttraumatic stress disorder: a randomized, double-
blind, placebo-controlled study. Journal of Clinical Psychiatry
2007;68(2):201-6.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

48

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Van Emmerik 2008 {published data only}

Bisson 2007a

Van Emmerik AAP, Kamphuis JH, Emmelkamp PMG. Treating
acute stress disorder and posttraumatic stress disorder
with cognitive behavioural therapy. Psychotherapy and
Psychosomatics 2008;77(2):93-100.

Watson 1997 {published data only}

Watson CG, Tuorila JR, Vickers KS, Gearhart LP, Mendez CM.
The efficacies of three relaxation regimens in the treatment of
PTSD in Vietnam war veterans. Journal of Clinical Psyhcology
1997;53(8):917-23.

Wilson 1995 {published data only}

Wilson SA, Becker LA, Tinker RH. Eye movement desensitisation
and reprocessing treatment for psychologically traumatised
individuals. Journal of Consulting and Clinical Psychology
1995;63(6):928-37.

Yeomans 2010 {published data only}

Yeomans PD, Forman EM, Herbert JD, Yuen E. A randomized
trial of a reconciliation workshop with and without PTSD
psychoeducation in Burundian sample. Journal of Traumatic
Stress 2010;23(3):305-12.

References to studies awaiting assessment

Krupnick 2008 {published data only}

Krupnick JL, Green BL, Stockton P, Miranda J, Krause E, Mete M.
Group interpersonal psychotherapy for low-income women
with posttraumatic stress disorder. Psychotherapy Research
2008;18(5):497-507.

Additional references

ACPMH 2007

Australian Centre for Posttraumatic Mental Health. Australian
Guidelines for the Treatment of Adults with Acute Stress
Disorder and Posttraumatic Stress Disorder. Melbourne:
Australian Centre for Posttraumatic Mental Health, 2007.

APA 1980

American Psychiatric Association. Diagnostic and Statistical
Manual of Mental Disorders (DSM-III) 3rd edition. Washington
DC: American Psychiatric Association, 1980.

Bisson JI. Post-traumatic stress disorder. British Medical Journal
2007;334:789-93.

Bisson 2007b

Bisson JI, Ehlers A, Matthews R, Pilling S, Richards D, Turner S.
Psychological treatments for chronic post-traumatic stress
disorder: Systematic review and meta-analysis. British Journal
of Psychiatry 2007;190(2):97-104.

Blake 1995

Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD,
Charney DS, et al. The development of a clinician administered
PTSD scale. Journal of Traumatic Stress 1995;8(1):75-90.

Bradley 2005

Bradley R, Green J, Russ E, Dutra L, Westen D. A
multidimensional meta-analysis of psychotherapy for PTSD.
American Journal of Psychiatry 2005;162(2):214-27.

Brewin 2003

Brewin CR, Holmes EA. Psychological theories of posttraumatic
stress disorder. Clinical Psychology Review 2003;23(3):339-76.

Creamer 2004

Creamer M, Forbes D, Phelps A, Humphreys L. .. Treating
Traumatic Stress: Conducting Imaginal Exposure. Australian
Centre for Posttraumatic Mental Health, 2004.

Foa 2000

Foa EB, Keane T, Friedman M. Effective Treatments for PTSD:
Practice Guidelines from the International Society for Traumatic
Stress Studies. New York, NY: Guildford Press, 2000.

Foa 2009

Foa, EB, Keane TM, Friedman MJ. Effective Treatments for PTSD:
Practice Guidelines from the International Society for Traumatic
Stress Studies. New York: Guilford Press, 2009.

Gillies 2012

Gillies D, Taylor F, Gray C, O'Brien L, D'Abrew N.
Psychological therapies for the treatment of post-traumatic
stress disorder in children and adolescents. Cochrane
Database of Systematic Reviews 2012, Issue 12. [DOI:
10.1002/14651858.CD006726.pub2]

APA 1987

Hetrick 2010

American Psychiatric Association. Diagnostic and Statistical
Manual of Mental Disorders. 3rd Edition. Washington DC, 1987.

APA 2000

American Psychiatric Association. Diagnostic and Statistical
Manual of Mental Disorders. 4th Edition. Washington DC, 2000.

Beck 1961

Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An
inventory for measuring depression. Archives of General
Psychiatry 1961;4:561-71.

Hetrick SE, Purcell R, Garner B, Parslow R. Combined
pharmacotherapy and psychological therapies for
post traumatic stress disorder (PTSD). Cochrane
Database of Systematic Reviews 2010, Issue 7. [DOI:
10.1002/14651858.CD007316.pub2]

Higgins 2003

Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring
inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.

Higgins 2011

Higgins JPT, Green S (editors). Cochrane Handbook for
Systematic Reviews of Interventions Version 5.1.0 [updated

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

49

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

March 2011]. The Cochrane Collaboration, 2011. Available from
www.cochrane-handbook.org.

Horowitz 1979

Horowitz MJ, Wilner N, Alvarez W. Impact of Event Scale:
a measure of subjective stress. Psychosomatic Medicine
1979;41(3):209-18.

Kessler 1995

Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB.
Posttraumatic stress disorder in the National Comorbidity
Survey. Archives of General Psychiatry 1995;52(12):1048-60.

Meichenbaum 1988

Meichenbaum D, Deffenbacher JL. Stress inoculation training.
Counseling Psychologist 1988;16:69-90.

NICE 2005

National Collaborating Centre for Mental Health (NCCMH). Post-
traumatic Stress Disorder (PTSD): The Management of PTSD
in Adults and Children in Primary and Secondary Care (CG26).
London: Gaskell and the British Psychological Society, 2005.

Pitman 1991

Pitman RK, Altman B, Greenwald E, Longpre RE, Macklin ML,
Poire RE, et al. Psychiatric complications during flooding
therapy for post-traumatic stress disorder. Journal of Clinical
Psychiatry 1991;52(1):17-20.

Resick 1992

Resick PA, Schnicke MK. Cognitive processing therapy for sexual
assault victims. Journal of Consulting and Clinical Psychology
1992;60(5):748-56.

RevMan 5 [Computer program]

The Nordic Cochrane Centre. Review Manager (RevMan).
Version 5.2. Copenhagen: The Nordic Cochrane Centre, 2012.

Roberts 2009

Roberts NP, Kitchiner NJ, Kenardy J, Bisson JI. Multiple session
early psychological interventions for the prevention of post-
traumatic stress disorder. Cochrane Database of Systematic
Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD006869.pub2]

Roberts 2010

Roberts NP, Kitchiner NJ, Kenardy J, Bisson JI. Early
psychological interventions to treat acute traumatic stress
symptoms. Cochrane Database of Systematic Reviews 2010,
Issue 3. [DOI: 10.1002/14651858.CD007944.pub2]

Rogers 1961

Rogers C. On Becoming a Person: A Therapist's View of
Psychotherapy. London: Constable, 1961.

C H A R A C T E R I S T I C S   O F   S T U D I E S

Characteristics of included studies [ordered by study ID]

Rose 2002

Rose S, Bisson J, Wessely S. Psychological debriefing
for preventing post traumatic stress disorder (PTSD).
Cochrane Database of Systematic Reviews 2002, Issue 2. [DOI:
10.1002/14651858.CD000560]

Shapiro 1989b

Shapiro F. Eye movement desensitisation: a new treatment for
post-traumatic stress disorder. Journal of Behavior Therapy and
Experimental Psychiatry 1989;20:211-7.

Spielberger 1973

Spielberger CD, Gorsuch RL, Lushene R. Manual for the State-
Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologist
Press, 1973.

Stein 2006

Stein DJ, Ipser JC, Seedat, S. Pharmacotherapy for
post traumatic stress disorder (PTSD). Cochrane
Database of Systematic Reviews 2006, Issue 1. [DOI:
10.1002/14651858.CD002795.pub2]

Van Etten 1988

Van Etten ML, Taylor S. Comparative efficacy of treatments
for post-traumatic stress disorder: a meta-analysis. Clinical
Psychology and Psychotherapy 1988;5:126-45.

WHO 1979

World Health Organization. ICD- 9 Clinical Descriptions and
Diagnostic Guidelines. Geneva: World Health Organization,
1992.

WHO 1992

World Health Organization. ICD-10 Classifications of Mental
and Behavioural Disorder: Clinical Descriptions and Diagnostic
Guidelines. Geneva: World Health Organization, 1992.

References to other published versions of this review

Bisson 2005

Bisson J, Andrew M. Psychological treatment of post-traumatic
stress disorder (PTSD). Cochrane Database of Systematic
Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD003388.pub3]

Bisson 2007

Bisson J, Andrew M. Psychological treatment of post-traumatic
stress disorder (PTSD). Cochrane Database of Systematic
Reviews 2007, Issue 3. [DOI: 10.1002/14651858.CD003388.pub3]

* Indicates the major publication for the study

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

50

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Adenauer 2011 

Methods

Randomised controlled trial

Cochrane Database of Systematic Reviews

Participants

34 refugees (in Germany) with a history of violence and persecution, suffering PTSD (15 women, 19
men)

Interventions

12 sessions of Narrative Exposure Therapy (NET) (n = 16) vs waitlist control (n = 18) in parallel

Outcomes

CAPS, HDRS, ssVEF

Notes

Risk of bias

Bias

Experienced therapists delivered therapy. Treatment adherence was not assessed, but monitored in
supervision sessions.

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Low risk

Quote: "Participants that fulfilled the inclusion criteria were randomized into
the two groups using a computer-generated list of random numbers".

Allocation concealment
(selection bias)

Unclear risk

Comment: Allocation concealment was not reported.

Incomplete outcome data
(attrition bias) 
All outcomes

High risk

Selective reporting (re-
porting bias)

High risk

Quote: " As this study focuses on brain changes through psychotherapy rather
than examining the clinical efficacy of the treatment, we restricted all analy-
ses to the sample of study completers". Drop-out rates were one participant
from treatment and two from waitlist, all due to deportation. Data for a further
4 participants were excluded from the treatment group, and another 8 from
waitlist, due to no/poor-quality MEG data.

www.clinicaltrials.gov-/ct2/show/NCT00563888 specified the CAPS as prima-
ry outcome and ssVEFs as secondary. The paper is written in terms of ssVEF as
primary outcome. The paper trials register also specifies a 4- and 9-month fol-
low-up.

Other bias

High risk

There was a mean difference of 16 points in pretreatment CAPS scores be-
tween the two groups (NET being greater).

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

High risk

Comment: Participants were aware of their allocation.

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Quote: "Two independent female masters-level psychologists, who were un-
aware of the patients’ treatment group, performed all assessments at pre-
treatment, posttreatment, and 3- and 6-month follow-up. The 12-month fol-
low-up assessment was conducted via mail. Blindness was maintained by en-
suring that the assessors had no access to group allocation and never talked
with patients about which group they were in."

Asukai 2010 

Methods

Randomised controlled trial

Participants

24 individuals (Japanese) with DSM-IV PTSD after various traumas (21 women, 3 men)

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

51

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Asukai 2010  (Continued)

Interventions

8 - 15 90-minute sessions of Prolonged Exposre (TFCBT) (n = 12) sessions vs treatment as usual (TAU) (n
= 12)

Outcomes

CAPS, IES-R, CES-D, GHQ-28

Notes

Risk of bias

Bias

Therapists were masters level psychologists. TAU included pharmacotherapy. Baseline demographics
were similar within both groups. The difference in scores between both groups was nonsignificant at
baseline on any of the assessment scales. Treatment adherence was measured.

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Low risk

Quote: "randomized by the study site based on computer-generated random
digit numbers by permuted blocks between 4 and 8."

Allocation concealment
(selection bias)

Unclear risk

Comment: Allocation concealment was not reported. Participants were ran-
domised at the study site.

Incomplete outcome data
(attrition bias) 
All outcomes

Low risk

Quote: "intention-to-treat analysis was performed to determine the relative
effect between the two treatment groups for each periodic posttreatment as-
sessment, and those between pre-PE (after the waiting period) and post-PE
treatment in the control group (CAPS total score, IES-R, CES-D, and GHQ-28)."

Comment: 3 dropped out from TFCBT, and one from TAU. A reason was only re-
ported for one of these drop-outs.

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Low risk

Comment: All specified and expected outcomes appear to have been reported.

Low risk

High risk

Comment: There were no other obvious sources of bias.

Comment: Participants were aware of their allocation.

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Quote: "Two independent female masters-level psychologists, who were un-
aware of the patients’ treatment group, performed all assessments at pre-
treatment, posttreatment, and 3- and 6-month follow-up. The 12-month fol-
low-up assessment was conducted via mail. Blindness was maintained by en-
suring that the assessors had no access to group allocation and never talked
with patients about which group they were in."

Basoglu 2005 

Methods

Randomised controlled trial

Participants

59 earthquake survivors in Turkey with DSM-IV PTSD (50 women, 9 men)

Interventions

Single session of CBT (n = 31) vs waitlist control (n = 28)

Outcomes

CAPS, TSSC, FAQ, BDI, WSA

Notes

Treatment delivered by psychologists trained in the approach. Treatment adherence was measured.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

52

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Basoglu 2005  (Continued)

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Low risk

Quote: "Random allocation was conducted according to a computer-generat-
ed randomization list. Blocking was used to ensure approximately equal cell
sizes."

Allocation concealment
(selection bias)

Low risk

Incomplete outcome data
(attrition bias) 
All outcomes

High risk

Quote: "The participants were recruited into the study by four independent as-
sessors, who did not have access to the random assignment schedule. The lat-
ter was implemented by the project coordinator, who did not take part in the
assessments at any stage during the trial."

Quote: "As a result of case attrition after week 6, two types of end-point impu-
tation analyses were carried out. First, the treatment effects were examined
at each follow-up, carrying forward the scores of the non-improved non-com-
pleters at their last available assessment to subsequent follow-up points. As
this procedure did not involve the improved non-completers and assumed
that the non-improved non-completers would have remained non-improved
had they stayed in the study, it led to a conservative analysis of the treatment
effects."

Comment: participants who did not have at least one follow-up after treat-
ment were replaced. Eight individuals dropped out of treatment group and 2
from waitlist. No reasons were given.

Selective reporting (re-
porting bias)

Low risk

Comment: All specified and expected outcomes appear to have been reported.

Other bias

Low risk

Comment: Baseline demographics are poorly reported. Groups were reported
to be similar in every baseline variable but gender (only 1 man in WL group vs 8
in the treatment group).

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

High risk

Comment: Participants were aware of their allocation.

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Quote "The assessments were conducted by four independent assessors
(three psychologists and one psychiatrist), who were blind as to the partici-
pants’ experimental condition. A Blindness Integrity Assessment Form was
used to elicit information about whether assessor blindness was maintained at
the second assessment and the assessor’s guess as to the study participant’s
experimental condition."

Basoglu 2007 

Methods

Randomised controlled trial

Participants

31 earthquake survivors in Turkey with DSM-IV PTSD (27 women, 4 men)

Interventions

Single session of CBT (n = 16) vs repeated assessments (n = 15)

Outcomes

CAPS, FAQ, BDI, WSA, GIS-S, GIS-A

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

53

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Basoglu 2007  (Continued)

Notes

Risk of bias

Bias

Treatment was delivered by therapists who were experienced in delivering the intervention on the ba-
sis of having done so as part of earlier trials.

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Low risk

Quote "A computer-generated sequence of random numbers that ensured
equal cell sizes and did not lead to allocation of more than two consecutive
cases to the same experimental condition was used in the randomization."

Allocation concealment
(selection bias)

Low risk

Quote "Participants were enrolled by two independent assessors (psycholo-
gists) and randomizations was conducted by the second author, who did not
participate in baseline assessments."

Incomplete outcome data
(attrition bias) 
All outcomes

High risk

Comment: Participants who did not have at least one follow-up after treat-
ment were replaced. ITT analyses were performed after this point. One person
dropped out of treatment group. No one dropped out from waitlist group. No
reasons were given.

Selective reporting (re-
porting bias)

Low risk

Comment: All specified and expected outcomes appear to have been reported.

Other bias

High risk

Comment: Treatment adherence was not assessed, since the treatment was
said to closely reflect the way treatment was delivered in routine fieldwork.
Poor reporting of baseline characteristics.

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

High risk

Comment: Participants were aware of their allocation.

Blinding of outcome as-
sessment (detection bias) 
All outcomes

High risk

Quote: "The assessors were blind as to the participants’ experimental condi-
tion at the week 4 and week 8 assessments."

Test of blinding included. However, 6 cases were followed up by therapists due
to an unexpected shortage of funding.

Beck 2009 

Methods

Randomised controlled trial

Participants

44 motor vehicle accident survivors (in the USA) with DSM-IV PTSD (36 women, 8 men)

Interventions

Group TFCBT (n = 17) vs minimum contact (n = 16)

Outcomes

CAPS, IES-R, BAI, BDI, ODI, PS-MPI

Notes

Risk of bias

Bias

Experienced therapists. Treatment adherence was assessed, as was competence.

Authors' judgement

Support for judgement

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

54

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Beck 2009  (Continued)

Random sequence genera-
tion (selection bias)

Unclear risk

Allocation concealment
(selection bias)

Unclear risk

Cochrane Database of Systematic Reviews

Quote "Groups of four to seven individuals were formed as participants be-
came eligible; a given group then was randomly assigned to either GCBT or
MCC conditions."

Comment: Method used to generate the allocation sequence is not described
in sufficient detail to assess the probability that it would produce comparable
groups.

Quote "Groups of four to seven individuals were formed as participants be-
came eligible; a given group then was randomly assigned to either GCBT or
MCC conditions."

Comment: There is no mention of any measures taken to conceal allocation

Incomplete outcome data
(attrition bias) 
All outcomes

High risk

Comment: Completers data were analysed. 7 individuals dropped out of the
treatment group and 2 from minimum contact. No reasons were given for
drop-out.

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Low risk

Low risk

High risk

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

All specified outcomes appear to have been reported, although results are dis-
cussed in terms of completers.

Comment: There were no other obvious sources of bias.

Comment: Participants were aware of their allocation.

Quote "Interviews for the POST and FU assessments were administered by an
individual who had not conducted the pre-treatment assessment and was un-
aware of patients' treatment status and their time of assessment (POST versus
FU)."

Bichescu 2007 

Methods

Randomised controlled trial

Participants

18 former political detainees (in Romania) with PTSD (17 men, 1 woman)

Interventions

Narrative Exposure Therapy (n = 9) vs psychoeducation (n = 9)

Outcomes

CIDI, BDI

Notes

Risk of bias

Bias

All treatment carried out by a PhD psychology student. Unclear whether adherence was measured, but
supervision was provided by email.

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

High risk

Quote: "Participants were assigned through a random selection procedure of
participants name-cards to one of two treatment groups: NET and PED."

Comment: It is unclear how exactly this was performed.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

55

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Bichescu 2007  (Continued)

Allocation concealment
(selection bias)

Incomplete outcome data
(attrition bias) 
All outcomes

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Unclear risk

Comment: The authors do not report any methods of allocation concealment.

Low risk

Comment: No drop-outs.

Low risk

Comment: All specified and expected outcomes appear to have been reported.

High risk

High risk

Comment: Very small sample size

Comment: Participants were aware of their allocation.

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Quote: "Our intent was to perform a blinded assessment by keeping the in-
terviewers unaware of the treatment condition and pre-test scores of the in-
dividual patients and by instructing the patients not to inform the interview-
ers about their treatment. However, due to the large differences in procedures
and number of sessions between the two treatment conditions, it was not pos-
sible for us to achieve complete blindness in all cases. Occasionally, a patient
revealed details about his treatment that might have affected the blindness of
the interviewer."

Blanchard 2003 

Methods

Randomised controlled trial

Participants

98 road traffic accident survivors in the USA (72 women, 26 men)

Interventions

8 - 12 sessions TFCBT (n = 27) vs 8 - 12 sessions supportive psychotherapy (n = 27) vs waiting list (n = 24)
(all three arms included in meta-analyses)

Outcomes

IES,STAI

Notes

Risk of bias

Bias

Therapists were practising psychologists, with over 5 years experience. Each had a cognitive behaviour-
al orientation, but treated participants in both active treatment arms. Adherence was assessed.

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

High risk

Quote "The senior author matched participants into triads, based on the CAPS
score and diagnosis,and then randomly assigned triads to a therapist and to
conditions within the triad."

Comment: Indicates that the method of sequence generation poses the poten-
tial for bias.

Allocation concealment
(selection bias)

Unclear risk

Comment: there were no reported measures of allocation concealment.

Incomplete outcome data
(attrition bias) 

Low risk

Quote "When we could not obtain dropout assessment data, we substituted
the initial assessment data in the intent to treat analysis." However, no rea-

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

56

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Blanchard 2003  (Continued)

All outcomes

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Blinding of outcome as-
sessment (detection bias) 
All outcomes

sons were reported for drop-outs (10 from CBT, 9 from supportive psychother-
apy, and 1 from waitlist).

Low risk

Comment: All specified and expected outcomes appear to have been reported.

Low risk

High risk

Comment: no other sources of bias detected.

Comment: Participants were aware of their allocation.

Low risk

Quote "The assessors were kept blind to treatment condition."

Brom 1989 

Methods

Randomised controlled trial

Participants

112 outpatients in the Netherlands. Various traumas, 89 bereaved. (88 women, 24 men)

Interventions

14 - 18 sessions of trauma desensitisation (n = 31), hypnotherapy (n = 29), psychodynamic therapy (n
= 29) or waiting list (n = 23) (data could not be entered into meta-analysis, included only intrusion and
avoidance sub-scales)

Outcomes

"trauma symptoms" on SCL-90

Notes

Risk of bias

Bias

Therapists with over 10 years experience in the specific method. Therapists conducted the therapies
they preferred outside the research setting (i.e. there were different therapists treating each treatment
arm). Supervision sessions ensured adherence.

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Unclear risk

Comment: The method of sequence generation is not reported. It is simply
stated that treatment assignment was random.

Allocation concealment
(selection bias)

Unclear risk

Comment: The method of sequence allocation is not reported,

Incomplete outcome data
(attrition bias) 
All outcomes

High risk

Comment: There were no reported reasons for drop-out. There was inade-
quate statistical correction for these drop-outs.

3 individuals dropped out of each of the treatment arms.

Selective reporting (re-
porting bias)

Unclear risk

Quote: "We focus in this article on the data from the standardized question-
naires, disregarding the physiological and behavioral tests that were admin-
istered. The domains that were covered by the questionnaires were general
symptoms, symptoms of the coping process, and personality."

Comment: It is unclear whether it had originally been the intention to report
the behavioural tests.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

57

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Brom 1989  (Continued)

Other bias

High risk

Cochrane Database of Systematic Reviews

Comment: Inadequate reporting of baseline characteristics. Each treatment
arm had its own dedicated therapists (i.e. differences in outcome may have
been attributable to expertise as opposed to the intervention).

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Blinding of outcome as-
sessment (detection bias) 
All outcomes

High risk

Comment: Participants were aware of their allocation.

Unclear risk

Comment: There is no mention of blinding outcome assessors.

Bryant 2003 

Methods

Randomised controlled trial

Participants

58 outpatient survivors of non-sexual assaults or road traffic accidents in Australia (30 women, 28 men)

Interventions

8 weekly 90-minute sessions of imaginal exposure (n = 20), imaginal exposure/cognitive restructuring
(n = 20) or supportive counselling (n = 18). (imaginal exposure and imaginal exposure/cognitive restruc-
turing were combined for meta-analysis).

Outcomes

CAPS, IES, STAI, BDI

Notes

Risk of bias

Bias

Therapists were masters level clinical psychologists. Treatment adherence was assessed.

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Low risk

Quote: "Randomization was conducted by a process of minimization strati-
fied on gender, trauma type, and PTSD total score. Participants were randomly
assigned according to a random numbers system and each month Richard A.
Bryant amended the allocation to ensure that gender, trauma type, and PTSD
severity were balanced across conditions."

Allocation concealment
(selection bias)

Unclear risk

Comment: It is unclear if/how allocation was concealed.

Incomplete outcome data
(attrition bias) 
All outcomes

Low risk

Quote "Intent-to-treat values were devised by using a last-value-carried for-
ward procedure to provide data for missing values that occurred because of
dropout."

Comment: Reasons for drop-out are not fully reported. ITT analyses were how-
ever reported. Drop-out by group was as follows: imaginal exposure (5), imagi-
nal exposure/cognitive restructuring (5) or supportive counselling (3).

Low risk

Comment: All specified and expected outcomes appear to have been reported.

Low risk

High risk

Comment: no other sources of bias detected.

Comment: Participants were aware of their allocation.

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

58

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Bryant 2003  (Continued)

All outcomes

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Cochrane Database of Systematic Reviews

Quote: "Initial assessments were conducted at pretreatment, posttreatment,
and 6-month follow-up by independent clinicians who were unaware of the
treatment condition of participants. Blindness was maintained by ensuring
that clinicians who conducted assessments did not have access to (a) partici-
pant notes, (b) treatment allocation of participants, or (c) supervision discus-
sions of therapy sessions."

Bryant 2011 

Methods

Randomised controlled trial

Participants

28 survivors of terrorist attacks in Southern Thailand (27 women, 1 man)

Interventions

8 weekly 60-minute sessions of CBT (n = 16) vs TAU (n = 12)

Outcomes

PSS, BDI, ICG

Notes

Risk of bias

Bias

Therapy was conducted by Thai psychologists or psychiatric nurses who were trained to use the treat-
ment manual in 3 2-day workshops occurring over 12 months. They had no previous experience of CBT.
During the trial itself, therapists conducted treatment without formal supervision. TAU comprised the
equivalent number of sessions of supportive counselling being provided by psychiatrists who were not
trained in CBT. Adherence was not assessed, but checklists indicated components of treatment com-
pleted.

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Low risk

Quote: "Patients were randomised according to a random numbers system ad-
ministered by health officials in Bangkok (fully independent of counsellors and
the study co-ordinator)."

Allocation concealment
(selection bias)

Low risk

Quote: "Patients were randomised according to a random numbers system ad-
ministered by health officials in Bangkok (fully independent of counsellors and
the study co-ordinator)."

Incomplete outcome data
(attrition bias) 
All outcomes

Low risk

Comment: Allocation was independent and remote from study site.

Quote: "There were no treatment drop-outs, and so analyses focus on all pa-
tients who were randomised into the study."

Selective reporting (re-
porting bias)

Low risk

Comment: All specified and expected outcomes appear to have been reported.

Other bias

High risk

Recruitment was terminated prematurely due to health workers being target-
ed by the terrorists.

Small sample size (n = 28)

High risk

Comment: Participants were aware of their allocation.

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

59

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Bryant 2011  (Continued)

Cochrane Database of Systematic Reviews

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Quote: "Assessments conducted at post-treatment and 3 months following
treatment were conducted by independent personnel unaware of patients’
treatment condition."

Carlson 1998 

Methods

Randomised controlled trial

Participants

35 men with combat-related PTSD in Hawaii

Interventions

12 bi-weekly sessions of 60-75 minutes EMDR (n = 10) vs 40 minutes biofeedback-assisted relaxation vs
routine care (n = 13) vs TAU (n = 12) (all interventions included in meta-analysis)

Outcomes

Mississippi PTSD scale, IES, STAI, BDI

Notes

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

Experienced therapists

Authors' judgement

Support for judgement

Unclear risk

Comment: The method of sequence generation was not reported.

Unclear risk

Comment: The method of allocation concealment (if any) was not reported.

Incomplete outcome data
(attrition bias) 
All outcomes

High risk

Comment: There was 1 drop-out from the biofeedback-assisted relaxation.
There was no reason given for this drop-out. These were not properly account-
ed for in terms of statistical tests.

Selective reporting (re-
porting bias)

Low risk

Comment: All specified and expected outcomes appear to have been reported.
The CAPS is emphasised as the primary outcome measure throughout.

Other bias

Unclear risk

Comment: There were no other obvious sources of bias.

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

High risk

Comment: Participants were aware of their allocation.

Blinding of outcome as-
sessment (detection bias) 
All outcomes

High risk

Comment: Assessors were not blind, although a second CAPS was adminis-
tered by a blind assessor.

Chard 2005 

Methods

Randomised controlled trial

Participants

71 female child sexual abuse survivors in the USA

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

60

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Chard 2005  (Continued)

Interventions

17 weekly 90-minute group sessions of cognitive processing therapy for sexual abuse survivors and a
60-minute individual session for first 9 weeks and 17th week (n = 36) vs minimal attention (weekly 5 to
10-minute phone call providing supportive counselling) (n = 35)

Outcomes

CAPS, MPSS, BDI-II, DES-II

Notes

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

 Experienced therapists delivered therapy and treatment adherence was assessed.

Authors' judgement

Support for judgement

Unclear risk

Comment: The method of sequence generation was not reported.

Unclear risk

Comment: The method of allocation concealment (if any) was not reported.

Incomplete outcome data
(attrition bias) 
All outcomes

Low risk

Comment: ITT analyses were conducted. No reasons were given for with-
drawals from the study (8 in the treatment arm and 7 from the minimal-atten-
tion group.)

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Unclear risk

Comment: All specified and expected outcomes appear to have been reported.

Low risk

High risk

Comment: There were no other obvious sources of bias.

Comment: Participants were aware of their allocation.

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Quote: "Research assistants blind to the assigned condition of the subject con-
ducted all interviews, and treatment completers were asked not to mention
having been in therapy at posttreatment assessments."

Cloitre 2002 

Methods

Randomised controlled trial

Participants

58 female child sexual abuse survivors in the USA

Interventions

16 bi-weekly sessions of 1½ hours of prolonged exposure and affect regulation (n = 22) vs waitlist (n =
24)

Outcomes

CAPS, BDI, STAI

Notes

Risk of bias

Bias

Experienced therapists. Treatment adherence measured.

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Unclear risk

Comment: The method of sequence generation was not reported.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

61

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Cloitre 2002  (Continued)

Allocation concealment
(selection bias)

Unclear risk

Comment: The method of allocation concealment (if any) was not reported.

Incomplete outcome data
(attrition bias) 
All outcomes

Low risk

Comment: There was a relatively high drop-out rate (9 from active treatment,
3 from the waitlist). There were no reasons given for drop-outs, but there were
said to be no sociodemographic, clinical or symptom differences between
completers and drop-outs. ITT analyses were performed

Selective reporting (re-
porting bias)

High risk

There is emphasis on reporting improvements in affect regulation and inter-
personal skills as opposed to PTSD symptoms. The Methods section does not
seem to indicate that these were the primary outcome measures.

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Low risk

High risk

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Comment: There were no other obvious sources of bias.

Comment: Participants were aware of their allocation.

Quote: "Clinician raters were blind to treatment condition at pre- and post-
treatment."

Cloitre 2010 

Methods

Randomised controlled trial

Participants

104 female child sexual abuse survivors in the USA

Interventions

STAIR/exposure vs support/exposure vs STAIR/support

Outcomes

Notes

Risk of bias

Bias

CAPS, PSS-SR, negative mood regulation scale, BDI, STAI, Inventory of Interpersonal Problems, Inter-
personal Support Evaluation List

Treatment was delivered by doctoral level psychologists, who had been trained by leading experts in
the field. Adherence was measured.

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Unclear risk

Comment: The method of sequence generation was not reported.

Allocation concealment
(selection bias)

Low risk

Quote "Randomization blocks of nine (three instances of each of the three con-
ditions) were employed, generated by an individual not otherwise involved
with the study. Within each randomly assigned condition, the participant was
assigned to one of three therapists, based on a match in availability."

Incomplete outcome data
(attrition bias) 
All outcomes

Low risk

Quote: "Analyses for all symptom outcome measures were performed on the
intent-to-treat sample using data from all participants according to their ran-
domizations assignment. Missing data were imputed using PROC MI in SAS
(SAS Institute, Cary, N.C.) to generate 10 imputed data sets."

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

62

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Cloitre 2010  (Continued)

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Comment: All specified outcomes were reported.

Low risk

High risk

Comment: There were no other obvious sources of bias.

Comment: Participants were aware of their allocation.

Low risk

Comment: Assessors were blinded.

Cooper 1989 

Methods

Randomised controlled trial

Participants

16 male Vietnam War veterans in the USA. All DSM-III PTSD

Interventions

6 - 14 90-minute flooding sessions plus standard treatment (n = 8) vs standard treatment (n = 8)

Outcomes

STAI, BDI

Notes

Risk of bias

Bias

No information was provided with regards to the therapists delivering treatment or any measures of
treatment adherence.

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

High risk

Quote: "Efforts were made to preclude bias in assessment by maintaining as
nearly random a procedure as possible"

Comment: There were no details of the method of sequence generation, but
the authors indicate that it was not entirely random.

Allocation concealment
(selection bias)

High risk

Quote: "In all cases group assignment was pre-decided before the participant
agreed to participate...there were three exceptions to the rule of pre-deter-
mined random assignment"

Comment: Allocation does not seem to have been concealed.

Incomplete outcome data
(attrition bias) 
All outcomes

High risk

All 16 participants provided posttreatment data, but 2 were removed from the
analysis of data from the experimental group due to not completing therapy (1
from each group). These individuals were said to have a more severe presenta-
tion.

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 

Low risk

Comment: All specified outcomes were reported.

High risk

High risk

Comment: Very small sample.

Comment: Participants were aware of their allocation.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

63

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Cooper 1989  (Continued)

All outcomes

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Unclear risk

Self-report measures only, but it is not clear how these were administered.

Devilly 1998 

Methods

Randomised controlled trial

Participants

51 male combat veterans with DSM-III-R PTSD in Australia

Interventions

12 sessions of EMDR (n = 19) vs biofeedback-assisted relaxation (n = 16) vs routine clinical care (n = 16)
(all interventions included in meta-analyses)

Outcomes

Mississippi scale, PTSD symptom scale, IES, STAI, BDI

Notes

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

Therapist trained by Francine Shapiro. No mention of an assessment of treatment adherence.

Authors' judgement

Support for judgement

Unclear risk

Comment: The method of sequence generation was not reported.

Unclear risk

Comment: There is no mention of any measures taken to conceal allocation.

Incomplete outcome data
(attrition bias) 
All outcomes

High risk

Comment: There were no reasons given for drop-outs (6 drop-outs from EMDR,
4 drop-outs from relaxation and 6 drop-outs from usual care). Data from the
completers were analysed.

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Comment: All specified outcomes were reported,

Low risk

High risk

There were no other obvious sources of bias.

Comment: Participants were aware of their allocation.

Low risk

Comment: All measures were self-reported and administered by post.

Devilly 1999 

Methods

Randomised controlled trial

Participants

32 participants with DSM-IIIR PTSD (11 men, 21 women) in Australia

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

64

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Devilly 1999  (Continued)

Interventions

8 sessions EMDR (n = 17) vs 9 sessions TFCBT (n = 15) in parallel.

Outcomes

BDI, SCL-90 Global distress, CMS, IES, PSS-SR, PTSD Interview (DSM-III-R)

Notes

Risk of bias

Bias

Therapists were appropriately trained and experienced. Treatment adherence was measured.

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

High risk

Quote: "Participants were assigned to their experimental group using a strat-
ified randomization technique: the first 10 referrals were assigned to the TTP
condition (after a 50% chance of either TTP or EMDR) and the following 10
were assigned to the EMDR condition. This was done in order to consolidate
therapist skills in each protocol and offset cross-pollination of the two, differ-
ent, therapeutic protocols. Subsequently, subjects were assigned alternatively
to the two conditions until a full cohort was obtained in each condition."

Allocation concealment
(selection bias)

Unclear risk

Comment: It is unclear whether any measures were in place for concealing al-
location.

Incomplete outcome data
(attrition bias) 
All outcomes

Selective reporting (re-
porting bias)

High risk

Comment: Only the data of completers were included in analyses.

Low risk

Comment: All specified outcomes were reported.

Other bias

High risk

Comment: There were differences in the baseline characteristics of the two
groups, for example, medication profiles (which were continued through the
course of the trial).

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Blinding of outcome as-
sessment (detection bias) 
All outcomes

High risk

Comment: Participants were aware of their allocation.

Unclear risk

Comment: It is unclear whether outcome assessors were blinded.

Duffy 2007 

Methods

Randomised controlled trial

Participants

58 participants mostly resulting from the troubles in Northern Ireland (23 women, 35 men)

Interventions

12 weekly sessions of cognitive therapy (n = 29) vs waiting list (n = 29). Cross-over trial.

Outcomes

PDS, BDI, SDS

Notes

Risk of bias

Experienced therapists (1 social worker, 1 psychiatrist, and 3 nurse therapists). Treatment adherence
does not seem to have been assessed.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

65

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Duffy 2007  (Continued)

Bias

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Unclear risk

Comment: The method of sequence generation was not reported. Participants
were randomised remotely.

Allocation concealment
(selection bias)

Low risk

Quote: "An independent office allocated patients to immediate therapy or to
wait followed by therapy on a stratified random basis using the minimisation
method of Pocock. Assessors were not aware of the allocation algorithm".

Incomplete outcome data
(attrition bias) 
All outcomes

Low risk

Quote: "We carried out analyses on an intention to treat basis". Reasons for
drop-out were reported (9 from cognitive therapy and 3 from waiting list).

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Low risk

Comment: All specified outcomes were reported,

High risk

High risk

Treatment adherence was not measured.

Comment: Participants were aware of their allocation.

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Unclear risk

Comment: Measures were self-reported, but it is unclear how these were ad-
ministered.

Dunne 2012 

Methods

Participants

Randomised controlled trial

26 adults (13 men, 13 women) with chronic motor vehicle collision PTSD with chronic whiplash-associ-
ated disorders, in Australia

Interventions

10 weekly sessions of TFCBT (n = 13) vs waiting list (n = 13)

Outcomes

SCID-PTSD, PDS, IES-R, DASS, SF-36

Notes

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

Comment: All therapy delivered by 1 psychologist with 12 months experience of delivering TFCBT. It is
unclear whether or not treatment adherence was assessed.

Authors' judgement

Support for judgement

Unclear risk

Comment: The method of sequence generation was not reported

Unclear risk

Comment: There is no mention of any measures taken to conceal allocation

Incomplete outcome data
(attrition bias) 
All outcomes

Low risk

Comment: Reasons for leaving the study were fully reported, ITT analyses were
performed. Appropriate methods of imputing data were used. One participant
dropped out of the treatment group and 2 from the waitlist group. Reasons for
attrition were not fully reported.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

66

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Dunne 2012  (Continued)

Selective reporting (re-
porting bias)

Low risk

Comment: All specified outcomes were reported.

Other bias

High risk

Comment: All therapy delivered by 1 psychologist with 12 months experience
of delivering TFCBT. It is unclear whether or not treatment adherence was as-
sessed.

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Blinding of outcome as-
sessment (detection bias) 
All outcomes

High risk

Comment: Participants were aware of their allocation.

Unclear risk

Comment: It is unclear whether the outcome assessor was blind.

Echeburua 1997 

Methods

Randomised controlled trial

Participants

20 female sexual aggression survivors in Spain

Interventions

6 weekly sessions of graded self exposure (n = 10) vs relaxation therapy (n = 10)

Outcomes

Global PTSD scale, STAI, BDI

Notes

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

Incomplete outcome data
(attrition bias) 
All outcomes

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Treatment delivered by an experienced clinical psychologist. Treatment adherence was not measured.

Authors' judgement

Support for judgement

Unclear risk

Comment: The method of sequence generation was not reported.

Unclear risk

Comment: There is no mention of any measures taken to conceal allocation.

Low risk

Comment: No drop-outs.

Low risk

Comment: All specified outcomes were reported.

High risk

High risk

Comment: Small sample size. Treatment adherence was not measured.

Comment: Participants were aware of their allocation.

Unclear risk

Comment: It is unclear whether assessors were blinded.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

67

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Ehlers 2003 

Methods

Participants

Interventions

Randomised controlled trial

69 participants with duration of PTSD greater than 3 months from a larger RCT of 85 participants with
DSM-IV PTSD in the UK. Various traumas.

12 x weekly sessions of CT (n = 22) vs repeated assessment (n = 20) vs self help (n = 27) (CT and repeated
assessment included in a meta-analysis).

Outcomes

CAPS, PDS, BDI, BAI

Notes

Risk of bias

Bias

Therapist details/credentials are not reported and it is unclear whether treatment adherence was mea-
sured.

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Unclear risk

Quote: "Randomization was stratified by sex and severity of PTSD symptoms
using the random permuted blocks within strata algorithm."

Allocation concealment
(selection bias)

Low risk

Incomplete outcome data
(attrition bias) 
All outcomes

High risk

Comment: The method of random sequence generation was not reported.

Quote: "Assessors who decided whether patients were suitable for inclusion
in the study could not predict what treatment condition would be assigned to
the patient, as (1) the allocation list was kept locked in a separate central of-
fice and the patient’s allocation was only revealed 3 weeks later, following the
self-monitoring assessment, and (2) the study was conducted at 2 sites."

Quote: "As the most conservative estimate of the efficacy of CT, we report a
completer analysis for the continuous outcome measures, comparing the full
sample of patients allocated to CT (as there were no dropouts) with the com-
pleters in the SH and RA
conditions." There were three drop-outs from self help and two from repeated
assessment. Reasons for drop-outs were fully reported.

Selective reporting (re-
porting bias)

Low risk

Comment: All specified outcomes were reported.

Other bias

High risk

Comment: Therapist details/credentials are not reported and it is unclear
whether treatment adherence was measured.

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

High risk

Comment: Participants were aware of their allocation.

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Quote: "Independent assessors (trained clinical psychologists or research
nurses) who were not aware of the treatment condition gave the Clinician-Ad-
ministered PTSD Scale (CAPS-SX) interview."

Comment: There was a test of blinding.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

68

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Ehlers 2005 

Methods

Randomised controlled trial

Participants

28 individuals with DSM-IV PTSD in the UK. Various traumas.

Interventions

12 x weekly sessions of CT (n=14) vs WL (n=14)

Outcomes

CAPS, PDS, BDI, BAI

Cochrane Database of Systematic Reviews

Notes

Risk of bias

Bias

Therapist details/credentials are not reported and it is unclear whether treatment adherence was mea-
sured.

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Unclear risk

Quote: "Patients were randomly allocated to either immediate cognitive thera-
py"

Allocation concealment
(selection bias)

Incomplete outcome data
(attrition bias) 
All outcomes

Selective reporting (re-
porting bias)

Comment: The method of randomisation is clear.

Unclear risk

Comment: The method of allocation concealment was unclear.

Low risk

Comment: ITT analyses were performed.

Low risk

Comment: All specified outcomes were reported.

Other bias

High risk

Comment: Therapist details/credentials are not reported and it is unclear
whether treatment adherence was measured.

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Fecteau 1999 

Methods

Participants

High risk

Comment: Participants were aware of their allocation.

Low risk

Quote: Independent assessors were used.

Randomised controlled trial

23 road traffic accidents in Canada. 14 women, 6 men completed the study. It is unclear how many men
and women entered the study originally

Interventions

8 - 10 hours CBT (n = 12) vs waitlist (n = 11)

Outcomes

CAPS, IES, BDI, BAI

Notes

Experienced therapists delivered therapy and treatment adherence was assessed

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

69

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Fecteau 1999  (Continued)

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Low risk

Quote: "participants were then randomly assigned to the treatment or WLC
groups by the flip of a coin".

Allocation concealment
(selection bias)

Unclear risk

Comment: There is no mention of any measures taken to conceal allocation.

Incomplete outcome data
(attrition bias) 
All outcomes

High risk

Comment: 2 participants dropped out of the treatment group and 1 dropped
off the waitlist. Reasons for attrition are reported. Only the data of completers
are included in the analysis.

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

High risk

High risk

Comment: All specified outcomes were reported, although the lack of effect on
the measure of depression is not divulged in the abstract.

Comment: Small sample size.

Comment: Participants were aware of their allocation.

Unclear risk

Comment: Outcome measures were rated by an "independent assessor".

Feske 2008 

Methods

Randomised controlled trial

Participants

27 low-income African-Americans with complex trauma histories and

Interventions

9 - 12 weekly sessions of PE vs 9 - 12 sessions of non-TF supportive counselling DSM-IV PTSD

Outcomes

PTSD Diagnostic Scale, BDI, BAI, BSQ, Anger Expression Inventory, Brief Symptom Inventory

Notes

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

Incomplete outcome data
(attrition bias) 
All outcomes

Authors' judgement

Support for judgement

Unclear risk

Comment: The method of sequence generation was not reported.

Unclear risk

Comment: There is no mention of any measures taken to conceal allocation.

High risk

Comment: Drop-outs reported (2 for unknown reasons).

Completers Analysis.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

70

 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Feske 2008  (Continued)

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Comment: All specified outcomes were reported.

High risk

High risk

Comment: Small sample size.

Comment: Participants were aware of their allocation.

Unclear risk

Comment: It is unclear whether outcome assessors were blinded.

Foa 1991 

Methods

Randomised controlled trial

Participants

55 female rape victims in the USA. All DSM-IIIR PTSD

Interventions

9 1½-hour sessions of prolonged exposure (n = 14) vs stress inoculation training (n = 17) vs supportive
counselling (n = 14) vs waiting list (n = 10) control (all interventions included in meta-analyses).

Outcomes

PTSD severity, BDI, STAI

Notes

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

Experienced therapists delivered therapy and treatment adherence was assessed.

Authors' judgement

Support for judgement

Unclear risk

Comment: The method of sequence generation was not reported.

Unclear risk

Comment: There is no mention of any measures taken to conceal allocation.

Incomplete outcome data
(attrition bias) 
All outcomes

High risk

Quote: "Subsequent analyses were conducted on data from the 45 com-
pleters."

Comment: 10 participants dropped out of treatment (prolonged exposure (4)
vs stress inoculation training (3) vs supportive counselling (3) vs waiting list
control (0)). No reasons reported for drop-outs.

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Low risk

Comment: All specified outcomes were reported.

Low risk

High risk

Comment: There were no other obvious sources of bias.

Comment: Participants were aware of their allocation.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

71

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Foa 1991  (Continued)

Cochrane Database of Systematic Reviews

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Quote: "Assessments at pre-treatment, posttreatment, and follow-up consist-
ed of clinical interviews conducted by an independent assessor, who was blind
to treatment conditions, and self report questionnaires"

Foa 1999 

Methods

Randomised controlled trial

Participants

96 female sexual assault victims (69 sexual assault) in the USA

Interventions

9 sessions (2 x 2 hours, 7 x 1½ hours) prolonged exposure (n = 25) vs stress inoculation training (n = 26)
vs combination PE-SIT (n = 30) vs waiting list (n = 15) (all interventions included in meta-analyses).

Outcomes

PSS-I, BDI, STAI

Notes

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

Experienced therapists delivered therapy and treatment adherence was assessed.

Authors' judgement

Support for judgement

Unclear risk

Comment: The method of sequence generation was not reported.

Unclear risk

Comment: There is no mention of any measures taken to conceal allocation.

Incomplete outcome data
(attrition bias) 
All outcomes

Low risk

Comment: ITT analyses performed. 17 participants dropped out of treatment
(2 from prolonged exposure, 7 from SIT and 8 from PE-SIT).

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Comment: All specified outcomes were reported.

High risk

High risk

Comment: There were no other obvious sources of bias.

Comment: Participants were aware of their allocation.

Low risk

Quote: "Independent evaluators... were unaware of treatment assignment".

Foa 2005 

Methods

Randomised controlled trial

Participants

171 female sexual assault survivors in the USA

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

72

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Foa 2005  (Continued)

Interventions

9 - 12 weekly 90- to 120-minute sessions of prolonged exposure (n = 79) vs 9 - 12 weekly 90- to 120-
minute sessions of prolonged exposure and cognitive restructuring (n = 74) vs waiting list (n = 26) (all
interventions included in meta-analyses).

Outcomes

PSS-I, BDI, SAS

Notes

Risk of bias

Bias

Experienced therapists delivered therapy and treatment adherence was assessed.

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Unclear risk

Allocation concealment
(selection bias)

Low risk

Quote: "The study statistician assigned participants who provided informed
consent to one of the three conditions using a weighted randomizations pro-
cedure such that participants were assigned to one of the active treatment
conditions at a greater rate than to WL."

Comment: Although reported to be carried out by a statistician, the method of
sequence generation is unclear.

Quote: "The study statistician assigned participants who provided informed
consent to one of the three conditions using a weighted randomizations pro-
cedure such that participants were assigned to one of the active treatment
conditions at a greater rate than to WL."

Comment: Participants were assigned to a group by an external person.

Incomplete outcome data
(attrition bias) 
All outcomes

Low risk

Comment: ITT analyses were performed. Reasons for drop-out were not fully
reported. There were many drop-outs (1 from waiting list, 30 from PE/CR and
27 from PE).

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Low risk

Comment: All specified outcomes were reported

Low risk

High risk

Comment: There were no other obvious sources of bias.

Comment: Participants were aware of their allocation.

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Quote: "All evaluations were conducted by trained doctoral or master’s level
CTSA clinicians who were blind to study condition."

"Participants were instructed by their therapists and the evaluators to not re-
veal any information that might unblind the evaluator to treatment condi-
tion."

Forbes 2012 

Methods

Randomised controlled trial

Participants

59 veterans (57 men) with military-related PTSD in Australia

Interventions

12 sessions of cognitive processing therapy (n = 30) vs treatment as usual (n = 29)

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

73

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Forbes 2012  (Continued)

Outcomes

CAPS, PCL, BDI-II, STAI-State, DAR-7, AUDIT, PTCI, ADAS, WHOQOL

Notes

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

Experienced therapists delivered therapy and treatment adherence was assessed.

Authors' judgement

Support for judgement

Unclear risk

Comment: The method of random sequence generation was not reported.

Low risk

Comment: A central method of allocation was employed.

Incomplete outcome data
(attrition bias) 
All outcomes

Low risk

Comment: Reasons for leaving the study were fully reported, ITT analyses were
performed. Appropriate methods of imputing data were used. 9 participants
dropped out of each group. Reasons for attrition are not fully reported.

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Low risk

Comment: All specified outcomes were reported.

High risk

High risk

Comment: Different therapists provided CPT and TAU.

Comment: Participants were aware of their allocation.

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Unclear risk

Quote: "All assessments were conducted by an independent clinical assessor
blind to allocation and treatment. To maintain blindness at post-treatment
and 3 month follow-up appointments the participants were reminded not to
reveal what treatment they had received."

Galovski 2012 

Methods

Participants

Randomised controlled trial (cross-over)

100 individuals (unclear how many were men and women) with PTSD after sexual or physical assault in
childhood or adulthood in the USA

Interventions

CPT (n = 47) vs symptom monitoring delayed treatment (n = 53)

Outcomes

CAPS, BDI-II, TRGI, QOLI, SF-36

Notes

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

Experienced therapists delivered therapy and treatment adherence was assessed.

Authors' judgement

Support for judgement

Unclear risk

Comment: The method of sequence generation was not reported.

Unclear risk

Comment: There is no mention of any measures taken to conceal allocation.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

74

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Galovski 2012  (Continued)

Incomplete outcome data
(attrition bias) 
All outcomes

Low risk

Cochrane Database of Systematic Reviews

Comment: 7 participants dropped out of symptom monitoring delayed treat-
ment and 14 dropped out of CPT. The reason for drop-out was unknown in
50% of cases. ITT analyses were performed.

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Low risk

Comment: All specified outcomes were reported.

Low risk

High risk

Comment: There were no other obvious sources of bias.

Comment: Participants were aware of their allocation.

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Quote: "Posttreatment and follow-up assessments were conducted by raters
blind to both randomization and dropout status."

Gamito 2010 

Methods

Randomised controlled trial

Participants

10 male war veterans of the Portugese Colonial War between 1963 and 1970 with DSM-IV PTSD

Interventions

Virtual reality exposure (n = 5) vs exposure in imagination versus WL (n = 3) vs exposure in imagination
(n = 3) in parallel

Outcomes

CAPS, IES

Notes

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

Incomplete outcome data
(attrition bias) 
All outcomes

Comment: It is unclear who delivered the therapy

Authors' judgement

Support for judgement

Unclear risk

Quote: "The participants were randomly assigned to three study groups".

Comment: The method of sequence generation was not reported.

Unclear risk

Comment: There is no mention of any measures taken to conceal allocation.

Unclear risk

Comment: There was 1 drop-out (from virtual reality exposure) without a rea-
son. It is unclear how these missing data were handled.

Selective reporting (re-
porting bias)

High risk

Comment: Improvements in depression and anxiety were emphasised, despite
measures of PTSD being indicated as the primary outcome measure.

Other bias

High risk

Very small sample size. It is unclear who delivered the therapy. Treatment ad-
herence was not measured. Baseline characteristics are poorly reported. The
issue of researcher allegiance cannot be ruled out.

Blinding of participants
and personnel (perfor-
mance bias) 

High risk

Comment: Participants were aware of their allocation.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

75

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Gamito 2010  (Continued)

All outcomes

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Unclear risk

Comment: It is unclear whether outcome assessors were blinded.

Gersons 2000 

Methods

Randomised controlled trial

Participants

42 police officers. DSM-IIIR PTSD. Various workplace traumas (5 women, 37 men) in the Netherlands

Interventions

16 x 60-minute sessions of brief eclectic therapy (n = 22) vs wait list (n = 20) in parallel

Outcomes

SI-PTSD, SCL-90

Notes

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

Experienced therapists delivered therapy. It is unclear whether or not treatment adherence was as-
sessed.

Authors' judgement

Support for judgement

Unclear risk

Comment: The method of sequence generation was not reported.

Unclear risk

Comment: There is no mention of any measures taken to conceal allocation.

Incomplete outcome data
(attrition bias) 
All outcomes

Low risk

Comment: ITT analyses were conducted. Only 1 participant dropped out, from
the waitlist. A reason was given for this individual leaving the study.

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Low risk

Comment: All specified outcomes were reported.

High risk

High risk

Comment: The issue of researcher allegiance cannot be ruled out.

Comment: Participants were aware of their allocation.

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Quote: "All assessments were performed by one of three independent asses-
sors".

Hensel-Dittmann 2011 

Methods

Randomised controlled trial

Participants

28 asylum seekers who had experienced war and torture

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

76

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Hensel-Dittmann 2011  (Continued)

Cochrane Database of Systematic Reviews

Interventions

Narrative Exposure Therapy (n = 15) vs Stress Innoculation Therapy (n = 13)

Outcomes

CAPS, HAM-D

Notes

Risk of bias

Bias

 Experienced therapists delivered therapy and treatment adherence was assessed

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Low risk

Quote: "Subjects were randomly assigned to either NET or SIT. Participants
were matched pairwise according to gender, age, and region of origin and
were then allocated to NET or SIT by flipping a coin."

Allocation concealment
(selection bias)

Low risk

Comment: There is no mention of any measures taken to conceal allocation.

Incomplete outcome data
(attrition bias) 
All outcomes

Low risk

Quote: "Aiming at an intention-to-treat analysis, all subjects who were ran-
domised were included in the outcome analysis. Much of the recent literature
indicates that last-observation- carried-forward procedures may produce seri-
ously biased results. Hence we used mixed effects models."

Comment: There were 3 drop-outs from TFCBT and 2 from non-TFCBT.

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Low risk

Comment: All specified outcomes were reported.

Low risk

High risk

Comment: There were no other obvious sources of bias.

Comment: Participants were aware of their allocation.

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Quote "We aimed to keep the assessors blind to the treatment conditions of
the subjects;
however, occasionally the treatment condition was revealed to the rater by re-
sponses from the patient."

Hinton 2005 

Methods

Randomised controlled trial

Participants

40 treatment-resistant Cambodian refugees with comorbid panic attacks (24 women, 16 men)

Interventions

12 weekly sessions of CBT (n = 10) vs delayed treatment (n = 10)

Outcomes

CAPS, ASI, N-PASS, O-PASS, N-FSS, O-FSS, SCL

Notes

Risk of bias

Bias

Experienced therapists delivered therapy. It is unclear whether or not treatment adherence was as-
sessed.

Authors' judgement

Support for judgement

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

77

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Hinton 2005  (Continued)

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

Unclear risk

Comment: The method of sequence generation was not reported.

Unclear risk

Comment: There is no mention of any measures taken to conceal allocation.

Incomplete outcome data
(attrition bias) 
All outcomes

Low risk

Quote: "All randomised patients completed the study, and there were no miss-
ing data."

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Low risk

Comment: All specified outcomes were reported.

Low risk

High risk

Comment: There were no other obvious sources of bias.

Comment: Participants were aware of their allocation.

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Quote: "Blind to treatment condition, all assessments were made by a Cam-
bodian bicultural worker (D.C., V.P.) with over 2 years of mental health experi-
ence."

Hinton 2011 

Methods

Randomised controlled trial

Participants

24 Latino women with treatment-resistant PTSD

Interventions

14 weekly sessions of TFCBT (n = 12) vs applied muscle relaxation (n = 12)

Outcomes

PTSD checklist, nervios scale, emotion regulation scale, SCL anxiety scale

Notes

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

Incomplete outcome data
(attrition bias) 
All outcomes

Selective reporting (re-
porting bias)

Experienced therapists delivered therapy. It is unclear whether or not treatment adherence was as-
sessed.

Authors' judgement

Support for judgement

Unclear risk

Comment: The method of sequence generation was not reported.

Unclear risk

Comment: There is no mention of any measures taken to conceal allocation.

Low risk

Comment: There were no drop-outs.

Low risk

Comment: All specified outcomes were reported.

Other bias

High risk

Small sample size.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

78

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Hinton 2011  (Continued)

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Participants continued medication and supportive therapy. Details were not
reported.

High risk

Comment: Participants were aware of their allocation.

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Unclear risk

Self-report questionnaires were used, but not clear how they were adminis-
tered

Hogberg 2007 

Methods

Randomised controlled trial

Participants

24 transportation workers with DSM-IV PTSD (19 men, 5 women) in Sweden.

Interventions

EMDR (n = 13) vs waitlist (n = 11)

Outcomes

GAF, HAM-A, HAM-D, IES, BAI

Notes

Risk of bias

Bias

Experienced therapists delivered therapy and treatment adherence was assessed.

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Low risk

Quote "The randomisation was done by picking a sealed ballot in the presence
of a research nurse who coordinated the study and followed the participants
through all phases."

Allocation concealment
(selection bias)

Unclear risk

Comment: The method of random sequence generation was not reported.

Incomplete outcome data
(attrition bias) 
All outcomes

High risk

Quote: "We decided not to use an intention to treat analysis because there
were no drop-outs during EMDR".

Comment: 2 individuals dropped out of the waitlist group.

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Low risk

Comment: All specified outcomes were reported.

High risk

High risk

Comment: Small sample size.

Comment: Participants were aware of their allocation.

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Quote: "by a psychiatrist not otherwise engaged in the study and blind to the
experimental condition of the participants."

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

79

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Hollifield 2007 

Methods

Randomised controlled trial

Cochrane Database of Systematic Reviews

Participants

84 individuals with DSM-IV PTSD, various traumas in the USA

Interventions

CBT (n = 28) vs acupuncture (n = 29) vs WL (n = 27) (CBT and WL included in a meta-analysis).

Outcomes

PSS-SR, HSCL-25, Sheehan Disability Scale

Notes

Risk of bias

Bias

There were no reported assessments of treatment fidelity, and little information about the individuals
who delivered the treatments.

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Low risk

Quote: “before enrolling participants, 90 study ID numbers were pre-random-
ized using a computerized random numbers procedure without restrictions.
This allocation procedure was concealed from clinicians.”

Allocation concealment
(selection bias)

Low risk

Quote: “before enrolling participants, 90 study ID numbers were pre-random-
ized using a computerized random numbers procedure without restrictions.
This allocation procedure was concealed from clinicians.”

Incomplete outcome data
(attrition bias) 
All outcomes

Low risk

Comment: ITT analyses were performed using acceptable methods. Reasons
for withdrawal were fully reported (10 from acupuncture, 7 from CBT and 27
from wait list).

Selective reporting (re-
porting bias)

Low risk

Comment: All specified outcomes were reported.

Other bias

High risk

Comment: Each intervention was delivered by a single practitioner. There
were no reported assessments of treatment fidelity, and little information
about the individuals who delivered the treatments.

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Blinding of outcome as-
sessment (detection bias) 
All outcomes

High risk

Comment: Participants were aware of their allocation.

Low risk

Self-report measures only.

Quote “The RC collected the data which were concealed from investiga-
tor/clinician.”

Ironson 2002 

Methods

Randomised controlled trial

Participants

22 victims of various traumas with DSM-IIIR PTSD (17 women, 5 men) in the USA

Interventions

3 preparatory sessions followed by 1 - 3 sessions of EMDR (n = 10) or prolonged exposure (n = 12)

Outcomes

PSS-SR, BDI

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

80

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Ironson 2002  (Continued)

Notes

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

Experienced therapists delivered therapy and treatment adherence was assessed. Therapists delivered
both treatments.

Authors' judgement

Support for judgement

Unclear risk

Comment: The method of sequence generation was not reported.

Unclear risk

Comment: There is no mention of any measures taken to conceal allocation.

Incomplete outcome data
(attrition bias) 
All outcomes

Low risk

Comment: ITT analyses were performed. Reasons for drop-out were not fully
reported (1 from EMDR, 6 from TFCBT).

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Comment: All specified outcomes were reported.

High risk

High risk

Comment: Baseline characteristics are poorly reported. Small sample size.

Comment: Participants were aware of their allocation.

High risk

Comment: All measures were self report, but assessors were not blind.

Jensen 1994 

Methods

Randomised controlled trial

Participants

29 male Vietnam War veterans with PTSD in the USA

Interventions

3 sessions of EMDR (n = 15) usually within 10 days vs usual care (n = 14)

Outcomes

SI-PTSD

Notes

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

Experienced therapists delivered therapy. It is unclear whether or not treatment adherence was as-
sessed.

Authors' judgement

Support for judgement

Unclear risk

Comment: The method of sequence generation was not reported.

Unclear risk

Comment: There is no mention of any measures taken to conceal allocation.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

81

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Jensen 1994  (Continued)

Incomplete outcome data
(attrition bias) 
All outcomes

Selective reporting (re-
porting bias)

High risk

Comment: Only the data of completers are included in the analysis. Reasons
for drop-outs were not fully reported. 2 participants dropped out from each
group.

Low risk

Comment: All specified outcomes were reported.

Other bias

High risk

Comment: Small sample size. Baseline characteristic are poorly reported. Un-
clear whether treatment adherence was measured.

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Blinding of outcome as-
sessment (detection bias) 
All outcomes

High risk

Comment: Participants were aware of their allocation.

Unclear risk

Comment: It is unclear whether outcome assessors were blinded.

Keane 1989 

Methods

Randomised controlled trial

Participants

24 male Vietnam War veterans with DSM-IIIR PTSD in the USA

Interventions

14 - 16 sessions implosive (flooding) (n = 11) versus waiting list control (n = 13)

Outcomes

PTSD subscale, BDI, STAI

Notes

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

Incomplete outcome data
(attrition bias) 
All outcomes

Experienced therapists delivered therapy. It is unclear whether or not treatment adherence was as-
sessed.

Authors' judgement

Support for judgement

Unclear risk

Comment: The method of sequence generation was not reported.

Unclear risk

Comment: There is no mention of any measures taken to conceal allocation.

Unclear risk

There is emphasis in the reporting on those scales where improvements were
evident.

Selective reporting (re-
porting bias)

Unclear risk

Comment: Only the data of completers are included in the analysis. One par-
ticipant dropped out of each group.

Other bias

High risk

Comment: Small sample size. Poor reporting of baseline characteristics. Un-
clear whether or not treatment adherence was measured.

Blinding of participants
and personnel (perfor-
mance bias) 

High risk

Comment: Participants were aware of their allocation.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

82

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Keane 1989  (Continued)

All outcomes

Blinding of outcome as-
sessment (detection bias) 
All outcomes

High risk

Quote: "therapists rated their own patients progress following treatment."

Kearney 2013 

Methods

Randomised controlled trial

Participants

47 veterans (37 men) with chronic PTSD in the USA

Interventions

Mindfulness-Based Stress Reduction (MBSR) (n = 25) group intervention vs TAU (n = 22)

Outcomes

PCL, PHQ-9, BADS, SF-8, FFMQ

Notes

Risk of bias

Bias

Therapist credentials/experience is not reported. It is unclear whether or not treatment adherence was
assessed.

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Unclear risk

Comment: The method of random sequence generation was not reported.

Allocation concealment
(selection bias)

Unclear risk

Quote: "assessment subjects were randomized using concealed allocation to
the intervention group" - precise methods of allocation concealment were not
reported.

Incomplete outcome data
(attrition bias) 
All outcomes

Low risk

Comment: Reasons for leaving the study were fully reported, ITT analyses were
performed. Appropriate methods of imputing data were used. 2 participants
dropped out from the treatment group and 1 from the waitlist.

Selective reporting (re-
porting bias)

Low risk

Comment: All specified outcomes were reported.

Other bias

High risk

Comment: Therapist credentials/experience is not reported. It is unclear
whether or not treatment adherence was assessed.

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Blinding of outcome as-
sessment (detection bias) 
All outcomes

High risk

Comment: Participants were aware of their allocation.

Unclear risk

There is no mention of the blinding of assessors. Measures were self report.

Krakow 2000 

Methods

Randomised controlled trial

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

83

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Krakow 2000  (Continued)

Cochrane Database of Systematic Reviews

Participants

169 female sexual abuse survivors reporting nightmares at least once a week in the USA

Interventions

3 sessions (2 x 3-hour 1 week apart and 1 x 1-hour follow-up 3 weeks later) of cognitive imagery re-
hearsal for nightmares (n = 87) vs waiting list (n = 82).

Outcomes

Nightmare Frequency Questionnaire, PSS, Pittsburgh Sleep Quality Index, Nightmare Effects Survey

Notes

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

It is unclear who delivered the intervention or whether or not treatment adherence was measured.

Authors' judgement

Support for judgement

Unclear risk

Comment: The method of sequence generation was not reported.

Unclear risk

Comment: There is no mention of any measures taken to conceal allocation.

Incomplete outcome data
(attrition bias) 
All outcomes

High risk

Quote: "The main analysis was conducted on the 91 completers". The drop-
out rate was very high and reasons for leaving the study were not fully report-
ed.

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

High risk

Comment: Completer data were reported despite a very high drop-out rate.

High risk

High risk

Comment: The issue of researcher allegiance cannot be ruled out.

Comment: Participants were aware of their allocation.

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Unclear risk

Comment: All measures were self-reported but it is unclear how these were ad-
ministered.

Krakow 2001 

Methods

Randomised controlled trial

Participants

168 female sexual assault survivors. 95% DSM-IIIR PTSD in the USA

Interventions

2 x 3-hour and 1 x 1-hour sessions of group imagery rehearsal (n = 88) versus waiting list (n = 80)

Outcomes

PSS

Notes

Risk of bias

Bias

Therapist credentials/experience is not reported. It is unclear whether or not treatment adherence was
assessed.

Authors' judgement

Support for judgement

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

84

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Krakow 2001  (Continued)

Random sequence genera-
tion (selection bias)

Unclear risk

Allocation concealment
(selection bias)

Low risk

Incomplete outcome data
(attrition bias) 
All outcomes

Low risk

Cochrane Database of Systematic Reviews

Quote: "To mask treatment assignment, patients mailed back a postcard after
intake to complete entry into the protocol The postcard’s time and date were
logged into a computer and entered into a previously generated list of num-
bers that randomly assigned participants to treatment and control groups. All
numbers and group assignments were generated at the start of the protocol".

Comment: The method of sequence generation was not reported

Quote: "To mask treatment assignment, patients mailed back a postcard after
intake to complete entry into the protocol The postcard’s time and date were
logged into a computer and entered into a previously generated list of num-
bers that randomly assigned participants to treatment and control groups. All
numbers and group assignments were generated at the start of the protocol".

Comment: ITT analyses were performed. 20 withdrew from waitlist and 22
from the treatment group. Reasons for attrition are not fully reported.

Selective reporting (re-
porting bias)

Low risk

 Comment: All specified outcomes were reported

Other bias

High risk

Comment: The issue of researcher allegiance cannot be ruled out. Therapist
credentials/experience is not reported. It is unclear whether or not treatment
adherence was assessed.

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

High risk

Comment: Participants were aware of their allocation.

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Quote "To limit external bias, blinding occurred at 3 points of data collection:
(1) at intake, group assignment had not been established; (2) at 3-month fol-
low-up, questionnaires were completed through the mail; and (3) at 6-month
follow-up, interviewers were unaware of group status."

Kubany 2003 

Methods

Randomised controlled trial

Participants

37 female survivors of assault in Hawaii

Interventions

8 - 11 bi-weekly 90-minute sessions of cognitive trauma therapy (n = 19) vs waitlist with delayed treat-
ment (n = 18)

Outcomes

CAPS, BDI

Notes

Risk of bias

Bias

Lead author was therapist for all participants. It is unclear whether treatment adherence was ad-
dressed

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Unclear risk

Quote: "After these assessments, the women were randomly assigned to either
an Immediate or a Delayed CTT-BW condition."

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

85

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Kubany 2003  (Continued)

Allocation concealment
(selection bias)

Comment: The method of random sequence generation was not reported,

Unclear risk

Comment: There is no mention of any measures taken to conceal allocation.

Incomplete outcome data
(attrition bias) 
All outcomes

Low risk

Comment: ITT analyses. 1 participant dropped out from the treatment group
and 4 from the waitlist.

Selective reporting (re-
porting bias)

Unclear risk

 Comment: All specified outcomes were reported.

Other bias

High risk

Comment: The issue of researcher allegiance cannot be ruled out. Lead author
originated CTT-BW and conducted all therapy.

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Blinding of outcome as-
sessment (detection bias) 
All outcomes

High risk

Comment: Participants were aware of their allocation.

Low risk

Quote: "The assessors were blind to participants’ condition assignments."

Kubany 2004 

Methods

Randomised controlled trial

Participants

125 female survivors of assault in Hawaii

Interventions

8 - 11 bi-weekly 90-minute sessions of cognitive trauma therapy (n = 63) vs waitlist (n = 62)

Outcomes

CAPS, BDI

Notes

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

Experienced therapists delivered therapy and treatment adherence was assessed.

Authors' judgement

Support for judgement

Unclear risk

Comment: The method of sequence generation was not reported.

Unclear risk

Comment: There is no mention of any measures taken to conceal allocation.

Incomplete outcome data
(attrition bias) 
All outcomes

Low risk

Comment: ITT analyses. Data were only available for 84 participants posttreat-
ment. 22 dropped out of waitlist and 18 from TFCBT.

Selective reporting (re-
porting bias)

Low risk

Comment: All specified outcomes were reported.

Other bias

High risk

Comment: The issue of researcher allegiance cannot be ruled out.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

86

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Kubany 2004  (Continued)

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Blinding of outcome as-
sessment (detection bias) 
All outcomes

High risk

Comment: Participants were aware of their allocation.

Low risk

Comment: Assessors were blinded

Lee 2002 

Methods

Randomised controlled trial

Participants

24 DSM-IV PTSD sufferers. Various traumas (11 women, 13 men) in Australia.

Interventions

7 weekly 90-minute sessions of stress inoculation training with prolonged exposure (n = 12) vs EMDR (n
= 12)

Outcomes

SI-PTSD, IES, BDI

Notes

Risk of bias

Bias

Experienced therapists delivered therapy and treatment adherence was assessed.

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Unclear risk

Quote: "There was random assignment to all conditions and multiple thera-
pists were used to deliver each of the treatments."

Comment: The method of random sequence generation was not reported.

Unclear risk

Comment: There is no mention of any measures taken to conceal allocation.

Low risk

Quote: "treatment non-completers were included in the analysis".

Comment: 3 participants dropped out from treatment, 1 from EMDR and one
from stress management. It is unclear what group the third drop-out was in.
Reasons for drop-out were not fully reported.

Low risk

 Comment: All specified outcomes were reported.

High risk

High risk

Comment: Small sample size.

Comment: Participants were aware of their allocation.

Low risk

Quote: "assessments by a blind independent observer".

Allocation concealment
(selection bias)

Incomplete outcome data
(attrition bias) 
All outcomes

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

87

 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Lindauer 2005 

Methods

Randomised controlled trial

Participants

24 DSM-IV PTSD sufferers. Various traumas (11 men, 13 women) in the Netherlands

Interventions

16 weekly 45- to 60-minute sessions of Brief Eclectic Psychotherapy (n = 12) vs waiting list (n = 12)

Outcomes

SI-PTSD, HADS

Notes

Risk of bias

Bias

Experienced therapists delivered therapy and treatment adherence was assessed.

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Low risk

Quote: "A colleague who had done no assessments used a computer program
to randomly assign 12 patients to each condition in a block design."

Allocation concealment
(selection bias)

Low risk

Quote: "A colleague who had done no assessments used a computer program
to randomly assign 12 patients to each condition in a block design."

Incomplete outcome data
(attrition bias) 
All outcomes

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Low risk

Quote: "Intention-to-treat and per-protocol analyses were calculated."

Comment: 5 participants dropped out of the treatment group and 1 from the
waitlist group. Reasons were fully reported.

Low risk

Comment: All specified outcomes were reported.

High risk

High risk

Comment: Small sample size.

Comment: Participants were aware of their allocation. The issue of researcher
allegiance cannot be ruled out.

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Quote: "Each patient was assessed by a researcher (R.J.L.L. or E.P.M.M.), who
were blind to all patients’ condition."

Marcus 1997 

Methods

Randomised controlled trial

Participants

67 DSM-IIIR PTSD. Various traumas. (53 women, 14 men) in the USA

Interventions

Variable number of 50-minute sessions of EMDR (n = 34) vs standard care (n = 33)

Outcomes

IES, M-PTSD, BDI, STAI, SCL-90

Notes

Risk of bias

Therapists were psychologists with experience ranging from less than one year to over 18. It is unclear
what experience the therapists delivering usual care had. There was no report of assessing treatment
adherence.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

88

 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Marcus 1997  (Continued)

Bias

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

Incomplete outcome data
(attrition bias) 
All outcomes

Selective reporting (re-
porting bias)

Unclear risk

Comment: The method of sequence generation was not reported.

Unclear risk

Comment: There is no mention of any measures taken to conceal allocation.

Unclear risk

Comment: 1 participant dropped out of each group. It is unclear how this was
handled.

Low risk

Comment: All specified outcomes were reported.

Other bias

High risk

Comment: The usual care group, which included an array of interventions was
not aimed at being optimally effective in terms of reducing symptom severi-
ty. There is little detail regarding the interventions offered as part of usual care
and the credentials/experience of therapists delivering these interventions is
not reported.

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

High risk

Comment: Participants were aware of their allocation.

Blinding of outcome as-
sessment (detection bias) 
All outcomes

High risk

Quote: "It was not possible to keep the independent evaluator blind to the
treatment condition".

Marks 1998 

Methods

Randomised controlled trial

Participants

87 DSM-IIIR PTSD, various traumas, in the UK

Interventions

10 x 90-minute sessions of exposure (n = 23) vs cognitive restructuring (n = 19) vs exposure and cog-
nitive restructuring (n = 24) vs relaxation therapy (n = 21) (the three exposure/cognitive-restructuring
groups were combined).

Outcomes

CAPS, IES, BDI, STAI

Notes

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

Experienced therapists delivered therapy. Treatment adherence was assessed, as was homework com-
pliance.

Authors' judgement

Support for judgement

Unclear risk

Comment: The method of sequence generation was not reported.

Unclear risk

Comment: There is no mention of any measures taken to conceal allocation.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

89

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Marks 1998  (Continued)

Incomplete outcome data
(attrition bias) 
All outcomes

Low risk

Cochrane Database of Systematic Reviews

Quote: "analyses were also done on end-point imputed-scores carrying for-
ward non-completers last available ratings".

Comment: There were drop-outs from each group: exposure (3) cognitive re-
structuring (1) exposure and cognitive restructuring (5) and relaxation therapy
(1). Reasons for drop-out were not fully reported.

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Comment: All specified outcomes were reported.

Low risk

High risk

Comment: no other sources of bias detected.

Comment: Participants were aware of their allocation.

Low risk

Quote: "assessors were kept unaware of the treatment condition".

McDonagh 2005 

Methods

Randomised controlled trial

Participants

74 female childhood sexual abuse survivors with DSM-IV PTSD in the USA

Interventions

7 x 2-hour and 7 x 1½-hour sessions of CBT (n = 29) versus 7 x 2-hour and 7 x 1½-hour sessions of PCT (n
= 22) versus waitlist control (n = 23). (all interventions included in meta-analyses).

Outcomes

CAPS, BDI, STAI, TSI, DES, STAXI

Notes

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

Experienced therapists delivered therapy and treatment adherence was assessed.

Authors' judgement

Support for judgement

Unclear risk

Comment: The method of sequence generation was not reported

Unclear risk

Comment: There is no mention of any measures taken to conceal allocation

Incomplete outcome data
(attrition bias) 
All outcomes

Low risk

Comment: ITT analyses using the LOCF method were performed. Reasons for
drop-out were not fully reported. 12 participants dropped out of CBT, 2 from
PCT and 3 from the waitlist.

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 

Low risk

Comment: All specified outcomes were reported.

Low risk

High risk

Comment: There were no other obvious sources of bias.

Comment: Participants were aware of their allocation.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

90

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

McDonagh 2005  (Continued)

All outcomes

Cochrane Database of Systematic Reviews

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Quote: "A separate group of female clinicians, who were blind to treatment
condition and who had no other role in the study conducted the four CAPS in-
terviews".

Monson 2006 

Methods

Randomised controlled trial

Participants

60 DSM-IV-TR PTSD. Combat veterans (54 men, 6 women) in the USA

Interventions

12 sessions of cognitive processing therapy conducted twice weekly when possible (n = 30) vs waitlist
(n = 30)

Outcomes

CAPS, PCL, BDI, STAI

Notes

Risk of bias

Bias

Experienced therapists delivered therapy and treatment adherence was assessed

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Unclear risk

Allocation concealment
(selection bias)

Low risk

Quote "Eligible participants were randomised to receive the treatment imme-
diately or to wait for 10 weeks to receive the treatment (10 weeks was equiva-
lent to the ideal 6 weeks of twice weekly sessions and the 1-month follow-up
period for those in the CPT condition). The study biostatistician provided the
participants’ condition assignment to the study coordinator."

Comment: The method of random sequence generation was not reported.

Quote "Eligible participants were randomised to receive the treatment imme-
diately or to wait for 10 weeks to receive the treatment (10 weeks was equiva-
lent to the ideal 6 weeks of twice weekly sessions and the 1-month follow-up
period for those in the CPT condition). The study biostatistician provided the
participants’ condition assignment to the study coordinator."

Incomplete outcome data
(attrition bias) 
All outcomes

Low risk

Quote "Primary analyses were performed according to the intention-to-treat
principle; data from all participants were used regardless of their treatment
completion."

Comment: 6 participants dropped out from the treatment group. 4 partici-
pants dropped out from the waitlist group.

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Low risk

Comment: All specified outcomes were reported.

Low risk

High risk

Comment: There were no other obvious sources of bias.

Comment: Participants were aware of their allocation.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

91

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Monson 2006  (Continued)

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Cochrane Database of Systematic Reviews

Quote "The independent clinician assessors were blinded to condition assign-
ment and participants were instructed to not disclose their condition assign-
ment to them."

Mueser 2008 

Methods

Participants

Randomised controlled trial

108 DSM-IV PTSD individuals with severe mental illness receiving treatment at community health cen-
tres (46 men, 62 women) in the USA

Interventions

12 - 16 sessions of TFCBT (n = 54) or TAU (n = 54)

Outcomes

CAPS, PTSD knowledge test, BAI, BDI, BPRS, WAI, SF-12

Notes

Risk of bias

Bias

Experienced therapists delivered therapy and treatment adherence was assessed.

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Unclear risk

Comment: The method of random sequence generation was not reported.

Allocation concealment
(selection bias)

Low risk

Quote: "Randomization was conducted at a central location in the research
centre by a computer-based randomizations program, with assignments not
known in advance by either clinical or research staff."

Incomplete outcome data
(attrition bias) 
All outcomes

Low risk

Comment: ITT analyses were performed. 11 participants dropped out of the
treatment group and 11 from TAU. 

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Low risk

Comment: All specified outcomes were reported.

High risk

High risk

Comment: There were no other obvious sources of bias.

Comment: Participants were aware of their allocation.

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Quote: “All assessments were conducted by master’s or Ph.D. level trained
clinical interviewers who were blind to treatment assignment. Clients were in-
structed at the beginning of interviews to not talk about any treatments for
trauma-related problems they may have received. Interviewers were request-
ed to inform the project coordinator if the client broke the blind during an in-
terview. Interviewers were not asked to guess clients’ treatment assignments,
to avoid directly encouraging them to formulate hypotheses about how treat-
ment may have affected clients’ symptoms, which could have influenced sub-
sequent ratings. No specific instances of blind breaking were noted in the
study.”

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

92

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Neuner 2004 

Methods

Randomised controlled trial

Cochrane Database of Systematic Reviews

Participants

43 Sudanese refugees in Uganda. All diagnosed with PTSD. (16 men, 27 women)

Interventions

4 sessions of NET (n = 17) vs 4 sessions of supportive counselling (n = 14) vs one session of psychoedu-
cation (n = 12) (NET and supportive counselling groups included in meta-analysis).

Outcomes

PDS

Notes

Risk of bias

Bias

Experienced therapists delivered therapy. Treatment adherence was not monitored,

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Low risk

Quote: "Each participant was randomly assigned (using a dice) to one of three
treatment groups: narrative exposure therapy, supportive counselling, or psy-
choeducation only."

Allocation concealment
(selection bias)

Unclear risk

Comment: There is no mention of any measures taken to conceal allocation.

Incomplete outcome data
(attrition bias) 
All outcomes

Low risk

Comment: One participant dropped out from NET and two from supportive
counselling. ITT analyses were performed. Reasons for drop-out were not fully
reported.

Selective reporting (re-
porting bias)

Low risk

Comment: All specified outcomes were reported.

Other bias

High risk

Comment: The issue of researcher allegiance cannot be ruled out. Treatment
adherence was not monitored.

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Unclear risk

Comment: Participants were aware of their allocation.

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Quote: "The local and expert interviewers who carried out the posttests, as
well as the follow-up tests, were blind for the individual participant’s treat-
mentcondition."

Neuner 2008 

Methods

Randomised controlled trial

Participants

277 Rwandan and Somalian refugees diagnosed with PTSD (142 women, 135 men)

Interventions

NET (n = 111) vs trauma counselling (n = 111) vs monitoring (n = 55) (NET and monitoring included in
meta-analysis).

Outcomes

PDS, DFMQ, SRQ-20, SF-12

Notes

Risk of bias

Experienced therapists delivered therapy. Treatment adherence was not monitored,

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

93

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Neuner 2008  (Continued)

Bias

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Unclear risk

Quote: "The participants were assigned to the groups in the following way:
The list of participants was ordered randomly; the first 4 were consecutively
assigned to the NET, TC, NET, and TC groups; and the fifth was assigned to the
MG (monitoring) group. This procedure was repeated until all 277 participants
were assigned."

Comment: The method of random sequence generation was not reported.

Allocation concealment
(selection bias)

Unclear risk

Comment: There is no mention of any measures taken to conceal allocation.

Incomplete outcome data
(attrition bias) 
All outcomes

Low risk

Quote: "Aiming at an intention-to-treat analysis, we included in the outcome
analysis all participants who were randomised. In anticipation of a high rate of
missing data, we considered a last observation- carried-forward procedure as
too conservative. Instead we chose to apply mixed-effects models that allow
the inclusion of all available data without the arbitrary replacement or imputa-
tion of missing values."

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Low risk

 Comment: All specified outcomes were reported.

Low risk

High risk

Comment: A large number of participants could not be located for follow-up.

Comment: Participants were aware of their allocation.

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Quote: "The participants who received treatment were reassessed 3 and 6
months later by the same local research assistants who had carried out the in-
terviews for the survey. They were blind with respect to the particular treat-
ment condition."`

Neuner 2010 

Methods

Randomised controlled trial

Participants

32 asylum seekers with DSM-IV PTSD (22 men, 10 women) in Germany

Interventions

NET (n = 16) vs TAU (n = 16)

Outcomes

Notes

Risk of bias

Bias

Posttraumatic Stress Diagnostic Scale, Hopkins Symptom Checklist-25 depression Scale, Composite In-
ternational Diagnostic Interview - C Pain Score

Experienced therapists delivered therapy. Treatment adherence was not monitored

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Unclear risk

Comment: The method of sequence generation was not reported.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

94

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Neuner 2010  (Continued)

Allocation concealment
(selection bias)

Unclear risk

Comment: There is no mention of any measures taken to conceal allocation

Incomplete outcome data
(attrition bias) 
All outcomes

Low risk

Quote: "all the participants who were randomised were included in the out-
come analysis."

Comment: 2 participants dropped out of the treatment group. Reasons for
drop-out are not fully reported.

Selective reporting (re-
porting bias)

Low risk

Comment: All specified outcomes were reported.

Other bias

High risk

Comment: The authors acknowledged having little information about the in-
terventions prescribed as part of TAU. The issue of researcher allegiance can-
not be ruled out. Treatment adherence was not monitored.

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

High risk

Comment: Participants were aware of their allocation.

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Quote: "we aimed at keeping interviewers blind to each participants condi-
tion."

Nijdam 2012 

Methods

Randomised controlled trial

Participants

140 adults with PTSD after a variety of different traumas (79 women, 61 men)

Interventions

Brief ecclectic psychotherapy (n = 70) or EMDR (n = 70)

Outcomes

IES-R, SI-PTSD, HADS depression, HADS anxiety

Notes

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

Incomplete outcome data
(attrition bias) 
All outcomes

Selective reporting (re-
porting bias)

Experienced therapists delivered therapy. It is unclear whether or not treatment adherence was as-
sessed.

Authors' judgement

Support for judgement

Unclear risk

Comment: The method of random sequence generation was not reported.

Low risk

Low risk

A method of central allocation was employed, whereby a psychologist unasso-
ciated with the rest of the study used a computer programme.

Comment: ITT analyses were performed. Reasons for treatment drop-out are
fully reported, and unlikely to have caused bias. Missing data were imputed
using appropriate methods. 28 individuals dropped out of EMDR and 22 from
BEP.

Low risk

Comment: All specified outcomes were reported.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

95

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Nijdam 2012  (Continued)

Other bias

Low risk

Cochrane Database of Systematic Reviews

Comment: The issue of researcher allegiance cannot be ruled out. Treatment
adherence was not monitored.

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

High risk

Comment: Participants were aware of their allocation.

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Quote: "To ensure masking of assessors, one psychologist who had no other
engagement in the study, had access to the computer program, kept a log file
of all random assignments and assigned the patients to the therapists."

Paunovic 2011 

Methods

Randomised controlled trial

Participants

29 adult victims of crime with chronic PTSD (12 men, 17 women)

Interventions

Exposure Inhibition Therapy (n = 14) vs waitlist (n = 15)

Outcomes

CAPS, PCL, IES-R, BAI, BDI, CSE, PTSI

Notes

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

Experienced therapists delivered therapy. It is unclear whether or not treatment adherence was as-
sessed.

Authors' judgement

Support for judgement

Unclear risk

Comment: The method of random sequence generation was not reported.

Unclear risk

Comment: The method of allocation concealement (if any) was not reported.

Incomplete outcome data
(attrition bias) 
All outcomes

High risk

Comment: Reasons for drop-outs are not given. It is unclear how missing data
were handled. There was one drop-out from each group.

Selective reporting (re-
porting bias)

Low risk

Comment: All specified outcomes were reported.

Other bias

High risk

There was only one author, who was seemingly responsible for all aspects of
the study (recruitment, randomisation, assessment, therapy, analysis). The au-
thor had conceived the therapy that was being evaluated, based on a theory
of PTSD they had previously formulated. The author acknowledged "this study
must be replicated with a more rigorous design that fulfills all of the golden
criteria for a randomized controlled study."

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

High risk

Comment: Participants were aware of their allocation.

Blinding of outcome as-
sessment (detection bias) 

High risk

Quote: "The assessor was both the therapist and the author of the current
study."

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

96

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Paunovic 2011  (Continued)

All outcomes

Cochrane Database of Systematic Reviews

Peniston 1991 

Methods

Randomised controlled trial

Participants

29 male Vietnam War combat veterans with DSM-III PTSD

Interventions

48 x 30-minute sessions of EMG (n = 15) assisted desensitisation vs no treatment (n = 14)

Outcomes

Nightmare and flashback frequency

Notes

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

Incomplete outcome data
(attrition bias) 
All outcomes

Selective reporting (re-
porting bias)

Therapist credentials/experience is not reported. It is unclear whether or not treatment adherence was
assessed.

Authors' judgement

Support for judgement

Unclear risk

Comment: The method of sequence generation was not reported.

Unclear risk

Comment: There is no mention of any measures taken to conceal allocation.

Unclear risk

Comment: It is unclear if there were any missing data, or how this was han-
dled.

Low risk

 Comment: All specified outcomes were reported.

Other bias

Unclear risk

Comment: The study is not well-reported. It is difficult to judge other sources
of bias.

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Blinding of outcome as-
sessment (detection bias) 
All outcomes

High risk

Comment: Participants were aware of their allocation.

Low risk

Comment: Blind assessors were used.

Power 2002 

Methods

Randomised controlled trial

Participants

105 outpatients with DSM-IV PTSD. Various traumas (gender of those starting the study unclear)

Interventions

10 x 90-minute weekly sessions of EMDR (n = 39) vs exposure plus cognitive restructuring (n = 37) vs
waitlist (n = 29) (all interventions included in meta-analyses).

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

97

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Power 2002  (Continued)

Outcomes

CAPS, HAM-A, MADRS

Cochrane Database of Systematic Reviews

Notes

Risk of bias

Bias

 Experienced therapists delivered therapy, and treatment adherence was assessed.

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Low risk

Quote: "Following completion of the entire initial assessment, for those pa-
tients who met entry criteria, the blind assessor then opened a sealed enve-
lope that informed as to which group patients were to be allocated."

Allocation concealment
(selection bias)

Low risk

Quote: "Following completion of the entire initial assessment, for those pa-
tients who met entry criteria, the blind assessor then opened a sealed enve-
lope that informed as to which group patients were to be allocated."

Incomplete outcome data
(attrition bias) 
All outcomes

High risk

Quote: "Comparison between the 33 drop-outs and the 72 completers regard-
ing presentation at time of initial assessment produced no significant differ-
ences on any of the demographic characteristics or treatment outcome mea-
sures with the sole exception of a higher frequency score on the CAPS-C Avoid-
ance subscale for the drop-outs t D 2.2, df D 103, p < 0.05. Subsequent analysis
was conducted on the 72 completers."

Comment: There were 12 drop-outs from EMDR, 16 from EMDR plus cognitive
restructuring and 5 from the waiting list. Reasons for drop-out were not fully
reported.

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Low risk

 Comment: All specified outcomes were reported.

Low risk

High risk

Comment: no other sources of bias detected.

Comment: Participants were aware of their allocation.

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Quote: "However, assessment at entry, end-point and follow-up were conduct-
ed by ‘blind’ assessors."

Ready 2010 

Methods

Randomised controlled trial

Participants

11 Vietnam War veterans with DSM-IV PTSD with a CAPS score greater than 60 in the USA

Interventions

10 sessions of Virtual Reality Exposure (n = 6) vs 10 sessions of person-centred therapy (n = 5)

Outcomes

CAPS, BDI

Notes

Risk of bias

Therapist credentials/experience is not reported. It is unclear whether or not treatment adherence was
assessed.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

98

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Ready 2010  (Continued)

Bias

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

Incomplete outcome data
(attrition bias) 
All outcomes

Selective reporting (re-
porting bias)

Unclear risk

Comment: The method of sequence generation was not reported.

Unclear risk

Comment: There is no mention of any measures taken to conceal allocation.

Unclear risk

Comment: One participant dropped out of each group. Reasons for drop-out
are not reported. It is unclear how missing data were handled.

Low risk

Comment: All specified outcomes were reported.

Other bias

High risk

Comment: PCT was developed as a control condition for the purposes of the
study.

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

High risk

Comment: Participants were aware of their allocation.

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Quote: “Participants were administered the measures or interviews at pre-
treatment, posttreatment, and six-month follow-up by a licensed clinical psy-
chologist with 3 years of experience working with Vietnam veterans. She re-
mained blind to treatment condition.”

Resick 2002 

Methods

Randomised controlled trial

Participants

171 female rape victims with DSM-IV PTSD

Interventions

13 hours of cognitive processing therapy or exposure bi-weekly over 6 weeks (n = 124) versus minimal
attention (n = 47).

Outcomes

CAPS, PSS, BDI

Notes

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

Experienced therapists delivered therapy, and treatment adherence was assessed.

Authors' judgement

Support for judgement

Unclear risk

Comment: The method of sequence generation was not reported.

Unclear risk

Comment: There is no mention of any measures taken to conceal allocation.

Incomplete outcome data
(attrition bias) 
All outcomes

Low risk

Comment: ITT analyses using LOCF. 33 participants dropped out from TFCBT
and 47 from the waitlist.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

99

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Resick 2002  (Continued)

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Low risk

Comment: All specified outcomes were reported.

High risk

High risk

Comment: The issue of researcher allegiance cannot be ruled out.

Comment: Participants were aware of their allocation.

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Quote: "Independent raters who were not otherwise involved in the project
conducted assessments of treatment adherence and therapist competence."

Rothbaum 1997 

Methods

Randomised controlled trial

Participants

21 female sexual assault victims with DSM-IIIR PTSD in the USA

Interventions

3 weekly 90-minute sessions of EMDR (n = 11) vs wait list control (n = 9) (1 dropped out immediately af-
ter assessment).

Outcomes

PSS, IES, BDI, STAI

Notes

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

Experienced therapists delivered therapy, and treatment adherence was assessed.

Authors' judgement

Support for judgement

Unclear risk

Comment: The method of sequence generation was not reported.

Unclear risk

Comment: There is no mention of any measures taken to conceal allocation.

Incomplete outcome data
(attrition bias) 
All outcomes

High risk

Comment: 3 participants dropped out: 1 immediately after assessment, and 1
from each of the groups. ITT analyses were not performed.

Selective reporting (re-
porting bias)

Low risk

 Comment: All specified outcomes were reported.

Other bias

Unclear risk

Comment: Small sample size.

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Blinding of outcome as-
sessment (detection bias) 
All outcomes

High risk

Comment: Participants were aware of their allocation.

Low risk

Quote: "independent assessor kept blind to the treatment condition".

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

100

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Rothbaum 2005 

Methods

Randomised controlled trial

Participants

74 female rape victims in the USA

Interventions

9 x 90-minute sessions of EMDR (25) vs 9 x 90-minute sessions of prolonged exposure (23) vs waiting list
(24) (two dropped out prior to randomisation).

Outcomes

CAPS, SLESQ, PSS-SR, IES-R, BDI, DES-II, STAI

Notes

Risk of bias

Bias

Experienced therapists delivered therapy, and treatment adherence was assessed.

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Unclear risk

Quote "If the participant met criteria and gave consent, she was then ran-
domised and scheduled accordingly".

Comment: It is unclear how the sequence was generated.

Allocation concealment
(selection bias)

Unclear risk

Comment: There is no mention of any measures taken to conceal allocation.

Incomplete outcome data
(attrition bias) 
All outcomes

High risk

Quote: "Because only 2 of 14 participants who did not complete the study (1
in each of the active treatments) provide data other than baseline, intent-to-
treat analyses provide no consequentially different results and are not includ-
ed here."

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Low risk

 Comment: All specified outcomes were reported.

Low risk

High risk

Comment: No other sources of bias detected.

Comment: Participants were aware of their allocation.

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Quote: "All assessments were conducted by IAs who were kept blind to the
treatment condition."

Scheck 1998 

Methods

Randomised controlled trial

Participants

60 16- to 25-year old female victims of various traumas. 77% DSM-IV PTSD in the USA

Interventions

2 usually weekly sessions of EMDR (n = 30) vs active listening (n = 30)

Outcomes

BDI, STAI, PENN, IES, TSCS

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

101

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Scheck 1998  (Continued)

Notes

Risk of bias

Bias

Experienced therapists (volunteers) delivered therapy. It is unclear whether or not treatment adher-
ence was assessed.

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Low risk

Quote: "Envelopes filled with papers labelled either EMDR or AL were shuffled
and numbered 1 through 100. During each interview, envelopes were opened
consecutively".

Allocation concealment
(selection bias)

Low risk

Quote: "Envelopes filled with papers labelled either EMDR or AL were shuffled
and numbered 1 through 100. During each interview, envelopes were opened
consecutively".

Incomplete outcome data
(attrition bias) 
All outcomes

High risk

Comment: Reasons for drop-out were not fully reported (1 participant from AL,
1 from EMDR) . Only the data of completers are included in the analysis.

Selective reporting (re-
porting bias)

Low risk

Comment: All specified outcomes were reported.

Other bias

High risk

Comment: It is unclear whether or not treatment adherence was assessed. Ac-
tive listening was not intended as an effective intervention. The aim was to
create a control that offered rapport, expectation of gain and sympathetic at-
tention.

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Blinding of outcome as-
sessment (detection bias) 
All outcomes

High risk

Quote: Comment: Participants were aware of their allocation.

Unclear risk

Comment: Insufficient information.

Schnurr 2003 

Methods

Randomised controlled trial

Participants

360 male Vietnam War veterans with DSM-IV PTSD in the USA

Interventions

Weekly present-focused group CBT for 30 weeks (n = 180) vs weekly trauma-focused CBT group therapy
for 30 weeks (n = 180)

Outcomes

CAPS, GHQ, SF36

Notes

Risk of bias

Bias

Experienced therapists delivered therapy, and treatment adherence was assessed.

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

High risk

Quote: "The randomizations were performed using permuted blocks of 4 in 3
blocks of CAPS severity scores to ensure balance in treatment groups by CAPS
score."

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

102

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Schnurr 2003  (Continued)

Allocation concealment
(selection bias)

Comment: The method of random sequence generation was not reported.

Unclear risk

Comment: There is no mention of any measures taken to conceal allocation.

Incomplete outcome data
(attrition bias) 
All outcomes

Low risk

Quote: "Often, intention-to-treat analysis is performed by using an individual’s
last measurement before treatment dropout as the last outcome or by carry-
ing it forward. This method has been criticized for the bias it can introduce.
Instead, we attempted to measure participants regardless of the number of
treatment sessions they attended or their treatment dropout status. To our
knowledge, no previous studies of PTSD treatment have taken this approach,
which is standard in clinical trials in other fields of medicine. Therefore, we al-
so performed secondary analyses to examine the effect of TFGT among partici-
pants who completed most of the scheduled sessions."

Comment: 62 dropped out from the TF group and 45 from the non-TF group.

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Unclear risk

Comment: All specified outcomes were reported.

Low risk

High risk

Comment: no other sources of bias detected.

Comment: Participants were aware of their allocation.

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Quote "Assessments were performed by a master’s- or doctoral level clinician
who was unaware of treatment assignment."

Schnurr 2007 

Methods

Randomised controlled trial

Participants

284 female veterans and active duty personnel in the USA

Interventions

10 weekly 90-minute sessions of prolonged exposure (n = 141) vs 10 weekly 90-minute sessions of
present-centred therapy (n = 143)

Outcomes

CAPS, SF36, SSAI, BDI, ASI, PTSD checklist

Notes

Risk of bias

Bias

Experienced therapists delivered therapy, and treatment adherence was assessed.

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Unclear risk

Quote: "Verified eligible participants were randomised within each site to pro-
longed exposure or present-centred therapy using permuted blocks with ran-
dom block sizes of 4 or 6. All study data were stored at the study coordinating
center."

Comment: The method of random sequence generation was not reported.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

103

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Schnurr 2007  (Continued)

Allocation concealment
(selection bias)

Unclear risk

Comment: There is no mention of any measures taken to conceal allocation.

Incomplete outcome data
(attrition bias) 
All outcomes

Low risk

Quote: "Primary analyses were performed on the intention-to-treat sample,
using data from all randomised participants." Reasons for drop-out were fully
reported (21 from PE and 17 from PCT).

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Low risk

Comment: All specified outcomes were reported.

Low risk

High risk

Comment: No other sources of bias detected.

Comment: Participants were aware of their allocation.

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Quote: "Blinded assessors collected data before and after treatment and at 3-
and 6-month follow-up."

Taylor 2003 

Methods

Randomised controlled trial

Participants

60 outpatients. Various traumas. DSM-IV PTSD.(45 women, 15 men) in the USA

Interventions

8 90-minute sessions of exposure therapy (n = 22), EMDR (n = 19) or relaxation training (n = 19) (all inter-
ventions included in meta-analyses).

Outcomes

CAPS, PDS, BDI

Notes

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

Experienced therapists delivered therapy. It is unclear whether or not treatment adherence was as-
sessed.

Authors' judgement

Support for judgement

Unclear risk

Comment: The method of sequence generation was not reported.

Unclear risk

Comment: There is no mention of any measures taken to conceal allocation.

Incomplete outcome data
(attrition bias) 
All outcomes

Low risk

Comment: ITT analyses. Drop-outs were from each group (exposure therapy
(7), EMDR (4) or relaxation training (4).

Selective reporting (re-
porting bias)

Unclear risk

Comment: Only measures of PTSD and depression are reported. It is unclear
whether any other data were collected.

Other bias

Low risk

Comment: no other sources of bias detected.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

104

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Taylor 2003  (Continued)

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

High risk

Comment: Participants were aware of their allocation.

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Quote: "All interviews were conducted by clinic staff, who were blind to the
participants’ treatment assignment."

Vaughan 1994 

Methods

Randomised controlled trial

Participants

36 various traumas. 78% DSM-IIIR PTSD. (23 women, 13 men) in Australia

Interventions

3 - 5 50-minute sessions of image habituation training (n = 13), EMDR (n = 12) or applied muscular relax-
ation (n = 11) (all interventions included in meta-analyses).

Outcomes

PTSD structured interview, IES, STAI, BDI

Notes

Risk of bias

Bias

Therapist credentials/experience is not reported. It is unclear whether or not treatment adherence was
assessed.

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Unclear risk

Comment: The method of random sequence generation was not reported.

Allocation concealment
(selection bias)

Unclear risk

Quote: "After assessment each subject was randomly assigned to a treatment
group and also to a wait list or non-waitlist group. The procedure resulted in
unequal numbers of subjects in the treatment groups -12 in EMD, 13 in IHT and
11 in AMR."

Incomplete outcome data
(attrition bias) 
All outcomes

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Low risk

Comment: No drop-outs.

Low risk

Comment: All specified outcomes were reported.

Low risk

High risk

Comment: no other sources of bias detected.

Comment: Participants were aware of their allocation.

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Quote: "As a check of the independent rater’s blindness as to patients’ treat-
ment categories, the rater was asked to guess the category post-treatment but
was unable to do this better than by chance (x2 = 3.72, P = ns)."

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

105

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Wells 2012 

Methods

Randomised controlled trial

Participants

20 individuals with DSM-IV PTSD (11 women, 9 men) in the UK

Interventions

Meta cognitive therapy (n = 10) vs delayed treatment (n = 10)

Outcomes

PDS, IES, BDI, BAI, TSQ

Cochrane Database of Systematic Reviews

Notes

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

Incomplete outcome data
(attrition bias) 
All outcomes

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Therapist credentials/experience is not reported. Treatment adherence was not formally assessed.

Authors' judgement

Support for judgement

Low risk

Comment: Allocated by a coin toss.

Low risk

Low risk

Comment: Allocation was performed by an individual otherwise not involved
with the study.

Comment: ITT analyses were performed. One participant dropped out of the
MCT group.

Low risk

Comment: All specified outcomes were reported.

High risk

High risk

Comment: Small sample size.

Comment: Participants were aware of their allocation.

Low risk

Comment: The assessor was blind.

Zang 2013 

Methods

Randomised controlled trial

Participants

22 (17 women, 5 men) adult survivors of the Sichuan earthquake with PTSD

Interventions

NET (n = 11) versus WL (n = 11)

Outcomes

IES-R, GHQ-28, HADS, CIOQ, MSPSS, SCSQ

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

106

 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Zang 2013  (Continued)

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

Incomplete outcome data
(attrition bias) 
All outcomes

Selective reporting (re-
porting bias)

Other bias

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Unclear risk

Comment: The method of random sequence generation was not reported.

Unclear risk

Comment: Specific methods of allocation concealment were not reported.

Low risk

Comment: No-one left the study early.

Low risk

Comment: All specified outcomes were reported.

High risk

High risk

Comment: Very small sample size.

Comment: Participants were aware of their allocation.

Blinding of outcome as-
sessment (detection bias) 
All outcomes

Low risk

Quote: "The pre and post treatment assessments were carried out by a re-
searcher not involved in treatment and blind to the treatment conditions."

Zlotnick 1997 

Methods

Randomised controlled trial

Participants

48 female sexual abuse survivors. All DSM-IIIR PTSD in the USA

Interventions

15 2-hour sessions of group affective management (n = 24) vs waiting list control (n = 24)

Outcomes

DTS, CR-PTSD, DES

Notes

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

Therapist credentials/experience is not reported. It is unclear whether or not treatment adherence was
assessed.

Authors' judgement

Support for judgement

Unclear risk

Comment: The method of sequence generation was not reported.

Unclear risk

Comment: There is no mention of any measures taken to conceal allocation.

Incomplete outcome data
(attrition bias) 
All outcomes

High risk

Comment: There were no reported reasons for drop-out (7 from treatment and
6 from the waitlist).Only the data of completers are included in the analysis.

Selective reporting (re-
porting bias)

Low risk

Comment: All specified outcomes were reported.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

107

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Zlotnick 1997  (Continued)

Other bias

High risk

Cochrane Database of Systematic Reviews

Therapist credentials/experience is not reported. It is unclear whether or not
treatment adherence was assessed.

Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes

Blinding of outcome as-
sessment (detection bias) 
All outcomes

High risk

Comment: Participants were aware of their allocation.

Low risk

Self report measures only.

ADAS - Abbreviated Dyadic Adjustment Scale
ADIS-R – Anxiety Disorders Interview Schedule -Revised
ASI – Addiction Severity Index
AUDIT - Alcohol Use Disorders Identification Test
BADS - Behavioural Activation for Depression Scale
BAI – Beck Anxiety Inventory
BDI – Beck Depression Inventory
BPRS - Brief Psychiatric Rating Scale
BSQ – Body Sensations Questionnaire
CAPS - Clinician-Administered PTSD Scale
CES-D - Centre for Epidemiologic Studies Depression Scale
CIDI - Composite International Diagnostic Interview
CIOQ - Changes in Outlook Questionnaire
CMS – Civilian Mississippi Scale
CPT - Continuous Performance Test
CT - Cognitive Therapy
CTSA - Centre for Treatment and Study of Anxiety
DAR-7 - Dimensions of Anger Reactions
DASS - Depression Anxiety and Stress Scale
DES-II – Dissociative Experiences Scale II
DFMQ - Demography of Forced Migration Scale
DTS – Davidson Trauma Scale
EMDR - eye movement desensitisation and reprocessing
EMG -Electromyographic
FAQ – Fear and Avoidance Scale
FFMQ - Five Facet Mindfulness Questionnaire
GAF - Global Assessment of Functioning
GHQ-28 - General Health Questionnaire 28
GIS-A – Global Improvement Scale – Assessor
GIS-S – Global Improvement Scale - Self
HADS - Hospital Anxiety and Depression Scale
HAM-A – Hamilton Rating Scale for Anxiety
HAM-D - Hamilton Rating Scale for Depression
HDRS - Hamilton Rating Scale for Depression
HSCL-25 – Hopkins Symptom Checklist-25
IES – Impact of Event Scale
IES-R Impact of Event Scale - Revised
ICG - Inventory of Complicated Grief
ITT - intention-to-treat
LOCF - last observation carried forward
MADRS - Montgomery-Asberg Depression Rating Scale
MEG -Magnetoencephalography
M-PTSD - Mississippi Post-Traumatic Stress Disorder Scale
MPSS - Modified PTSD Symptom Scale
N-FSS – Neck-Focused Flashback Severity Scale
N-PASS – Neck-Focused Panic Attack Severity Scale
NET - narrative exposure therapy

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

108

 
 
Cochrane Database of Systematic Reviews

Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

ODI – Oswestry Disability Index
O-FSS – Orthostatic-Focused Panic Attack Severity Scale
O-PASS - Orthostatic Panic Attack Severity Scale
PCL - PTSD Checklist
PCT - Psychological Commitment to Team Scale
PDS – Posttraumatic Diagnostic Scale
PE-SIT - Prolonged Exposure - Stress Innoculation Training
PENN - Penn Inventory for PTSD
PHQ-9 - Patient Health Questionnaire - 9
PS-MPI – Pain Subscale – Multidimensional Pain Inventory
PSS-I - PTSD Symptom Scale - Interview
PSS-SR - PTSD Symptom Scale – Self Report
PTCI - Posttraumatic Cognitions Inventory
QOLI - Quality of Life Inventory
SAS – Social Adjustment Scale
SAS-SR - Social Adjustment Scale Self Report
SCID-PTSD - Structured Clinical Interview for DSM-IV - PTSD
SCL-90 - Symptom Checklist - 90
SDS - Sheehan Disability Scale
SF-8 - 8-item Short Form Health Survey
SF-36 - 36-item Short Form Health Survey
SI-PTSD – Structured Interview for PTSD
SLESQ - Stressful Life Events Screening Questionnaire
SPSI - Social Problem Solving Inventory
SRQ-20 - Self Regualtion Questionnaire - 20
SSAI - Spielberger State Anxiety Inventory
ssVEF - steady-state visual evoked fields
STAI - Spielberger State—Trait Anxiety Inventory
STAXI - State-Trait Anger Expression Inventory
TAU - treatment as usual
TRGI - Trauma Related Guilt Inventory
TSCS - Tennessee Self Concept Scale
TSI – Trauma Symptom Inventory
TSQ - Trauma Screening Questionnaire
TSSC – Traumatic Stress Symptom Checklist
WAI - Working Alliance Inventory
WHOQOL - World Health Organisation Quality of Life
WSA – Work and Social Adjustment Scale

Characteristics of excluded studies [ordered by study ID]

Study

Reason for exclusion

Abbasnejad 2007

No formal diagnosis of PTSD.

Arntz 2007

TFCBT vs TFCBT.

Barabasz 2013

Unclear how many participants were suffering ASD as opposed to PTSD (length of time since trau-
ma was not reported). Not a true RCT.

Boudewyns 1990

Group treatment with exposure or conventional one-to-one counselling.

Chemtob 1997

Treatment designed for anger vs PTSD with anger measures used as primary outcomes.

Classen 2001

Classen 2010

Cole 2007

No formal diagnosis of PTSD.

No formal diagnosis of PTSD.

No formal diagnosis of PTSD.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

109

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Study

Davis 2007

Reason for exclusion

Only 67.3% of participants met diagnostic criteria for PTSD before entry into study.

Difede 2007a

Only 67.7% of participants met diagnostic criteria for PTSD before entry into study.

DuHamel 2010

Only 19% of participants met diagnostic criteria for PTSD before entry into study.

Dunn 2007

Treatment for depression not PTSD.

Echeburua 1996

Trauma < 3 months before entry into study.

Edmond 1999

No formal diagnosis of PTSD.

Falsetti 2001

Falsetti 2005

Foa 2006

No formal diagnosis of PTSD.

Trauma < 3 months before entry into study.

Frommberger 2004

Psychological therapy vs pharmacotherapy.

Gidron 1996

Not psychological treatment.

Ginzberg 2009

No diagnosis of PTSD.

Glynn 1999

Hiari 2005

Not an individual or group therapy.

Participants only required to meet re-experiencing and avoidance criteria of DSM-IV criteria for
PTSD.

Jaberghaderi 2004

Participants under 18 (study included in Gillies 2012).

Knaevelsrud 2007

No formal diagnosis of PTSD.

Lange 2001

Lange 2003

Litz 2007

Maercker 2006

No formal diagnosis of PTSD.

No formal diagnosis of PTSD.

No formal diagnosis of PTSD.

Only 48% of participants met diagnostic criteria for PTSD. Remainder had a diagnosis of "sub-syn-
dromal PTSD".

Mithoefer 2011

TFCBT vs TFCBT.

Najavits 2006

Mean age of participants 16 years [study included in Gillies 2012]

Paunovic 2001

TFCBT vs TFCBT.

Price 2007

Rabe 2008

No formal diagnosis of PTSD made.

Only 48.5% of participants met diagnostic criteria for PTSD before entry into study.

Rothbaum 2006

Pharmacotherapy versus pharmacotherapy plus psychological therapy.

Ryan 2005

No formal diagnosis of PTSD.

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

110

 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Study

Reason for exclusion

Schaal 2009

Age range 14 - 28.

Shapiro 1989a

No formal diagnosis of PTSD.

Sloan 2004

Sloan 2005

Spence 2011

Tarrier 1999

No formal diagnosis of PTSD.

No formal diagnosis of PTSD.

Information on duration was not collected. Unkown whether participants had acute/chronic PTSD.

Compared trauma focused cognitive therapy with exposure therapy therefore both treatments =
TFCBT.

Tucker 2007

Pharmacotherapy versus placebo.

Van Emmerik 2008

Only 46.6% diagnosis of PTSD.

Watson 1997

Wilson 1995

Considered 3 different types of relaxation training with no other comparison group.

< 50% PTSD at entry to study.

Yeomans 2010

No formal diagnosis of PTSD.

Characteristics of studies awaiting assessment [ordered by study ID]

Krupnick 2008 

Methods

Randomised Controlled Trial

Participants

37 female victims of domestic violence with DSM-III R PTSD

Interventions

Group interpersonal psychotherapy (n = 32) versus WL (n = 16).

CAPS, Interpersonal Sensitivity, Need for Social Approval, Lack of Sociability, and Interpersonal
Ambivalence

Outcomes

Notes

D A T A   A N D   A N A L Y S E S

Comparison 1.   Trauma-focused CBT/Exposure therapy vs waitlist/usual care

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

1 Severity of PTSD symptoms -
clinician

32

Std. Mean Difference (IV, Random,
95% CI)

Subtotals only

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

111

 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

1.1 Clinician PTSD

1.2 Clinician PTSD severity
women-only subgroup analysis)

1.3 Clinician PTSD excluding
studies of Vietnam War veterans

1.4 Self report

2 Severity of PTSD symptoms at
1 - 4 month follow-up

2.1 Clinician

3 Severity of PTSD symptoms at
5 - 8 month follow-up.

4 Severity of PTSD symptoms 9 -
12 month follow-up

28

9

27

16

4

4

3

1

5 Leaving the study early for any
reason

33

6 Severity of PTSD symptoms
- self report: 1 - 4 month fol-
low-up

7 Severity of PTSD symptoms -
self report: 5 - 8 months)

8 Severity of PTSD symptoms -
self report: 9 - 12 month follow
up

9 Depression

10 Depression 1 - 4 month fol-
low-up

11 Depression 5 - 8 month fol-
low-up

12 Depression 9 - 12 month fol-
low-up

13 Anxiety

2

2

1

28

7

2

1

17

14 Anxiety 1 - 4 month follow-up

3

1256

562

1232

666

336

192

Std. Mean Difference (IV, Random,
95% CI)

-1.62 [-2.03, -1.21]

Std. Mean Difference (IV, Random,
95% CI)

-1.83 [-2.31, -1.36]

Std. Mean Difference (IV, Random,
95% CI)

-1.67 [-2.09, -1.25]

Std. Mean Difference (IV, Random,
95% CI)

-1.57 [-2.01, -1.14]

Std. Mean Difference (IV, Random,
95% CI)

Subtotals only

Std. Mean Difference (IV, Random,
95% CI)

-1.18 [-2.20, -0.17]

Std. Mean Difference (IV, Fixed,
95% CI)

-0.47 [-0.77, -0.18]

Std. Mean Difference (IV, Fixed,
95% CI)

Totals not select-
ed

1756

Risk Ratio (M-H, Fixed, 95% CI)

1.64 [1.30, 2.06]

181

208

1213

413

150

644

189

Std. Mean Difference (IV, Random,
95% CI)

-3.03 [-6.51, 0.45]

Std. Mean Difference (IV, Fixed,
95% CI)

-0.61 [-0.90, -0.32]

Std. Mean Difference (IV, Fixed,
95% CI)

Totals not select-
ed

Std. Mean Difference (IV, Random,
95% CI)

-1.28 [-1.62, -0.94]

Std. Mean Difference (IV, Random,
95% CI)

-0.75 [-1.33, -0.18]

Std. Mean Difference (IV, Fixed,
95% CI)

-0.50 [-0.82, -0.17]

Std. Mean Difference (IV, Fixed,
95% CI)

Totals not select-
ed

Std. Mean Difference (IV, Random,
95% CI)

-0.81 [-1.03, -0.59]

Std. Mean Difference (IV, Fixed,
95% CI)

-0.32 [-0.60, -0.03]

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

112

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

15 Anxiety 9 - 12 month fol-
low-up

16 Exploration of publication
bias

16.1 Clinician

17 Sensitivity analysis - clini-
cian-rated PTSD symptoms -
studies at low risk of bias only

18 PTSD diagnosis after treat-
ment

1

28

28

1

19

Std. Mean Difference (IV, Fixed,
95% CI)

Totals not select-
ed

Std. Mean Difference (IV, Random,
95% CI)

Subtotals only

1256

Std. Mean Difference (IV, Random,
95% CI)

-1.62 [-2.03, -1.21]

Std. Mean Difference (IV, Fixed,
95% CI)

Totals not select-
ed

910

Risk Ratio (M-H, Random, 95% CI)

0.51 [0.41, 0.64]

Analysis 1.1.   Comparison 1 Trauma-focused CBT/Exposure therapy vs
waitlist/usual care, Outcome 1 Severity of PTSD symptoms - clinician.

Study or subgroup

Trauma Fo-
cused CBT

Waitlist/Usual Care

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

1.1.1 Clinician PTSD

Adenauer 2011

Asukai 2010

Basoglu 2005

Basoglu 2007

Bichescu 2007

Blanchard 2003

Brom 1989

Cloitre 2002

Ehlers 2003

Ehlers 2005

Fecteau 1999

Foa 1991

Foa 1999

Foa 2005

Forbes 2012

Gamito 2010

Gersons 2000

Hinton 2005

Keane 1989

Kubany 2003

Kubany 2004

McDonagh 2005

Monson 2006

Mueser 2008

Paunovic 2011

Resick 2002

11

12

31

16

9

27

27

22

22

14

10

10

45

96

30

6

22

20

11

18

45

17

30

32

14

81

52.8 (18.8)

43.8 (8.4)

44.4 (25)

38.7 (18.7)

5.4 (1.3)

23.7 (26.2)

56.2 (24.1)

31 (25.2)

20.9 (20.5)

21.6 (28.6)

37.5 (30.4)

15.4 (11.1)

12.6 (8.4)

9.3 (8.7)

48 (27.9)

62.1 (29.8)

3 (10)

39.3 (19.9)

28.8 (15)

10.1 (19.3)

15.8 (14.4)

38.5 (27.7)

52.1 (3.9)

55.5 (27.9)

21.8 (14.1)

23 (19.9)

8

12

28

15

9

24

23

24

20

14

10

10

15

25

29

3

20

20

13

14

40

20

30

27

15

40

87.9 (18.5)

84.8 (8)

54.7 (21.4)

54.5 (16.9)

9.9 (1.3)

54 (25.9)

66.4 (24.3)

62 (22.7)

46.5 (24.9)

74.6 (19.1)

74.6 (24.7)

19.5 (7.2)

26.9 (8.5)

26.2 (9.4)

57.7 (20)

60 (19.5)

9 (13)

73.1 (9.4)

31.9 (12)

76.1 (25.2)

71.9 (23.8)

62.5 (17)

76 (3.7)

67.8 (26.8)

81.4 (14.4)

69.7 (19.2)

3.23%

2.45%

3.97%

3.72%

2.66%

3.89%

3.92%

3.84%

3.82%

3.45%

3.41%

3.53%

3.81%

3.98%

3.97%

2.85%

3.87%

3.66%

3.64%

3.34%

3.87%

3.78%

3.03%

3.97%

2.92%

4%

-1.8[-2.91,-0.68]

-4.83[-6.53,-3.14]

-0.44[-0.95,0.08]

-0.86[-1.6,-0.12]

-3.3[-4.83,-1.77]

-1.14[-1.74,-0.55]

-0.42[-0.98,0.15]

-1.27[-1.91,-0.63]

-1.11[-1.76,-0.45]

-2.12[-3.07,-1.16]

-1.28[-2.27,-0.3]

-0.42[-1.31,0.47]

-1.68[-2.35,-1.02]

-1.9[-2.4,-1.39]

-0.39[-0.91,0.12]

0.07[-1.32,1.46]

-0.51[-1.13,0.11]

-2.13[-2.92,-1.34]

-0.22[-1.03,0.58]

-2.92[-3.95,-1.88]

-2.87[-3.48,-2.25]

-1.04[-1.74,-0.35]

-6.2[-7.46,-4.95]

-0.44[-0.96,0.08]

-4.06[-5.4,-2.72]

-2.36[-2.84,-1.87]

Favours TFCBT/exposure

-10

-5

0

5

10

Favours WL/UC

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

113

 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Study or subgroup

Rothbaum 2005

Vaughan 1994

Subtotal ***

Trauma Fo-
cused CBT

Mean(SD)

21.3 (22.5)

23 (10.2)

N

20

13

711

Waitlist/Usual Care

Std. Mean Difference

Weight

Std. Mean Difference

Random, 95% CI

Mean(SD)

64.6 (19.9)

28.5 (8.9)

N

20

17

545

3.68%

3.72%

100%

Random, 95% CI

-2[-2.77,-1.23]

-0.56[-1.3,0.17]

-1.62[-2.03,-1.21]

Heterogeneity: Tau2=1.03; Chi2=237.95, df=27(P<0.0001); I2=88.65%

Test for overall effect: Z=7.74(P<0.0001)

1.1.2 Clinician PTSD severity women-only subgroup analysis)

Cloitre 2002

Foa 1991

Foa 1999

Foa 2005

Kubany 2003

Kubany 2004

McDonagh 2005

Resick 2002

Rothbaum 2005

Subtotal ***

22

10

45

96

18

45

17

81

20

31 (25.2)

15.4 (11.1)

12.6 (8.4)

9.3 (8.7)

10.1 (19.3)

15.8 (14.4)

38.5 (27.7)

23 (19.9)

21.3 (22.5)

24

10

15

25

14

40

20

40

20

62 (22.7)

19.5 (7.2)

26.9 (8.5)

26.2 (9.4)

76.1 (25.2)

71.9 (23.8)

62.5 (17)

69.7 (19.2)

64.6 (19.9)

354

208

Heterogeneity: Tau2=0.41; Chi2=37.39, df=8(P<0.0001); I2=78.61%

Test for overall effect: Z=7.51(P<0.0001)

1.1.3 Clinician PTSD excluding studies of Vietnam War veterans

Adenauer 2011

Asukai 2010

Basoglu 2005

Basoglu 2007

Bichescu 2007

Blanchard 2003

Brom 1989

Cloitre 2002

Ehlers 2003

Ehlers 2005

Fecteau 1999

Foa 1991

Foa 1999

Foa 2005

Forbes 2012

Gamito 2010

Gersons 2000

Hinton 2005

Kubany 2003

Kubany 2004

McDonagh 2005

Monson 2006

Mueser 2008

Paunovic 2011

Resick 2002

Rothbaum 2005

Vaughan 1994

Subtotal ***

11

12

31

16

9

27

27

22

22

14

10

10

45

96

30

6

22

20

18

45

17

30

32

14

81

20

13

52.8 (18.8)

43.8 (8.4)

44.4 (25)

38.7 (18.7)

5.4 (1.3)

23.7 (26.2)

56.2 (24.1)

31 (25.2)

20.9 (20.5)

21.6 (28.6)

37.5 (30.4)

15.4 (11.1)

12.6 (8.4)

9.3 (8.7)

48 (27.9)

62.1 (29.8)

3 (10)

39.3 (19.9)

10.1 (19.3)

15.8 (14.4)

38.5 (27.7)

52.1 (3.9)

55.5 (27.9)

21.8 (14.1)

23 (19.9)

21.3 (22.5)

23 (10.2)

8

12

28

15

9

24

23

24

20

14

10

10

15

25

29

3

20

20

14

40

20

30

27

15

40

20

17

87.9 (18.5)

84.8 (8)

54.7 (21.4)

54.5 (16.9)

9.9 (1.3)

54 (25.9)

66.4 (24.3)

62 (22.7)

46.5 (24.9)

74.6 (19.1)

74.6 (24.7)

19.5 (7.2)

26.9 (8.5)

26.2 (9.4)

57.7 (20)

60 (19.5)

9 (13)

73.1 (9.4)

76.1 (25.2)

71.9 (23.8)

62.5 (17)

76 (3.7)

67.8 (26.8)

81.4 (14.4)

69.7 (19.2)

64.6 (19.9)

28.5 (8.9)

700

532

11.56%

9.7%

11.39%

12.55%

8.67%

11.75%

11.15%

12.67%

10.56%

100%

3.35%

2.55%

4.12%

3.86%

2.76%

4.04%

4.07%

3.99%

3.97%

3.58%

3.54%

3.67%

3.96%

4.13%

4.12%

2.96%

4.01%

3.8%

3.46%

4.02%

3.92%

3.15%

4.12%

3.02%

4.15%

3.82%

3.87%

100%

-1.27[-1.91,-0.63]

-0.42[-1.31,0.47]

-1.68[-2.35,-1.02]

-1.9[-2.4,-1.39]

-2.92[-3.95,-1.88]

-2.87[-3.48,-2.25]

-1.04[-1.74,-0.35]

-2.36[-2.84,-1.87]

-2[-2.77,-1.23]

-1.83[-2.31,-1.36]

-1.8[-2.91,-0.68]

-4.83[-6.53,-3.14]

-0.44[-0.95,0.08]

-0.86[-1.6,-0.12]

-3.3[-4.83,-1.77]

-1.14[-1.74,-0.55]

-0.42[-0.98,0.15]

-1.27[-1.91,-0.63]

-1.11[-1.76,-0.45]

-2.12[-3.07,-1.16]

-1.28[-2.27,-0.3]

-0.42[-1.31,0.47]

-1.68[-2.35,-1.02]

-1.9[-2.4,-1.39]

-0.39[-0.91,0.12]

0.07[-1.32,1.46]

-0.51[-1.13,0.11]

-2.13[-2.92,-1.34]

-2.92[-3.95,-1.88]

-2.87[-3.48,-2.25]

-1.04[-1.74,-0.35]

-6.2[-7.46,-4.95]

-0.44[-0.96,0.08]

-4.06[-5.4,-2.72]

-2.36[-2.84,-1.87]

-2[-2.77,-1.23]

-0.56[-1.3,0.17]

-1.67[-2.09,-1.25]

Heterogeneity: Tau2=1.03; Chi2=230.39, df=26(P<0.0001); I2=88.71%

Test for overall effect: Z=7.85(P<0.0001)

Favours TFCBT/exposure

-10

-5

0

5

10

Favours WL/UC

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

114

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Study or subgroup

Trauma Fo-
cused CBT

Waitlist/Usual Care

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

1.1.4 Self report

Asukai 2010

Basoglu 2007

Blanchard 2003

Brom 1989

Cloitre 2002

Duffy 2007

Dunne 2012

Ehlers 2003

Ehlers 2005

Fecteau 1999

Forbes 2012

Gamito 2010

Paunovic 2011

Peniston 1991

Power 2002

Resick 2002

Subtotal ***

12

16

27

27

22

29

13

22

14

10

29

6

14

15

21

80

21.2 (5.5)

30.3 (14.5)

12.1 (14.9)

28 (19.5)

29 (27.6)

21.8 (14.4)

15.6 (8.2)

9 (10.8)

10.3 (8.9)

15.5 (20.3)

45.7 (16.7)

48.3 (13.6)

28.1 (6)

11 (6)

19.2 (12.3)

10.1 (8.2)

12

15

24

23

24

29

13

20

14

10

30

3

15

14

24

39

53.8 (5.2)

51 (22.5)

36.6 (17.2)

46.5 (15.2)

58 (28.6)

33.4 (11.6)

23.3 (8)

21.2 (12.3)

29.8 (8.4)

48.8 (14.7)

53.8 (11.1)

52.3 (18.6)

63.1 (13)

35 (6)

29.6 (8.6)

28 (8.4)

357

309

3.04%

6.64%

7.1%

7.21%

7.14%

7.39%

6.44%

7.03%

5.91%

5.52%

7.45%

4.48%

5.18%

4.77%

7.12%

7.59%

100%

-5.86[-7.85,-3.88]

-1.07[-1.83,-0.31]

-1.51[-2.13,-0.88]

-1.03[-1.63,-0.44]

-1.01[-1.63,-0.4]

-0.88[-1.42,-0.33]

-0.92[-1.74,-0.11]

-1.04[-1.69,-0.39]

-2.19[-3.15,-1.22]

-1.8[-2.87,-0.72]

-0.57[-1.09,-0.05]

-0.24[-1.63,1.15]

-3.32[-4.49,-2.15]

-3.89[-5.19,-2.59]

-0.97[-1.6,-0.35]

-2.16[-2.63,-1.68]

-1.57[-2.01,-1.14]

Heterogeneity: Tau2=0.59; Chi2=80.39, df=15(P<0.0001); I2=81.34%

Test for overall effect: Z=7.11(P<0.0001)

Favours TFCBT/exposure

-10

-5

0

5

10

Favours WL/UC

Analysis 1.2.   Comparison 1 Trauma-focused CBT/Exposure therapy vs waitlist/
usual care, Outcome 2 Severity of PTSD symptoms at 1 - 4 month follow-up.

Study or subgroup

Treatment

Control

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

1.2.1 Clinician

Forbes 2012

Monson 2006

Mueser 2008

Resick 2002

Subtotal ***

45.3 (28.2)

58.1 (4.5)

55.1 (26)

49.2 (32.9)

30

30

54

62

176

52.6 (18.9)

74.4 (4.3)

64.8 (28.3)

69.3 (18.6)

29

30

54

47

160

Heterogeneity: Tau2=0.99; Chi2=52.3, df=3(P<0.0001); I2=94.26%

Test for overall effect: Z=2.29(P=0.02)

25.26%

22.76%

26.02%

25.96%

100%

-0.3[-0.81,0.22]

-3.64[-4.48,-2.8]

-0.36[-0.74,0.03]

-0.72[-1.11,-0.33]

-1.18[-2.2,-0.17]

Favours TFCBT/exposure

-10

-5

0

5

10

Favours WL/UC

Analysis 1.3.   Comparison 1 Trauma-focused CBT/Exposure therapy vs waitlist/
usual care, Outcome 3 Severity of PTSD symptoms at 5 - 8 month follow-up..

Study or subgroup

Treatment

Control

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Fixed, 95% CI

Ehlers 2003

Keane 1989

Mueser 2008

22

11

54

20.4 (20.7)

29.1 (15.5)

57.5 (25.3)

20

31

54

33.9 (29.9)

31.9 (12)

70.9 (24.2)

22.85%

18.28%

58.87%

Fixed, 95% CI

-0.52[-1.14,0.1]

-0.21[-0.9,0.48]

-0.54[-0.92,-0.15]

Favours TFCBT/exposure

-5

-2.5

0

2.5

5

Favours WL/UC

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

115

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Study or subgroup

Treatment

Control

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Fixed, 95% CI

Fixed, 95% CI

Total ***

87

105

100%

-0.47[-0.77,-0.18]

Heterogeneity: Tau2=0; Chi2=0.68, df=2(P=0.71); I2=0%

Test for overall effect: Z=3.15(P=0)

Favours TFCBT/exposure

-5

-2.5

0

2.5

5

Favours WL/UC

Analysis 1.4.   Comparison 1 Trauma-focused CBT/Exposure therapy vs waitlist/
usual care, Outcome 4 Severity of PTSD symptoms 9 - 12 month follow-up.

Study or subgroup

Treatment

Control

Std. Mean Difference

Std. Mean Difference

Resick 2002

N

62

Mean(SD)

47 (33.7)

N

47

Mean(SD)

69.3 (18.6)

Fixed, 95% CI

Fixed, 95% CI

-0.78[-1.18,-0.39]

Favours TFCBT/exposure

-2

-1

0

1

2

Favours WL/UC

Analysis 1.5.   Comparison 1 Trauma-focused CBT/Exposure therapy vs
waitlist/usual care, Outcome 5 Leaving the study early for any reason.

Study or subgroup

Trauma Fo-
cused CBT

n/N

Waitlist/Usu-
al Care

n/N

Risk Ratio

Weight

Risk Ratio

M-H, Fixed, 95% CI

M-H, Fixed, 95% CI

Adenauer 2011

Asukai 2010

Bichescu 2007

Blanchard 2003

Brom 1989

Cloitre 2002

Cooper 1989

Duffy 2007

Dunne 2012

Ehlers 2003

Ehlers 2005

Fecteau 1999

Foa 1991

Foa 1999

Foa 2005

Forbes 2012

Galovski 2012

Gamito 2010

Gersons 2000

Hinton 2005

Keane 1989

Kubany 2003

Kubany 2004

Lindauer 2005

McDonagh 2005

Monson 2006

Mueser 2008

1/16

3/12

0/9

10/37

4/31

9/31

4/11

9/29

1/13

0/22

0/14

2/12

4/14

10/55

57/153

6/30

14/47

1/7

1/22

0/20

1/11

1/19

18/63

3/12

12/29

6/30

11/54

2/18

1/12

0/9

1/25

1/23

3/27

4/11

3/29

2/13

2/23

0/14

1/11

1/10

1/15

1/26

6/29

7/53

0/3

1/20

0/20

1/13

4/18

22/62

1/12

3/23

4/30

11/54

1.8%

0.96%

1.14%

1.1%

3.07%

3.83%

2.87%

1.92%

2.34%

1%

1.12%

1.51%

1.64%

5.84%

6.3%

0.64%

1%

0.88%

3.93%

21.24%

0.96%

3.21%

3.83%

10.54%

0.56[0.06,5.63]

3[0.36,24.92]

Not estimable

6.76[0.92,49.53]

2.97[0.35,24.82]

2.61[0.79,8.68]

1[0.33,3.02]

3[0.9,9.97]

0.5[0.05,4.86]

0.21[0.01,4.12]

Not estimable

1.83[0.19,17.51]

2.86[0.37,21.87]

2.73[0.38,19.65]

9.69[1.4,66.93]

0.97[0.35,2.65]

2.26[1,5.11]

1.5[0.08,29.15]

0.91[0.06,13.59]

Not estimable

1.18[0.08,16.78]

0.24[0.03,1.92]

0.81[0.48,1.35]

3[0.36,24.92]

3.17[1.01,9.93]

1.5[0.47,4.78]

1[0.47,2.11]

Favours TFCBT/exposure

0.01

0.1

1

10

100

Favours WL/UC

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

116

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Study or subgroup

Neuner 2010

Paunovic 2011

Power 2002

Resick 2002

Vaughan 1994

Zang 2013

Total (95% CI)

Trauma Fo-
cused CBT

n/N

Waitlist/Usu-
al Care

n/N

Risk Ratio

Weight

Risk Ratio

M-H, Fixed, 95% CI

M-H, Fixed, 95% CI

2/16

1/14

12/37

33/124

1/13

0/11

1018

0/16

1/15

5/29

7/47

1/17

0/11

738

0.48%

0.92%

5.37%

9.72%

0.83%

5[0.26,96.59]

1.07[0.07,15.54]

1.88[0.75,4.73]

1.79[0.85,3.76]

1.31[0.09,19]

Not estimable

100%

1.64[1.3,2.06]

Total events: 237 (Trauma Focused CBT), 97 (Waitlist/Usual Care)

Heterogeneity: Tau2=0; Chi2=28.97, df=28(P=0.41); I2=3.36%

Test for overall effect: Z=4.22(P<0.0001)

Favours TFCBT/exposure

0.01

0.1

1

10

100

Favours WL/UC

Analysis 1.6.   Comparison 1 Trauma-focused CBT/Exposure therapy vs waitlist/
usual care, Outcome 6 Severity of PTSD symptoms - self report: 1 - 4 month follow-up.

Study or subgroup

TFCBT

WL/UC

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Monson 2006

Resick 2002

Total ***

45.6 (2.4)

14.7 (11.8)

30

61

91

30

60

90

56.4 (2)

27.8 (8.1)

Heterogeneity: Tau2=6.16; Chi2=40.04, df=1(P<0.0001); I2=97.5%

Test for overall effect: Z=1.7(P=0.09)

49.07%

50.93%

Random, 95% CI

-4.84[-5.87,-3.81]

-1.28[-1.68,-0.89]

100%

-3.03[-6.51,0.45]

Favours TFCBT/exposure

-10

-5

0

5

10

Favours WL/UC

Analysis 1.7.   Comparison 1 Trauma-focused CBT/Exposure therapy vs waitlist/
usual care, Outcome 7 Severity of PTSD symptoms - self report: 5 - 8 months).

Study or subgroup

Experimental

Control

Std. Mean Difference

Weight

Std. Mean Difference

Ehlers 2003

Neuner 2008

Total ***

N

22

111

133

Mean(SD)

N

Mean(SD)

Fixed, 95% CI

8.7 (8.8)

6.1 (6.8)

18.6 (14.3)

10.1 (8.1)

20

55

75

21.21%

78.79%

Fixed, 95% CI

-0.83[-1.46,-0.19]

-0.55[-0.88,-0.22]

100%

-0.61[-0.9,-0.32]

Heterogeneity: Tau2=0; Chi2=0.59, df=1(P=0.44); I2=0%

Test for overall effect: Z=4.08(P<0.0001)

Favours TFCBT/exposure

-5

-2.5

0

2.5

5

Favours WL/UC

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

117

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 1.8.   Comparison 1 Trauma-focused CBT/Exposure therapy vs waitlist/usual
care, Outcome 8 Severity of PTSD symptoms - self report: 9 - 12 month follow up.

Study or subgroup

Experimental

Control

Std. Mean Difference

Std. Mean Difference

Resick 2002

N

61

Mean(SD)

15.1 (12)

N

60

Mean(SD)

27.8 (8.1)

Fixed, 95% CI

Fixed, 95% CI

-1.22[-1.61,-0.83]

Favours TFCBT/exposure

-2

-1

0

1

2

Favours WL/UC

Analysis 1.9.   Comparison 1 Trauma-focused CBT/Exposure therapy vs waitlist/usual care, Outcome 9 Depression.

Study or subgroup

Trauma Fo-
cused CBT

Waitlist/Usual Care

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Adenauer 2011

Asukai 2010

Basoglu 2007

Bichescu 2007

Blanchard 2003

Cloitre 2002

Cooper 1989

Duffy 2007

Dunne 2012

Ehlers 2003

Ehlers 2005

Fecteau 1999

Foa 1991

Foa 1999

Foa 2005

Forbes 2012

Gersons 2000

Kubany 2003

Kubany 2004

Lindauer 2005

McDonagh 2005

Monson 2006

Mueser 2008

Neuner 2010

Power 2002

Resick 2002

Vaughan 1994

Zang 2013

11

12

16

9

27

22

7

29

13

22

14

10

10

44

95

30

22

18

45

12

17

30

32

16

21

77

13

11

14.9 (5.5)

20.3 (4)

13.1 (6.2)

5.8 (2.6)

11.6 (12.3)

8 (7.8)

12 (8.2)

22.6 (14.1)

6.4 (6.6)

7.4 (6.7)

10.6 (8.6)

20.1 (17.1)

13.4 (14.2)

8 (7.7)

7.8 (8.2)

15.9 (12)

21 (7.4)

3.6 (4.9)

4.6 (5.3)

8 (6.7)

7.5 (7.9)

17.4 (1.6)

21.9 (11.5)

2.6 (0.6)

8.6 (5.8)

9.1 (8.1)

11.2 (5.8)

4.2 (2.4)

8

12

15

9

24

24

7

29

13

20

14

10

10

14

22

29

20

14

40

12

20

30

27

16

24

37

17

11

27.9 (7.4)

34.8 (3.7)

20.5 (7.4)

15.3 (8.7)

24 (12.1)

20 (11.4)

17 (12.1)

33.4 (11.6)

13.5 (7.3)

17 (10.2)

19.3 (7.2)

24.7 (8.1)

15.4 (9.7)

22.1 (15)

21 (10.7)

20.8 (11.8)

28.5 (9.6)

30.2 (8.5)

27.2 (10.5)

9.1 (5.7)

20.1 (12.1)

27.1 (1.4)

27.7 (14.8)

2.9 (0.5)

12.8 (5.6)

22.3 (9.1)

13.8 (4.7)

7.1 (3)

2.94%

2.54%

3.63%

3.1%

3.92%

3.85%

3.09%

3.99%

3.52%

3.81%

3.56%

3.41%

3.42%

3.8%

4.04%

4.03%

3.84%

2.8%

3.9%

3.56%

3.72%

2.73%

4.02%

3.72%

3.89%

4.13%

3.67%

3.38%

-1.96[-3.1,-0.81]

-3.67[-5.06,-2.28]

-1.06[-1.82,-0.3]

-1.41[-2.47,-0.35]

-1[-1.59,-0.41]

-1.2[-1.83,-0.57]

-0.45[-1.52,0.61]

-0.83[-1.36,-0.29]

-1[-1.83,-0.18]

-1.1[-1.76,-0.45]

-1.07[-1.86,-0.27]

-0.33[-1.21,0.55]

-0.16[-1.04,0.72]

-1.41[-2.07,-0.75]

-1.5[-2.01,-1]

-0.41[-0.92,0.11]

-0.86[-1.5,-0.23]

-3.87[-5.1,-2.64]

-2.74[-3.34,-2.14]

-0.17[-0.97,0.63]

-1.19[-1.89,-0.48]

-6.33[-7.61,-5.05]

-0.44[-0.96,0.08]

-0.53[-1.24,0.18]

-0.72[-1.33,-0.12]

-1.56[-2,-1.11]

-0.49[-1.22,0.25]

-1.05[-1.95,-0.15]

Total ***

685

528

Heterogeneity: Tau2=0.67; Chi2=171.15, df=27(P<0.0001); I2=84.22%

Test for overall effect: Z=7.41(P<0.0001)

100%

-1.28[-1.62,-0.94]

Favours TFCBT/exposure

-10

-5

0

5

10

Favours WL/UC

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

118

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 1.10.   Comparison 1 Trauma-focused CBT/Exposure therapy
vs waitlist/usual care, Outcome 10 Depression 1 - 4 month follow-up.

Study or subgroup

TFCBT

WL/UC

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Cooper 1989

Forbes 2012

Gersons 2000

Monson 2006

Mueser 2008

Resick 2002

Zang 2013

7

30

22

30

54

61

11

13 (8.8)

14.8 (12.9)

21.6 (8.5)

18.8 (1.9)

21.7 (13.3)

16.5 (11.6)

4.9 (3)

7

29

20

30

54

47

11

18 (14.8)

19.1 (10.2)

30.5 (10.5)

23.9 (1.8)

30.7 (15.3)

22.6 (8.6)

3.7 (2.1)

Total ***

215

198

Heterogeneity: Tau2=0.49; Chi2=41.24, df=6(P<0.0001); I2=85.45%

Test for overall effect: Z=2.58(P=0.01)

10.99%

15.43%

14.45%

13.8%

16.31%

16.3%

12.72%

-0.38[-1.45,0.68]

-0.37[-0.88,0.15]

-0.92[-1.56,-0.28]

-2.76[-3.48,-2.04]

-0.62[-1.01,-0.24]

-0.58[-0.97,-0.2]

0.44[-0.41,1.28]

100%

-0.75[-1.33,-0.18]

Favours TFCBT/exposure

-10

-5

0

5

10

Favours WL/UC

Analysis 1.11.   Comparison 1 Trauma-focused CBT/Exposure therapy
vs waitlist/usual care, Outcome 11 Depression 5 - 8 month follow-up.

Study or subgroup

TFCBT

WL/UC

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Fixed, 95% CI

Ehlers 2003

Mueser 2008

Total ***

6.7 (7.1)

25 (13.5)

22

54

76

12.2 (11.6)

31.3 (12.9)

20

54

74

Heterogeneity: Tau2=0; Chi2=0.06, df=1(P=0.8); I2=0%

Test for overall effect: Z=3.01(P=0)

27.66%

72.34%

Fixed, 95% CI

-0.57[-1.19,0.05]

-0.47[-0.86,-0.09]

100%

-0.5[-0.82,-0.17]

Favours TFCBT/exposure

-5

-2.5

0

2.5

5

Favours WL/UC

Analysis 1.12.   Comparison 1 Trauma-focused CBT/Exposure therapy
vs waitlist/usual care, Outcome 12 Depression 9 - 12 month follow-up.

Study or subgroup

TFCBT

Resick 2002

N

61

Mean(SD)

16.4 (11.4)

N

47

WL/UC

Mean(SD)

22.6 (8.6)

Std. Mean Difference

Std. Mean Difference

Fixed, 95% CI

Fixed, 95% CI

-0.6[-0.99,-0.21]

Favours TFCBT/exposure

-5

-2.5

0

2.5

5

Favours WL/UC

Analysis 1.13.   Comparison 1 Trauma-focused CBT/Exposure therapy vs waitlist/usual care, Outcome 13 Anxiety.

Study or subgroup

Trauma Fo-
cused CBT

Waitlist/Usual Care

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Blanchard 2003

Brom 1989

Cloitre 2002

27

27

22

38.9 (14)

45.1 (13.2)

36 (8.6)

24

23

24

58.8 (12.3)

48.2 (13)

55 (14.9)

6.72%

7.57%

6.3%

-1.48[-2.11,-0.86]

-0.23[-0.79,0.33]

-1.52[-2.18,-0.85]

Favours TFCBT/exposure

-4

-2

0

2

4

Favours WL/UC

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

119

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Study or subgroup

Trauma Fo-
cused CBT

Waitlist/Usual Care

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Cooper 1989

Dunne 2012

Ehlers 2003

Ehlers 2005

Fecteau 1999

Foa 1991

Foa 1999

Forbes 2012

Gersons 2000

Lindauer 2005

McDonagh 2005

Mueser 2008

Power 2002

Zang 2013

7

13

22

14

10

10

44

30

22

12

17

32

21

11

44 (9)

4.3 (4.3)

5.9 (6.1)

8.2 (10.8)

15.8 (13.8)

41.5 (13.8)

36.3 (13.3)

44.6 (13.1)

7.7 (1.6)

8.1 (4.8)

39.4 (11.9)

42.6 (13)

9.6 (5)

5.3 (2.8)

7

13

20

14

10

10

15

29

20

12

20

27

24

11

52 (17.3)

10.5 (6)

14.5 (10.3)

12.2 (11.2)

32 (13.3)

49.9 (13.8)

50.4 (13.8)

48.3 (12.8)

9.8 (3.7)

12 (4.7)

52.7 (10.1)

45.8 (14.2)

14.2 (4.6)

8.6 (3.6)

Total ***

341

303

Heterogeneity: Tau2=0.08; Chi2=27.09, df=16(P=0.04); I2=40.94%

Test for overall effect: Z=7.28(P<0.0001)

3.25%

4.66%

6.48%

5.45%

3.85%

4.24%

6.82%

8.19%

6.7%

4.69%

5.84%

8.18%

6.79%

4.25%

-0.54[-1.62,0.53]

-1.16[-2,-0.32]

-1.01[-1.66,-0.36]

-0.35[-1.1,0.39]

-1.14[-2.11,-0.18]

-0.58[-1.48,0.32]

-1.04[-1.66,-0.42]

-0.28[-0.8,0.23]

-0.74[-1.36,-0.11]

-0.79[-1.63,0.04]

-1.19[-1.89,-0.48]

-0.24[-0.75,0.28]

-0.94[-1.56,-0.32]

-1.01[-1.91,-0.11]

100%

-0.81[-1.03,-0.59]

Favours TFCBT/exposure

-4

-2

0

2

4

Favours WL/UC

Analysis 1.14.   Comparison 1 Trauma-focused CBT/Exposure therapy
vs waitlist/usual care, Outcome 14 Anxiety 1 - 4 month follow-up.

Study or subgroup

Experimental

Control

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Fixed, 95% CI

Forbes 2012

Mueser 2008

Zang 2013

Total ***

43.6 (11.5)

41.1 (14.3)

5.5 (3)

30

54

11

95

29

54

11

94

47.3 (16.2)

48 (15.6)

4.8 (2.5)

Heterogeneity: Tau2=0; Chi2=2.16, df=2(P=0.34); I2=7.28%

Test for overall effect: Z=2.16(P=0.03)

31.53%

56.69%

11.78%

Fixed, 95% CI

-0.26[-0.77,0.25]

-0.46[-0.84,-0.08]

0.22[-0.62,1.06]

100%

-0.32[-0.6,-0.03]

Favours TFCBT/exposure

-1

-0.5

0

0.5

1

Favours WL/UC

Analysis 1.15.   Comparison 1 Trauma-focused CBT/Exposure therapy
vs waitlist/usual care, Outcome 15 Anxiety 9 - 12 month follow-up.

Study or subgroup

Mueser 2008

TFCBT

Mean(SD)

43.6 (12)

N

54

WL/UC

Std. Mean Difference

Std. Mean Difference

N

54

Mean(SD)

47.8 (13.7)

Fixed, 95% CI

Fixed, 95% CI

-0.33[-0.71,0.05]

Favours TFCBT/exposure

-5

-2.5

0

2.5

5

Favours WL/UC

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

120

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 1.16.   Comparison 1 Trauma-focused CBT/Exposure therapy
vs waitlist/usual care, Outcome 16 Exploration of publication bias.

Study or subgroup

Trauma Fo-
cused CBT

Waitlist/Usual Care

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

1.16.1 Clinician

Adenauer 2011

Asukai 2010

Basoglu 2005

Basoglu 2007

Bichescu 2007

Blanchard 2003

Brom 1989

Cloitre 2002

Ehlers 2003

Ehlers 2005

Fecteau 1999

Foa 1991

Foa 1999

Foa 2005

Forbes 2012

Gamito 2010

Gersons 2000

Hinton 2005

Keane 1989

Kubany 2003

Kubany 2004

McDonagh 2005

Monson 2006

Mueser 2008

Paunovic 2011

Resick 2002

Rothbaum 2005

Vaughan 1994

Subtotal ***

11

12

31

16

9

27

27

22

22

14

10

10

45

96

30

6

22

20

11

18

45

17

30

32

14

81

20

13

52.8 (18.8)

43.8 (8.4)

44.4 (25)

38.7 (18.7)

5.4 (1.3)

23.7 (26.2)

56.2 (24.1)

31 (25.2)

20.9 (20.5)

21.6 (28.6)

37.5 (30.4)

15.4 (11.1)

12.6 (8.4)

9.3 (8.7)

48 (27.9)

62.1 (29.8)

3 (10)

39.3 (19.9)

28.8 (15)

10.1 (19.3)

15.8 (14.4)

38.5 (27.7)

52.1 (3.9)

55.5 (27.9)

21.8 (14.1)

23 (19.9)

21.3 (22.5)

23 (10.2)

8

12

28

15

9

24

23

24

20

14

10

10

15

25

29

3

20

20

13

14

40

20

30

27

15

40

20

17

87.9 (18.5)

84.8 (8)

54.7 (21.4)

54.5 (16.9)

9.9 (1.3)

54 (25.9)

66.4 (24.3)

62 (22.7)

46.5 (24.9)

74.6 (19.1)

74.6 (24.7)

19.5 (7.2)

26.9 (8.5)

26.2 (9.4)

57.7 (20)

60 (19.5)

9 (13)

73.1 (9.4)

31.9 (12)

76.1 (25.2)

71.9 (23.8)

62.5 (17)

76 (3.7)

67.8 (26.8)

81.4 (14.4)

69.7 (19.2)

64.6 (19.9)

28.5 (8.9)

711

545

3.23%

2.45%

3.97%

3.72%

2.66%

3.89%

3.92%

3.84%

3.82%

3.45%

3.41%

3.53%

3.81%

3.98%

3.97%

2.85%

3.87%

3.66%

3.64%

3.34%

3.87%

3.78%

3.03%

3.97%

2.92%

4%

3.68%

3.72%

100%

-1.8[-2.91,-0.68]

-4.83[-6.53,-3.14]

-0.44[-0.95,0.08]

-0.86[-1.6,-0.12]

-3.3[-4.83,-1.77]

-1.14[-1.74,-0.55]

-0.42[-0.98,0.15]

-1.27[-1.91,-0.63]

-1.11[-1.76,-0.45]

-2.12[-3.07,-1.16]

-1.28[-2.27,-0.3]

-0.42[-1.31,0.47]

-1.68[-2.35,-1.02]

-1.9[-2.4,-1.39]

-0.39[-0.91,0.12]

0.07[-1.32,1.46]

-0.51[-1.13,0.11]

-2.13[-2.92,-1.34]

-0.22[-1.03,0.58]

-2.92[-3.95,-1.88]

-2.87[-3.48,-2.25]

-1.04[-1.74,-0.35]

-6.2[-7.46,-4.95]

-0.44[-0.96,0.08]

-4.06[-5.4,-2.72]

-2.36[-2.84,-1.87]

-2[-2.77,-1.23]

-0.56[-1.3,0.17]

-1.62[-2.03,-1.21]

Heterogeneity: Tau2=1.03; Chi2=237.95, df=27(P<0.0001); I2=88.65%

Test for overall effect: Z=7.74(P<0.0001)

Favours TFCBT/exposure

-10

-5

0

5

10

Favours WL/UC

Analysis 1.17.   Comparison 1 Trauma-focused CBT/Exposure therapy vs waitlist/usual care,
Outcome 17 Sensitivity analysis - clinician-rated PTSD symptoms - studies at low risk of bias only.

Study or subgroup

TFCBT

Waitlist/Usual Care

Std. Mean Difference

Std. Mean Difference

Basoglu 2005

N

31

Mean(SD)

44.4 (25)

N

28

Mean(SD)

54.7 (21.4)

Fixed, 95% CI

Fixed, 95% CI

-0.44[-0.95,0.08]

Favours TFCBT/exposure

-4

-2

0

2

4

Favours WL/UC

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

121

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 1.18.   Comparison 1 Trauma-focused CBT/Exposure therapy
vs waitlist/usual care, Outcome 18 PTSD diagnosis after treatment.

Study or subgroup

Trauma Fo-
cused CBT

n/N

Waitlist/Usu-
al Care

n/N

Risk Ratio

Weight

Risk Ratio

M-H, Random, 95% CI

M-H, Random, 95% CI

Blanchard 2003

Brom 1989

Cloitre 2002

Dunne 2012

Ehlers 2005

Fecteau 1999

Foa 1991

Foa 1999

Gersons 2000

Keane 1989

Kubany 2003

Lindauer 2005

McDonagh 2005

Monson 2006

Neuner 2010

Peniston 1991

Power 2002

Resick 2002

Vaughan 1994

Total (95% CI)

16/37

12/31

7/31

5/13

4/14

7/12

10/14

27/55

2/22

4/11

2/19

2/12

21/29

18/30

15/16

3/15

28/37

58/124

6/13

535

18/25

17/23

20/27

12/13

14/14

11/11

10/10

15/15

10/20

13/13

18/18

9/12

19/23

29/30

16/16

14/14

28/29

44/45

17/17

375

6.05%

5.63%

4.49%

4.39%

4%

5.8%

6.63%

7.09%

1.9%

4.22%

2.48%

2.09%

7.02%

6.97%

7.65%

3.29%

7.54%

7.55%

5.22%

0.6[0.39,0.94]

0.52[0.32,0.87]

0.3[0.15,0.61]

0.42[0.21,0.84]

0.31[0.14,0.68]

0.6[0.37,0.97]

0.73[0.51,1.05]

0.51[0.38,0.67]

0.18[0.05,0.73]

0.39[0.19,0.81]

0.13[0.04,0.41]

0.22[0.06,0.82]

0.88[0.65,1.17]

0.62[0.46,0.84]

0.94[0.79,1.11]

0.23[0.09,0.57]

0.78[0.64,0.95]

0.48[0.39,0.58]

0.48[0.27,0.84]

100%

0.51[0.41,0.64]

Total events: 247 (Trauma Focused CBT), 334 (Waitlist/Usual Care)

Heterogeneity: Tau2=0.16; Chi2=101.56, df=18(P<0.0001); I2=82.28%

Test for overall effect: Z=5.94(P<0.0001)

Favours TFCBT/exposure

0.01

0.1

1

10

100

Favours WL/UC

Comparison 2.   Trauma-focused CBT/Exposure therapy vs non-TFCBT

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

1 Severity of PTSD Symptoms -
clinician

2 Severity of PTSD symptoms -
clinician - follow-up (1 - 4 months)

3 Severity of PTSD symptoms -
clinician - follow-up (5 - 8 months)

4 Severity of PTSD symptoms
- clinician - follow-up (9 - 12
months)

5 Leaving the study early for any
reason

7

5

2

2

7

267

127

48

48

312

Std. Mean Difference (IV, Ran-
dom, 95% CI)

-0.27 [-0.63, 0.10]

Std. Mean Difference (IV, Ran-
dom, 95% CI)

-0.51 [-1.00, -0.01]

Std. Mean Difference (IV, Ran-
dom, 95% CI)

1.00 [-2.17, 0.17]

Mean Difference (IV, Fixed, 95%
CI)

-12.93 [-18.72,
-7.14]

Risk Ratio (M-H, Fixed, 95% CI)

1.19 [0.71, 2.00]

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

122

 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

6 Severity of PTSD symptoms - self
report

7 Severity of PTSD symptoms - self
report - follow-up (1-4 months)

8 Depression

9 Depression - follow-up (1 - 4
months)

10 Depression - follow-up (5 - 8
months)

11 Depression - follow-up (9 - 12
months)

12 Anxiety

13 Anxiety - follow-up (1 - 4
months)

14 Anxiety - follow-up (5 - 8
months)

15 Anxiety - follow-up (9 - 12
months)

16 PTSD diagnosis after treatment

3

2

6

5

2

1

4

4

1

1

6

127

54

189

147

48

127

117

284

Std. Mean Difference (IV, Fixed,
95% CI)

-0.37 [-0.74, 0.01]

Std. Mean Difference (IV, Fixed,
95% CI)

-0.44 [-0.99, 0.10]

Std. Mean Difference (IV, Fixed,
95% CI)

-0.27 [-0.56, 0.03]

Std. Mean Difference (IV, Fixed,
95% CI)

-0.28 [-0.62, 0.06]

Std. Mean Difference (IV, Fixed,
95% CI)

-0.71 [-1.30, -0.12]

Mean Difference (IV, Fixed, 95%
CI)

Totals not select-
ed

Std. Mean Difference (IV, Fixed,
95% CI)

-0.12 [-0.49, 0.26]

Std. Mean Difference (IV, Ran-
dom, 95% CI)

-0.24 [-0.79, 0.30]

Std. Mean Difference (IV, Fixed,
95% CI)

Totals not select-
ed

Std. Mean Difference (IV, Fixed,
95% CI)

Totals not select-
ed

Risk Ratio (M-H, Random, 95%
CI)

0.83 [0.60, 1.17]

Analysis 2.1.   Comparison 2 Trauma-focused CBT/Exposure therapy
vs non-TFCBT, Outcome 1 Severity of PTSD Symptoms - clinician.

Study or subgroup

Trauma Fo-
cused CBT

non-TFCBT

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Echeburua 1997

Foa 1991

Foa 1999

Hensel-Dittmann 2011

Marks 1998

Taylor 2003

Vaughan 1994

10

10

45

15

57

15

13

12 (5.5)

15.4 (11.1)

12.6 (8.4)

76.7 (26.2)

35.3 (28.8)

25.5 (22.6)

23 (10.2)

10

14

19

13

20

15

11

22 (7.6)

11.1 (4)

12.9 (9)

82.6 (18.8)

43.7 (24)

47 (36.2)

23.1 (12.5)

Total ***

165

102

Heterogeneity: Tau2=0.11; Chi2=11.25, df=6(P=0.08); I2=46.67%

Test for overall effect: Z=1.42(P=0.16)

9.34%

12.1%

18.87%

13.71%

19.57%

13.83%

12.58%

-1.44[-2.45,-0.43]

0.54[-0.29,1.37]

-0.03[-0.57,0.5]

-0.25[-0.99,0.5]

-0.3[-0.81,0.21]

-0.7[-1.44,0.04]

-0.01[-0.81,0.79]

100%

-0.27[-0.63,0.1]

Favours TFCBT

-4

-2

0

2

4

Favours non-TFCBT

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

123

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 2.2.   Comparison 2 Trauma-focused CBT/Exposure therapy vs non-
TFCBT, Outcome 2 Severity of PTSD symptoms - clinician - follow-up (1 - 4 months).

Study or subgroup

Trauma Fo-
cused CBT

non-TFCBT

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Echeburua 1997

Foa 1991

Foa 1999

Taylor 2003

Vaughan 1994

Total ***

5.9 (1.9)

10.4 (8.2)

11.6 (9)

23.6 (22.6)

20.6 (14.1)

10

9

19

15

13

66

19.9 (12.1)

12.3 (9.6)

15.1 (13.3)

42.3 (23.3)

19.6 (10.9)

10

9

16

15

11

61

Heterogeneity: Tau2=0.14; Chi2=7.3, df=4(P=0.12); I2=45.19%

Test for overall effect: Z=2(P=0.05)

15.29%

17.42%

24.61%

22.15%

20.54%

-1.55[-2.57,-0.52]

-0.2[-1.13,0.73]

-0.3[-0.97,0.37]

-0.79[-1.54,-0.05]

0.08[-0.73,0.88]

100%

-0.51[-1,-0.01]

Favours TFCBT

-4

-2

0

2

4

Favours non-TFCBT

Analysis 2.3.   Comparison 2 Trauma-focused CBT/Exposure therapy vs non-
TFCBT, Outcome 3 Severity of PTSD symptoms - clinician - follow-up (5 - 8 months).

Study or subgroup

Trauma Fo-
cused CBT

non-TFCBT

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Echeburua 1997

Hensel-Dittmann 2011

Total ***

5 (1.6)

72.3 (18.1)

10

15

25

10

13

23

18.5 (11)

82.7 (26.2)

Heterogeneity: Tau2=0.5; Chi2=3.32, df=1(P=0.07); I2=69.9%

Test for overall effect: Z=1.67(P=0.1)

45.23%

54.77%

-1.65[-2.7,-0.61]

-0.45[-1.21,0.3]

100%

-1[-2.17,0.17]

Favours TFCBT

-5

-2.5

0

2.5

5

Favours non-TFCBT

Analysis 2.4.   Comparison 2 Trauma-focused CBT/Exposure therapy vs non-
TFCBT, Outcome 4 Severity of PTSD symptoms - clinician - follow-up (9 - 12 months).

Study or subgroup

Trauma Fo-
cused CBT

non-TFCBT

Mean Difference

Weight

Mean Difference

N

Mean(SD)

N

Mean(SD)

Fixed, 95% CI

Echeburua 1997

Hensel-Dittmann 2011

Total ***

4.2 (2.7)

64.1 (24)

10

15

25

16.9 (9.3)

80.1 (33.9)

10

13

23

Heterogeneity: Tau2=0; Chi2=0.08, df=1(P=0.78); I2=0%

Test for overall effect: Z=4.38(P<0.0001)

93.1%

6.9%

Fixed, 95% CI

-12.7[-18.7,-6.7]

-16.02[-38.07,6.03]

100%

-12.93[-18.72,-7.14]

Favours TFCBT

-100

-50

0

50

100

Favours non-TFCBT

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

124

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 2.5.   Comparison 2 Trauma-focused CBT/Exposure therapy
vs non-TFCBT, Outcome 5 Leaving the study early for any reason.

Study or subgroup

Echeburua 1997

Foa 1991

Foa 1999

Hensel-Dittmann 2011

Marks 1998

Taylor 2003

Vaughan 1994

Total (95% CI)

Trauma Fo-
cused CBT

n/N

0/10

4/14

10/55

3/15

9/66

7/22

1/13

195

Total events: 34 (Trauma Focused CBT), 18 (non-TFCBT)

Heterogeneity: Tau2=0; Chi2=2.94, df=5(P=0.71); I2=0%

Test for overall effect: Z=0.66(P=0.51)

non-TFCBT

Risk Ratio

Weight

Risk Ratio

n/N

M-H, Fixed, 95% CI

M-H, Fixed, 95% CI

0/10

3/17

7/26

2/13

1/21

4/19

1/11

117

12.75%

44.73%

10.08%

7.14%

20.2%

5.1%

Not estimable

1.62[0.43,6.06]

0.68[0.29,1.57]

1.3[0.26,6.62]

2.86[0.38,21.3]

1.51[0.52,4.38]

0.85[0.06,12.01]

100%

1.19[0.71,2]

Favours TFCBT

0.02

0.1

1

10

50

Favours non-TFCBT

Analysis 2.6.   Comparison 2 Trauma-focused CBT/Exposure therapy
vs non-TFCBT, Outcome 6 Severity of PTSD symptoms - self report.

Study or subgroup

Trauma Fo-
cused CBT

non-TFCBT

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Fixed, 95% CI

Marks 1998

Taylor 2003

Vaughan 1994

Total ***

16.7 (14.4)

19.4 (13.4)

30.2 (20.5)

53

15

13

81

20

15

11

46

22.3 (12.2)

22.8 (13.5)

40.2 (23.1)

Heterogeneity: Tau2=0; Chi2=0.16, df=2(P=0.92); I2=0%

Test for overall effect: Z=1.93(P=0.05)

51.92%

27.04%

21.05%

Fixed, 95% CI

-0.4[-0.92,0.12]

-0.24[-0.96,0.47]

-0.44[-1.26,0.37]

100%

-0.37[-0.74,0.01]

Favours TFCBT

-2

-1

0

1

2

Favours non-TFCBT

Analysis 2.7.   Comparison 2 Trauma-focused CBT/Exposure therapy vs non-
TFCBT, Outcome 7 Severity of PTSD symptoms - self report - follow-up (1-4 months).

Study or subgroup

Trauma Fo-
cused CBT

non-TFCBT

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Fixed, 95% CI

Taylor 2003

Vaughan 1994

Total ***

15.2 (10.8)

28.9 (22.5)

15

13

28

15

11

26

23.4 (13)

32.8 (20.6)

Heterogeneity: Tau2=0; Chi2=0.78, df=1(P=0.38); I2=0%

Test for overall effect: Z=1.59(P=0.11)

54.31%

45.69%

Fixed, 95% CI

-0.67[-1.4,0.07]

-0.17[-0.98,0.63]

100%

-0.44[-0.99,0.1]

Favours TFCBT

-4

-2

0

2

4

Favours non-TFCBT

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

125

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 2.8.   Comparison 2 Trauma-focused CBT/Exposure therapy vs non-TFCBT, Outcome 8 Depression.

Study or subgroup

Trauma Fo-
cused CBT

non-TFCBT

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Fixed, 95% CI

Fixed, 95% CI

Echeburua 1997

Foa 1991

Foa 1999

Hensel-Dittmann 2011

Taylor 2003

Vaughan 1994

Total ***

6.2 (3.2)

13.4 (14.2)

8 (7.7)

24.7 (8.1)

13 (10.6)

20.6 (12.5)

10

10

44

15

15

13

107

10

14

19

13

15

11

82

10.8 (8.9)

9.9 (6.8)

10.1 (8.1)

28.1 (9.9)

21 (13.8)

20.4 (14.1)

Heterogeneity: Tau2=0; Chi2=4.23, df=5(P=0.52); I2=0%

Test for overall effect: Z=1.75(P=0.08)

10.77%

13.21%

30.29%

15.71%

16.31%

13.7%

-0.66[-1.56,0.25]

0.33[-0.49,1.14]

-0.26[-0.8,0.28]

-0.37[-1.12,0.38]

-0.63[-1.37,0.1]

0.01[-0.79,0.82]

100%

-0.27[-0.56,0.03]

Favours TFCBT

-4

-2

0

2

4

Favours non-TFCBT

Analysis 2.9.   Comparison 2 Trauma-focused CBT/Exposure therapy
vs non-TFCBT, Outcome 9 Depression - follow-up (1 - 4 months).

Study or subgroup

Trauma Fo-
cused CBT

non-TFCBT

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Fixed, 95% CI

Fixed, 95% CI

Echeburua 1997

Foa 1991

Foa 1999

Taylor 2003

Vaughan 1994

Total ***

6.7 (4.8)

6.4 (7.6)

10.9 (8.9)

12.7 (8.9)

15.6 (8.1)

10

9

39

15

13

86

11.3 (6.6)

10.3 (11.7)

14.6 (12.2)

16.7 (10.8)

11.9 (7.2)

10

9

16

15

11

61

Heterogeneity: Tau2=0; Chi2=4.47, df=4(P=0.35); I2=10.57%

Test for overall effect: Z=1.64(P=0.1)

13.79%

13.21%

33.6%

22.05%

17.35%

-0.76[-1.68,0.15]

-0.38[-1.32,0.55]

-0.37[-0.95,0.22]

-0.39[-1.12,0.33]

0.46[-0.35,1.28]

100%

-0.28[-0.62,0.06]

Favours TFCBT

-4

-2

0

2

4

Favours non-TFCBT

Analysis 2.10.   Comparison 2 Trauma-focused CBT/Exposure therapy
vs non-TFCBT, Outcome 10 Depression - follow-up (5 - 8 months).

Study or subgroup

Trauma Fo-
cused CBT

non-TFCBT

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Fixed, 95% CI

Echeburua 1997

Hensel-Dittmann 2011

Total ***

5.7 (4.5)

20.3 (7.5)

10

15

25

12 (8.4)

25.6 (10.2)

10

13

23

Heterogeneity: Tau2=0; Chi2=0.26, df=1(P=0.61); I2=0%

Test for overall effect: Z=2.37(P=0.02)

40.1%

59.9%

Fixed, 95% CI

-0.9[-1.83,0.03]

-0.59[-1.35,0.17]

100%

-0.71[-1.3,-0.12]

Favours TFCBT

-5

-2.5

0

2.5

5

Favours non-TFCBT

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

126

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 2.11.   Comparison 2 Trauma-focused CBT/Exposure therapy
vs non-TFCBT, Outcome 11 Depression - follow-up (9 - 12 months).

Study or subgroup

Trauma Focused CBT

non-TFCBT

Echeburua 1997

N

10

Mean(SD)

4.4 (3.3)

N

10

Mean(SD)

12.4 (9.4)

Mean Difference

Fixed, 95% CI

Mean Difference

Fixed, 95% CI

-8[-14.14,-1.86]

Favours TFCBT

-100

-50

0

50

100

Favours non-TFCBT

Analysis 2.12.   Comparison 2 Trauma-focused CBT/Exposure therapy vs non-TFCBT, Outcome 12 Anxiety.

Study or subgroup

Trauma Fo-
cused CBT

non-TFCBT

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Fixed, 95% CI

Fixed, 95% CI

Echeburua 1997

Foa 1991

Foa 1999

Vaughan 1994

Total ***

17.6 (9.5)

41.5 (13.8)

36.3 (13.3)

52.4 (15.9)

10

10

44

13

77

26.5 (15.3)

37.2 (7.6)

39.1 (11.6)

52.4 (18.3)

10

14

15

11

50

Heterogeneity: Tau2=0; Chi2=3.12, df=3(P=0.37); I2=3.95%

Test for overall effect: Z=0.62(P=0.54)

17.01%

20.76%

40.54%

21.69%

-0.67[-1.58,0.24]

0.4[-0.42,1.22]

-0.21[-0.8,0.37]

0[-0.8,0.8]

100%

-0.12[-0.49,0.26]

Favours TFCBT

-4

-2

0

2

4

Favours non-TFCBT

Analysis 2.13.   Comparison 2 Trauma-focused CBT/Exposure therapy
vs non-TFCBT, Outcome 13 Anxiety - follow-up (1 - 4 months).

Study or subgroup

Trauma Fo-
cused CBT

non-TFCBT

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Echeburua 1997

Foa 1991

Foa 1999

Vaughan 1994

Total ***

18.9 (10.7)

32.4 (7)

40.5 (13.5)

50.3 (16.1)

10

9

39

13

71

10

9

16

11

46

25 (17.2)

50 (19.4)

41.3 (14)

45.4 (9.9)

Heterogeneity: Tau2=0.14; Chi2=5.56, df=3(P=0.13); I2=46.06%

Test for overall effect: Z=0.87(P=0.38)

22.41%

18.91%

33.8%

24.88%

-0.41[-1.3,0.48]

-1.15[-2.17,-0.14]

-0.06[-0.64,0.52]

0.35[-0.46,1.16]

100%

-0.24[-0.79,0.3]

Favours TFCBT

-4

-2

0

2

4

Favours non-TFCBT

Analysis 2.14.   Comparison 2 Trauma-focused CBT/Exposure therapy
vs non-TFCBT, Outcome 14 Anxiety - follow-up (5 - 8 months).

Study or subgroup

Trauma Focused CBT

non-TFCBT

Std. Mean Difference

Std. Mean Difference

Echeburua 1997

N

10

Mean(SD)

14.9 (8.7)

N

10

Mean(SD)

23.6 (16.9)

Fixed, 95% CI

Fixed, 95% CI

-0.62[-1.52,0.28]

Favours TFCBT

-10

-5

0

5

10

Favours non-TFCBT

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

127

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 2.15.   Comparison 2 Trauma-focused CBT/Exposure therapy
vs non-TFCBT, Outcome 15 Anxiety - follow-up (9 - 12 months).

Study or subgroup

Trauma Focused CBT

non-TFCBT

Std. Mean Difference

Std. Mean Difference

Echeburua 1997

N

10

Mean(SD)

13.8 (4.7)

N

10

Mean(SD)

24 (14.9)

Fixed, 95% CI

Fixed, 95% CI

-0.88[-1.81,0.04]

Favours TFCBT

-5

-2.5

0

2.5

5

Favours non-TFCBT

Analysis 2.16.   Comparison 2 Trauma-focused CBT/Exposure
therapy vs non-TFCBT, Outcome 16 PTSD diagnosis after treatment.

Study or subgroup

Echeburua 1997

Foa 1991

Foa 1999

Marks 1998

Taylor 2003

Vaughan 1994

Total (95% CI)

Trauma Fo-
cused CBT

n/N

1/10

10/14

28/55

27/66

9/22

6/13

180

non-TFCBT

Risk Ratio

Weight

Risk Ratio

n/N

M-H, Random, 95% CI

M-H, Random, 95% CI

9/10

10/17

15/26

10/21

13/19

5/11

104

3.01%

21.23%

25.66%

20.56%

18.54%

11.01%

0.11[0.02,0.72]

1.21[0.72,2.04]

0.88[0.58,1.34]

0.86[0.5,1.47]

0.6[0.33,1.08]

1.02[0.42,2.43]

100%

0.83[0.6,1.17]

Total events: 81 (Trauma Focused CBT), 62 (non-TFCBT)

Heterogeneity: Tau2=0.07; Chi2=8.59, df=5(P=0.13); I2=41.79%

Test for overall effect: Z=1.06(P=0.29)

Favours TFCBT

0.1

0.2

0.5

1

2

5

10

Favours non-TFCBT

Comparison 3.   Trauma-focused CBT/Exposure Therapy vs other therapies

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

1 Severity of PTSD symptoms - clini-
cian

10

2 Severity of PTSD symptoms - clini-
cian - 1 - 4 month follow-up

3 Severity of PTSD symptoms - clini-
cian - 5 - 8 month follow-up

4 Severity of PTSD symptoms - clini-
cian - 9 - 12 month follow-up

5 Leaving the study early for any rea-
son

6 Severity of PTSD symptoms - self re-
port

8

4

2

11

6

625

548

434

90

762

574

Std. Mean Difference (IV, Ran-
dom, 95% CI)

-0.48 [-0.83, -0.14]

Std. Mean Difference (IV, Ran-
dom, 95% CI)

-0.34 [-0.64, -0.04]

Std. Mean Difference (IV, Ran-
dom, 95% CI)

-0.58 [-1.20, 0.04]

Std. Mean Difference (IV, Ran-
dom, 95% CI)

-0.76 [-1.35, -0.17]

Risk Ratio (M-H, Fixed, 95%
CI)

1.39 [1.01, 1.92]

Std. Mean Difference (IV, Ran-
dom, 95% CI)

-0.60 [-1.15, -0.06]

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

128

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

7 Severity of PTSD symptoms - self re-
port - follow-up (1 - 4 months)

8 Severity of PTSD symptoms - self-re-
port - follow-up (5 - 8 months)

9 Severity of PTSD symptoms - self-re-
port - follow-up (9 - 12 months)

10 Depression - self report

11 Depression - self-report - follow-up
(1-4 months)

12 Depression - follow-up (5-8
months)

13 Depression 9-12 month follow up

14 Anxiety - self report

15 Anxiety - self-report - follow-up (1 -
4 months)

16 Anxiety - follow-up (5 - 8 months)

17 PTSD diagnosis after treatment

18 Severity of PTSD symptoms - clini-
cian - 13-24 month follow-up

19 Sensitivity analysis - PTSD symp-
toms - studies at low risk of bias only

20 Sensitivity analysis - drop-out -
studies at low risk of bias only

21 Subgroup analysis: severity of
PTSD symptoms - women-only stud-
ies

22 Subgroup analysis: severity of
PTSD symptoms - clinician - exclud-
ing Vietnam veterans

5

3

2

9

7

5

1

7

5

2

7

1

1

1

3

9

526

338

90

570

510

443

539

454

329

358

129

599

Std. Mean Difference (IV,
Fixed, 95% CI)

-0.29 [-0.47, -0.12]

Std. Mean Difference (IV, Ran-
dom, 95% CI)

-0.90 [-2.05, 0.25]

Mean Difference (IV, Fixed,
95% CI)

-2.66 [-5.71, 0.38]

Std. Mean Difference (IV, Ran-
dom, 95% CI)

-0.37 [-0.63, -0.11]

Std. Mean Difference (IV, Ran-
dom, 95% CI)

-0.29 [-0.62, 0.03]

Std. Mean Difference (IV, Ran-
dom, 95% CI)

-0.43 [-0.87, 0.01]

Mean Difference (IV, Fixed,
95% CI)

Totals not select-
ed

Std. Mean Difference (IV, Ran-
dom, 95% CI)

-0.45 [-0.77, -0.12]

Std. Mean Difference (IV, Ran-
dom, 95% CI)

-0.33 [-0.68, 0.02]

Std. Mean Difference (IV, Ran-
dom, 95% CI)

-0.56 [-1.69, 0.58]

Risk Ratio (M-H, Random,
95% CI)

0.75 [0.59, 0.96]

Mean Difference (IV, Fixed,
95% CI)

Totals not select-
ed

Std. Mean Difference (IV,
Fixed, 95% CI)

Totals not select-
ed

Risk Ratio (M-H, Fixed, 95%
CI)

Totals not select-
ed

Std. Mean Difference (IV, Ran-
dom, 95% CI)

0.03 [-0.42, 0.47]

Std. Mean Difference (IV, Ran-
dom, 95% CI)

-0.46 [-0.80, -0.11]

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

129

 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 3.1.   Comparison 3 Trauma-focused CBT/Exposure Therapy
vs other therapies, Outcome 1 Severity of PTSD symptoms - clinician.

Study or subgroup

Trauma Fo-
cused CBT

Other Therapy

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Blanchard 2003

Bryant 2003

Bryant 2011

Cloitre 2010

Feske 2008

Foa 1991

McDonagh 2005

Neuner 2004

Ready 2010

Schnurr 2007

27

40

16

33

9

10

17

16

5

23.7 (26.2)

36.4 (13.2)

4.1 (8)

39.7 (18.3)

19.2 (11.6)

15.4 (11.1)

38.5 (27.7)

19.1 (11.7)

59.2 (32.2)

27

18

12

38

12

11

20

26

4

40.1 (25.7)

58 (15.9)

12.3 (8.4)

32.3 (23)

30.4 (7.4)

18.1 (7.1)

44.9 (22.1)

20.5 (10.2)

75.5 (22.2)

141

52.9 (30.9)

143

60.1 (28.7)

Total ***

314

311

Heterogeneity: Tau2=0.19; Chi2=29.33, df=9(P=0); I2=69.31%

Test for overall effect: Z=2.74(P=0.01)

11.61%

10.66%

8.74%

12.57%

7.35%

8.11%

10.37%

10.68%

4.66%

15.26%

-0.62[-1.17,-0.08]

-1.52[-2.14,-0.89]

-0.97[-1.77,-0.18]

0.35[-0.12,0.82]

-1.14[-2.09,-0.2]

-0.28[-1.14,0.58]

-0.25[-0.9,0.4]

-0.13[-0.75,0.5]

-0.51[-1.86,0.84]

-0.24[-0.47,-0.01]

100%

-0.48[-0.83,-0.14]

Favours TFCBT/exposure

-4

-2

0

2

4

Favours 'other therapies'

Analysis 3.2.   Comparison 3 Trauma-focused CBT/Exposure Therapy vs other
therapies, Outcome 2 Severity of PTSD symptoms - clinician - 1 - 4 month follow-up.

Study or subgroup

Trauma Fo-
cused CBT

Other Therapy

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Blanchard 2003

Bryant 2011

Cloitre 2010

Feske 2008

Foa 1991

McDonagh 2005

Neuner 2004

Schnurr 2007

26

16

33

9

9

17

15

22.1 (24.8)

7.5 (11.1)

39.7 (17.6)

18.8 (10.7)

10.4 (8.2)

32.8 (20.4)

24.5 (7.8)

26

12

38

12

9

17

25

40.4 (29.8)

15.2 (13.1)

31.9 (23)

30.5 (9.1)

16.1 (9.4)

44.4 (17.7)

25.3 (8.4)

141

49.7 (30)

143

56 (33.2)

Total ***

266

282

Heterogeneity: Tau2=0.09; Chi2=15.13, df=7(P=0.03); I2=53.74%

Test for overall effect: Z=2.22(P=0.03)

13.81%

9.71%

16.03%

7.33%

7.28%

11.09%

12.04%

22.7%

-0.66[-1.22,-0.1]

-0.62[-1.39,0.15]

0.37[-0.1,0.85]

-1.15[-2.1,-0.2]

-0.61[-1.56,0.34]

-0.59[-1.28,0.1]

-0.09[-0.73,0.55]

-0.2[-0.43,0.03]

100%

-0.34[-0.64,-0.04]

Favours TFCBT/exposure

-4

-2

0

2

4

Favours 'other therapies'

Analysis 3.3.   Comparison 3 Trauma-focused CBT/Exposure Therapy vs other
therapies, Outcome 3 Severity of PTSD symptoms - clinician - 5 - 8 month follow-up.

Study or subgroup

Treatment

Control

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Bryant 2003

Cloitre 2010

McDonagh 2005

30

33

17

27.4 (10.7)

28.6 (21)

31.9 (27.8)

15

38

17

54.5 (20)

32.5 (22.7)

43.3 (23.4)

21.49%

26.32%

22.51%

-1.85[-2.59,-1.11]

-0.18[-0.65,0.29]

-0.43[-1.11,0.25]

Favours TFCBT/exposure

-2

-1

0

1

2

Favours 'other therapies'

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

130

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Study or subgroup

Treatment

Control

Std. Mean Difference

Weight

Std. Mean Difference

Schnurr 2007

Total ***

Mean(SD)

50.4 (32.4)

N

141

221

Mean(SD)

54.5 (31.4)

N

143

213

Heterogeneity: Tau2=0.32; Chi2=19.43, df=3(P=0); I2=84.56%

Test for overall effect: Z=1.84(P=0.07)

Random, 95% CI

Random, 95% CI

29.68%

-0.13[-0.36,0.1]

100%

-0.58[-1.2,0.04]

Favours TFCBT/exposure

-2

-1

0

1

2

Favours 'other therapies'

Analysis 3.4.   Comparison 3 Trauma-focused CBT/Exposure Therapy vs other
therapies, Outcome 4 Severity of PTSD symptoms - clinician - 9 - 12 month follow-up.

Study or subgroup

Experimental

Control

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Blanchard 2003

Neuner 2004

Total ***

21.3 (28.4)

16 (5.1)

28

14

42

35.5 (27.5)

23.5 (7.4)

24

24

48

Heterogeneity: Tau2=0.08; Chi2=1.75, df=1(P=0.19); I2=42.98%

Test for overall effect: Z=2.53(P=0.01)

56.91%

43.09%

-0.5[-1.05,0.05]

-1.11[-1.82,-0.4]

100%

-0.76[-1.35,-0.17]

Favours TFCBT/exposure

-10

-5

0

5

10

Favours 'other therapies'

Analysis 3.5.   Comparison 3 Trauma-focused CBT/Exposure Therapy
vs other therapies, Outcome 5 Leaving the study early for any reason.

Study or subgroup

Trauma Fo-
cused CBT

n/N

Other
Therapies

n/N

Risk Ratio

Weight

Risk Ratio

M-H, Fixed, 95% CI

M-H, Fixed, 95% CI

Blanchard 2003

Brom 1989

Bryant 2003

Bryant 2011

Cloitre 2010

Feske 2008

Foa 1991

McDonagh 2005

Neuner 2004

Ready 2010

Schnurr 2007

10/37

4/31

10/40

0/16

13/33

2/13

4/14

12/29

0/16

1/6

9/36

8/58

3/18

0/12

10/38

1/14

2/14

2/22

2/26

1/5

21/141

17/143

17.13%

10.46%

7.77%

17.45%

1.81%

3.75%

4.27%

3.63%

2.05%

31.69%

1.08[0.5,2.35]

0.94[0.31,2.86]

1.5[0.47,4.8]

Not estimable

1.5[0.76,2.95]

2.15[0.22,21.03]

2[0.43,9.21]

4.55[1.13,18.29]

0.32[0.02,6.22]

0.83[0.07,10.2]

1.25[0.69,2.27]

Total (95% CI)

376

386

100%

1.39[1.01,1.92]

Total events: 77 (Trauma Focused CBT), 55 (Other Therapies)

Heterogeneity: Tau2=0; Chi2=5.33, df=9(P=0.8); I2=0%

Test for overall effect: Z=2.04(P=0.04)

Favours TFCBT/exposure

0.01

0.1

1

10

100

Favours 'other therapies'

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

131

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 3.6.   Comparison 3 Trauma-focused CBT/Exposure Therapy vs
other therapies, Outcome 6 Severity of PTSD symptoms - self report.

Study or subgroup

Trauma Fo-
cused CBT

Other Therapy

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Blanchard 2003

Brom 1989

Bryant 2003

Cloitre 2010

Neuner 2004

Schnurr 2007

27

27

30

33

17

12.1 (14.9)

28 (19.5)

23.8 (7.7)

19 (9.8)

13.1 (5.1)

27

50

15

38

26

27.4 (19.1)

33.2 (20)

52.7 (16.3)

14.5 (12.8)

14.8 (4.1)

141

41.6 (19.5)

143

48.9 (18.7)

Total ***

275

299

Heterogeneity: Tau2=0.39; Chi2=39.39, df=5(P<0.0001); I2=87.31%

Test for overall effect: Z=2.16(P=0.03)

16.47%

17.37%

13.67%

17.36%

15.89%

19.24%

-0.88[-1.44,-0.32]

-0.26[-0.73,0.21]

-2.53[-3.36,-1.7]

0.39[-0.08,0.86]

-0.37[-0.99,0.25]

-0.38[-0.62,-0.15]

100%

-0.6[-1.15,-0.06]

Favours TFCBT/exposure

-4

-2

0

2

4

Favours 'other therapies'

Analysis 3.7.   Comparison 3 Trauma-focused CBT/Exposure Therapy vs other therapies,
Outcome 7 Severity of PTSD symptoms - self report - follow-up (1 - 4 months).

Study or subgroup

Trauma Fo-
cused CBT

Other Therapy

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Fixed, 95% CI

Fixed, 95% CI

Blanchard 2003

Brom 1989

Cloitre 2010

Neuner 2004

Schnurr 2007

27

27

33

15

12.2 (13.6)

31.3 (21.1)

12.5 (11.4)

11.9 (4.9)

27

50

38

25

24 (20)

29.4 (19.7)

17.3 (10.1)

14 (3.3)

141

43.5 (19.5)

143

48.8 (21.4)

Total ***

243

283

Heterogeneity: Tau2=0; Chi2=5.44, df=4(P=0.24); I2=26.53%

Test for overall effect: Z=3.32(P=0)

10.01%

13.8%

13.57%

7.15%

55.47%

-0.68[-1.23,-0.13]

0.1[-0.37,0.56]

-0.44[-0.91,0.03]

-0.51[-1.16,0.14]

-0.26[-0.49,-0.02]

100%

-0.29[-0.47,-0.12]

Favours TFCBT/exposure

-4

-2

0

2

4

Favours 'other therapies'

Analysis 3.8.   Comparison 3 Trauma-focused CBT/Exposure Therapy vs other therapies,
Outcome 8 Severity of PTSD symptoms - self-report - follow-up (5 - 8 months).

Study or subgroup

Treatment

Control

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Bryant 2003

Ready 2010

Schnurr 2007

30

4

25.5 (9.3)

64.8 (34.1)

15

5

46.4 (16)

87 (6.3)

141

44.6 (20.7)

143

48.5 (19.9)

Total ***

175

163

Heterogeneity: Tau2=0.85; Chi2=16.14, df=2(P=0); I2=87.61%

Test for overall effect: Z=1.53(P=0.13)

34.98%

25.08%

39.94%

-1.72[-2.45,-1]

-0.87[-2.29,0.55]

-0.19[-0.42,0.04]

100%

-0.9[-2.05,0.25]

Favours TFCBT/exposure

-4

-2

0

2

4

Favours 'other therapies'

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

132

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 3.9.   Comparison 3 Trauma-focused CBT/Exposure Therapy vs other therapies,
Outcome 9 Severity of PTSD symptoms - self-report - follow-up (9 - 12 months).

Study or subgroup

Experimental

Control

Blanchard 2003

Neuner 2004

Total ***

N

Mean(SD)

N

Mean(SD)

14.2 (17.5)

11 (5.1)

28

14

42

19.2 (17.5)

13.4 (4.5)

24

24

48

Heterogeneity: Tau2=0; Chi2=0.26, df=1(P=0.61); I2=0%

Test for overall effect: Z=1.72(P=0.09)

Mean Difference

Fixed, 95% CI

Weight

Mean Difference

10.17%

89.83%

Fixed, 95% CI

-5[-14.54,4.54]

-2.4[-5.61,0.81]

100%

-2.66[-5.71,0.38]

Favours TFCBT/exposure

-20

-10

0

10

20

Favours 'other therapies'

Analysis 3.10.   Comparison 3 Trauma-focused CBT/Exposure
Therapy vs other therapies, Outcome 10 Depression - self report.

Study or subgroup

Trauma Fo-
cused CBT

Other Therapy

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Blanchard 2003

Bryant 2003

Bryant 2011

Cloitre 2010

Feske 2008

Foa 1991

McDonagh 2005

Ready 2010

Schnurr 2007

27

30

16

33

9

10

17

5

11.6 (12.3)

10.7 (9.8)

3.2 (87)

12.9 (9.4)

17.7 (7.5)

13.4 (14.2)

7.5 (7.9)

14.2 (8.2)

27

15

12

38

12

11

20

4

19.7 (12.1)

19.9 (8.4)

11.3 (11.3)

11.9 (8.5)

25.1 (8.9)

15.4 (14)

10.4 (10.2)

27 (5)

141

17.4 (12.6)

143

19.9 (11.8)

Total ***

288

282

Heterogeneity: Tau2=0.06; Chi2=13.34, df=8(P=0.1); I2=40.03%

Test for overall effect: Z=2.76(P=0.01)

13.16%

10.58%

8.75%

15.69%

6.5%

7.15%

10.64%

2.31%

25.22%

-0.65[-1.2,-0.11]

-0.96[-1.61,-0.3]

-0.12[-0.87,0.63]

0.11[-0.36,0.58]

-0.86[-1.77,0.06]

-0.13[-0.99,0.72]

-0.31[-0.96,0.34]

-1.62[-3.27,0.03]

-0.2[-0.44,0.03]

100%

-0.37[-0.63,-0.11]

Favours TFCBT/exposure

-4

-2

0

2

4

Favours 'other therapies'

Analysis 3.11.   Comparison 3 Trauma-focused CBT/Exposure Therapy vs other
therapies, Outcome 11 Depression - self-report - follow-up (1-4 months).

Study or subgroup

Trauma Fo-
cused CBT

Other Therapy

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Blanchard 2003

Bryant 2011

Cloitre 2010

Feske 2008

Foa 1991

McDonagh 2005

Schnurr 2007

Total ***

27

16

33

9

9

17

141

252

12.6 (13.5)

6.4 (12.2)

14.2 (10.1)

15.6 (8.4)

6.4 (7.6)

7.3 (8.2)

27

12

38

12

9

17

17.8 (13)

11 (11.6)

9.8 (10)

25.5 (10.4)

15.9 (10.2)

10.8 (8.6)

18.5 (13.2)

143

21.1 (12.1)

16.15%

11.24%

18.05%

8.58%

7.72%

12.74%

25.53%

-0.39[-0.93,0.15]

-0.37[-1.13,0.38]

0.43[-0.04,0.91]

-0.99[-1.92,-0.07]

-1.01[-2,-0.01]

-0.41[-1.09,0.27]

-0.2[-0.44,0.03]

258

100%

-0.29[-0.62,0.03]

Heterogeneity: Tau2=0.09; Chi2=13.28, df=6(P=0.04); I2=54.81%

Favours TFCBT/exposure

-2

-1

0

1

2

Favours 'other therapies'

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

133

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Study or subgroup

Trauma Fo-
cused CBT

Other Therapy

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Test for overall effect: Z=1.78(P=0.07)

Favours TFCBT/exposure

-2

-1

0

1

2

Favours 'other therapies'

Analysis 3.12.   Comparison 3 Trauma-focused CBT/Exposure Therapy
vs other therapies, Outcome 12 Depression - follow-up (5-8 months).

Study or subgroup

Treatment

Control

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Bryant 2003

Cloitre 2010

McDonagh 2005

Ready 2010

Schnurr 2007

30

33

17

4

10.5 (9.2)

13.6 (9.1)

7.1 (8.6)

15.7 (2.5)

15

38

17

5

20.3 (8.2)

13.4 (8.8)

12.3 (10.3)

25.2 (6.5)

141

19.2 (12.6)

143

20.4 (13.6)

Total ***

225

218

Heterogeneity: Tau2=0.15; Chi2=12.31, df=4(P=0.02); I2=67.5%

Test for overall effect: Z=1.9(P=0.06)

19.35%

24.76%

18.77%

5.91%

31.2%

-1.08[-1.74,-0.42]

0.02[-0.44,0.49]

-0.54[-1.22,0.15]

-1.63[-3.29,0.02]

-0.09[-0.32,0.14]

100%

-0.43[-0.87,0.01]

Favours TFCBT/exposure

-5

-2.5

0

2.5

5

Favours 'other therapies'

Analysis 3.13.   Comparison 3 Trauma-focused CBT/Exposure Therapy
vs other therapies, Outcome 13 Depression 9-12 month follow up.

Study or subgroup

Experimental

Control

Blanchard 2003

N

28

Mean(SD)

13.8 (14.2)

N

24

Mean(SD)

18.8 (11.9)

Mean Difference

Fixed, 95% CI

Mean Difference

Fixed, 95% CI

-5[-12.09,2.09]

Favours TFCBT/exposure

-50

-25

0

25

50

Favours 'other therapies'

Analysis 3.14.   Comparison 3 Trauma-focused CBT/Exposure
Therapy vs other therapies, Outcome 14 Anxiety - self report.

Study or subgroup

Trauma Fo-
cused CBT

Other Therapy

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Blanchard 2003

Brom 1989

Bryant 2003

Feske 2008

Foa 1991

McDonagh 2005

Schnurr 2007

27

27

30

9

10

17

38.9 (14)

45.1 (13.2)

36.7 (11.2)

18.3 (10.9)

41.5 (13.8)

39.4 (11.9)

27

50

15

12

11

20

50.7 (12.6)

42.6 (14.5)

49.1 (11.7)

26.8 (10.2)

43.7 (16.8)

45.6 (11)

141

45.7 (18.3)

143

50.3 (17.8)

Total ***

261

278

Heterogeneity: Tau2=0.1; Chi2=14.75, df=6(P=0.02); I2=59.31%

Test for overall effect: Z=2.67(P=0.01)

15.05%

17.32%

12.83%

8.86%

9.47%

12.88%

23.6%

-0.87[-1.43,-0.31]

0.18[-0.29,0.65]

-1.07[-1.73,-0.4]

-0.77[-1.67,0.13]

-0.14[-1,0.72]

-0.53[-1.19,0.13]

-0.25[-0.49,-0.02]

100%

-0.45[-0.77,-0.12]

Favours TFCBT/exposure

-4

-2

0

2

4

Favours 'other therapies'

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

134

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 3.15.   Comparison 3 Trauma-focused CBT/Exposure Therapy vs
other therapies, Outcome 15 Anxiety - self-report - follow-up (1 - 4 months).

Study or subgroup

Trauma Fo-
cused CBT

Other Therapy

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Blanchard 2003

Brom 1989

Feske 2008

Foa 1991

Schnurr 2007

27

27

9

9

42.6 (15.4)

41.4 (14.8)

18.9 (9.4)

32.4 (7)

27

50

12

9

49.1 (14.5)

40.9 (13.9)

28.3 (8.9)

50 (19.4)

141

48.8 (17.7)

143

50.5 (16.9)

Total ***

213

241

Heterogeneity: Tau2=0.08; Chi2=8.54, df=4(P=0.07); I2=53.14%

Test for overall effect: Z=1.83(P=0.07)

20.95%

23.91%

10.67%

9.23%

35.25%

-0.43[-0.97,0.11]

0.04[-0.43,0.51]

-0.98[-1.91,-0.06]

-1.15[-2.17,-0.14]

-0.1[-0.33,0.13]

100%

-0.33[-0.68,0.02]

Favours TFCBT/exposure

-4

-2

0

2

4

Favours 'other therapies'

Analysis 3.16.   Comparison 3 Trauma-focused CBT/Exposure Therapy
vs other therapies, Outcome 16 Anxiety - follow-up (5 - 8 months).

Study or subgroup

Treatment

Control

Std. Mean Difference

Weight

Std. Mean Difference

Bryant 2003

Schnurr 2007

Total ***

Mean(SD)

37.9 (11.8)

50.4 (18.9)

N

30

141

171

N

15

143

158

Mean(SD)

51.1 (9.1)

50.8 (16.9)

Heterogeneity: Tau2=0.61; Chi2=10.28, df=1(P=0); I2=90.27%

Test for overall effect: Z=0.96(P=0.33)

Random, 95% CI

46.18%

53.82%

Random, 95% CI

-1.18[-1.85,-0.51]

-0.02[-0.25,0.21]

100%

-0.56[-1.69,0.58]

Favours TFCBT/exposure

-4

-2

0

2

4

Favours 'other therapies'

Analysis 3.17.   Comparison 3 Trauma-focused CBT/Exposure Therapy
vs other therapies, Outcome 17 PTSD diagnosis after treatment.

Study or subgroup

Blanchard 2003

Brom 1989

Bryant 2003

Feske 2008

Foa 1991

McDonagh 2005

Neuner 2004

Total (95% CI)

Trauma Fo-
cused CBT

n/N

16/37

12/31

17/40

3/9

10/14

21/29

4/14

174

Other Therapy

Risk Ratio

Weight

Risk Ratio

n/N

M-H, Random, 95% CI

M-H, Random, 95% CI

21/36

23/58

12/18

10/12

13/14

15/22

19/24

184

16.45%

13.31%

15.41%

5.54%

21.31%

21.23%

6.74%

0.74[0.47,1.18]

0.98[0.57,1.68]

0.64[0.39,1.04]

0.4[0.15,1.04]

0.77[0.54,1.1]

1.06[0.74,1.53]

0.36[0.15,0.85]

100%

0.75[0.59,0.96]

Total events: 83 (Trauma Focused CBT), 113 (Other Therapy)

Heterogeneity: Tau2=0.04; Chi2=9.54, df=6(P=0.15); I2=37.12%

Test for overall effect: Z=2.3(P=0.02)

Favours TFCBT/exposure

0.1

0.2

0.5

1

2

5

10

Favours 'other therapies'

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

135

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 3.18.   Comparison 3 Trauma-focused CBT/Exposure Therapy vs other
therapies, Outcome 18 Severity of PTSD symptoms - clinician - 13-24 month follow-up.

Study or subgroup

Experimental

Control

Blanchard 2003

N

22

Mean(SD)

20.1 (25)

N

17

Mean(SD)

29.7 (24.5)

Mean Difference

Fixed, 95% CI

Mean Difference

Fixed, 95% CI

-9.6[-25.25,6.05]

Favours TFCBT/exposure

-100

-50

0

50

100

Favours 'other therapies'

Analysis 3.19.   Comparison 3 Trauma-focused CBT/Exposure Therapy vs other therapies,
Outcome 19 Sensitivity analysis - PTSD symptoms - studies at low risk of bias only.

Study or subgroup

TFCBT

Other Therapy

Std. Mean Difference

Std. Mean Difference

Bryant 2003

N

40

Mean(SD)

36.4 (13.2)

N

18

Mean(SD)

58 (15.9)

Fixed, 95% CI

Fixed, 95% CI

-1.52[-2.14,-0.89]

Favours TFCBT/exposure

-10

-5

0

5

10

Favours 'other therapies'

Analysis 3.20.   Comparison 3 Trauma-focused CBT/Exposure Therapy vs other
therapies, Outcome 20 Sensitivity analysis - drop-out - studies at low risk of bias only.

Study or subgroup

Experimental

n/N

Control

n/N

Risk Ratio

Risk Ratio

M-H, Fixed, 95% CI

M-H, Fixed, 95% CI

Bryant 2003

10/40

3/18

1.5[0.47,4.8]

Favours TFCBT/exposure

0.01

0.1

1

10

100

Favours 'other therapies'

Analysis 3.21.   Comparison 3 Trauma-focused CBT/Exposure Therapy vs other therapies,
Outcome 21 Subgroup analysis: severity of PTSD symptoms - women-only studies.

Study or subgroup

Trauma Fo-
cused CBT

Other Therapy

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Cloitre 2010

Foa 1991

McDonagh 2005

Total ***

39.7 (18.3)

15.4 (11.1)

38.5 (27.7)

33

10

17

60

38

11

20

69

32.3 (23)

18.1 (7.1)

44.9 (22.1)

Heterogeneity: Tau2=0.05; Chi2=2.93, df=2(P=0.23); I2=31.75%

Test for overall effect: Z=0.12(P=0.91)

47.29%

20.89%

31.81%

0.35[-0.12,0.82]

-0.28[-1.14,0.58]

-0.25[-0.9,0.4]

100%

0.03[-0.42,0.47]

Favours TFCBT/exposure

-4

-2

0

2

4

Favours 'other therapies'

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

136

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 3.22.   Comparison 3 Trauma-focused CBT/Exposure Therapy vs other therapies, Outcome
22 Subgroup analysis: severity of PTSD symptoms - clinician - excluding Vietnam veterans.

Study or subgroup

Trauma Fo-
cused CBT

Other Therapy

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Blanchard 2003

Bryant 2003

Bryant 2011

Cloitre 2010

Feske 2008

Foa 1991

McDonagh 2005

Neuner 2004

Schnurr 2007

27

30

12

33

9

10

17

16

23.7 (26.2)

25.9 (10)

4.1 (8)

39.7 (18.3)

19.2 (11.6)

15.4 (11.1)

38.5 (27.7)

19.1 (11.7)

27

15

12

38

12

11

20

26

40.1 (25.7)

50.9 (26.1)

12.3 (8.4)

32.3 (23)

30.4 (7.4)

18.1 (7.1)

44.9 (22.1)

20.5 (10.2)

141

52.9 (30.9)

143

60.1 (28.7)

12.41%

10.39%

8.51%

13.54%

7.6%

8.44%

10.98%

11.33%

16.79%

-0.62[-1.17,-0.08]

-1.45[-2.14,-0.75]

-0.97[-1.82,-0.11]

0.35[-0.12,0.82]

-1.14[-2.09,-0.2]

-0.28[-1.14,0.58]

-0.25[-0.9,0.4]

-0.13[-0.75,0.5]

-0.24[-0.47,-0.01]

Total ***

295

304

100%

-0.46[-0.8,-0.11]

Heterogeneity: Tau2=0.17; Chi2=25, df=8(P=0); I2=68%

Test for overall effect: Z=2.61(P=0.01)

Favours TFCBT/exposure

-4

-2

0

2

4

Favours 'other therapies'

Comparison 4.   EMDR vs waitlist/usual care

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

1 Severity of PTSD symptoms
- Clinician

2 Leaving study early due to
any reason

3 Severity of PTSD symptoms
- self report

4 Depression

5 Anxiety

6 PTSD diagnosis after treat-
ment

6

7

6

7

6

6

183

227

159

226

160

209

Std. Mean Difference (IV, Random,
95% CI)

-1.17 [-2.04, -0.30]

Risk Ratio (M-H, Fixed, 95% CI)

1.05 [0.62, 1.79]

Std. Mean Difference (IV, Random,
95% CI)

-0.80 [-1.68, 0.07]

Std. Mean Difference (IV, Random,
95% CI)

-1.15 [-1.52, -0.78]

Std. Mean Difference (IV, Fixed, 95%
CI)

-1.02 [-1.36, -0.69]

Risk Ratio (M-H, Fixed, 95% CI)

0.51 [0.42, 0.62]

Analysis 4.1.   Comparison 4 EMDR vs waitlist/usual care, Outcome 1 Severity of PTSD symptoms - Clinician.

Study or subgroup

EMDR

Waitlist/Usual Care

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Hogberg 2007

Jensen 1994

Power 2002

12

13

27

78.9 (12.5)

35.7 (12)

16.8 (17.2)

9

12

24

66.8 (6)

46.9 (10.2)

45.5 (16.1)

16.4%

17.1%

18.26%

1.13[0.19,2.07]

-0.97[-1.81,-0.13]

-1.69[-2.34,-1.05]

Favours EMDR

-5

-2.5

0

2.5

5

Favours WL/UC

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

137

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Study or subgroup

EMDR

Waitlist/Usual Care

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Rothbaum 1997

Rothbaum 2005

Vaughan 1994

Total ***

14.3 (8.4)

31.7 (21.3)

16.8 (6.2)

9

20

12

93

8

20

17

90

35 (5.9)

64.6 (19.9)

28.5 (8.9)

Heterogeneity: Tau2=0.97; Chi2=31.52, df=5(P<0.0001); I2=84.14%

Test for overall effect: Z=2.64(P=0.01)

13.32%

17.85%

17.09%

-2.68[-4.08,-1.28]

-1.57[-2.29,-0.85]

-1.44[-2.28,-0.6]

100%

-1.17[-2.04,-0.3]

Favours EMDR

-5

-2.5

0

2.5

5

Favours WL/UC

Analysis 4.2.   Comparison 4 EMDR vs waitlist/usual care, Outcome 2 Leaving study early due to any reason.

Study or subgroup

Carlson 1998

Devilly 1998

Hogberg 2007

Jensen 1994

Power 2002

Rothbaum 1997

Vaughan 1994

Total (95% CI)

EMDR

n/N

Waitlist/Usu-
al Care

n/N

Risk Ratio

Weight

Risk Ratio

M-H, Fixed, 95% CI

M-H, Fixed, 95% CI

1/10

6/19

1/13

2/15

12/39

1/11

1/13

120

1/12

6/16

2/11

2/14

5/29

2/8

1/17

107

4.42%

31.66%

10.53%

10.05%

27.87%

11.25%

4.21%

1.2[0.09,16.84]

0.84[0.34,2.1]

0.42[0.04,4.06]

0.93[0.15,5.76]

1.78[0.71,4.51]

0.36[0.04,3.35]

1.31[0.09,19]

100%

1.05[0.62,1.79]

Total events: 24 (EMDR), 19 (Waitlist/Usual Care)

Heterogeneity: Tau2=0; Chi2=3.03, df=6(P=0.8); I2=0%

Test for overall effect: Z=0.18(P=0.85)

Favours EMDR

0.01

0.1

1

10

100

Favours WL/UC

Analysis 4.3.   Comparison 4 EMDR vs waitlist/usual care, Outcome 3 Severity of PTSD symptoms - self report.

Study or subgroup

EMDR

Wait list/usual care

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Carlson 1998

Devilly 1998

Hogberg 2007

Jensen 1994

Power 2002

Rothbaum 1997

Total ***

35.2 (22)

110.4 (27.7)

23.2 (17.4)

129.3 (13.4)

11.8 (12)

12.4 (11.2)

10

12

12

13

27

10

84

38.7 (16.2)

111.2 (24.8)

34 (16.2)

124.5 (12.3)

29.6 (8.6)

45.4 (6.4)

12

10

9

12

24

8

75

Heterogeneity: Tau2=0.97; Chi2=30.66, df=5(P<0.0001); I2=83.69%

Test for overall effect: Z=1.79(P=0.07)

17.25%

17.26%

16.94%

17.57%

18.46%

12.52%

-0.18[-1.02,0.66]

-0.03[-0.87,0.81]

-0.61[-1.5,0.28]

0.36[-0.43,1.15]

-1.66[-2.31,-1.02]

-3.34[-4.89,-1.8]

100%

-0.8[-1.68,0.07]

Favours EMDR

-5

-2.5

0

2.5

5

Favours WL/UC

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

138

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 4.4.   Comparison 4 EMDR vs waitlist/usual care, Outcome 4 Depression.

Study or subgroup

EMDR

Wait list/usual care

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Carlson 1998

Devilly 1998

Hogberg 2007

Power 2002

Rothbaum 1997

Rothbaum 2005

Vaughan 1994

10

13

12

27

20

20

12

6.9 (5.9)

21.2 (15.5)

26.8 (5)

4 (5)

10.7 (11.5)

10.7 (11.5)

6.3 (3.8)

12

10

9

24

20

20

17

23.5 (12.8)

24.5 (11.7)

31.3 (4.5)

12.8 (5.6)

22.2 (10.6)

22.2 (10.6)

13.8 (4.7)

Total ***

114

112

Heterogeneity: Tau2=0.09; Chi2=9.61, df=6(P=0.14); I2=37.58%

Test for overall effect: Z=6.07(P<0.0001)

10.46%

13.22%

11.53%

17.91%

17.28%

17.28%

12.32%

-1.55[-2.53,-0.57]

-0.23[-1.05,0.6]

-0.9[-1.82,0.01]

-1.64[-2.28,-1]

-1.02[-1.69,-0.36]

-1.02[-1.69,-0.36]

-1.67[-2.55,-0.8]

100%

-1.15[-1.52,-0.78]

Favours EMDR

-5

-2.5

0

2.5

5

Favours WL/UC

Analysis 4.5.   Comparison 4 EMDR vs waitlist/usual care, Outcome 5 Anxiety.

Study or subgroup

EMDR

Waitlist/Usual Care

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Fixed, 95% CI

Fixed, 95% CI

Carlson 1998

Devilly 1998

Hogberg 2007

Jensen 1994

Power 2002

Rothbaum 1997

Total ***

34.9 (9)

49.1 (17.8)

9.8 (7.2)

6.2 (2.8)

7.5 (5.1)

31.8 (14.7)

10

13

12

13

27

10

85

51.4 (17.8)

55.6 (10.3)

16.1 (5.1)

8.5 (1.4)

14.2 (4.6)

48.5 (15.5)

12

10

9

12

24

8

75

Heterogeneity: Tau2=0; Chi2=3.2, df=5(P=0.67); I2=0%

Test for overall effect: Z=5.97(P<0.0001)

13.56%

16.17%

13.3%

15.98%

29.89%

11.09%

-1.09[-2.01,-0.18]

-0.42[-1.25,0.42]

-0.94[-1.87,-0.02]

-0.99[-1.83,-0.15]

-1.35[-1.97,-0.74]

-1.06[-2.06,-0.05]

100%

-1.02[-1.36,-0.69]

Favours EMDR

-4

-2

0

2

4

Favours WL/UC

Analysis 4.6.   Comparison 4 EMDR vs waitlist/usual care, Outcome 6 PTSD diagnosis after treatment.

Study or subgroup

Carlson 1998

Jensen 1994

Power 2002

Rothbaum 1997

Rothbaum 2005

Vaughan 1994

Total (95% CI)

EMDR

n/N

Waitlist/Usu-
al Care

n/N

Risk Ratio

Weight

Risk Ratio

M-H, Fixed, 95% CI

M-H, Fixed, 95% CI

3/10

14/15

22/39

2/11

5/20

6/12

107

12/12

13/14

28/29

9/10

18/20

17/17

102

11.56%

13.57%

32.4%

9.51%

18.16%

14.81%

0.33[0.14,0.79]

1.01[0.82,1.23]

0.58[0.44,0.78]

0.2[0.06,0.72]

0.28[0.13,0.6]

0.51[0.3,0.89]

100%

0.51[0.42,0.62]

Total events: 52 (EMDR), 97 (Waitlist/Usual Care)

Heterogeneity: Tau2=0; Chi2=51.19, df=5(P<0.0001); I2=90.23%

Test for overall effect: Z=6.53(P<0.0001)

Favours EMDR

0.01

0.1

1

10

100

Favours WL/UC

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

139

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Comparison 5.   EMDR vs Trauma-focused CBT

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

1 Severity of PTSD symptoms -
clinician

2 Severity of PTSD symptoms
- clinician - follow-up (1 - 4
months)

3 Leaving study early for any rea-
son

4 Severity of PTSD symptoms -
self report

5 Severity of PTSD symptoms
- self-report - follow-up (1 - 4
months)

6 Depression

7 Depression - follow-up (1 - 4
months)

8 Anxiety

9 Anxiety - follow-up (1 - 4
months)

10 PTSD diagnosis after treat-
ment

7

3

8

7

5

8

5

4

2

8

327

76

408

306

111

346

111

236

48

350

Std. Mean Difference (IV, Random,
95% CI)

-0.03 [-0.43, 0.38]

Std. Mean Difference (IV, Random,
95% CI)

-0.19 [-0.97, 0.58]

Risk Ratio (M-H, Fixed, 95% CI)

1.00 [0.74, 1.35]

Std. Mean Difference (IV, Random,
95% CI)

-0.30 [-0.60, 0.01]

Std. Mean Difference (IV, Random,
95% CI)

-0.04 [-0.61, 0.52]

Std. Mean Difference (IV, Random,
95% CI)

-0.31 [-0.75, 0.13]

Std. Mean Difference (IV, Random,
95% CI)

-0.13 [-0.64, 0.38]

Std. Mean Difference (IV, Fixed,
95% CI)

-0.28 [-0.53, -0.02]

Std. Mean Difference (IV, Fixed,
95% CI)

0.24 [-0.33, 0.81]

Risk Ratio (M-H, Fixed, 95% CI)

0.95 [0.74, 1.22]

Analysis 5.1.   Comparison 5 EMDR vs Trauma-focused CBT, Outcome 1 Severity of PTSD symptoms - clinician.

Study or subgroup

EMDR

TFCBT

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Devilly 1999

Lee 2002

Nijdam 2012

Power 2002

Rothbaum 2005

Taylor 2003

Vaughan 1994

11

10

70

27

20

15

12

49.5 (20.4)

17 (12.9)

17.7 (11.1)

20.6 (24.6)

31.7 (25.3)

42.2 (22.2)

16.8 (6.2)

12

11

70

21

20

15

13

34.2 (20.6)

25.1 (13.3)

20.5 (12.8)

32 (24.5)

21.3 (22.5)

25.5 (22.6)

23 (10.2)

Total ***

165

162

Heterogeneity: Tau2=0.18; Chi2=16.49, df=6(P=0.01); I2=63.61%

Test for overall effect: Z=0.14(P=0.89)

11.61%

11.21%

20.59%

16.05%

15.16%

13.22%

12.14%

0.72[-0.13,1.57]

-0.59[-1.47,0.29]

-0.24[-0.57,0.1]

-0.46[-1.03,0.12]

0.43[-0.2,1.05]

0.73[-0.01,1.47]

-0.7[-1.52,0.11]

100%

-0.03[-0.43,0.38]

Favours EMDR

-5

-2.5

0

2.5

5

Favours Individual TFCBT

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

140

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 5.2.   Comparison 5 EMDR vs Trauma-focused CBT, Outcome
2 Severity of PTSD symptoms - clinician - follow-up (1 - 4 months).

Study or subgroup

EMDR

TFCBT

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Lee 2002

Taylor 2003

Vaughan 1994

Total ***

14.4 (12.2)

36.9 (26.9)

15.6 (7.4)

10

15

12

37

11

15

13

39

24.1 (12)

23.6 (22.6)

20.6 (14.1)

Heterogeneity: Tau2=0.3; Chi2=5.56, df=2(P=0.06); I2=64.02%

Test for overall effect: Z=0.49(P=0.62)

30.73%

35.63%

33.64%

-0.77[-1.66,0.12]

0.52[-0.21,1.25]

-0.42[-1.22,0.37]

100%

-0.19[-0.97,0.58]

Favours EMDR

-5

-2.5

0

2.5

5

Favours Individual TFCBT

Analysis 5.3.   Comparison 5 EMDR vs Trauma-focused CBT, Outcome 3 Leaving study early for any reason.

Study or subgroup

EMDR

n/N

TFCBT

n/N

Risk Ratio

M-H, Fixed, 95% CI

Weight

Risk Ratio

M-H, Fixed, 95% CI

Devilly 1999

Ironson 2002

Lee 2002

Nijdam 2012

Power 2002

Rothbaum 2005

Taylor 2003

Vaughan 1994

Total (95% CI)

6/17

1/10

2/12

28/70

12/39

5/25

4/19

1/12

204

3/15

6/12

1/12

22/70

16/37

3/23

7/22

1/13

204

Total events: 59 (EMDR), 59 (TFCBT)

Heterogeneity: Tau2=0; Chi2=7.2, df=7(P=0.41); I2=2.74%

Test for overall effect: Z=0.01(P=0.99)

5.44%

9.3%

1.71%

37.52%

28.01%

5.33%

11.06%

1.64%

1.76[0.53,5.86]

0.2[0.03,1.4]

2[0.21,19.23]

1.27[0.81,2]

0.71[0.39,1.29]

1.53[0.41,5.71]

0.66[0.23,1.92]

1.08[0.08,15.46]

100%

1[0.74,1.35]

Favours EMDR

0.01

0.1

1

10

100

Favours Individual TFCBT

Analysis 5.4.   Comparison 5 EMDR vs Trauma-focused CBT, Outcome 4 Severity of PTSD symptoms - self report.

Study or subgroup

EMDR

TFCBT

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Devilly 1999

Ironson 2002

Lee 2002

Nijdam 2012

Power 2002

Taylor 2003

Vaughan 1994

11

10

10

70

27

15

12

35.6 (21.7)

9.1 (11.2)

21.2 (19)

28.5 (29.6)

11.8 (12)

20.5 (9.4)

10.3 (5.6)

12

9

11

70

21

15

13

20.8 (22.3)

15.8 (9.2)

32.3 (20.2)

38 (34.4)

19.2 (12.3)

19.4 (13.4)

15.6 (8.4)

Total ***

155

151

Heterogeneity: Tau2=0.05; Chi2=8.82, df=6(P=0.18); I2=31.96%

10.25%

8.82%

9.67%

30.02%

17.28%

13.11%

10.85%

0.65[-0.19,1.5]

-0.62[-1.55,0.31]

-0.54[-1.42,0.33]

-0.29[-0.63,0.04]

-0.6[-1.18,-0.02]

0.1[-0.62,0.81]

-0.71[-1.53,0.1]

100%

-0.3[-0.6,0.01]

Favours EMDR

-2

-1

0

1

2

Favours Individual TFCBT

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

141

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Study or subgroup

EMDR

TFCBT

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Test for overall effect: Z=1.9(P=0.06)

Favours EMDR

-2

-1

0

1

2

Favours Individual TFCBT

Analysis 5.5.   Comparison 5 EMDR vs Trauma-focused CBT, Outcome
5 Severity of PTSD symptoms - self-report - follow-up (1 - 4 months).

Study or subgroup

EMDR

TFCBT

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Devilly 1999

Ironson 2002

Lee 2002

Taylor 2003

Vaughan 1994

Total ***

41.7 (23.1)

11.5 (8.2)

17.2 (18.7)

16.9 (11.4)

12.7 (9.5)

11

6

10

15

12

54

12

6

11

15

13

57

21.1 (22.8)

15.7 (4.9)

34.7 (20)

15.2 (10.8)

12.9 (11.4)

Heterogeneity: Tau2=0.22; Chi2=8.46, df=4(P=0.08); I2=52.71%

Test for overall effect: Z=0.15(P=0.88)

20.25%

14.58%

19.36%

23.74%

22.07%

0.87[0,1.73]

-0.57[-1.73,0.6]

-0.86[-1.77,0.04]

0.14[-0.57,0.86]

-0.02[-0.8,0.77]

100%

-0.04[-0.61,0.52]

Favours EMDR

-5

-2.5

0

2.5

5

Favours Individual TFCBT

Analysis 5.6.   Comparison 5 EMDR vs Trauma-focused CBT, Outcome 6 Depression.

Study or subgroup

EMDR

TFCBT

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Devilly 1999

Ironson 2002

Lee 2002

Nijdam 2012

Power 2002

Rothbaum 2005

Taylor 2003

Vaughan 1994

11

10

10

70

27

20

15

12

18 (15.7)

5.5 (4.4)

7.3 (5.7)

5.7 (4.5)

4 (5)

10.7 (11.5)

16.4 (9.1)

10.8 (4.9)

12

9

11

70

21

20

15

13

13.3 (14.4)

10.7 (3.1)

14.2 (12)

7.4 (6.4)

8.6 (5.8)

4.7 (5)

13 (10.6)

20.6 (12.5)

Total ***

175

171

Heterogeneity: Tau2=0.27; Chi2=24.04, df=7(P=0); I2=70.88%

Test for overall effect: Z=1.37(P=0.17)

11.4%

9.5%

10.73%

17.02%

14.03%

13.53%

12.56%

11.24%

0.3[-0.52,1.13]

-1.29[-2.3,-0.28]

-0.69[-1.58,0.2]

-0.31[-0.64,0.03]

-0.84[-1.44,-0.25]

0.67[0.03,1.31]

0.33[-0.39,1.06]

-0.98[-1.82,-0.14]

100%

-0.31[-0.75,0.13]

Favours EMDR

-5

-2.5

0

2.5

5

Favours Individual TFCBT

Analysis 5.7.   Comparison 5 EMDR vs Trauma-focused CBT, Outcome 7 Depression - follow-up (1 - 4 months).

Study or subgroup

EMDR

TFCBT

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Devilly 1999

Ironson 2002

Lee 2002

11

6

10

22.8 (16.3)

8.3 (5.9)

7.4 (4.6)

12

6

11

13.6 (14.5)

11.7 (3.7)

16.3 (12.1)

20.78%

13.5%

18.89%

0.58[-0.26,1.42]

-0.63[-1.8,0.54]

-0.92[-1.83,-0.01]

Favours EMDR

-5

-2.5

0

2.5

5

Favours Individual TFCBT

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

142

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Study or subgroup

EMDR

TFCBT

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Taylor 2003

Vaughan 1994

Total ***

14.4 (11)

14.3 (9.4)

15

12

54

12.7 (8.9)

15.6 (8.1)

15

13

57

Heterogeneity: Tau2=0.14; Chi2=6.93, df=4(P=0.14); I2=42.31%

Test for overall effect: Z=0.5(P=0.62)

24.5%

22.32%

0.17[-0.55,0.88]

-0.14[-0.93,0.64]

100%

-0.13[-0.64,0.38]

Favours EMDR

-5

-2.5

0

2.5

5

Favours Individual TFCBT

Analysis 5.8.   Comparison 5 EMDR vs Trauma-focused CBT, Outcome 8 Anxiety.

Study or subgroup

EMDR

TFCBT

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Fixed, 95% CI

Fixed, 95% CI

Devilly 1999

Nijdam 2012

Power 2002

Vaughan 1994

Total ***

49.2 (15.6)

6.7 (4.7)

7.7 (5.1)

44.3 (7.5)

11

70

27

12

120

46.1 (19.7)

8 (5.8)

9.6 (5)

52.4 (15.9)

12

70

21

13

116

Heterogeneity: Tau2=0; Chi2=1.94, df=3(P=0.58); I2=0%

Test for overall effect: Z=2.1(P=0.04)

9.87%

59.91%

20.03%

10.19%

0.17[-0.65,0.99]

-0.26[-0.59,0.07]

-0.37[-0.95,0.21]

-0.62[-1.43,0.19]

100%

-0.28[-0.53,-0.02]

Favours EMDR

-5

-2.5

0

2.5

5

Favours Individual TFCBT

Analysis 5.9.   Comparison 5 EMDR vs Trauma-focused CBT, Outcome 9 Anxiety - follow-up (1 - 4 months).

Study or subgroup

Treatment

Control

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Fixed, 95% CI

Devilly 1999

Vaughan 1994

Total ***

55.1 (17.1)

50.4 (10.1)

11

12

23

12

13

25

44.8 (22.5)

50.3 (16.1)

Heterogeneity: Tau2=0; Chi2=0.7, df=1(P=0.4); I2=0%

Test for overall effect: Z=0.81(P=0.42)

47%

53%

Fixed, 95% CI

0.5[-0.34,1.33]

0.01[-0.78,0.79]

100%

0.24[-0.33,0.81]

Favours EMDR

-5

-2.5

0

2.5

5

Favours Individual TFCBT

Analysis 5.10.   Comparison 5 EMDR vs Trauma-focused CBT, Outcome 10 PTSD diagnosis after treatment.

Study or subgroup

Devilly 1999

Ironson 2002

Lee 2002

Nijdam 2012

Power 2002

Rothbaum 2005

EMDR

n/N

TFCBT

n/N

Risk Ratio

M-H, Fixed, 95% CI

Weight

Risk Ratio

M-H, Fixed, 95% CI

13/17

1/10

4/12

3/48

22/39

5/20

5/15

8/12

4/12

6/42

28/37

1/20

7.95%

10.88%

5.99%

9.58%

43%

1.5%

Favours EMDR

0.01

0.1

1

10

100

Favours Individual TFCBT

2.29[1.07,4.92]

0.15[0.02,1]

1[0.32,3.1]

0.44[0.12,1.64]

0.75[0.54,1.04]

5[0.64,39.06]

143

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Study or subgroup

Taylor 2003

Vaughan 1994

Total (95% CI)

EMDR

n/N

TFCBT

n/N

Risk Ratio

M-H, Fixed, 95% CI

10/19

6/12

177

9/22

6/13

173

Total events: 64 (EMDR), 67 (TFCBT)

Heterogeneity: Tau2=0; Chi2=15.56, df=7(P=0.03); I2=55.02%

Test for overall effect: Z=0.4(P=0.69)

Cochrane Database of Systematic Reviews

Weight

Risk Ratio

12.48%

8.62%

M-H, Fixed, 95% CI

1.29[0.67,2.49]

1.08[0.48,2.45]

100%

0.95[0.74,1.22]

Favours EMDR

0.01

0.1

1

10

100

Favours Individual TFCBT

Comparison 6.   EMDR vs non-TFCBT

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

1 Severity of PTSD symptoms -
clinician

2 Severity of PTSD symptoms -
clinician - follow-up (1-4 months)

3 Leaving the study early for any
reason

4 Severity of PTSD symptoms -
self report

5 Severity of PTSD symptoms
- self-report - follow-up (1 - 4
months)

6 Depression

7 Depression - follow-up (1 - 4
months)

8 Anxiety

9 Anxiety - follow-up (1 - 4
months)

10 PTSD diagnosis after treat-
ment

2

3

3

3

3

3

3

2

2

3

53

71

84

75

75

75

75

45

45

84

Std. Mean Difference (IV, Fixed,
95% CI)

-0.35 [-0.90, 0.19]

Std. Mean Difference (IV, Ran-
dom, 95% CI)

-0.74 [-1.64, 0.15]

Risk Ratio (M-H, Fixed, 95% CI)

1.03 [0.37, 2.88]

Std. Mean Difference (IV, Fixed,
95% CI)

-0.40 [-0.86, 0.06]

Std. Mean Difference (IV, Fixed,
95% CI)

-0.52 [-0.98, -0.05]

Std. Mean Difference (IV, Fixed,
95% CI)

-0.67 [-1.14, -0.20]

Std. Mean Difference (IV, Ran-
dom, 95% CI)

-0.25 [-0.86, 0.36]

Std. Mean Difference (IV, Fixed,
95% CI)

-0.75 [-1.36, -0.13]

Std. Mean Difference (IV, Ran-
dom, 95% CI)

-0.42 [-2.21, 1.37]

Risk Ratio (M-H, Random, 95%
CI)

0.71 [0.41, 1.22]

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

144

 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 6.1.   Comparison 6 EMDR vs non-TFCBT, Outcome 1 Severity of PTSD symptoms - clinician.

Study or subgroup

EMDR

non-TFCBT

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Fixed, 95% CI

Taylor 2003

Vaughan 1994

Total ***

42.2 (22.2)

16.8 (6.2)

15

12

27

15

11

26

47 (36.2)

23.1 (12.5)

Heterogeneity: Tau2=0; Chi2=0.69, df=1(P=0.41); I2=0%

Test for overall effect: Z=1.27(P=0.21)

57.96%

42.04%

Fixed, 95% CI

-0.15[-0.87,0.56]

-0.62[-1.47,0.22]

100%

-0.35[-0.9,0.19]

Favours EMDR

-2

-1

0

1

2

Favours non-TFCBT

Analysis 6.2.   Comparison 6 EMDR vs non-TFCBT, Outcome 2
Severity of PTSD symptoms - clinician - follow-up (1-4 months).

Study or subgroup

EMDR

non-TFCBT

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Carlson 1998

Taylor 2003

Vaughan 1994

Total ***

1.5 (1.3)

36.9 (26.9)

15.6 (7.4)

9

15

12

36

4 (1.2)

42.3 (23.3)

19.6 (10.9)

9

15

11

35

Heterogeneity: Tau2=0.42; Chi2=6.16, df=2(P=0.05); I2=67.54%

Test for overall effect: Z=1.62(P=0.1)

27.18%

37.82%

35%

-1.9[-3.06,-0.74]

-0.21[-0.93,0.51]

-0.42[-1.25,0.41]

100%

-0.74[-1.64,0.15]

Favours EMDR

-10

-5

0

5

10

Favours non-TFCBT

Analysis 6.3.   Comparison 6 EMDR vs non-TFCBT, Outcome 3 Leaving the study early for any reason.

Study or subgroup

Carlson 1998

Taylor 2003

Vaughan 1994

Total (95% CI)

EMDR

n/N

non-TFCBT

n/N

Risk Ratio

M-H, Fixed, 95% CI

Weight

Risk Ratio

M-H, Fixed, 95% CI

1/10

4/19

1/12

41

1/13

4/19

1/11

43

14.71%

67.65%

17.65%

1.3[0.09,18.33]

1[0.29,3.43]

0.92[0.06,12.95]

100%

1.03[0.37,2.88]

Total events: 6 (EMDR), 6 (non-TFCBT)

Heterogeneity: Tau2=0; Chi2=0.04, df=2(P=0.98); I2=0%

Test for overall effect: Z=0.06(P=0.96)

Favours EMDR

0.01

0.1

1

10

100

Favours non-TFCBT

Analysis 6.4.   Comparison 6 EMDR vs non-TFCBT, Outcome 4 Severity of PTSD symptoms - self report.

Study or subgroup

EMDR

non-TFCBT

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Fixed, 95% CI

Carlson 1998

Taylor 2003

Vaughan 1994

10

15

12

35.2 (22)

20.5 (9.4)

28.4 (13.3)

12

15

11

44.5 (17.4)

22.8 (13.5)

40.6 (23.1)

29.11%

41.08%

29.81%

Fixed, 95% CI

-0.46[-1.31,0.4]

-0.19[-0.91,0.53]

-0.63[-1.47,0.21]

Favours EMDR

-10

-5

0

5

10

Favours non-TFCBT

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

145

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Study or subgroup

EMDR

non-TFCBT

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Fixed, 95% CI

Fixed, 95% CI

Total ***

37

38

100%

-0.4[-0.86,0.06]

Heterogeneity: Tau2=0; Chi2=0.64, df=2(P=0.73); I2=0%

Test for overall effect: Z=1.7(P=0.09)

Favours EMDR

-10

-5

0

5

10

Favours non-TFCBT

Analysis 6.5.   Comparison 6 EMDR vs non-TFCBT, Outcome 5
Severity of PTSD symptoms - self-report - follow-up (1 - 4 months).

Study or subgroup

EMDR

non-TFCBT

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Fixed, 95% CI

Carlson 1998

Taylor 2003

Vaughan 1994

Total ***

29.1 (22)

16.9 (11.4)

12.6 (17.6)

10

15

12

37

12

15

11

38

45.7 (15)

21 (13.8)

20.4 (14.1)

Heterogeneity: Tau2=0; Chi2=0.89, df=2(P=0.64); I2=0%

Test for overall effect: Z=2.18(P=0.03)

27.46%

41.41%

31.12%

Fixed, 95% CI

-0.86[-1.75,0.02]

-0.32[-1.04,0.4]

-0.47[-1.3,0.36]

100%

-0.52[-0.98,-0.05]

Favours EMDR

-10

-5

0

5

10

Favours non-TFCBT

Analysis 6.6.   Comparison 6 EMDR vs non-TFCBT, Outcome 6 Depression.

Study or subgroup

EMDR

non-TFCBT

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Fixed, 95% CI

Carlson 1998

Taylor 2003

Vaughan 1994

Total ***

6.9 (5.9)

16.4 (9.1)

10.8 (4.9)

10

15

12

37

15.8 (12.5)

21 (13.8)

20.4 (14.1)

12

15

11

38

Heterogeneity: Tau2=0; Chi2=1.02, df=2(P=0.6); I2=0%

Test for overall effect: Z=2.77(P=0.01)

28.29%

42.24%

29.47%

Fixed, 95% CI

-0.85[-1.73,0.03]

-0.38[-1.11,0.34]

-0.89[-1.76,-0.03]

100%

-0.67[-1.14,-0.2]

Favours EMDR

-10

-5

0

5

10

Favours non-TFCBT

Analysis 6.7.   Comparison 6 EMDR vs non-TFCBT, Outcome 7 Depression - follow-up (1 - 4 months).

Study or subgroup

EMDR

non-TFCBT

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Carlson 1998

Taylor 2003

Vaughan 1994

Total ***

8.6 (9.4)

14.4 (11)

14.3 (9.4)

10

15

12

37

18.3 (11.7)

16.7 (10.8)

11.9 (7.2)

12

15

11

38

Heterogeneity: Tau2=0.12; Chi2=3.45, df=2(P=0.18); I2=42.09%

Test for overall effect: Z=0.79(P=0.43)

29.7%

37.81%

32.49%

-0.87[-1.76,0.02]

-0.21[-0.92,0.51]

0.27[-0.55,1.1]

100%

-0.25[-0.86,0.36]

Favours EMDR

-10

-5

0

5

10

Favours non-TFCBT

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

146

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 6.8.   Comparison 6 EMDR vs non-TFCBT, Outcome 8 Anxiety.

Study or subgroup

EMDR

non-TFCBT

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Fixed, 95% CI

Carlson 1998

Vaughan 1994

Total ***

34.9 (9)

44.3 (7.5)

10

12

22

46.3 (13.3)

52.4 (18.3)

12

11

23

Heterogeneity: Tau2=0; Chi2=0.37, df=1(P=0.54); I2=0%

Test for overall effect: Z=2.39(P=0.02)

46.74%

53.26%

Fixed, 95% CI

-0.95[-1.84,-0.05]

-0.57[-1.41,0.27]

100%

-0.75[-1.36,-0.13]

Favours EMDR

-4

-2

0

2

4

Favours non-TFCBT

Analysis 6.9.   Comparison 6 EMDR vs non-TFCBT, Outcome 9 Anxiety - follow-up (1 - 4 months).

Study or subgroup

EMDR

non-TFCBT

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Carlson 1998

Vaughan 1994

Total ***

40.6 (4.9)

50.4 (10.1)

10

12

22

12

11

23

47.7 (5.2)

45.4 (9.9)

Heterogeneity: Tau2=1.47; Chi2=8.09, df=1(P=0); I2=87.63%

Test for overall effect: Z=0.46(P=0.65)

49.2%

50.8%

-1.35[-2.3,-0.4]

0.48[-0.35,1.31]

100%

-0.42[-2.21,1.37]

Favours EMDR

-10

-5

0

5

10

Favours non-TFCBT

Analysis 6.10.   Comparison 6 EMDR vs non-TFCBT, Outcome 10 PTSD diagnosis after treatment.

Study or subgroup

Carlson 1998

Taylor 2003

Vaughan 1994

Total (95% CI)

EMDR

n/N

non-TFCBT

n/N

Risk Ratio

Weight

Risk Ratio

M-H, Random, 95% CI

M-H, Random, 95% CI

3/10

10/19

6/12

41

11/13

13/19

5/11

43

23.13%

49.15%

27.72%

0.35[0.13,0.94]

0.77[0.46,1.3]

1.1[0.47,2.6]

100%

0.71[0.41,1.22]

Total events: 19 (EMDR), 29 (non-TFCBT)

Heterogeneity: Tau2=0.08; Chi2=3.09, df=2(P=0.21); I2=35.34%

Test for overall effect: Z=1.24(P=0.22)

Favours EMDR

0.01

0.1

1

10

100

Favours non-TFCBT

Comparison 7.   EMDR vs other therapies

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

1 Leaving study early for
any reason

2

127

Risk Ratio (M-H, Fixed, 95% CI)

1.48 [0.26, 8.54]

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

147

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

2 Severity of PTSD symp-
toms - self report

3 Depression

4 Anxiety

5 PTSD diagnosis after treat-
ment

2

2

2

1

124

127

126

Std. Mean Difference (IV, Fixed, 95%
CI)

-0.84 [-1.21, -0.47]

Std. Mean Difference (IV, Fixed, 95%
CI)

-0.67 [-1.03, -0.32]

Std. Mean Difference (IV, Fixed, 95%
CI)

-0.72 [-1.08, -0.36]

Risk Ratio (M-H, Fixed, 95% CI)

Totals not selected

Analysis 7.1.   Comparison 7 EMDR vs other therapies, Outcome 1 Leaving study early for any reason.

Study or subgroup

Marcus 1997

Scheck 1998

Total (95% CI)

EMDR

n/N

1/34

2/30

64

Total events: 3 (EMDR), 2 (Other Therapy)

Heterogeneity: Tau2=0; Chi2=0.16, df=1(P=0.69); I2=0%

Test for overall effect: Z=0.44(P=0.66)

Other Therapy

Risk Ratio

Weight

Risk Ratio

n/N

M-H, Fixed, 95% CI

1/33

1/30

63

50.37%

49.63%

M-H, Fixed, 95% CI

0.97[0.06,14.88]

2[0.19,20.9]

100%

1.48[0.26,8.54]

Favours EMDR

0.01

0.1

1

10

100

Favours other therapy

Analysis 7.2.   Comparison 7 EMDR vs other therapies, Outcome 2 Severity of PTSD symptoms - self report.

Study or subgroup

EMDR

Other Therapies

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Fixed, 95% CI

Marcus 1997

Scheck 1998

Total ***

17.9 (16.5)

23.4 (18.4)

34

28

62

33

29

62

35 (20.2)

36.4 (15.6)

Heterogeneity: Tau2=0; Chi2=0.19, df=1(P=0.66); I2=0%

Test for overall effect: Z=4.47(P<0.0001)

53.22%

46.78%

Fixed, 95% CI

-0.92[-1.42,-0.41]

-0.75[-1.29,-0.21]

100%

-0.84[-1.21,-0.47]

Favours EMDR

-4

-2

0

2

4

Favours other therapy

Analysis 7.3.   Comparison 7 EMDR vs other therapies, Outcome 3 Depression.

Study or subgroup

EMDR

Other Therapies

Std. Mean Difference

Weight

Std. Mean Difference

Marcus 1997

Scheck 1998

34

30

8.4 (8.3)

9.3 (9.8)

33

30

15.3 (12.9)

17.8 (13.4)

N

Mean(SD)

N

Mean(SD)

Fixed, 95% CI

53.11%

46.89%

Fixed, 95% CI

-0.63[-1.13,-0.14]

-0.72[-1.24,-0.19]

Favours EMDR

-4

-2

0

2

4

Favours other therapy

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

148

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Study or subgroup

EMDR

Other Therapies

Std. Mean Difference

Weight

Std. Mean Difference

Total ***

Mean(SD)

N

64

N

63

Heterogeneity: Tau2=0; Chi2=0.05, df=1(P=0.82); I2=0%

Test for overall effect: Z=3.68(P=0)

Mean(SD)

Fixed, 95% CI

Fixed, 95% CI

100%

-0.67[-1.03,-0.32]

Favours EMDR

-4

-2

0

2

4

Favours other therapy

Analysis 7.4.   Comparison 7 EMDR vs other therapies, Outcome 4 Anxiety.

Study or subgroup

EMDR

Other Therapies

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Fixed, 95% CI

Marcus 1997

Scheck 1998

Total ***

38.1 (11.2)

35.2 (13.9)

34

29

63

33

30

63

47.8 (13.4)

44.5 (14.2)

Heterogeneity: Tau2=0; Chi2=0.1, df=1(P=0.75); I2=0%

Test for overall effect: Z=3.9(P<0.0001)

52.66%

47.34%

Fixed, 95% CI

-0.78[-1.27,-0.28]

-0.66[-1.18,-0.13]

100%

-0.72[-1.08,-0.36]

Favours EMDR

-4

-2

0

2

4

Favours other therapy

Analysis 7.5.   Comparison 7 EMDR vs other therapies, Outcome 5 PTSD diagnosis after treatment.

Study or subgroup

EMDR

n/N

Other Therapy

n/N

Risk Ratio

Risk Ratio

M-H, Fixed, 95% CI

M-H, Fixed, 95% CI

Marcus 1997

7/34

17/33

0.4[0.19,0.84]

Favours EMDR

0.01

0.1

1

10

100

Favours other therapy

Comparison 8.   Non-TFCBT vs waitlist/usual care

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

1 Severity of PTSD symptoms
- Clinician

2 Leaving the study early for
any reason

3 Severity of PTSD symptoms
- Self-report

4 Depression

5 Anxiety

6 PTSD diagnosis after treat-
ment

4

5

2

5

4

4

106

141

44

129

102

121

Std. Mean Difference (IV, Random,
95% CI)

-1.22 [-1.76, -0.69]

Risk Ratio (M-H, Fixed, 95% CI)

1.96 [0.70, 5.48]

Std. Mean Difference (IV, Random,
95% CI)

-0.86 [-3.27, 1.55]

Std. Mean Difference (IV, Random,
95% CI)

-0.93 [-1.43, -0.42]

Std. Mean Difference (IV, Fixed, 95%
CI)

-0.83 [-1.24, -0.42]

Risk Ratio (M-H, Random, 95% CI)

0.65 [0.50, 0.86]

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

149

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 8.1.   Comparison 8 Non-TFCBT vs waitlist/usual care, Outcome 1 Severity of PTSD symptoms - Clinician.

Study or subgroup

Non-TFCBT

Waitlist/Usual Care

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Foa 1991

Foa 1999

Vaughan 1994

Wells 2012

Total ***

11.1 (4)

12.9 (9)

23.1 (12.5)

3.9 (2.3)

14

19

11

10

54

10

15

17

10

52

19.5 (7.2)

26.9 (8.5)

28.5 (8.9)

6.7 (1.1)

Heterogeneity: Tau2=0.11; Chi2=4.62, df=3(P=0.2); I2=35.12%

Test for overall effect: Z=4.46(P<0.0001)

22.71%

28.32%

28.88%

20.09%

-1.48[-2.41,-0.54]

-1.57[-2.35,-0.78]

-0.5[-1.27,0.27]

-1.49[-2.5,-0.47]

100%

-1.22[-1.76,-0.69]

Favours non-TFCBT

-4

-2

0

2

4

Favours WL/UC

Analysis 8.2.   Comparison 8 Non-TFCBT vs waitlist/usual care, Outcome 2 Leaving the study early for any reason.

Study or subgroup

non-TFCBT

Waitlist/Usu-
al Care

Risk Ratio

Weight

Risk Ratio

n/N

n/N

M-H, Fixed, 95% CI

M-H, Fixed, 95% CI

Carlson 1998

Foa 1991

Foa 1999

Vaughan 1994

Wells 2012

Total (95% CI)

1/13

3/17

7/26

1/11

1/10

77

1/12

1/10

1/15

1/17

1/10

64

Total events: 13 (non-TFCBT), 5 (Waitlist/Usual Care)

Heterogeneity: Tau2=0; Chi2=1.1, df=4(P=0.89); I2=0%

Test for overall effect: Z=1.29(P=0.2)

19.43%

23.52%

23.69%

14.68%

18.68%

0.92[0.06,13.18]

1.76[0.21,14.76]

4.04[0.55,29.74]

1.55[0.11,22.23]

1[0.07,13.87]

100%

1.96[0.7,5.48]

Favours non-TFCBT

0.01

0.1

1

10

100

Favours WL/UC

Analysis 8.3.   Comparison 8 Non-TFCBT vs waitlist/usual care, Outcome 3 Severity of PTSD symptoms - Self-report.

Study or subgroup

non-TFCBT

Waitlist/Usual Care

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Carlson 1998

Wells 2012

Total ***

44.5 (17.4)

20.5 (18.1)

12

10

22

38.7 (16.2)

54.8 (12.3)

12

10

22

Heterogeneity: Tau2=2.76; Chi2=11.83, df=1(P=0); I2=91.55%

Test for overall effect: Z=0.7(P=0.48)

51.42%

48.58%

Random, 95% CI

0.33[-0.47,1.14]

-2.12[-3.27,-0.98]

100%

-0.86[-3.27,1.55]

Favours non-TFCBT

-5

-2.5

0

2.5

5

Favours WL/UC

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

150

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 8.4.   Comparison 8 Non-TFCBT vs waitlist/usual care, Outcome 4 Depression.

Study or subgroup

non-TFCBT

Waitlist/Usual care

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Carlson 1998

Foa 1991

Foa 1999

Vaughan 1994

Wells 2012

Total ***

15.8 (12.5)

9.9 (6.8)

10.1 (8.1)

10.6 (6.3)

8.9 (8.7)

12

14

19

11

10

66

23.5 (12.8)

15.4 (9.7)

22.1 (15)

13.8 (4.7)

29.6 (8.5)

12

10

14

17

10

63

Heterogeneity: Tau2=0.14; Chi2=7.04, df=4(P=0.13); I2=43.15%

Test for overall effect: Z=3.6(P=0)

20.91%

20.46%

23.36%

22.21%

13.06%

-0.59[-1.41,0.23]

-0.66[-1.5,0.18]

-1.02[-1.76,-0.29]

-0.58[-1.35,0.2]

-2.31[-3.49,-1.12]

100%

-0.93[-1.43,-0.42]

Favours non-TFCBT

-4

-2

0

2

4

Favours WL/UC

Analysis 8.5.   Comparison 8 Non-TFCBT vs waitlist/usual care, Outcome 5 Anxiety.

Study or subgroup

non-TFCBT

Waitlist/Usual Care

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Fixed, 95% CI

Fixed, 95% CI

Carlson 1998

Foa 1991

Foa 1999

Wells 2012

Total ***

46.3 (13.3)

37.2 (7.6)

39.1 (11.6)

12.9 (12.7)

12

14

19

10

55

51.4 (17.8)

49.9 (13.8)

50.4 (13.8)

28.3 (14.8)

12

10

15

10

47

Heterogeneity: Tau2=0; Chi2=2.38, df=3(P=0.5); I2=0%

Test for overall effect: Z=3.94(P<0.0001)

26.17%

21.57%

33.49%

18.78%

-0.31[-1.12,0.49]

-1.16[-2.05,-0.28]

-0.88[-1.59,-0.17]

-1.07[-2.02,-0.12]

100%

-0.83[-1.24,-0.42]

Favours non-TFCBT

-4

-2

0

2

4

Favours WL/UC

Analysis 8.6.   Comparison 8 Non-TFCBT vs waitlist/usual care, Outcome 6 PTSD diagnosis after treatment.

Study or subgroup

non-TFCBT

Waitlist/Usu-
al Care

Risk Ratio

Weight

Risk Ratio

n/N

n/N

M-H, Random, 95% CI

M-H, Random, 95% CI

Carlson 1998

Foa 1991

Foa 1999

Vaughan 1994

Total (95% CI)

11/13

10/17

15/26

5/11

67

12/12

10/10

15/15

17/17

54

Total events: 41 (non-TFCBT), 54 (Waitlist/Usual Care)

Heterogeneity: Tau2=0.04; Chi2=6.15, df=3(P=0.1); I2=51.18%

Test for overall effect: Z=3.04(P=0)

33.97%

23.51%

28.53%

14%

0.85[0.65,1.12]

0.61[0.41,0.92]

0.59[0.42,0.83]

0.47[0.25,0.88]

100%

0.65[0.5,0.86]

Favours non-TFCBT

0.1

0.2

0.5

1

2

5

10

Favours WL/UC

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

151

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Comparison 9.   Non-TFCBT vs other therapies

Cochrane Database of Systematic Reviews

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

1 Severity of PTSD symptoms -
Clincian

2 Severity of PTSD symptoms -
clinician - follow-up (3 months)

3 Leaving the study early for any
reason

4 Depression - self report

5 Depression - self report - fol-
low-up (3 months)

6 Anxiety - self report

7 Anxiety - self report - follow-up
(3 months)

8 PTSD diagnosis after treatment

1

1

1

1

1

1

1

1

Std. Mean Difference (IV, Fixed,
95% CI)

Totals not selected

Std. Mean Difference (IV, Fixed,
95% CI)

Totals not selected

Risk Ratio (M-H, Fixed, 95% CI)

Totals not selected

Std. Mean Difference (IV, Fixed,
95% CI)

Totals not selected

Std. Mean Difference (IV, Fixed,
95% CI)

Totals not selected

Std. Mean Difference (IV, Fixed,
95% CI)

Totals not selected

Std. Mean Difference (IV, Fixed,
95% CI)

Totals not selected

Risk Ratio (M-H, Fixed, 95% CI)

Totals not selected

Analysis 9.1.   Comparison 9 Non-TFCBT vs other therapies, Outcome 1 Severity of PTSD symptoms - Clincian.

Study or subgroup

non-TFCBT

Other Therapy

Std. Mean Difference

Std. Mean Difference

Foa 1991

N

14

Mean(SD)

11.1 (4)

N

11

Mean(SD)

18.1 (7.1)

Fixed, 95% CI

Fixed, 95% CI

-1.22[-2.09,-0.35]

Favours non-TFCBT

-4

-2

0

2

4

Favours other therapies

Analysis 9.2.   Comparison 9 Non-TFCBT vs other therapies, Outcome
2 Severity of PTSD symptoms - clinician - follow-up (3 months).

Study or subgroup

non-TFCBT

Other Therapies

Std. Mean Difference

Std. Mean Difference

Foa 1991

N

9

Mean(SD)

12.3 (9.6)

N

9

Mean(SD)

16.1 (9.4)

Fixed, 95% CI

Fixed, 95% CI

-0.38[-1.31,0.55]

Favours non-TFCBT

-4

-2

0

2

4

Favours other therapies

Analysis 9.3.   Comparison 9 Non-TFCBT vs other therapies, Outcome 3 Leaving the study early for any reason.

Study or subgroup

non-TFCBT

n/N

Other Therapies

n/N

Risk Ratio

Risk Ratio

M-H, Fixed, 95% CI

M-H, Fixed, 95% CI

Foa 1991

3/17

3/14

0.82[0.2,3.46]

Favours non-TFCBT

0.1

0.2

0.5

1

2

5

10

Favours other therapies

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

152

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 9.4.   Comparison 9 Non-TFCBT vs other therapies, Outcome 4 Depression - self report.

Study or subgroup

non-TFCBT

Other Therapy

Std. Mean Difference

Std. Mean Difference

Foa 1991

N

14

Mean(SD)

9.9 (6.8)

N

11

Mean(SD)

15.4 (14)

Fixed, 95% CI

Fixed, 95% CI

-0.51[-1.31,0.3]

Favours non-TFCBT

-4

-2

0

2

4

Favours other therapies

Analysis 9.5.   Comparison 9 Non-TFCBT vs other therapies,
Outcome 5 Depression - self report - follow-up (3 months).

Study or subgroup

non-TFCBT

Other Therapies

Std. Mean Difference

Std. Mean Difference

Foa 1991

N

9

Mean(SD)

10.3 (11.7)

N

9

Mean(SD)

15.9 (10.2)

Fixed, 95% CI

Fixed, 95% CI

-0.48[-1.42,0.46]

Favours non-TFCBT

-4

-2

0

2

4

Favours other therapies

Analysis 9.6.   Comparison 9 Non-TFCBT vs other therapies, Outcome 6 Anxiety - self report.

Study or subgroup

non-TFCBT

Other Therapy

Std. Mean Difference

Std. Mean Difference

Foa 1991

N

14

Mean(SD)

37.2 (7.6)

N

11

Mean(SD)

43.7 (16.8)

Fixed, 95% CI

Fixed, 95% CI

-0.51[-1.32,0.29]

Favours non-TFCBT

-4

-2

0

2

4

Favours other therapies

Analysis 9.7.   Comparison 9 Non-TFCBT vs other therapies, Outcome 7 Anxiety - self report - follow-up (3 months).

Study or subgroup

non-TFCBT

Other Therapies

Std. Mean Difference

Std. Mean Difference

Foa 1991

N

9

Mean(SD)

37.6 (15.4)

N

9

Mean(SD)

50 (19.4)

Fixed, 95% CI

Fixed, 95% CI

-0.68[-1.64,0.28]

Favours non-TFCBT

-4

-2

0

2

4

Favours other therapies

Analysis 9.8.   Comparison 9 Non-TFCBT vs other therapies, Outcome 8 PTSD diagnosis after treatment.

Study or subgroup

non-TFCBT

n/N

Other Therapy

n/N

Risk Ratio

Risk Ratio

M-H, Fixed, 95% CI

M-H, Fixed, 95% CI

Foa 1991

7/17

10/14

0.58[0.3,1.11]

Favours non-TFCBT

0.1

0.2

0.5

1

2

5

10

Favours other therapies

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

153

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Comparison 10.   Group TFCBT vs waitlist/usual care/minimal contact

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

1 Clinician-rated

2 Severity of PTSD 5 - 8
month follow-up

3 Leaving the study early for
any reason

4 Severity of PTSD symptoms
- self report

5 Severity of PTSD - self re-
port - 1 - 4 months

6 Depression

7 Depression 1 - 4 month fol-
low-up

8 Anxiety

9 Anxiety 1 - 4 month fol-
low-up

10 PTSD diagnosis after treat-
ment

3

1

7

6

2

3

1

3

2

1

185

573

274

73

137

106

73

Std. Mean Difference (IV, Random,
95% CI)

-1.28 [-2.25, -0.31]

Std. Mean Difference (IV, Fixed,
95% CI)

Totals not selected

Risk Ratio (M-H, Fixed, 95% CI)

1.21 [0.94, 1.55]

Std. Mean Difference (IV, Random,
95% CI)

-1.20 [-1.70, -0.69]

Std. Mean Difference (IV, Random,
95% CI)

-1.14 [-1.78, -0.50]

Std. Mean Difference (IV, Random,
95% CI)

-1.15 [-1.98, -0.32]

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Std. Mean Difference (IV, Fixed,
95% CI)

-0.66 [-1.06, -0.27]

Mean Difference (IV, Fixed, 95% CI)

-0.43 [-0.72, -0.14]

Risk Ratio (M-H, Fixed, 95% CI)

Totals not selected

Analysis 10.1.   Comparison 10 Group TFCBT vs waitlist/usual care/minimal contact, Outcome 1 Clinician-rated.

Study or subgroup

Experimental

Waitlist/Usual Care

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Beck 2009

Chard 2005

Krakow 2001

Total ***

28.9 (19.9)

9 (11)

49.6 (24)

17

28

45

90

16

27

52

95

49.4 (27)

63 (30.7)

68.4 (27.3)

Heterogeneity: Tau2=0.63; Chi2=15.6, df=2(P=0); I2=87.18%

Test for overall effect: Z=2.59(P=0.01)

31.82%

32.16%

36.02%

-0.85[-1.56,-0.13]

-2.32[-3.02,-1.63]

-0.72[-1.14,-0.31]

100%

-1.28[-2.25,-0.31]

Favours group TFCBT

-4

-2

0

2

4

Favours WL/UC

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

154

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 10.2.   Comparison 10 Group TFCBT vs waitlist/usual care/
minimal contact, Outcome 2 Severity of PTSD 5 - 8 month follow-up.

Study or subgroup

Experimental

Waitlist/Usual Care

Std. Mean Difference

Std. Mean Difference

Krakow 2001

N

45

Mean(SD)

49.6 (24)

N

52

Mean(SD)

68.4 (27.3)

Fixed, 95% CI

Fixed, 95% CI

-0.72[-1.14,-0.31]

Favours group TFCBT

-4

-2

0

2

4

Favours WL/UC

Analysis 10.3.   Comparison 10 Group TFCBT vs waitlist/usual care/
minimal contact, Outcome 3 Leaving the study early for any reason.

Study or subgroup

Group Therapy

Waitlist/Usu-
al Care

Risk Ratio

Weight

Risk Ratio

n/N

n/N

M-H, Fixed, 95% CI

M-H, Fixed, 95% CI

Beck 2009

Chard 2005

Hinton 2011

Hollifield 2007

Krakow 2000

Krakow 2001

Zlotnick 1997

Total (95% CI)

9/26

8/36

0/12

4/25

44/87

22/88

7/24

298

2/18

7/35

0/12

3/24

34/82

20/80

6/24

275

Total events: 94 (Group Therapy), 72 (Waitlist/Usual Care)

Heterogeneity: Tau2=0; Chi2=2.28, df=5(P=0.81); I2=0%

Test for overall effect: Z=1.46(P=0.14)

3.17%

9.53%

4.11%

47%

28.13%

8.06%

3.12[0.76,12.75]

1.11[0.45,2.74]

Not estimable

1.28[0.32,5.13]

1.22[0.88,1.7]

1[0.59,1.69]

1.17[0.46,2.96]

100%

1.21[0.94,1.55]

Favours group TFCBT

0.01

0.1

1

10

100

Favours WL/UC

Analysis 10.4.   Comparison 10 Group TFCBT vs waitlist/usual care/
minimal contact, Outcome 4 Severity of PTSD symptoms - self report.

Study or subgroup

Group Therapy

Waitlist/Usual Care

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Beck 2009

Chard 2005

Hinton 2011

Hollifield 2007

Krakow 2000

Zlotnick 1997

17

28

12

25

39

16

1 (0.9)

7.5 (9.5)

39.1 (15.1)

20 (10.6)

15 (10.3)

45.8 (34.1)

16

27

12

24

41

17

1.9 (1)

57.7 (27.5)

61.6 (13.2)

27.9 (12.3)

25.7 (12.6)

73.1 (29.9)

Total ***

137

137

Heterogeneity: Tau2=0.28; Chi2=17.53, df=5(P=0); I2=71.48%

Test for overall effect: Z=4.64(P<0.0001)

16.01%

16.32%

13.24%

18.26%

19.96%

16.2%

-0.99[-1.71,-0.26]

-2.42[-3.13,-1.72]

-1.53[-2.46,-0.6]

-0.68[-1.26,-0.1]

-0.92[-1.38,-0.46]

-0.83[-1.55,-0.12]

100%

-1.2[-1.7,-0.69]

Favours group TFCBT

-4

-2

0

2

4

Favours WL/UC

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

155

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 10.5.   Comparison 10 Group TFCBT vs waitlist/usual care/
minimal contact, Outcome 5 Severity of PTSD - self report - 1 - 4 months.

Study or subgroup

Experimental

Waitlist/Usual Care

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Hinton 2011

Hollifield 2007

Total ***

36.4 (12.7)

16.7 (12.2)

12

25

37

58.9 (14.7)

27.9 (12.3)

12

24

36

Heterogeneity: Tau2=0.07; Chi2=1.45, df=1(P=0.23); I2=30.8%

Test for overall effect: Z=3.52(P=0)

35.03%

64.97%

Random, 95% CI

-1.58[-2.52,-0.64]

-0.9[-1.49,-0.31]

100%

-1.14[-1.78,-0.5]

Favours group TFCBT

-4

-2

0

2

4

Favours WL/UC

Analysis 10.6.   Comparison 10 Group TFCBT vs waitlist/usual care/minimal contact, Outcome 6 Depression.

Study or subgroup

Experimental

Waitlist/Usual Care

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Random, 95% CI

Random, 95% CI

Chard 2005

Hollifield 2007

Beck 2009

Total ***

3.3 (4.8)

2 (0.6)

16.6 (12.4)

28

25

17

70

22.4 (12.6)

2.5 (0.7)

26.2 (17)

27

24

16

67

Heterogeneity: Tau2=0.43; Chi2=9.91, df=2(P=0.01); I2=79.82%

Test for overall effect: Z=2.7(P=0.01)

33.16%

34.64%

32.19%

-2[-2.66,-1.35]

-0.8[-1.39,-0.22]

-0.63[-1.33,0.07]

100%

-1.15[-1.98,-0.32]

Favours group TFCBT

-4

-2

0

2

4

Favours WL/UC

Analysis 10.7.   Comparison 10 Group TFCBT vs waitlist/usual care/
minimal contact, Outcome 7 Depression 1 - 4 month follow-up.

Study or subgroup

Experimental

Waitlist/Usual Care

Hollifield 2007

N

25

Mean(SD)

1.9 (0.7)

N

24

Mean(SD)

2.5 (0.7)

Mean Difference

Fixed, 95% CI

Mean Difference

Fixed, 95% CI

-0.62[-1,-0.24]

Favours group TFCBT

-2

-1

0

1

2

Favours WL/UC

Analysis 10.8.   Comparison 10 Group TFCBT vs waitlist/usual care/minimal contact, Outcome 8 Anxiety.

Study or subgroup

Experimental

Waitlist/Usual Care

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Fixed, 95% CI

Beck 2009

Hinton 2011

Hollifield 2007

Total ***

15.9 (10.6)

1.5 (0.7)

1.8 (0.5)

17

12

25

54

23.3 (16.3)

2.2 (0.7)

2.1 (0.6)

16

12

24

52

Heterogeneity: Tau2=0; Chi2=0.65, df=2(P=0.72); I2=0%

Test for overall effect: Z=3.3(P=0)

31.92%

21.2%

46.88%

Fixed, 95% CI

-0.53[-1.22,0.17]

-0.97[-1.82,-0.11]

-0.62[-1.19,-0.04]

100%

-0.66[-1.06,-0.27]

Favours group TFCBT

-2

-1

0

1

2

Favours WL/UC

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

156

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 10.9.   Comparison 10 Group TFCBT vs waitlist/usual care/
minimal contact, Outcome 9 Anxiety 1 - 4 month follow-up.

Study or subgroup

Experimental

Waitlist/Usual Care

Hinton 2011

Hollifield 2007

Total ***

N

Mean(SD)

N

Mean(SD)

12

25

37

1.4 (0.6)

1.8 (0.6)

12

24

36

2.1 (0.8)

2.1 (0.6)

Heterogeneity: Tau2=0; Chi2=1.2, df=1(P=0.27); I2=16.93%

Test for overall effect: Z=2.87(P=0)

Mean Difference

Fixed, 95% CI

Weight

Mean Difference

26.72%

73.28%

Fixed, 95% CI

-0.7[-1.27,-0.13]

-0.33[-0.67,0.01]

100%

-0.43[-0.72,-0.14]

Favours group TFCBT

-2

-1

0

1

2

Favours WL/UC

Analysis 10.10.   Comparison 10 Group TFCBT vs waitlist/usual care/
minimal contact, Outcome 10 PTSD diagnosis after treatment.

Study or subgroup

Group Therapy

Waitlist/Usual Care

Risk Ratio

Risk Ratio

n/N

n/N

M-H, Fixed, 95% CI

M-H, Fixed, 95% CI

Zlotnick 1997

9/24

16/24

0.56[0.31,1.01]

Favours group TFCBT

0.1

0.2

0.5

1

2

5

10

Favours WL/UC

Comparison 11.   Group CBT (trauma-focused) vs Group CBT (non-trauma-focused)

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

1 Severity of PTSD symptoms

2 Leaving the study early for any
reason

3 PTSD diagnosis after treatment

1

1

1

Std. Mean Difference (IV, Fixed,
95% CI)

Totals not selected

Risk Ratio (M-H, Fixed, 95% CI)

Totals not selected

Risk Ratio (M-H, Fixed, 95% CI)

Totals not selected

Analysis 11.1.   Comparison 11 Group CBT (trauma-focused) vs Group
CBT (non-trauma-focused), Outcome 1 Severity of PTSD symptoms.

Study or subgroup

Group Therapy

Group Therapy

Std. Mean Difference

Std. Mean Difference

Schnurr 2003

N

162

Mean(SD)

74 (16.8)

N

163

Mean(SD)

76 (16.9)

Fixed, 95% CI

Fixed, 95% CI

Favours group TFCBT

-1

-0.5

0

0.5

1

-0.12[-0.34,0.1]

Favours group non-
TFCBT

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

157

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 11.2.   Comparison 11 Group CBT (trauma-focused) vs Group CBT
(non-trauma-focused), Outcome 2 Leaving the study early for any reason.

Study or subgroup

Group Therapy

Group Therapy

Risk Ratio

Risk Ratio

n/N

n/N

M-H, Fixed, 95% CI

M-H, Fixed, 95% CI

Schnurr 2003

62/180

45/180

Favours group TFCBT

0.2

0.5

1

2

5

1.38[1,1.9]

Favours group non-
TFCBT

Analysis 11.3.   Comparison 11 Group CBT (trauma-focused) vs Group
CBT (non-trauma-focused), Outcome 3 PTSD diagnosis after treatment.

Study or subgroup

Group Therapy

Group Therapy

Risk Ratio

Risk Ratio

n/N

n/N

M-H, Fixed, 95% CI

M-H, Fixed, 95% CI

Schnurr 2003

110/180

112/180

Favours group TFCBT

0.5

0.7

1

1.5

2

0.98[0.83,1.16]

Favours group non-
TFCBT

Comparison 12.   Other therapies vs waitlist/usual care

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

1 Severity of PTSD symptoms -
clinician

2 Leaving the study early due
to any reason

3 Severity of PTSD symptoms -
self report

4 Depression

5 Anxiety - Self report

6 PTSD diagnosis after treat-
ment

3

4

2

3

4

4

112

211

132

112

193

210

Std. Mean Difference (IV, Fixed,
95% CI)

-0.58 [-0.96, -0.20]

Risk Ratio (M-H, Fixed, 95% CI)

2.45 [0.99, 6.10]

Std. Mean Difference (IV, Fixed,
95% CI)

-0.61 [-0.98, -0.24]

Std. Mean Difference (IV, Fixed,
95% CI)

-0.45 [-0.83, -0.07]

Std. Mean Difference (IV, Fixed,
95% CI)

-0.52 [-0.82, -0.22]

Risk Ratio (M-H, Random, 95% CI)

0.80 [0.61, 1.05]

Analysis 12.1.   Comparison 12 Other therapies vs waitlist/
usual care, Outcome 1 Severity of PTSD symptoms - clinician.

Study or subgroup

Other Therapy

Waitlist/Usual Care

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Fixed, 95% CI

Blanchard 2003

Foa 1991

McDonagh 2005

27

11

20

40.1 (25.7)

18.1 (7.1)

44.9 (22.1)

24

10

20

54 (25.9)

19.5 (7.2)

62.5 (17)

46.21%

19.67%

34.13%

Fixed, 95% CI

-0.53[-1.09,0.03]

-0.19[-1.05,0.67]

-0.87[-1.53,-0.22]

Favours other therapies

-4

-2

0

2

4

Favours WL/UC

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

158

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Study or subgroup

Other Therapy

Waitlist/Usual Care

Std. Mean Difference

Weight

Std. Mean Difference

Total ***

Mean(SD)

N

58

N

54

Heterogeneity: Tau2=0; Chi2=1.61, df=2(P=0.45); I2=0%

Test for overall effect: Z=2.99(P=0)

Mean(SD)

Fixed, 95% CI

Fixed, 95% CI

100%

-0.58[-0.96,-0.2]

Favours other therapies

-4

-2

0

2

4

Favours WL/UC

Analysis 12.2.   Comparison 12 Other therapies vs waitlist/
usual care, Outcome 2 Leaving the study early due to any reason.

Study or subgroup

Other Therapy

wait list

n/N

n/N

Risk Ratio

M-H, Fixed, 95% CI

Weight

Risk Ratio

M-H, Fixed, 95% CI

Blanchard 2003

Brom 1989

Foa 1991

McDonagh 2005

Total (95% CI)

9/36

8/58

3/14

2/22

130

1/25

1/23

1/10

3/23

81

Total events: 22 (Other Therapy), 6 (wait list)

Heterogeneity: Tau2=0; Chi2=3.04, df=3(P=0.39); I2=1.42%

Test for overall effect: Z=1.93(P=0.05)

17.58%

21.34%

17.38%

43.7%

6.25[0.84,46.27]

3.17[0.42,23.96]

2.14[0.26,17.72]

0.7[0.13,3.78]

100%

2.45[0.99,6.1]

Favours other therapies

0.01

0.1

1

10

100

Favours WL/UC

Analysis 12.3.   Comparison 12 Other therapies vs waitlist/
usual care, Outcome 3 Severity of PTSD symptoms - self report.

Study or subgroup

Other Therapy

Wait list

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Fixed, 95% CI

Blanchard 2003

Brom 1989

Total ***

27.4 (19.1)

33.2 (20)

27

58

85

36.6 (17.2)

46.5 (15.2)

24

23

47

Heterogeneity: Tau2=0; Chi2=0.29, df=1(P=0.59); I2=0%

Test for overall effect: Z=3.23(P=0)

44.01%

55.99%

Fixed, 95% CI

-0.5[-1.06,0.06]

-0.7[-1.2,-0.21]

100%

-0.61[-0.98,-0.24]

Favours other therapies

-4

-2

0

2

4

Favours WL/UC

Analysis 12.4.   Comparison 12 Other therapies vs waitlist/usual care, Outcome 4 Depression.

Study or subgroup

Other Therapy

Waitlist/Usual Care

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Fixed, 95% CI

Fixed, 95% CI

Blanchard 2003

Foa 1991

McDonagh 2005

Total ***

19.7 (12.1)

15.4 (14)

10.4 (10.2)

27

11

20

58

24

10

20

54

24 (12.1)

15.4 (9.7)

20.1 (12.1)

Heterogeneity: Tau2=0; Chi2=2.62, df=2(P=0.27); I2=23.74%

46.59%

19.52%

33.88%

-0.35[-0.9,0.2]

-0[-0.86,0.85]

-0.85[-1.5,-0.2]

100%

-0.45[-0.83,-0.07]

Favours other therapies

-4

-2

0

2

4

Favours WL/UC

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

159

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Study or subgroup

Other Therapy

Waitlist/Usual Care

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Fixed, 95% CI

Fixed, 95% CI

Test for overall effect: Z=2.34(P=0.02)

Favours other therapies

-4

-2

0

2

4

Favours WL/UC

Analysis 12.5.   Comparison 12 Other therapies vs waitlist/usual care, Outcome 5 Anxiety - Self report.

Study or subgroup

Other Therapy

Wait list

Std. Mean Difference

Weight

Std. Mean Difference

N

Mean(SD)

N

Mean(SD)

Fixed, 95% CI

Fixed, 95% CI

Blanchard 2003

Brom 1989

Foa 1991

McDonagh 2005

Total ***

50.7 (12.6)

42.6 (14.5)

43.7 (16.8)

45.6 (11)

27

58

11

20

116

24

23

10

20

77

58.8 (12.3)

48.2 (13)

49.9 (13.8)

52.7 (10.1)

Heterogeneity: Tau2=0; Chi2=0.7, df=3(P=0.87); I2=0%

Test for overall effect: Z=3.41(P=0)

28.14%

37.85%

11.97%

22.04%

-0.64[-1.2,-0.08]

-0.4[-0.88,0.09]

-0.38[-1.25,0.48]

-0.66[-1.3,-0.02]

100%

-0.52[-0.82,-0.22]

Favours other therapies

-4

-2

0

2

4

Favours WL/UC

Analysis 12.6.   Comparison 12 Other therapies vs waitlist/usual care, Outcome 6 PTSD diagnosis after treatment.

Study or subgroup

Other Therapy

wait list

Risk Ratio

Weight

Risk Ratio

n/N

n/N

M-H, Random, 95% CI

M-H, Random, 95% CI

Blanchard 2003

Brom 1989

Foa 1991

McDonagh 2005

Total (95% CI)

21/36

24/58

13/14

15/22

130

18/25

17/23

9/10

19/22

80

Total events: 73 (Other Therapy), 63 (wait list)

Heterogeneity: Tau2=0.05; Chi2=8.34, df=3(P=0.04); I2=64.04%

Test for overall effect: Z=1.61(P=0.11)

23.14%

22.01%

29.65%

25.2%

0.81[0.56,1.17]

0.56[0.38,0.83]

1.03[0.8,1.33]

0.79[0.57,1.1]

100%

0.8[0.61,1.05]

Favours other therapies

0.2

0.5

1

2

5

Favours WL/UC

Comparison 13.   Group non-TFCBT vs waitlist/usual care

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

1 Leaving the study early for
any reason

2 Severity of PTSD symptoms -
self report

3 Severity of PTSD symptoms -
self report 1 - 4 months

1

1

1

Risk Ratio (M-H, Fixed, 95% CI)

Totals not selected

Std. Mean Difference (IV, Fixed,
95% CI)

Totals not selected

Std. Mean Difference (IV, Fixed,
95% CI)

Totals not selected

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

160

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

4 Depression

5 Depression - 1 - 4 months

1

1

Std. Mean Difference (IV, Fixed,
95% CI)

Totals not selected

Std. Mean Difference (IV, Fixed,
95% CI)

Totals not selected

Analysis 13.1.   Comparison 13 Group non-TFCBT vs waitlist/
usual care, Outcome 1 Leaving the study early for any reason.

Study or subgroup

Group Therapy

Group Therapy

Risk Ratio

Risk Ratio

n/N

n/N

M-H, Fixed, 95% CI

M-H, Fixed, 95% CI

Kearney 2013

2/25

1/22

1.76[0.17,18.11]

Favours group non-TFCBT

0.05

0.2

1

5

20

Favours WL/UC

Analysis 13.2.   Comparison 13 Group non-TFCBT vs waitlist/
usual care, Outcome 2 Severity of PTSD symptoms - self report.

Study or subgroup

Group Therapy

Group Therapy

Std. Mean Difference

Std. Mean Difference

Kearney 2013

N

25

Mean(SD)

52.5 (13)

N

22

Mean(SD)

58.5 (11)

Fixed, 95% CI

Fixed, 95% CI

-0.49[-1.07,0.09]

Favours group non-TFCBT

-4

-2

0

2

4

Favours WL/UC

Analysis 13.3.   Comparison 13 Group non-TFCBT vs waitlist/usual
care, Outcome 3 Severity of PTSD symptoms - self report 1 - 4 months.

Study or subgroup

Group Therapy

Group Therapy

Std. Mean Difference

Std. Mean Difference

Kearney 2013

N

25

Mean(SD)

54.4 (15)

N

22

Mean(SD)

60.2 (13)

Fixed, 95% CI

Fixed, 95% CI

-0.4[-0.98,0.18]

Favours group non-TFCBT

-4

-2

0

2

4

Favours WL/UC

Analysis 13.4.   Comparison 13 Group non-TFCBT vs waitlist/usual care, Outcome 4 Depression.

Study or subgroup

Group non-TFCBT

Waillist/UC

Std. Mean Difference

Std. Mean Difference

Kearney 2013

N

25

Mean(SD)

12 (6)

N

22

Mean(SD)

12.4 (6)

Fixed, 95% CI

Fixed, 95% CI

-0.06[-0.64,0.51]

Favours group non-TFCBT

-4

-2

0

2

4

Favours WL/UC

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

161

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 13.5.   Comparison 13 Group non-TFCBT vs waitlist/usual care, Outcome 5 Depression - 1 - 4 months.

Study or subgroup

Group non-TFCBT

Waillist/UC

Std. Mean Difference

Std. Mean Difference

Kearney 2013

N

25

Mean(SD)

15.5 (5)

N

22

Mean(SD)

15.6 (5)

Fixed, 95% CI

Fixed, 95% CI

-0.03[-0.6,0.54]

Favours group non-TFCBT

-4

-2

0

2

4

Favours WL/UC

W H A T ' S   N E W

Date

Event

Description

26 August 2015

Amended

Corrected typographical error in results section.

H I S T O R Y

Protocol first published: Issue 4, 2001
Review first published: Issue 2, 2005

Date

Event

13 December 2013

New citation required but conclusions
have not changed

Description

Major update

13 December 2013

New search has been performed

Updated to include studies completed by 12th April 2013.

5 November 2008

New citation required and conclusions
have changed

Substantive amendment

C O N T R I B U T I O N S   O F   A U T H O R S

JIB has been involved in the identification of studies, quality appraisal, data entry, analysis and writing of the review.
NPR has been involved in quality appraisal.
MA has been involved in the identification of studies, quality appraisal and writing of the review.
RC has been involved in the identification of studies, quality appraisal and data entry.
CL has been involved in the identification of studies, quality appraisal, data entry, analysis and writing of the review.

D E C L A R A T I O N S   O F   I N T E R E S T

None known.

I N D E X   T E R M S

Medical Subject Headings (MeSH)

Behavior Therapy  [methods];  Chronic Disease;  Cognitive Behavioral Therapy  [methods];  Psychotherapy  [*methods];  Psychotherapy,
Group;  Randomized Controlled Trials as Topic;  Stress Disorders, Post-Traumatic  [psychology]  [*therapy]

MeSH check words

Adult; Humans

Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

162
